protein_ID,ASCA_PC1_loadings,ASCA_PC_threshold_pass,ClusterColor,SimpleClusterColor,UniprotID,Protein_names,Protein_fams,Gene_names,GO_terms,GO_bp_IDs,sig_bp_GO,sig_bp_GOslim
CHOYP_LOC100892181.1.1.m.49777,0.0384745869101556,Yes,darkorange3,orange,Q9ET66,Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364),CRISP family,Pi16 Cripi,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],GO:0005615; GO:0030414; GO:0061052,GO:0061052,cell differentiation; growth; anatomical structure development
CHOYP_ADD.3.5.m.17639,0.0371223448330728,Yes,darkorange3,orange,Q02645,Protein hu-li tai shao (Adducin-like protein),Aldolase class II family; Adducin subfamily,hts CG9325,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793; GO:0098794,GO:0048135,reproduction; cell proliferation; cell differentiation; anatomical structure development
CHOYP_SMP_012720.1.2.m.31152,0.0467349861475229,Yes,darkorange3,orange,Q9WUM3,Coronin-1B (Coronin-2),WD repeat coronin family,Coro1b,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0008092; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0044877; GO:0048471; GO:0051015; GO:0051017; GO:0070528; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000393; GO:2000394,GO:0035767; GO:0070528,signal transduction; locomotion; cell motility
CHOYP_LOC100377392.2.4.m.21904,0.0330433189374123,Yes,darkorange3,orange,P05539,Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin],Fibrillar collagen family,Col2a1,collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; notochord development [GO:0030903]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to X-ray [GO:0010165]; skeletal system development [GO:0001501],GO:0001501; GO:0002062; GO:0003417; GO:0005201; GO:0005581; GO:0005585; GO:0005615; GO:0005737; GO:0009612; GO:0010165; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0046872; GO:0051216; GO:0060351; GO:0062023; GO:0071260; GO:0071300; GO:0071306; GO:0071316; GO:0071356; GO:0071374; GO:0071375; GO:0071774; GO:1990314,GO:0030903,embryo development; anatomical structure development
CHOYP_BRAFLDRAFT_118867.1.1.m.27944,-0.0286435598722,Yes,darkorange3,orange,P26221,Endoglucanase E-4 (EC 3.2.1.4) (Cellulase E-4) (Cellulase E4) (Endo-1;4-beta-glucanase E-4),Glycosyl hydrolase 9 (cellulase E) family,celD,cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],GO:0008810; GO:0030245; GO:0030248,GO:0030245,carbohydrate metabolic process; catabolic process
CHOYP_DMOJ_GI18492.1.1.m.8903,0.0424269913121694,Yes,darkorange3,orange,Q95ZJ1,Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),Glycosyltransferase 2 family; GalNAc-T subfamily,gly-5 Y39E4B.12,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018243; GO:0030246; GO:0046872,GO:0018243,cellular protein modification process; biosynthetic process
CHOYP_LOC100375029.6.10.m.36981,0.033597218426485,Yes,darkorange3,orange,O17389,Thymosin beta (Tetrathymosin beta),Thymosin beta family,tth-1 F08F1.8,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054,GO:0007015,cytoskeleton organization
CHOYP_LOC100375029.8.10.m.60484,-0.0399099256208671,Yes,darkorange3,orange,O17389,Thymosin beta (Tetrathymosin beta),Thymosin beta family,tth-1 F08F1.8,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054,GO:0007015,cytoskeleton organization
CHOYP_LOC100367535.1.2.m.4730,0.0301453954728997,Yes,darkorange3,orange,Q8R238,Serine dehydratase-like (EC 4.3.1.17) (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (SDH),Serine/threonine dehydratase family,Sdsl Sds,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],GO:0003941; GO:0004794; GO:0005739; GO:0006565; GO:0006567; GO:0042802,GO:0006567,cellular amino acid metabolic process; catabolic process; small molecule metabolic process
CHOYP_LOC100710578.1.1.m.62426,0.0425144191707291,Yes,darkorange3,orange,Q29448,Hydroxymethylglutaryl-CoA lyase; mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase),HMG-CoA lyase family,HMGCL,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262],GO:0000287; GO:0004419; GO:0005102; GO:0005739; GO:0005759; GO:0005777; GO:0006552; GO:0006629; GO:0007005; GO:0030145; GO:0042803; GO:0046872; GO:0046951; GO:0051262,GO:0006552,cellular amino acid metabolic process; catabolic process; small molecule metabolic process
CHOYP_LOC101063838.1.1.m.50540,0.0305057914800787,Yes,darkorange3,orange,Q5BJI9,Probable signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),SPCS2 family,spcs2 zgc:110364,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0031090; GO:0045047,GO:0006465,cellular nitrogen compound metabolic process; protein maturation
CHOYP_contig_044078.m.50900,0.0443280051397942,Yes,darkorange3,orange,Q01484,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),,ANK2 ANKB,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259,GO:0003283; GO:0010881; GO:0033292; GO:0060307; GO:0086005; GO:0086091; GO:0098910; GO:1901018,circulatory system process; transport; plasma membrane organization; signal transduction; cell-cell signaling; cell differentiation; homeostatic process; anatomical structure development; transmembrane transport; membrane organization
CHOYP_LOC100367954.2.2.m.66596,0.0330352679700459,Yes,darkorange3,orange,E9Q3C1,C2 domain-containing protein 2,,C2cd2 Kiaa4045,integral component of membrane [GO:0016021],GO:0016021,NA,NA
CHOYP_FABP6.2.2.m.59518,-0.0270908127134586,Yes,darkorange3,orange,O01812,Fatty acid-binding protein homolog 6,Calycin superfamily; Fatty-acid binding protein (FABP) family,lbp-6 W02D3.5,lipid binding [GO:0008289],GO:0008289,NA,NA
CHOYP_LOC100373522.2.5.m.19698,0.0490810796688082,Yes,darkorange3,orange,Q95230,Sperm surface protein Sp17 (Sperm autoantigenic protein 17),,SPA17 SP17,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],GO:0007339; GO:0016020,NA,NA
CHOYP_LOC101065149.1.1.m.49591,0.041130409239496,Yes,darkorange3,orange,Q6P7S1,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase),Acid ceramidase family,Asah1,lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; response to organic substance [GO:0010033],GO:0005764; GO:0006629; GO:0010033; GO:0016810; GO:0017040; GO:0030324; GO:0102121,NA,NA
CHOYP_NEMVEDRAFT_V1G154974.1.1.m.44261,0.0366644733861516,Yes,darkorange3,orange,Q9Y1A3,Mitochondrial import inner membrane translocase subunit Tim8,Small Tim family,Tim8 CG1728,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626],GO:0005739; GO:0005744; GO:0005758; GO:0006626; GO:0015450; GO:0046872; GO:0072321,NA,NA
CHOYP_F10A1.4.4.m.44752,0.0313031920060396,Yes,darkorange3,orange,Q5ZLF0,Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog),FAM10 family,ST13 FAM10A1 RCJMB04_6h13,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],GO:0005737; GO:0046983; GO:0051085,NA,NA
CHOYP_SSU72.1.1.m.2079,0.0308484717417427,Yes,darkorange3,orange,Q5ZJQ7,RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16),SSU72 phosphatase family,SSU72 RCJMB04_16f24,cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369],GO:0005737; GO:0005847; GO:0006369; GO:0006378; GO:0008420; GO:0070940,NA,NA
CHOYP_LOC584270.1.1.m.49225,0.0342410727824284,Yes,darkorange3,orange,Q9NX08,COMM domain-containing protein 8,,COMMD8 MDS022,cytosol [GO:0005829]; nucleoplasm [GO:0005654],GO:0005654; GO:0005829,NA,NA
CHOYP_LOC100369290.1.1.m.66929,0.0410383633240411,Yes,darkorange3,orange,A4IF78,Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8),TNFAIP8 family,TNFAIP8,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065],GO:0005654; GO:0005737; GO:0043027; GO:0043065,NA,NA
CHOYP_MOB1.1.1.m.19452,0.03065938692188,Yes,darkorange3,orange,Q95RA8,MOB kinase activator-like 1 (Mob as tumor suppressor protein 1) (Dmob1) (Mps one binder kinase activator-like 1),MOB1/phocein family,mats CG13852,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165],GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0007059; GO:0007165; GO:0007275; GO:0008283; GO:0019901; GO:0030295; GO:0030707; GO:0035329; GO:0046872,NA,NA
CHOYP_QPCT.1.1.m.38977,0.0335783781504979,Yes,darkorange3,orange,Q16769,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (sQC) (Glutaminyl-tRNA cyclotransferase) (Glutamyl cyclase) (EC),Glutaminyl-peptide cyclotransferase family,QPCT,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],GO:0005576; GO:0006464; GO:0008270; GO:0016603; GO:0017186; GO:0035580; GO:0043312; GO:0070062; GO:1904724; GO:1904813,NA,NA
CHOYP_ACT.23.27.m.58454,-0.0446527872630919,Yes,darkorange3,orange,O17320,Actin,Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_LOC752782.1.1.m.53937,0.048493091032282,Yes,darkorange3,orange,O17320,Actin,Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_BRAFLDRAFT_208436.28.32.m.61328,0.0359931571855254,Yes,darkorange3,orange,Q96MM6,Heat shock 70 kDa protein 12B,Heat shock protein 70 family,HSPA12B C20orf60,ATP binding [GO:0005524],GO:0005524,NA,NA
CHOYP_NF70.1.4.m.31159,0.0322165200520798,Yes,darkorange3,orange,Q01240,60 kDa neurofilament protein (NF60),Intermediate filament family,,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],GO:0005198; GO:0005882,NA,NA
CHOYP_BRAFLDRAFT_284774.2.3.m.15260,0.0704176209644959,Yes,darkorange3,orange,P80895,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),Methyltransferase superfamily; L-isoaspartyl/D-aspartyl protein methyltransferase family,PCMT1,cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],GO:0004719; GO:0005737,NA,NA
CHOYP_CLK2.1.1.m.3081,0.0322135811002148,Yes,darkorange3,orange,P49760,Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2),Protein kinase superfamily; CMGC Ser/Thr protein kinase family; Lammer subfamily,CLK2,nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777,NA,NA
CHOYP_GPX1.1.4.m.11300,0.0416062538913523,Yes,darkorange3,orange,Q8MJ14,Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase),Glutathione peroxidase family,GPX1,cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],GO:0004602; GO:0005737; GO:0006979,NA,NA
CHOYP_LOC592142.4.9.m.49474,0.0383919068787085,Yes,darkorange3,orange,C3YWU0,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Glycosyl hydrolase 29 family,BRAFLDRAFT_56888,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,NA,NA
CHOYP_RPS24.1.8.m.571,0.0315352226691116,Yes,darkorange3,orange,O42387,40S ribosomal protein S24,Eukaryotic ribosomal protein eS24 family,rps24,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,NA,NA
CHOYP_LOC100730443.1.1.m.57698,0.0436145546105187,Yes,darkorange3,orange,Q4V348,Zinc finger protein 658B,Krueppel C2H2-type zinc-finger protein family,ZNF658B,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],GO:0003677; GO:0005634; GO:0046872,NA,NA
CHOYP_LOC660510.1.1.m.56258,0.044670005895181,Yes,darkorange3,orange,Q8BHR2,Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)],ENOX family,Enox1,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],GO:0003676; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0016491,NA,NA
CHOYP_DSIM_GD24875.1.1.m.66201,0.0303368277715688,Yes,darkorange3,orange,Q3T149,Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27),Small heat shock protein (HSP20) family,HSPB1 HSP27,axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932],GO:0001932; GO:0005634; GO:0005737; GO:0005819; GO:0042802; GO:0042803; GO:0044183; GO:0061077; GO:0099641; GO:1904115,NA,NA
CHOYP_LOC576797.1.1.m.8986,0.0369697790528176,Yes,darkorange3,orange,O43822,Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2),,CFAP410 C21orf2 LRRC76,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; DNA damage response; detection of DNA damage [GO:0042769]; motile cilium assembly [GO:0044458]; regulation of cell shape [GO:0008360],GO:0001750; GO:0005737; GO:0005739; GO:0005886; GO:0005929; GO:0007010; GO:0008360; GO:0031514; GO:0032391; GO:0036064; GO:0042769; GO:0044458; GO:0060271; GO:0060294,NA,NA
CHOYP_contig_009176.m.10652,0.0374665555063314,Yes,darkorange3,orange,Q9NR12,PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) (Protein enigma),,PDLIM7 ENIGMA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898],GO:0001503; GO:0001725; GO:0001726; GO:0005634; GO:0005829; GO:0005913; GO:0005925; GO:0006898; GO:0007411; GO:0015629; GO:0030036; GO:0045669; GO:0046872,NA,NA
CHOYP_ISCW_ISCW008316.1.3.m.11997,0.0364347445620946,Yes,darkorange3,orange,Q8MQI6,Transcription elongation factor 1 homolog,ELOF1 family,CG40228,transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368],GO:0000993; GO:0006368; GO:0008023; GO:0046872; GO:0048096,NA,NA
CHOYP_LOC100696604.1.1.m.40638,0.0487399307286711,Yes,darkorange3,orange,Q5M9G3,Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (RNA granule protein 105),Caprin family,Caprin1 Gpiap1 Rng105,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],GO:0000932; GO:0003723; GO:0005829; GO:0010494; GO:0017148; GO:0030425; GO:0050775; GO:0061003; GO:0098794; GO:0098978,NA,NA
CHOYP_LOC100876515.1.2.m.37063,0.0340313868691063,Yes,darkorange3,orange,Q8NF91,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),Nesprin family,SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292,NA,NA
CHOYP_CNOT1.1.1.m.12106,0.0337483662398224,Yes,darkorange3,orange,O54879,High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4),HMGB family,Hmgb3 Hmg2a Hmg4,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000400; GO:0000790; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0032392; GO:0045087; GO:0045089; GO:0045578; GO:0045638; GO:0045944,NA,NA
CHOYP_KPYK.2.4.m.19753,0.0440683374397851,Yes,darkorange3,orange,P00548,Pyruvate kinase PKM (EC 2.7.1.40),Pyruvate kinase family,PKM,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096],GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006096; GO:0016301; GO:0030955; GO:0032869,NA,NA
CHOYP_LOC100120260.1.1.m.41888,0.0317054443837385,Yes,darkorange3,orange,Q62685,Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) (RLD-1),Nuclear hormone receptor family; NR1 subfamily,Nr1h3 Lxra,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of nuclear receptor transcription coactivator activity [GO:2000325],GO:0000122; GO:0000976; GO:0000977; GO:0000981; GO:0003707; GO:0003713; GO:0005634; GO:0005737; GO:0006629; GO:0007275; GO:0008134; GO:0008270; GO:0008286; GO:0010875; GO:0030154; GO:0030374; GO:0038023; GO:0042632; GO:0043565; GO:0045893; GO:0045944; GO:0046965; GO:0046982; GO:0050728; GO:0055088; GO:0071222; GO:0090575; GO:0120163; GO:2000325,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.1.2.m.46431,0.0397212046729513,Yes,darkorange3,orange,P74148,Universal stress protein Sll1388 (USP Sll1388),Universal stress protein A family,sll1388,,,NA,NA
CHOYP_TPM.17.19.m.63919,-0.038184099561342,Yes,darkorange3,orange,Q25145,Tropomyosin,Tropomyosin family,,,,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.5.6.m.34525,0.046574543792385,Yes,darkorange3,orange,O07552,Stress response protein NhaX,Universal stress protein A family,nhaX yheK BSU09690,,,NA,NA
CHOYP_LOC101173335.4.4.m.49816,-0.0375031059419185,Yes,darkorange3,orange,Q24799,Myophilin,Calponin family,,,,NA,NA
CHOYP_BRAFLDRAFT_118602.3.5.m.19626,0.0302841460573674,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126750.1.1.m.40768,0.0387155972089783,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_220356.5.6.m.38505,0.0332496963063462,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4265,0.0323176953364577,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000189.m.198,0.0314069232279591,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002417.m.2661,0.0321775587626591,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005396.m.6126,0.0349214431822852,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010154.m.11827,0.0585189920159753,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016120.m.18916,0.0310344813475314,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016292.m.19158,0.032519365417585,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016854.m.19834,0.0326660332169416,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033740.m.38360,0.0425084469421515,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038550.m.43669,0.0516837664040218,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039208.m.44410,0.037890069122054,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041288.m.47081,0.0326050896617945,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043280.m.49983,0.0531462297749919,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043576.m.50359,0.0448894740070202,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049548.m.58834,0.0396735000943017,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EPDR2.1.1.m.33988,0.0372922317856208,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRF.2.4.m.37051,0.0361145981845987,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.2.2.m.17779,0.0480941614804913,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW000210.4.4.m.38490,0.0475391790417226,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100205674.1.1.m.5810,0.0534299884311217,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100635182.1.1.m.5368,0.0464996716166504,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100705966.1.1.m.45957,0.030588619364483,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.1.9.m.547,0.0376916622500993,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586122.3.4.m.63155,0.0344320729127407,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G243463.1.1.m.49871,0.0368495118116784,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RSSA.3.10.m.22114,0.0325632805350421,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SREC2.9.9.m.66799,0.0331986940618254,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEL_0889.1.2.m.168,0.0313244767535352,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI33.5.8.m.56889,0.0335253995893339,Yes,darkorange3,orange,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_114350.1.1.m.14176,-0.034645955222402,Yes,cyan4,dark teal,A6H791,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A),Class I-like SAM-binding methyltransferase superfamily; TRM61 family,TRMT61A TRM61,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],GO:0005634; GO:0016429; GO:0030488; GO:0031515; GO:0061953; GO:0080009,GO:0080009,cellular nitrogen compound metabolic process
CHOYP_MET14.1.1.m.5073,-0.0344132533299315,Yes,cyan4,dark teal,Q6NZ22,N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14),MT-A70-like family,mettl14 zgc:77296,nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0061157; GO:0080009,GO:0080009,cellular nitrogen compound metabolic process
CHOYP_PCDH9.5.5.m.59488,-0.0417370566959767,Yes,cyan4,dark teal,O95453,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease),CAF1 family,PARN DAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669],GO:0000175; GO:0000184; GO:0000289; GO:0000495; GO:0003723; GO:0003730; GO:0004518; GO:0004535; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0007292; GO:0009451; GO:0010587; GO:0019901; GO:0032212; GO:0043169; GO:0043488; GO:0046872; GO:0051973; GO:0070034; GO:0071051; GO:0090503; GO:0090669; GO:0110008; GO:1904872,GO:0071051,cellular nitrogen compound metabolic process
CHOYP_NRDC.1.1.m.28526,-0.0337606559708029,Yes,cyan4,dark teal,Q8BHG1,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Peptidase M16 family,Nrdc Nrd1,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548],GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163,GO:0052548,NA
CHOYP_BRAFLDRAFT_84054.1.2.m.8523,-0.0315993633380111,Yes,cyan4,dark teal,Q4R918,Kinesin-like protein KIF25,TRAFAC class myosin-kinesin ATPase superfamily; Kinesin family,KIF25 QtsA-10923,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_BRAFLDRAFT_278918.4.5.m.39356,-0.0581339124653545,Yes,cyan4,dark teal,Q8MP06,Senecionine N-oxygenase (SNO) (EC 1.14.13.101),FMO family,sno1,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_NEMVEDRAFT_V1G235461.1.1.m.28341,-0.0294276093394909,Yes,cyan4,dark teal,Q8MP06,Senecionine N-oxygenase (SNO) (EC 1.14.13.101),FMO family,sno1,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],GO:0004499; GO:0005576; GO:0009820; GO:0033784; GO:0050660; GO:0050661; GO:0051289; GO:0055114,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_EXOS3.1.1.m.10596,-0.0269799167434429,Yes,cyan4,dark teal,Q9NQT5,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),RRP40 family,EXOSC3 RRP40 CGI-102,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051,GO:0043928; GO:0071051,catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process
CHOYP_LOC100693418.2.2.m.56971,-0.0281079062080026,Yes,cyan4,dark teal,P32320,Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase),Cytidine and deoxycytidylate deaminase family,CDA CDD,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytidine deaminase activity [GO:0004126]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine-containing compound salvage [GO:0008655],GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042803; GO:0043097; GO:0043312; GO:0045980; GO:0051289; GO:1904724; GO:1904813,GO:0043312; GO:0051289,immune system process; transport; vesicle-mediated transport; cellular component assembly; protein-containing complex assembly
CHOYP_LOC100561410.1.1.m.58687,-0.0275608315101422,Yes,cyan4,dark teal,Q9P000,COMM domain-containing protein 9,,COMMD9 HSPC166,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; cholesterol homeostasis [GO:0042632]; neutrophil degranulation [GO:0043312]; sodium ion transport [GO:0006814],GO:0005576; GO:0005634; GO:0005794; GO:0005829; GO:0006814; GO:0034774; GO:0042632; GO:0043312; GO:1904813,GO:0043312,immune system process; transport; vesicle-mediated transport
CHOYP_MICPUN_58704.1.1.m.54967,-0.0337416857315374,Yes,cyan4,dark teal,Q9Y5Z4,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),HEBP family,HEBP2 C6orf34 SOUL,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062,GO:0035794; GO:0043312,immune system process; transport; mitochondrion organization; vesicle-mediated transport; membrane organization
CHOYP_VOLCADRAFT_89567.1.1.m.27272,-0.0317389686450022,Yes,cyan4,dark teal,Q9Y5Z4,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),HEBP family,HEBP2 C6orf34 SOUL,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062,GO:0035794; GO:0043312,immune system process; transport; mitochondrion organization; vesicle-mediated transport; membrane organization
CHOYP_BRAFLDRAFT_249506.2.2.m.60314,-0.0328649706517197,Yes,cyan4,dark teal,Q6Q899,Probable ATP-dependent RNA helicase DDX58 (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Helicase family; RLR subfamily,Ddx58,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],GO:0002230; GO:0002735; GO:0003690; GO:0003725; GO:0003727; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0035549; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:1902741; GO:1904469; GO:2000778,GO:0032757,NA
CHOYP_C10.1.2.m.23678,-0.0410007069019096,Yes,cyan4,dark teal,O35127,Protein C10,UPF0456 family,Grcc10 C10,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678],GO:0005737; GO:0009791; GO:0014819; GO:0016607; GO:0021540; GO:0021678; GO:0036343; GO:0048593; GO:0050890,GO:0014819,NA
CHOYP_ANK3.7.9.m.43272,-0.0259852366933288,Yes,cyan4,dark teal,Q01484,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),,ANK2 ANKB,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259,GO:0010881; GO:0051597,circulatory system process; transport; signal transduction; homeostatic process; transmembrane transport
CHOYP_GSTO1.1.2.m.14745,-0.0415848172401346,Yes,cyan4,dark teal,P78417,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),GST superfamily; Omega family,GSTO1 GSTTLP28,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],GO:0004364; GO:0005737; GO:0005829; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0032259; GO:0035722; GO:0042178; GO:0045174; GO:0050610; GO:0055114; GO:0060315; GO:0060316; GO:0070062; GO:0071243; GO:1901687,GO:0010881,circulatory system process; transport; signal transduction; homeostatic process; transmembrane transport
CHOYP_BRAFLDRAFT_206907.11.11.m.60959,-0.028827848252879,Yes,cyan4,dark teal,P50429,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Sulfatase family,Arsb As1 As1-s,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0097065,GO:0009268; GO:0051597; GO:0061580,locomotion; cell motility
CHOYP_BRAFLDRAFT_246447.1.1.m.30255,-0.0264885805852458,Yes,cyan4,dark teal,P50430,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Sulfatase family,Arsb,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],GO:0003943; GO:0004065; GO:0005739; GO:0005764; GO:0005791; GO:0005794; GO:0006914; GO:0007417; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0043627; GO:0046872; GO:0051597; GO:0061580,GO:0009268; GO:0051597; GO:0061580,locomotion; cell motility
CHOYP_LOC584364.2.2.m.57790,-0.0363617026110848,Yes,cyan4,dark teal,P02553,Tubulin alpha chain (Fragment),Tubulin family,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,GO:0007017,NA
CHOYP_TBA.1.6.m.12217,-0.0303098063827762,Yes,cyan4,dark teal,P02553,Tubulin alpha chain (Fragment),Tubulin family,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,GO:0007017,NA
CHOYP_TBA.5.6.m.37448,-0.0347464878041054,Yes,cyan4,dark teal,P02553,Tubulin alpha chain (Fragment),Tubulin family,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,GO:0007017,NA
CHOYP_TBA1A.2.4.m.19573,-0.0425898060345994,Yes,cyan4,dark teal,P09645,Tubulin alpha-8 chain (Fragment),Tubulin family,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,GO:0007017,NA
CHOYP_LOC100909243.1.1.m.22728,-0.0271314445115463,Yes,cyan4,dark teal,Q99M87,DnaJ homolog subfamily A member 3; mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog),,Dnaja3 Tid1,actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006469; GO:0006915; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340; GO:0106137,GO:0006919; GO:0043124,signal transduction; cell death
CHOYP_BRAFLDRAFT_80064.1.1.m.40175,-0.0274182546916032,Yes,cyan4,dark teal,Q13546,Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1),Protein kinase superfamily; TKL Ser/Thr protein kinase family,RIPK1 RIP RIP1,cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular protein catabolic process [GO:0044257]; cellular response to growth factor stimulus [GO:0071363]; cellular response to tumor necrosis factor [GO:0071356]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway [GO:0097191]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; MAPK cascade [GO:0000165]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ATP:ADP antiporter activity [GO:0070926]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; toll-like receptor 3 signaling pathway [GO:0034138]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032],GO:0000165; GO:0001934; GO:0002756; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0007249; GO:0007257; GO:0010008; GO:0010803; GO:0010940; GO:0016032; GO:0016579; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0033209; GO:0034138; GO:0034612; GO:0035666; GO:0036289; GO:0042802; GO:0043065; GO:0043068; GO:0043123; GO:0043124; GO:0043235; GO:0044257; GO:0044877; GO:0045121; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0051092; GO:0051260; GO:0051291; GO:0060545; GO:0070231; GO:0070266; GO:0070513; GO:0070926; GO:0071356; GO:0071363; GO:0071550; GO:0097190; GO:0097191; GO:0097342; GO:0097343; GO:0097527; GO:1901026; GO:1902041; GO:1902042; GO:1905206; GO:1990000; GO:2000379; GO:2001237; GO:2001238; GO:2001240,GO:0006919; GO:0032757; GO:0043124,signal transduction; cell death
CHOYP_LOC585972.1.1.m.25356,-0.025975101329358,Yes,cyan4,dark teal,Q0P5A2,2-methoxy-6-polyprenyl-1;4-benzoquinol methylase; mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5),Class I-like SAM-binding methyltransferase superfamily; MenG/UbiE family,COQ5,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1;4-benzoquinone methylase activity [GO:0043333]; ubiquinone biosynthetic process [GO:0006744],GO:0005739; GO:0005759; GO:0006744; GO:0031314; GO:0032991; GO:0043333,GO:0006744,biosynthetic process; small molecule metabolic process; cofactor metabolic process
CHOYP_COQ9.1.2.m.4620,-0.0359328814340343,Yes,cyan4,dark teal,O75208,Ubiquinone biosynthesis protein COQ9; mitochondrial,COQ9 family,COQ9 C16orf49 HSPC326 PSEC0129,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744],GO:0005739; GO:0005743; GO:0006120; GO:0006744; GO:0008289; GO:0042803,GO:0006744,biosynthetic process; small molecule metabolic process; cofactor metabolic process
CHOYP_LOC100369712.1.1.m.64282,-0.0272508088988294,Yes,cyan4,dark teal,O15116,U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm),SnRNP Sm proteins family,LSM1 CASM,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Lsm1-7-Pat1 complex [GO:1990726]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827],GO:0000290; GO:0000339; GO:0000375; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005845; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0030424; GO:0030425; GO:0036002; GO:0043025; GO:0043928; GO:0045665; GO:0071044; GO:1990124; GO:1990726,GO:0000290; GO:0043928,catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process
CHOYP_LOC100367637.1.1.m.55661,-0.0430678931234042,Yes,cyan4,dark teal,Q96C86,m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS),HIT family,DCPS DCS1 HINT5 HSPC015,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288],GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0036245; GO:0043069; GO:0043928; GO:0045292; GO:0050072,GO:0000290; GO:0043928,catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process
CHOYP_TBG1.1.1.m.28190,-0.0260141819378303,Yes,cyan4,dark teal,P23258,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),Tubulin family,TUBG1 TUBG,apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],GO:0000070; GO:0000086; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0010389; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0045177; GO:0055037; GO:0097711; GO:0097730,GO:0000212; GO:0007017,reproduction; cytoskeleton organization; cell cycle
CHOYP_ADD.2.5.m.15081,-0.0359778697085381,Yes,cyan4,dark teal,Q02645,Protein hu-li tai shao (Adducin-like protein),Aldolase class II family; Adducin subfamily,hts CG9325,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],GO:0000212; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0007098; GO:0007282; GO:0007294; GO:0007411; GO:0007527; GO:0008302; GO:0014069; GO:0016328; GO:0030507; GO:0030723; GO:0030724; GO:0035183; GO:0044853; GO:0045169; GO:0045170; GO:0045172; GO:0045214; GO:0045478; GO:0048134; GO:0048135; GO:0048477; GO:0051015; GO:0051016; GO:0051017; GO:0061572; GO:0072499; GO:0098793; GO:0098794,GO:0000212,reproduction; cytoskeleton organization; cell cycle
CHOYP_CI064.1.1.m.9517,-0.0273427140106219,Yes,cyan4,dark teal,Q1JP73,Queuosine salvage protein,Queuosine salvage protein family,,tRNA-guanine transglycosylation [GO:0101030],GO:0101030,NA,NA
CHOYP_MD27A.1.2.m.18338,-0.0388287013138502,Yes,cyan4,dark teal,Q5XHA1,Mediator of RNA polymerase II transcription subunit 27 (Cofactor required for Sp1 transcriptional activation subunit 8) (CRSP complex subunit 8) (Mediator complex subunit 27),Mediator complex subunit 27 family,med27 crsp8,mediator complex [GO:0016592],GO:0016592,NA,NA
CHOYP_PYRD2.1.1.m.26691,-0.0284258595399147,Yes,cyan4,dark teal,Q68FT3,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-),Carotenoid/retinoid oxidoreductase family,Pyroxd2,oxidoreductase activity [GO:0016491],GO:0016491,NA,NA
CHOYP_BET1L.1.1.m.8210,-0.0266494734141068,Yes,cyan4,dark teal,Q5RBX2,BET1-like protein,,BET1L,integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031],GO:0015031; GO:0030173,NA,NA
CHOYP_LOC100644613.1.1.m.55011,-0.0306212447804351,Yes,cyan4,dark teal,A0R5M8,Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase),Methyltransferase superfamily; EgtD family,egtD MSMEG_6247 MSMEI_6086,dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha;N-alpha;N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha;N-alpha;N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707],GO:0008276; GO:0030745; GO:0052704; GO:0052707,NA,NA
CHOYP_LOC100638431.3.10.m.24462,-0.0426842301148587,Yes,cyan4,dark teal,Q5UR67,N-glycosidase R617 (EC 3.2.2.-) (Riboflavin biosynthesis intermediates N-glycosidase),YbiA family,MIMI_R617,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],GO:0008152; GO:0016798,NA,NA
CHOYP_ANM12.1.1.m.53881,-0.0295827439026529,Yes,cyan4,dark teal,A2XYY8,Probable protein arginine N-methyltransferase 6.1 (EC 2.1.1.-),Class I-like SAM-binding methyltransferase superfamily; Protein arginine N-methyltransferase family; PRMT6 subfamily,PRMT6.1 H0402C08.4 OsI_017281,methyltransferase activity [GO:0008168]; protein methylation [GO:0006479],GO:0006479; GO:0008168,NA,NA
CHOYP_LOC576498.1.1.m.10455,-0.0284137235677678,Yes,cyan4,dark teal,Q5FWU8,Zinc finger MYND domain-containing protein 10,ZMYND10 family,zmynd10,apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505],GO:0005929; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044458; GO:0046872; GO:1905505,NA,NA
CHOYP_CADM4.1.1.m.60661,-0.0312880485611002,Yes,cyan4,dark teal,Q7ZXX1,Cell adhesion molecule 3 (Immunoglobulin superfamily member 4B) (IgSF4B),Nectin family,cadm3 igsf4b,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030054,NA,NA
CHOYP_LOC100376749.1.1.m.27252,-0.0299606676835911,Yes,cyan4,dark teal,Q5FW12,TIP41-like protein,TIP41 family,tiprl,cytosol [GO:0005829]; chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]; TOR signaling [GO:0031929],GO:0005829; GO:0007165; GO:0031929; GO:0043009; GO:0043066,NA,NA
CHOYP_LOC100373578.1.1.m.478,-0.0275301434284299,Yes,cyan4,dark teal,Q5U4F6,WD repeat-containing protein 34,,Wdr34,axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018],GO:0005814; GO:0005829; GO:0005868; GO:0005930; GO:0007018; GO:0030286; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014,NA,NA
CHOYP_LOC100372208.1.1.m.18397,-0.0262321367628298,Yes,cyan4,dark teal,Q9N5Y2,Probable very-long-chain enoyl-CoA reductase art-1 (EC 1.3.1.93),Steroid 5-alpha reductase family,art-1 C15F1.6,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761],GO:0005789; GO:0016021; GO:0016491; GO:0042761; GO:0102758,NA,NA
CHOYP_LOC100740246.1.1.m.25108,-0.0367053669991547,Yes,cyan4,dark teal,A9C3P0,Malectin,Malectin family,mlec si:dkey-117k10.5,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975],GO:0005783; GO:0005789; GO:0005975; GO:0016021; GO:0030246,NA,NA
CHOYP_AN13B.1.1.m.15287,-0.031375931513435,Yes,cyan4,dark teal,Q6PD24,Ankyrin repeat domain-containing protein 13D,,Ankrd13d,late endosome [GO:0005770]; plasma membrane [GO:0005886],GO:0005770; GO:0005886,NA,NA
CHOYP_BRAFLDRAFT_85896.1.1.m.38692,-0.0299209975017326,Yes,cyan4,dark teal,C0HBB2,Glycosylated lysosomal membrane protein (Lysosomal protein NCU-G1),GLMP family,glmp,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],GO:0005764; GO:0005765; GO:0016021,NA,NA
CHOYP_LOC100368023.1.1.m.14890,-0.0317187124704936,Yes,cyan4,dark teal,Q9BSF4,Mitochondrial import inner membrane translocase subunit Tim29 (TIM29),,TIMM29 c19orf52,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein import into mitochondrial inner membrane [GO:0045039],GO:0005743; GO:0005758; GO:0016021; GO:0042721; GO:0045039,NA,NA
CHOYP_AOF.1.1.m.7109,-0.0299642021592523,Yes,cyan4,dark teal,Q6NSN2,Amine oxidase [flavin-containing] (EC 1.4.3.4) (Monoamine oxidase) (MAO) (Z-MAO),Flavin monoamine oxidase family,mao zgc:85761,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584]; cellular biogenic amine catabolic process [GO:0042402]; neurotransmitter catabolic process [GO:0042135],GO:0005741; GO:0006584; GO:0008131; GO:0016021; GO:0042135; GO:0042402,NA,NA
CHOYP_LOC100642891.1.1.m.25638,-0.0272236301858613,Yes,cyan4,dark teal,Q1LZ96,ATP synthase mitochondrial F1 complex assembly factor 2,ATP12 family,ATPAF2,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461],GO:0005739; GO:0005829; GO:0016607; GO:0043461,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19149,-0.0441004884634216,Yes,cyan4,dark teal,Q8CEI1,BolA-like protein 3,BolA/IbaG family,Bola3,mitochondrion [GO:0005739],GO:0005739,NA,NA
CHOYP_UBR7.1.1.m.7300,-0.0341496444056594,Yes,cyan4,dark teal,Q8N806,Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7),,UBR7 C14orf130,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0005737; GO:0008270; GO:0061630,NA,NA
CHOYP_LOC101064328.2.3.m.57090,-0.0317570439158588,Yes,cyan4,dark teal,Q9Z0T0,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),Class I-like SAM-binding methyltransferase superfamily; TPMT family,Tpmt,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; response to organic cyclic compound [GO:0014070]; response to testosterone [GO:0033574],GO:0005737; GO:0008119; GO:0014070; GO:0033574,NA,NA
CHOYP_LOC725079.1.1.m.66349,-0.0413951592051384,Yes,cyan4,dark teal,Q9DCD5,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),,Tjap1 Pilt Tjp4,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030],GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0007030,NA,NA
CHOYP_CCBL1.1.1.m.30637,-0.0369360142641936,Yes,cyan4,dark teal,Q7T3E5,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Class-I pyridoxal-phosphate-dependent aminotransferase family,kyat3 ccbl2 kat3 zgc:63929,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],GO:0005737; GO:0005739; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0047315; GO:0047804; GO:0070189,NA,NA
CHOYP_NOL10.1.1.m.1606,-0.0263491184862423,Yes,cyan4,dark teal,Q7T0Q5,Nucleolar protein 10,WD repeat NOL10/ENP2 family,nol10,nucleolus [GO:0005730],GO:0005730,NA,NA
CHOYP_EPN4.1.3.m.10807,-0.0424129267465941,Yes,cyan4,dark teal,A7Z035,Clathrin interactor 1 (Epsin-4),Epsin family,CLINT1 EPN4,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],GO:0005654; GO:0005798; GO:0005802; GO:0006897; GO:0008289; GO:0016020; GO:0030136; GO:0030276; GO:0048471,NA,NA
CHOYP_BRAFLDRAFT_277797.1.1.m.26394,-0.0297361871841683,Yes,cyan4,dark teal,O75884,Putative hydrolase RBBP9 (EC 3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9),RBBP9 family,RBBP9 BOG RBBP10,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; regulation of cell proliferation [GO:0042127],GO:0005654; GO:0005737; GO:0016787; GO:0042127,NA,NA
CHOYP_LOC100376200.1.1.m.19157,-0.0362286250375376,Yes,cyan4,dark teal,B9EQ30,SOSS complex subunit C (INTS3- and NABP-interacting protein) (Sensor of single-strand DNA complex subunit C) (Sensor of ssDNA subunit C) (SOSS-C) (Single-stranded DNA-binding protein-interacting protein 1) (SSB-interacting protein 1),SOSS-C family,inip ssbip1,nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212],GO:0005634; GO:0006281; GO:0006974; GO:0010212; GO:0070876,NA,NA
CHOYP_NAEGRDRAFT_47557.1.1.m.11283,-0.0364507097908002,Yes,cyan4,dark teal,Q0VD31,F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4),,FBXL4,mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005634; GO:0005758; GO:0006511; GO:0016567; GO:0019005; GO:0031146,NA,NA
CHOYP_BRAFLDRAFT_113696.1.1.m.54166,-0.0261161479160932,Yes,cyan4,dark teal,P20695,Interferon-related developmental regulator 1 (IRPR) (Nerve growth factor-inducible protein PC4),IFRD family,Ifrd1 Pc4,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; glial cell proliferation [GO:0014009]; muscle cell differentiation [GO:0042692]; neuroblast proliferation [GO:0007405]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0005634; GO:0005737; GO:0005886; GO:0007405; GO:0014009; GO:0042692; GO:0045944; GO:0051091; GO:0061629,NA,NA
CHOYP_LOC100369194.1.1.m.42345,-0.0259839593495336,Yes,cyan4,dark teal,Q5EAJ7,Major vault protein (MVP),,MVP,cytoplasm [GO:0005737]; nucleus [GO:0005634],GO:0005634; GO:0005737,NA,NA
CHOYP_LOC100378445.1.1.m.7111,-0.0260067213320818,Yes,cyan4,dark teal,Q5SSI6,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),WD repeat UTP18 family,Utp18 Wdr50,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],GO:0005634; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388,NA,NA
CHOYP_ARB_02478.1.1.m.29725,-0.0374050101883907,Yes,cyan4,dark teal,D4B1Z7,Uncharacterized FAD-linked oxidoreductase ARB_02478 (EC 1.-.-.-),Oxygen-dependent FAD-linked oxidoreductase family,ARB_02478,extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491],GO:0005576; GO:0016491; GO:0071949,NA,NA
CHOYP_SMP_148160.1.1.m.11635,-0.0302636986057152,Yes,cyan4,dark teal,Q9NWH7,Spermatogenesis-associated protein 6,SPATA6 family,SPATA6,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005576; GO:0007275; GO:0007283; GO:0030154; GO:0032027; GO:0044458; GO:0097224,NA,NA
CHOYP_LOC101072591.1.1.m.1861,-0.0267393647759156,Yes,cyan4,dark teal,Q32LJ2,ADP-ribosylation factor-related protein 1 (ARF-related protein 1),Small GTPase superfamily; Arf family,ARFRP1,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport; endosome to Golgi [GO:0042147],GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007369; GO:0016020; GO:0033365; GO:0034067; GO:0042147; GO:0043001,NA,NA
CHOYP_ACT.5.27.m.15585,-0.0261934683187812,Yes,cyan4,dark teal,Q26065,Actin; adductor muscle,Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_ACT.6.27.m.15622,-0.0499557307166933,Yes,cyan4,dark teal,Q92193,Actin (Fragment),Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_PAN2.1.1.m.44693,-0.0385172359485293,Yes,cyan4,dark teal,Q92193,Actin (Fragment),Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_UBE2C.1.1.m.55757,-0.025573338612176,Yes,cyan4,dark teal,P56616,Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UBC-X) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C),Ubiquitin-conjugating enzyme family,ube2c ubch10 ubcx,anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0005524; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0016740; GO:0031145; GO:0051301; GO:0070979,NA,NA
CHOYP_LOC100890099.1.1.m.11505,0.0440360138624742,Yes,cyan4,dark teal,P53486,Actin; cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin; cytoplasmic 3; N-terminally processed],Actin family,actbc,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524],GO:0005524; GO:0005634; GO:0005737; GO:0005856,NA,NA
CHOYP_BRAFLDRAFT_208197.2.21.m.9816,-0.0304423700146302,Yes,cyan4,dark teal,Q96MM6,Heat shock 70 kDa protein 12B,Heat shock protein 70 family,HSPA12B C20orf60,ATP binding [GO:0005524],GO:0005524,NA,NA
CHOYP_BRAFLDRAFT_208293.15.20.m.61604,-0.0297097125375628,Yes,cyan4,dark teal,Q96MM6,Heat shock 70 kDa protein 12B,Heat shock protein 70 family,HSPA12B C20orf60,ATP binding [GO:0005524],GO:0005524,NA,NA
CHOYP_CALM.37.50.m.52385,-0.0251240018491301,Yes,cyan4,dark teal,P02594,Calmodulin (CaM),Calmodulin family,calm,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],GO:0005509; GO:0019722,NA,NA
CHOYP_BRAFLDRAFT_122339.1.1.m.58748,-0.0347655443531803,Yes,cyan4,dark teal,Q9CQ46,Dynein regulatory complex protein 8 (EF-hand calcium-binding domain-containing protein 2),DRC8 family,Efcab2 Drc8,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509],GO:0005509; GO:0005737; GO:0005856; GO:0031514,NA,NA
CHOYP_LOC592209.1.1.m.48009,-0.0337578113919122,Yes,cyan4,dark teal,Q8IVU9,Ciliary-associated calcium-binding coiled-coil protein 1,,CABCOCO1 C10orf107,centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509],GO:0005509; GO:0005737; GO:0005813; GO:0036126,NA,NA
CHOYP_LOC100565534.1.3.m.28075,-0.0273243746420002,Yes,cyan4,dark teal,P02597,Calmodulin; striated muscle,Calmodulin family,CCM1,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],GO:0005509; GO:0005634; GO:0019722; GO:0051300,NA,NA
CHOYP_TSP_02835.1.1.m.26375,-0.037682428860568,Yes,cyan4,dark teal,O01814,Fatty acid-binding protein homolog 5,Calycin superfamily; Fatty-acid binding protein (FABP) family,lbp-5 W02D3.7,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],GO:0005504; GO:0005634; GO:0048471,NA,NA
CHOYP_BRAFLDRAFT_205939.3.3.m.64021,-0.032729449639592,Yes,cyan4,dark teal,Q96RW7,Hemicentin-1 (Fibulin-6) (FIBL-6),,HMCN1 FIBL6,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],GO:0005201; GO:0005509; GO:0005604; GO:0005913; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0038023; GO:0042803; GO:0050839; GO:0051301; GO:0062023; GO:0070062,NA,NA
CHOYP_AMACR.1.1.m.21950,-0.0347824476034543,Yes,cyan4,dark teal,O09174,Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase),CaiB/BaiF CoA-transferase family,Amacr Macr1,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300],GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206; GO:0008300; GO:0043231,NA,NA
CHOYP_DSEC_GM16292.1.1.m.12184,-0.0404242558156246,Yes,cyan4,dark teal,Q868Z9,Papilin,Papilin family,Ppn CG33103,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],GO:0004867; GO:0005201; GO:0005604; GO:0007275; GO:0008233; GO:0030198,NA,NA
CHOYP_SPR.1.3.m.17978,-0.0266340752452824,Yes,cyan4,dark teal,B0BML7,Sepiapterin reductase (SPR) (EC 1.1.1.153),Sepiapterin reductase family,spr,cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729],GO:0004757; GO:0005737; GO:0006729,NA,NA
CHOYP_LOC100890753.1.3.m.50299,-0.0284939682034923,Yes,cyan4,dark teal,Q99M80,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Protein-tyrosine phosphatase family; Receptor class 2B subfamily,Ptprt,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098978; GO:0099061; GO:1904893; GO:1990264,NA,NA
CHOYP_TXND3.2.4.m.21415,-0.0338795750903411,Yes,cyan4,dark teal,P90666,Thioredoxin domain-containing protein 3 homolog (Intermediate chain 1) (NME/NM23 family member 8),NDK family,NME8 IC1,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454,NA,NA
CHOYP_CP3AB.4.4.m.47872,-0.0253030917077134,Yes,cyan4,dark teal,Q64459,Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT),Cytochrome P450 family,Cyp3a11 Cyp3a-11,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; testosterone 6-beta-hydroxylase activity [GO:0050649]; response to bacterium [GO:0009617],GO:0004497; GO:0005506; GO:0005789; GO:0009617; GO:0016491; GO:0020037; GO:0031090; GO:0032451; GO:0043231; GO:0050649; GO:0070330; GO:0101020,NA,NA
CHOYP_LOC100222774.1.1.m.56990,-0.0497239298409951,Yes,cyan4,dark teal,Q9V9A7,Probable methylcrotonoyl-CoA carboxylase beta chain; mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta),AccD/PCCB family,l(2)04524 CG3267,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563],GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0007563; GO:1905202,NA,NA
CHOYP_PRP6.2.2.m.34365,-0.025238470119125,Yes,cyan4,dark teal,P30568,Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta),GST superfamily; Theta family,,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],GO:0004364; GO:0005737,NA,NA
CHOYP_LOC100367137.1.1.m.23977,-0.0399078982138766,Yes,cyan4,dark teal,O08663,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),Peptidase M24A family; Methionine aminopeptidase eukaryotic type 2 subfamily,Metap2 Mnpep P67eif2,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485],GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084,NA,NA
CHOYP_BRAFLDRAFT_204923.2.2.m.63877,-0.0317314328647882,Yes,cyan4,dark teal,Q9XTA2,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),Peptidase S9A family,PREP,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],GO:0004175; GO:0004252; GO:0005737; GO:0005829; GO:0070008; GO:0070012,NA,NA
CHOYP_LOC100123907.1.1.m.2987,-0.0576532875056584,Yes,cyan4,dark teal,Q7ZWE9,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),Adenylate kinase family; UMP-CMP kinase subfamily,cmpk cmpk1,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006221; GO:0009041; GO:0009142,NA,NA
CHOYP_EHHADH.1.1.m.26459,-0.0263653906916947,Yes,cyan4,dark teal,Q6NYL3,Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3;2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)],Enoyl-CoA hydratase/isomerase family; 3-hydroxyacyl-CoA dehydrogenase family,ehhadh echd si:dkeyp-30d5.2 zgc:77526,peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635,NA,NA
CHOYP_RS8.8.14.m.44842,-0.0386113457927,Yes,cyan4,dark teal,Q8WQI5,40S ribosomal protein S8,Eukaryotic ribosomal protein eS8 family,RpS8,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,NA,NA
CHOYP_LOC100869188.1.1.m.18952,-0.0312873572133181,Yes,cyan4,dark teal,Q9CXW2,28S ribosomal protein S22; mitochondrial (MRP-S22) (S22mt),Mitochondrion-specific ribosomal protein mS22 family,Mrps22 Rpms22,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735],GO:0003735; GO:0005739; GO:0005763,NA,NA
CHOYP_LOC101159300.1.1.m.26609,-0.0282093546141392,Yes,cyan4,dark teal,Q99N92,39S ribosomal protein L27; mitochondrial (L27mt) (MRP-L27),Bacterial ribosomal protein bL27 family,Mrpl27,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0005739; GO:0005762; GO:0006412,NA,NA
CHOYP_LARP7.1.1.m.35019,-0.0261098359066056,Yes,cyan4,dark teal,Q7ZWE3,La-related protein 7 (La ribonucleoprotein domain family member 7),,larp7 zgc:56476,nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396],GO:0003723; GO:0005654; GO:0006396; GO:0060043; GO:0061026; GO:1990904,NA,NA
CHOYP_RNOY.1.3.m.4495,-0.031615308363293,Yes,cyan4,dark teal,Q7M456,Ribonuclease Oy (RNase Oy) (EC 3.1.27.-),RNase T2 family,,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],GO:0003723; GO:0005576; GO:0033897,NA,NA
CHOYP_RNOY.3.3.m.58342,-0.0286762311362764,Yes,cyan4,dark teal,Q7M456,Ribonuclease Oy (RNase Oy) (EC 3.1.27.-),RNase T2 family,,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],GO:0003723; GO:0005576; GO:0033897,NA,NA
CHOYP_DDX47.1.1.m.11144,-0.0392909762677979,Yes,cyan4,dark teal,Q9CWX9,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),DEAD box helicase family; DDX47/RRP3 subfamily,Ddx47,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],GO:0003723; GO:0004386; GO:0005524; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625,NA,NA
CHOYP_NEMVEDRAFT_V1G96234.1.1.m.27743,-0.0403815827599803,Yes,cyan4,dark teal,Q8WUA2,Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4),Cyclophilin-type PPIase family; PPIL4 subfamily,PPIL4,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407],GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407,NA,NA
CHOYP_LOC100368004.1.1.m.62584,-0.031502234787517,Yes,cyan4,dark teal,Q5FVB2,LIM domain transcription factor LMO4.1 (LIM domain only protein 4.1) (LMO-4.1),,lmo4.1 lmo4,metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; embryonic camera-type eye development [GO:0031076]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; mesoderm development [GO:0007498]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0003712; GO:0007369; GO:0007498; GO:0030900; GO:0031076; GO:0045665; GO:0045944; GO:0046872,NA,NA
CHOYP_LOC100119750.1.1.m.7019,-0.0273618409750623,Yes,cyan4,dark teal,Q80YR4,E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598),ZNF598 family,Znf598 Zfp598,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344],GO:0003676; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344,NA,NA
CHOYP_POLR3K.1.1.m.8423,-0.0504587994125087,Yes,cyan4,dark teal,Q9Y2Y1,DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11),Archaeal RpoM/eukaryotic RPA12/RPB9/RPC11 RNA polymerase family,POLR3K RPC11 My010,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779],GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005730; GO:0005829; GO:0006383; GO:0006386; GO:0008270; GO:0042779; GO:0045087; GO:0051607,NA,NA
CHOYP_LOC100367581.3.3.m.56472,-0.0318799613737684,Yes,cyan4,dark teal,Q69Z37,Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like),,Samd9l Kiaa2005,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],GO:0002244; GO:0005737; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536,NA,NA
CHOYP_SMP_168770.1.1.m.18618,-0.0369604217609693,Yes,cyan4,dark teal,Q9VF08,Mitochondrial import inner membrane translocase subunit Tim16 (Protein black pearl),TIM16/PAM16 family,blp CG5268,TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; instar larval development [GO:0002168]; protein import into mitochondrial matrix [GO:0030150],GO:0002168; GO:0005744; GO:0030150,NA,NA
CHOYP_SODM.2.2.m.62946,-0.0302010885808716,Yes,cyan4,dark teal,Q28709,CD63 antigen (CD antigen CD63),Tetraspanin (TM4SF) family,CD63,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],GO:0002092; GO:0005765; GO:0007160; GO:0009986; GO:0015031; GO:0016021; GO:0016477; GO:0031226; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:2001046,NA,NA
CHOYP_TRIADDRAFT_37121.1.1.m.51940,-0.0350319054353988,Yes,cyan4,dark teal,Q8BYK4,Retinol dehydrogenase 12 (EC 1.1.1.-),Short-chain dehydrogenases/reductases (SDR) family,Rdh12,intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]; retinol dehydrogenase activity [GO:0004745]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],GO:0001917; GO:0004745; GO:0005622; GO:0007601; GO:0042572; GO:0050896,NA,NA
CHOYP_DCDC2.7.7.m.46807,-0.0264044741463883,Yes,cyan4,dark teal,Q9UHG0,Doublecortin domain-containing protein 2 (Protein RU2S),,DCDC2 KIAA1154 RU2,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605],GO:0001764; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0006968; GO:0007605; GO:0015630; GO:0019894; GO:0030111; GO:0035556; GO:0045880; GO:0048813; GO:0060091; GO:0060271; GO:0072686; GO:1902017,NA,NA
CHOYP_TRIADDRAFT_49883.1.1.m.29857,-0.0274761523317905,Yes,cyan4,dark teal,Q9QY94,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225),Glutamine synthetase family,GLUL,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],GO:0001525; GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006542; GO:0010594; GO:0018345; GO:0019706; GO:0046872; GO:1903670,NA,NA
CHOYP_BRAFLDRAFT_127065.5.7.m.28848,-0.03508550102823,Yes,cyan4,dark teal,P82198,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3),,Tgfbi,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023,NA,NA
CHOYP_LOC764898.1.1.m.28118,-0.0471504658697016,Yes,cyan4,dark teal,Q9Y547,Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Placental protein 25) (PP25),IFT25 family,HSPB11 C1orf41 IFT25 HSPC034,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; heart development [GO:0007507]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0030154; GO:0030324; GO:0030992; GO:0035735; GO:0046872; GO:0070986; GO:0097542,NA,NA
CHOYP_P3A2.1.3.m.11560,-0.0432149171587595,Yes,cyan4,dark teal,Q04073,DNA-binding protein P3A2,NRF1/Ewg family,,nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000978; GO:0001046; GO:0003700; GO:0005634; GO:0006357,NA,NA
CHOYP_LOC100378487.1.1.m.64108,-0.0259410671533368,Yes,cyan4,dark teal,Q7SXN4,Cytoplasmic polyadenylation element-binding protein 4 (CPE-BP4) (CPE-binding protein 4) (CPEB-4),RRM CPEB family,cpeb4 zgc:66166,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; translation factor activity; RNA binding [GO:0008135]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931],GO:0000900; GO:0002931; GO:0003730; GO:0005634; GO:0005737; GO:0005783; GO:0008135; GO:0014069; GO:0030054; GO:0030425; GO:0030426; GO:0035235; GO:0036294; GO:0042149; GO:0043005; GO:0043022; GO:0043197; GO:0043524; GO:0045202; GO:0045211; GO:0048471; GO:0071230; GO:1990124; GO:2000766,NA,NA
CHOYP_XRN2.1.1.m.13943,-0.0250135388920002,Yes,cyan4,dark teal,Q5ZIP4,5'-3' exoribonuclease 2 (EC 3.1.13.-),5'-3' exonuclease family; XRN2/RAT1 subfamily,XRN2 RCJMB04_24h23,aggresome [GO:0016235]; nucleolus [GO:0005730]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process; exonucleolytic [GO:0000738]; DNA-templated transcription; termination [GO:0006353]; mRNA processing [GO:0006397]; spermatogenesis [GO:0007283],GO:0000738; GO:0001147; GO:0004534; GO:0005730; GO:0006353; GO:0006397; GO:0007283; GO:0008409; GO:0016235; GO:0046872,NA,NA
CHOYP_BRAFLDRAFT_277920.1.1.m.28845,-0.0253904045112143,Yes,cyan4,dark teal,Q5E9N0,Bystin,Bystin family,BYSL,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; cell proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829],GO:0000462; GO:0001829; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0008283; GO:0030515; GO:0030688; GO:0045177,NA,NA
CHOYP_TXN4A.1.2.m.59542,-0.0363744219391598,Yes,cyan4,dark teal,P83877,Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD),DIM1 family,Txnl4a Dim1 Txnl4,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398],GO:0000398; GO:0005634; GO:0005682; GO:0005737; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005,NA,NA
CHOYP_LOC592411.1.1.m.19664,-0.028641748223045,Yes,cyan4,dark teal,Q6NUB2,Protein CWC15 homolog A,CWC15 family,cwc15-a,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],GO:0000398; GO:0003723; GO:0005634; GO:0071007,NA,NA
CHOYP_CELF4.1.1.m.22429,-0.0254095615585895,Yes,cyan4,dark teal,Q6DGV1,CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4),CELF/BRUNOL family,celf4 brunol4 zgc:92761,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904,NA,NA
CHOYP_BRAFLDRAFT_59154.3.3.m.53255,-0.0256963251720174,Yes,cyan4,dark teal,P61025,Cyclin-dependent kinases regulatory subunit 1 (CKS-1) (Sid 1334),CKS family,Cks1b Cks1 Sid1334,cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription; DNA-templated [GO:0006355],GO:0000307; GO:0006355; GO:0007346; GO:0008283; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0044772; GO:0045737; GO:0051301; GO:0061575,NA,NA
CHOYP_BRAFLDRAFT_212086.4.11.m.42448,-0.0365239349061456,Yes,cyan4,dark teal,P54922,[Protein ADP-ribosylarginine] hydrolase (ADP-ribosylarginine hydrolase) (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme),ADP-ribosylglycohydrolase family,ADPRH ARH1,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],GO:0000287; GO:0003875; GO:0005096; GO:0005623; GO:0006464; GO:0006886; GO:0017137; GO:0030955; GO:0051725; GO:0090630,NA,NA
CHOYP_FEN1.1.1.m.66181,-0.0379663162378504,Yes,cyan4,dark teal,A7RRJ0,Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1),XPG/RAD2 endonuclease family; FEN1 subfamily,FEN1 v1g201054,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; apoptotic DNA fragmentation [GO:0006309]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication; removal of RNA primer [GO:0043137]; positive regulation of sister chromatid cohesion [GO:0045876],GO:0000287; GO:0003677; GO:0004523; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006281; GO:0006284; GO:0006309; GO:0008409; GO:0017108; GO:0030145; GO:0043137; GO:0045876; GO:0048256,NA,NA
CHOYP_LOC100372473.3.5.m.39839,-0.0252899967427395,Yes,cyan4,dark teal,Q6B9X6,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Protein kinase superfamily; Alpha-type protein kinase family; ALPK subfamily,vwkA DDB_G0268144,contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177,NA,NA
CHOYP_LOC662320.2.2.m.19454,-0.0358828476284735,Yes,cyan4,dark teal,Q42404,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),,RNU1 At3g50670 T3A5.50,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],GO:0000243; GO:0000398; GO:0003729; GO:0005634; GO:0005685; GO:0016607; GO:0030619,NA,NA
CHOYP_LOC101169131.2.2.m.32499,-0.0357350200424154,Yes,cyan4,dark teal,O70277,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),TRIM/RBCC family,Trim3 Berp Rnf22,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978,NA,NA
CHOYP_B3GT2.1.1.m.35771,-0.0258924909210199,Yes,cyan4,dark teal,Q9MYM7,Beta-1;3-galactosyltransferase 1 (Beta-1;3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1;3-galactosyltransferase 1),Glycosyltransferase 31 family,B3GALT1,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0016021; GO:0047275,NA,NA
CHOYP_GOPC.1.1.m.45489,-0.025676330950614,Yes,cyan4,dark teal,Q8BH60,Golgi-associated PDZ and coiled-coil motif-containing protein (PDZ protein interacting specifically with TC10) (PIST),,Gopc,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289],GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0008022; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030054; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042803; GO:0043004; GO:0044325; GO:0045202; GO:0045211; GO:0051260; GO:2000009,NA,NA
CHOYP_LOC101076180.1.1.m.41749,-0.0268375467512009,Yes,cyan4,dark teal,Q3SYU1,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),NOC2 family,NOC2L NIR,cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0070491; GO:2001243,NA,NA
CHOYP_LOC100374254.1.1.m.22199,-0.0256935935313681,Yes,cyan4,dark teal,B0BLT0,Zinc finger protein 593,ZNF593/BUD20 C2H2-type zinc-finger protein family,znf593,cell [GO:0005623]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055],GO:0000055; GO:0003676; GO:0005623; GO:0008270; GO:0030687; GO:0043023,NA,NA
CHOYP_BRAFLDRAFT_277091.1.3.m.1103,-0.0392566306618979,Yes,cyan4,dark teal,P02434,60S ribosomal protein L35a (L32),Eukaryotic ribosomal protein eL33 family,rpl35a,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412],GO:0000049; GO:0003735; GO:0005840; GO:0006412,NA,NA
CHOYP_LOC100368360.1.1.m.9672,-0.0292062724749631,Yes,cyan4,dark teal,Q4KKZ1,Uncharacterized protein C1orf158 homolog,,,,,NA,NA
CHOYP_LOC592857.1.1.m.62834,-0.0309498684625134,Yes,cyan4,dark teal,B2RC85,Radial spoke head 10 homolog B2,,RSPH10B2,,,NA,NA
CHOYP_CCD43.1.1.m.63636,-0.0360957036817043,Yes,cyan4,dark teal,Q6PFL6,Coiled-coil domain-containing protein 43,CCDC43 family,ccdc43 zgc:66277,,,NA,NA
CHOYP_ANT_25430.1.2.m.613,-0.0258197928836591,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATRP.1.1.m.22451,-0.0355181068764608,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62781,-0.0263978841373473,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119209.1.1.m.4850,-0.0323852819758907,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121667.1.2.m.12193,-0.059155611714379,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125862.1.1.m.27159,-0.0282635221955431,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88543.1.2.m.54473,-0.0276332377760096,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.5.23.m.12847,-0.0266203333905284,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LIN.24.1.1.m.5076,-0.0280794126200181,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001317.m.1351,-0.0512085825423009,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004869.m.5573,-0.0277231005256866,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005029.m.5761,-0.0478670663869725,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006214.m.7057,-0.0485294209135146,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007858.m.9121,-0.0263494665588728,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008452.m.9831,-0.0326884031400492,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013837.m.15768,-0.0279805229772736,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014205.m.16198,-0.0264139124987823,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016375.m.19279,-0.0469306022221873,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016559.m.19503,-0.0340086487799234,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023897.m.27203,-0.0348308905217956,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025759.m.29400,-0.0269229480447672,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025862.m.29523,-0.0290369578092234,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035697.m.40446,-0.0252792999526418,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035889.m.40603,-0.0423209620909981,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037467.m.42206,-0.0455101580806844,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040238.m.45604,-0.0441384418308914,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044803.m.51967,-0.0265584904371222,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048805.m.57897,-0.039281312781673,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049586.m.58876,-0.0280158224777037,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051499.m.61590,-0.0288177544856312,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053912.m.64506,-0.0387715790743208,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055225.m.65857,-0.0313233028886433,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055335.m.66005,-0.0276033289880659,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44178,-0.0375140448439829,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DDX58.9.9.m.62758,-0.0332066551287786,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW013795.1.1.m.12153,-0.030179840647359,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.7.13.m.40006,-0.0337222473828188,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100005318.1.1.m.30043,-0.0255330963831253,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100119236.1.1.m.22785,-0.0320097145020318,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367089.1.4.m.1412,-0.0288035231719648,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368071.1.1.m.6755,-0.0272871996146351,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372473.1.5.m.7845,-0.0301345166787958,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485383.1.1.m.52650,-0.0414812961957274,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067281.1.2.m.14666,-0.0288854172177443,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101162206.1.1.m.53261,-0.0330132930579121,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590756.3.6.m.40372,-0.0276672406888761,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MSMB.4.5.m.40217,-0.0267479538600054,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G202687.1.1.m.8886,-0.0352609907073428,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.3.5.m.31061,-0.0276483209405874,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_001000.1.1.m.39561,-0.0251271882154304,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.7.22.m.16997,-0.0302058526576371,Yes,cyan4,dark teal,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_14332.1.2.m.5643,0.00694906272133991,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_14332.2.2.m.61737,-0.010848854865953,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_1433E.1.2.m.3638,-0.000251471711814895,No,NA,NA,P92177,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_1433G.2.2.m.63450,0.000903541745824965,No,NA,NA,P68252,NA,NA,NA,cytoplasm [GO:0005737]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167],NA,NA,NA
CHOYP_1433G.2.2.m.63451,-0.00189947285269051,No,NA,NA,Q4R979,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_1433Z.1.1.m.17045,0.000324098984013896,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_2A5D.2.3.m.32240,-0.0169024291387897,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2A5D.3.3.m.37716,0.000579020362786019,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2AAA.1.1.m.13306,0.00230902885931595,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_2AAA.1.1.m.13307,-0.0168777850635973,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_3BP2.2.3.m.19302,-0.0013506615692881,No,NA,NA,Q06649,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_41.2.3.m.31169,0.0113911533940146,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_4EBP1.1.1.m.12045,0.00336515227774003,No,NA,NA,Q13541,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_4ET.1.1.m.1941,-0.00901662576988124,No,NA,NA,Q9NRA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605]; mRNA binding [GO:0003729]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_5HTR.1.1.m.64867,0.000634835767976778,No,NA,NA,Q25414,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_5NT3.1.1.m.24925,-0.00806306292353438,No,NA,NA,Q5ZKF6,NA,NA,NA,cytoplasm [GO:0005737]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; dephosphorylation [GO:0016311]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_A1CF.1.2.m.8145,-0.00113662739949594,No,NA,NA,Q5R9H4,NA,NA,NA,apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_A2M.2.3.m.54214,0.0108973050155314,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_A4.2.3.m.7550,0.00734476022097694,No,NA,NA,Q10651,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]; body morphogenesis [GO:0010171]; cell differentiation [GO:0030154]; ecdysis; collagen and cuticulin-based cuticle [GO:0042395]; nematode larval development [GO:0002119]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_A4.3.3.m.22262,-0.00626861713194993,No,NA,NA,Q8CH02,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_AACS.1.1.m.66267,0.00122248077801818,No,NA,NA,Q28BL6,NA,NA,NA,cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_AADAT.1.1.m.12672,-0.00228828813254155,No,NA,NA,Q8N5Z0,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_AAEL_AAEL000057.1.1.m.36013,-0.0073062642049839,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001424.1.1.m.40785,-0.0085567561606712,No,NA,NA,Q2KI92,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; serine-type peptidase activity [GO:0008236]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_AAEL_AAEL001503.1.1.m.10649,-7.7986599617177e-05,No,NA,NA,P48763,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],NA,NA,NA
CHOYP_AAEL_AAEL001706.1.1.m.43821,-0.0151788589440302,No,NA,NA,Q5ZLH0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_AAEL_AAEL002456.1.1.m.35591,0.021668177793196,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_AAEL_AAEL002467.1.2.m.47358,0.0271575002935752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL003539.1.1.m.16619,0.00145695827786074,No,NA,NA,Q8BHJ5,NA,NA,NA,histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_AAEL_AAEL003853.1.2.m.39529,0.000254099175519496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL004399.1.1.m.3003,-0.0148797038628742,No,NA,NA,P47799,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_AAEL_AAEL004839.1.1.m.13815,-0.00126402913595809,No,NA,NA,Q7TQK0,NA,NA,NA,cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL005197.1.1.m.59507,0.00218880460695036,No,NA,NA,Q9HB90,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL006854.1.1.m.13363,0.000282543097542363,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_AAEL_AAEL006988.1.1.m.49733,0.0223770922234228,No,NA,NA,Q91857,NA,NA,NA,MLL1 complex [GO:0071339]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_AAEL_AAEL007173.1.1.m.41471,-0.0175792932320054,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AAEL_AAEL007437.1.1.m.29443,-0.0224364760624062,No,NA,NA,P86948,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_AAEL_AAEL007549.1.1.m.13827,-0.0101618932098257,No,NA,NA,Q9D9G2,NA,NA,NA,lysosome [GO:0005764],NA,NA,NA
CHOYP_AAEL_AAEL007787.1.1.m.13188,-0.00338554399004497,No,NA,NA,P13195,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to platinum ion [GO:0070541],NA,NA,NA
CHOYP_AAEL_AAEL008069.1.2.m.58164,0.00587560652638138,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60920,0.00741260391079437,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60921,0.0240410164329983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008257.2.3.m.36861,-0.00466032801730399,No,NA,NA,P48809,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing; via spliceosome [GO:0048024]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_AAEL_AAEL009169.1.1.m.24699,-0.00299732301388761,No,NA,NA,Q3TZZ7,NA,NA,NA,endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_AAEL_AAEL009187.1.1.m.25730,-0.000540692656257667,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009387.1.1.m.66163,-0.00319486341168428,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_AAEL_AAEL009414.1.1.m.639,-0.00070220851867477,No,NA,NA,Q5BK63,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006],NA,NA,NA
CHOYP_AAEL_AAEL010339.1.1.m.63259,0.00476610407930724,No,NA,NA,Q8R035,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity; codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_AAEL_AAEL010626.1.1.m.52019,0.00763514858932042,No,NA,NA,P56719,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_AAEL_AAEL010939.1.1.m.64870,-0.00421126727908102,No,NA,NA,Q66HY8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_AAEL_AAEL011273.1.1.m.12717,0.00279268321708458,No,NA,NA,Q9NWZ5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032],NA,NA,NA
CHOYP_AAEL_AAEL011391.1.1.m.10090,-0.00178353260266339,No,NA,NA,Q58DQ5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011527.1.1.m.20909,0.000304020127123168,No,NA,NA,Q99L45,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584],NA,NA,NA
CHOYP_AAEL_AAEL011814.1.1.m.48797,0.00160284214417353,No,NA,NA,P82924,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011979.1.1.m.59057,0.00348099488160782,No,NA,NA,Q91WQ9,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_AAEL_AAEL012012.1.1.m.11873,0.00573312774824381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL012950.1.1.m.1373,-0.00235827841610362,No,NA,NA,P91929,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_AAEL_AAEL013229.1.2.m.30359,0,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_AAEL_AAEL013229.2.2.m.57593,0.0277946669141413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL014931.1.1.m.24932,0.00351103144700702,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAEL_AAEL015271.1.1.m.56223,-0.0118617227543465,No,NA,NA,P15153,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase regulator activity [GO:0019887]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAK1.1.1.m.14768,-0.0110867153396624,No,NA,NA,Q2M2I8,NA,NA,NA,cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_AAK1.1.1.m.14769,0.018596194022278,No,NA,NA,Q9UBL3,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355]; response to estrogen [GO:0043627]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAKG2.1.1.m.55638,0.0125841412802238,No,NA,NA,Q9UGJ0,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; ATP biosynthetic process [GO:0006754]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_AAMP.1.1.m.13698,-0.00871692764522368,No,NA,NA,Q13685,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_AASI_1435.2.35.m.17918,-0.015710671247153,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_AASI_1435.28.35.m.60443,0.000220529072168675,No,NA,NA,O70511,NA,NA,NA,axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AASI_1435.35.35.m.65339,-0.00318789542332489,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_AATF.1.1.m.34004,-0.0178851694840425,No,NA,NA,Q5ZIM6,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; leucine zipper domain binding [GO:0043522]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_AATM.1.1.m.32176,0.000362543403323963,No,NA,NA,Q28F67,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536],NA,NA,NA
CHOYP_ABCA1.1.3.m.6501,0.000475910031918835,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA1.3.3.m.56453,0.000606862553355143,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA3.2.6.m.4295,-0.00391301649019496,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA3.5.6.m.54787,0.000603916780399749,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA4.1.1.m.31461,0.000120416521326831,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCB6.2.3.m.11344,0.0015973833124491,No,NA,NA,O94760,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ABCB6.3.3.m.53101,0.00606348747381443,No,NA,NA,Q08D64,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626],NA,NA,NA
CHOYP_ABCE1.1.2.m.7437,0.00854979310268324,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCE1.2.2.m.42246,-0.00117426866324687,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCF2.1.2.m.28360,-0.0094014100385873,No,NA,NA,Q99LE6,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_ABCF2.1.2.m.28362,0.00036445892426186,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_ABCG8.1.1.m.3707,0.00663650868413115,No,NA,NA,Q9H222,NA,NA,NA,apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cholesterol transporter activity [GO:0017127]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABHD2.2.2.m.32276,-0.00374973995379256,No,NA,NA,Q9QXM0,NA,NA,NA,acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; steroid hormone receptor activity [GO:0003707]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of cell migration [GO:0030336]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401],NA,NA,NA
CHOYP_ABI2.2.2.m.65629,-0.00172387418233106,No,NA,NA,Q9QZM5,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; transcription factor binding [GO:0008134]; actin polymerization or depolymerization [GO:0008154]; postsynapse to nucleus signaling pathway [GO:0099527],NA,NA,NA
CHOYP_ABL1.1.1.m.55647,-0.0174276764626248,No,NA,NA,P00522,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; morphogenesis of an epithelium [GO:0002009]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370],NA,NA,NA
CHOYP_ACA1_060860.1.1.m.52568,4.00985289188262e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_091870.1.1.m.43726,-0.0139247048655375,No,NA,NA,Q6R520,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_ACA1_394750.1.2.m.54181,0.0230608754800419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAA2.1.1.m.30666,0.000414640756224473,No,NA,NA,Q3T0R7,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],NA,NA,NA
CHOYP_ACAC.1.2.m.16888,-0.00448909342643071,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAC.2.2.m.58115,0.0108176389378393,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAD8.1.1.m.9135,-0.000363194164513493,No,NA,NA,Q9D7B6,NA,NA,NA,mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_ACADL.1.1.m.5508,-0.000701405857780772,No,NA,NA,P51174,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process; CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ACBD5.1.2.m.16744,0.0100169360846495,No,NA,NA,Q5T8D3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_ACBP.1.4.m.15501,-0.000689027670362242,No,NA,NA,Q9PRL8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_ACDOPBH.1.9.m.8787,0.00401782368367169,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.5.9.m.42992,0.00840547573011016,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.8.9.m.52946,-0.0112177103567892,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.9.9.m.63296,0.00713274894430512,No,NA,NA,Q98ST7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_ACE.2.4.m.5302,0.0100422679702148,No,NA,NA,Q10751,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; exopeptidase activity [GO:0008238]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ACE.4.4.m.17563,-0.00725317740132619,No,NA,NA,P09470,NA,NA,NA,basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_ACH5.1.1.m.3951,-0.00920232778448107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACH7.2.2.m.66217,-0.00717794334536034,No,NA,NA,Q27218,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of locomotion [GO:0040012]; regulation of membrane potential [GO:0042391]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ACIN1A.2.2.m.51408,-0.00064973690653169,No,NA,NA,Q9JIX8,NA,NA,NA,ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; apoptotic chromosome condensation [GO:0030263]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ACL6B.1.1.m.62588,-0.00152334806236111,No,NA,NA,O94805,NA,NA,NA,nBAF complex [GO:0071565]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_ACLA_093460.1.1.m.41459,2.17073119044691e-05,No,NA,NA,O36022,NA,NA,NA,alpha-1;6-mannosyltransferase complex [GO:0000136]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; cell wall mannoprotein biosynthetic process [GO:0000032]; mannosylation [GO:0097502]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_ACLY.1.1.m.65081,-0.000857266326007397,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_ACO13.1.1.m.30659,-0.00174341938316348,No,NA,NA,Q5R833,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617],NA,NA,NA
CHOYP_ACON.1.1.m.61060,-0.000565462836263725,No,NA,NA,Q99798,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ACOX1.3.3.m.26948,-0.0245410576700781,No,NA,NA,Q9R0H0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ACOX3.1.1.m.60111,-0.012821473891982,No,NA,NA,O15254,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ACSA.1.1.m.61294,0.00099540719295515,No,NA,NA,Q9VP61,NA,NA,NA,cytoplasm [GO:0005737]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; short-chain fatty acid-CoA ligase activity [GO:0031955]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; behavioral response to ethanol [GO:0048149]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACSF2.2.4.m.30204,-0.0110351307305352,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_ACSF3.1.1.m.14825,0.000140907714334172,No,NA,NA,Q58DN7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; malonate catabolic process [GO:0090410],NA,NA,NA
CHOYP_ACSL1.1.1.m.685,0.000125286298500508,No,NA,NA,Q9JID6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_ACSL1.1.1.m.686,0.00256987604954054,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_ACSL4.1.1.m.24576,-0.000476150146757597,No,NA,NA,Q9QUJ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_ACSM3.1.1.m.23686,0.00340270815264472,No,NA,NA,Q3UNX5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACSS3.1.1.m.64144,-0.0035019506015716,No,NA,NA,Q5REB8,NA,NA,NA,mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.13.27.m.39351,-0.00297091613952362,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.19.27.m.53936,-0.000315166285968299,No,NA,NA,Q5R9Z1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ACT.22.27.m.58204,-0.00297146274448756,No,NA,NA,P10994,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.4.27.m.14034,0.0061110898165419,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.3.7.m.25836,0.00616377161672059,No,NA,NA,P53470,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.4.7.m.29125,-0.0126393065637246,No,NA,NA,P02578,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.1.3.m.23292,0.0126103062078225,No,NA,NA,P41340,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.3.3.m.66907,0.00088853912485534,No,NA,NA,Q25010,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25941,0.015337965893588,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25943,-0.00271411596723705,No,NA,NA,P52503,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; cardiovascular system development [GO:0072358]; fatty acid metabolic process [GO:0006631]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_ACT5.3.3.m.41147,-0.0157069222673559,No,NA,NA,P53505,NA,NA,NA,cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.2.6.m.15315,0.0017480389335904,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.3.6.m.21571,0.0134709011625361,No,NA,NA,P17126,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTN.1.2.m.15252,0.00155832842665643,No,NA,NA,L7UZ85,NA,NA,NA,actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]; actin filament bundle assembly [GO:0051017],NA,NA,NA
CHOYP_ACTN.2.2.m.63975,0.00985748116251912,No,NA,NA,P18091,NA,NA,NA,focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; cytoskeletal anchoring at plasma membrane [GO:0007016]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_ACTP1.1.1.m.30455,-0.00233464198396088,No,NA,NA,Q5UCA8,NA,NA,NA,extrinsic component of membrane [GO:0019898]; pore complex [GO:0046930]; channel activity [GO:0015267]; cation transport [GO:0006812]; hemolysis in other organism involved in symbiotic interaction [GO:0052331]; pore complex assembly [GO:0046931],NA,NA,NA
CHOYP_ACTZ.1.1.m.12877,0.00242671924522586,No,NA,NA,P85515,NA,NA,NA,cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; COPI-coated vesicle [GO:0030137]; dynactin complex [GO:0005869]; manchette [GO:0002177]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ADA.1.1.m.5625,0.00404266501639099,No,NA,NA,Q6DG22,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],NA,NA,NA
CHOYP_ADA17.1.3.m.798,0.00707441745306021,No,NA,NA,Q568K2,NA,NA,NA,nucleus [GO:0005634]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ADA17.3.3.m.54971,0.00197489202007126,No,NA,NA,P27169,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_ADAL.1.1.m.57556,0.0080766661216076,No,NA,NA,Q4V9P6,NA,NA,NA,adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ADAMTS12.1.2.m.29930,0.017057954112585,No,NA,NA,Q9UKP5,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976],NA,NA,NA
CHOYP_ADAMTS16.1.1.m.28149,-0.0121077252836637,No,NA,NA,Q8TE56,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_ADAMTS18.1.2.m.4932,0.000752196980754872,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ADAR.2.3.m.45677,-0.010439295512138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADHX.1.1.m.60159,0.000515038490374993,No,NA,NA,P81431,NA,NA,NA,cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_AFG32.1.1.m.59372,-0.0022875162705872,No,NA,NA,Q9Y4W6,NA,NA,NA,m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_AFG32.1.1.m.59373,0.00291860601210343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFUA_1G01020.33.50.m.43179,-0.0173733326597381,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AFUA_1G01020.7.50.m.19296,-0.00908578560103398,No,NA,NA,Q8Q0U0,NA,NA,NA,,NA,NA,NA
CHOYP_AFURIN2.1.1.m.59865,-0.0229681273489677,No,NA,NA,Q92824,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_AGAP_AGAP000232.1.1.m.1999,0.00236621074063103,No,NA,NA,Q9Z2H2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_AGAP_AGAP000991.1.1.m.5123,-0.0154392921504232,No,NA,NA,Q9JJL8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_AGAP_AGAP002199.1.1.m.25337,-0.00919429513069586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37286,0.00276733263682822,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37287,0.00386971719137405,No,NA,NA,P53683,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777],NA,NA,NA
CHOYP_AGAP_AGAP002739.1.5.m.19925,-0.000884524440549974,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_AGAP_AGAP002739.3.5.m.47030,0.00212138364188989,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AGAP_AGAP002739.4.5.m.55695,0.00187220314076715,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_AGAP_AGAP002739.5.5.m.60925,0.00222412788627117,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AGAP_AGAP004136.1.3.m.24172,0.00831011622887472,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44418,-0.00530684378394835,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44420,-0.000920377683237314,No,NA,NA,P62864,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AGAP_AGAP004179.1.1.m.33303,0.000372830232132666,No,NA,NA,Q86XE3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851],NA,NA,NA
CHOYP_AGAP_AGAP004481.1.1.m.8676,-0.0224066923286713,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP004499.1.1.m.13546,-0.00690442631832648,No,NA,NA,Q96JP0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_AGAP_AGAP004861.2.2.m.54567,0.000635952200413251,No,NA,NA,P28648,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_AGAP_AGAP004868.1.1.m.60336,0.000878882639561516,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AGAP_AGAP004885.1.1.m.29831,0.00968144616015443,No,NA,NA,B1AR13,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034],NA,NA,NA
CHOYP_AGAP_AGAP005057.1.1.m.62428,0.00895183094603121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP005942.1.3.m.3157,-0.000736979424673012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP006478.1.1.m.44472,0.000320696588710282,No,NA,NA,Q80TB8,NA,NA,NA,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_AGAP_AGAP006590.1.1.m.42108,-0.0118575849250922,No,NA,NA,P91620,NA,NA,NA,cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803],NA,NA,NA
CHOYP_AGAP_AGAP006810.1.2.m.12514,-0.0102472465551587,No,NA,NA,Q68ER9,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_AGAP_AGAP007120.1.1.m.57542,0.00208253872104318,No,NA,NA,Q01768,NA,NA,NA,cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_AGAP_AGAP007340.1.2.m.2953,0.00266326827053906,No,NA,NA,P11167,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to osmotic stress [GO:0006970]; response to Thyroglobulin triiodothyronine [GO:1904016]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_AGAP_AGAP007368.1.1.m.8474,-0.000706792936873611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP007681.1.1.m.36727,-0.00834331354019038,No,NA,NA,P55040,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGAP_AGAP008046.1.1.m.58394,-0.000377018262358847,No,NA,NA,Q4V920,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_AGAP_AGAP008287.1.1.m.58727,-0.00226983008643247,No,NA,NA,Q8AVR4,NA,NA,NA,Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62503,-0.00547237466976356,No,NA,NA,Q8NDA2,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62505,-0.000254363829808574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP010490.1.1.m.51445,0.017506834524569,No,NA,NA,Q8TDJ6,NA,NA,NA,cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_AGAP_AGAP011617.1.2.m.29071,0.00631609679808721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP013102.1.1.m.50186,-0.01090711477922,No,NA,NA,Q29RU1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_AGO2.1.1.m.17145,0.00540575955498902,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGPS.1.1.m.62910,-0.0124567907548394,No,NA,NA,P97275,NA,NA,NA,nucleolus [GO:0005730]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611],NA,NA,NA
CHOYP_AGRIN.2.5.m.5339,0.00389162002326018,No,NA,NA,P25304,NA,NA,NA,axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_AGRIN.3.5.m.5652,0.00251476745770731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGRIN.4.5.m.27580,-0.00805113827262726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGSA.1.1.m.5200,0.0181625519053454,No,NA,NA,P15287,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_AHCTF1.1.1.m.17461,-0.00322191087926394,No,NA,NA,Q8CJF7,NA,NA,NA,chromatin [GO:0000785]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell cycle [GO:0007049]; cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AIFM1.1.1.m.1582,0.0017484179087254,No,NA,NA,O95831,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065],NA,NA,NA
CHOYP_AIMP1.1.1.m.16360,-0.00157371834978092,No,NA,NA,O54873,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],NA,NA,NA
CHOYP_AJL2.1.1.m.26431,0.0111687011567351,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_AK5.1.2.m.7331,-0.0125574381853297,No,NA,NA,A4IFD0,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_AKD1.2.3.m.49697,0.00950747479055782,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKD1.3.3.m.63103,-0.00500340770159117,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKP13.1.5.m.12951,0.00211377937900618,No,NA,NA,Q12802,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein kinase A binding [GO:0051018]; protein-containing complex scaffold activity [GO:0032947]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_AKT1.2.2.m.51125,-0.00239002275738106,No,NA,NA,Q8INB9,NA,NA,NA,cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration; open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_AL1A1.1.1.m.24832,0.00105835047175479,No,NA,NA,Q8MI17,NA,NA,NA,cytosol [GO:0005829]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; retinal dehydrogenase activity [GO:0001758]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_AL4A1.1.1.m.28988,0.00233385030928335,No,NA,NA,Q7SY23,NA,NA,NA,mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; identical protein binding [GO:0042802]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_AL8A1.1.1.m.13904,0.00656999570183989,No,NA,NA,Q66I21,NA,NA,NA,cytoplasm [GO:0005737]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; liver development [GO:0001889],NA,NA,NA
CHOYP_ALAT2.1.1.m.15163,-0.00141460963032641,No,NA,NA,Q6GM82,NA,NA,NA,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_ALDH2.3.3.m.25044,0.000752177586197515,No,NA,NA,P20000,NA,NA,NA,mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_ALDR.1.1.m.50075,-0.000156960152168661,No,NA,NA,P82125,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 1;5-anhydro-D-fructose reductase activity [GO:0050571]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ALF.1.3.m.25601,0.0023584471080897,No,NA,NA,P53442,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.2.3.m.40474,0.000824563194681213,No,NA,NA,Q9GP32,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.3.3.m.66837,0.00885035619579521,No,NA,NA,P53442,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALG1.1.1.m.40067,-0.00766690810588912,No,NA,NA,Q921Q3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_ALKB8.1.2.m.27789,2.10617820988169e-05,No,NA,NA,Q95K79,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ALPHATUB84D.1.1.m.16562,0.00979200048225874,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_ALS2.1.3.m.33568,-0.00508972767183501,No,NA,NA,Q96Q42,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_ALS2.2.3.m.37861,0.0227706096598378,No,NA,NA,P06144,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_AMDHD2.2.2.m.52160,-0.0169068697890714,No,NA,NA,Q6P0U0,NA,NA,NA,metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_AMO.1.5.m.28337,0.00825955373150233,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMO.5.5.m.66428,0.0298098499580778,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMPD2.1.2.m.1295,-0.0177819786340703,No,NA,NA,Q01433,NA,NA,NA,cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_AMPL.1.1.m.27061,-0.000829661413793157,No,NA,NA,P00727,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_AMRP.1.1.m.36070,-0.0122664510857467,No,NA,NA,P30533,NA,NA,NA,cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259],NA,NA,NA
CHOYP_AMY.2.3.m.15473,-0.00594067871702766,No,NA,NA,P91778,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AMY.3.3.m.64271,0.00545061005118532,No,NA,NA,P91778,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_ANGP4.3.7.m.24608,0.0106254418677603,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_ANGP4.4.7.m.33574,-0.00582120767209558,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_ANK.2.3.m.19487,-0.00690110993271967,No,NA,NA,G5E8K5,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_ANK3.3.9.m.6798,0.000218405114264212,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANKK1.1.1.m.56194,0.0128304262738387,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ANKMY2.1.1.m.18238,0.00590730905146984,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANKRD27.1.1.m.12550,-0.0051428844185351,No,NA,NA,Q5REW9,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ANKRD5.1.2.m.11711,0.000804198358396117,No,NA,NA,Q9D2J7,NA,NA,NA,,NA,NA,NA
CHOYP_ANKY2.2.2.m.44213,0.0197129883421087,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANLN.1.1.m.6530,0.00715105054840837,No,NA,NA,Q801E2,NA,NA,NA,bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172],NA,NA,NA
CHOYP_ANM3.1.1.m.376,-0.00718796664682115,No,NA,NA,O60678,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ANM5.1.1.m.1529,0.000703473973178809,No,NA,NA,O14744,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; cell proliferation [GO:0008283]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription; termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ANR11.1.1.m.56842,0.0141249691817183,No,NA,NA,Q6UB98,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ANR17.1.2.m.772,-0.0018190056266605,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_ANR31.1.1.m.61075,-0.00136607466425726,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_ANR40.1.1.m.1429,0.00998493505119696,No,NA,NA,Q5SUE8,NA,NA,NA,,NA,NA,NA
CHOYP_ANS1B.1.1.m.46724,0.00245725607397964,No,NA,NA,A5PMU4,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],NA,NA,NA
CHOYP_ANT_25430.2.2.m.5862,0.000595103975103514,No,NA,NA,P55906,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_ANXA4.1.2.m.19913,-0.00184320774283473,No,NA,NA,P08132,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; epithelial cell differentiation [GO:0030855]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_ANXA7.1.4.m.4514,-0.00383344596405542,No,NA,NA,Q07076,NA,NA,NA,chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_AP1G1.1.1.m.13111,0.00084927396533878,No,NA,NA,P22892,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP1M1.1.1.m.56248,-2.18629497951756e-05,No,NA,NA,Q9BXS5,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690],NA,NA,NA
CHOYP_AP2A2.1.1.m.62726,0.000379093072066366,No,NA,NA,P17427,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP2M1.1.1.m.25996,0.00333014573598573,No,NA,NA,Q5ZMP6,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP2S1.1.1.m.61530,0.0112722059198014,No,NA,NA,P62744,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP3M2.1.1.m.43706,0.000159080133713687,No,NA,NA,Q5R478,NA,NA,NA,axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Rab GTPase binding [GO:0017137]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_APBP2.1.1.m.62244,0.00698423261206278,No,NA,NA,A5HK05,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_API5.1.1.m.17066,-0.000617952983947576,No,NA,NA,Q9BZZ5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270],NA,NA,NA
CHOYP_APLA.1.2.m.191,-0.00025565409553019,No,NA,NA,O88444,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226],NA,NA,NA
CHOYP_APLP.1.2.m.5955,-0.0102779589813358,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APLP.2.2.m.55987,-0.0102779389482259,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APN.1.3.m.316,0.0056533044953855,No,NA,NA,O57579,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_APPBP2.1.1.m.9093,-0.0138778673221413,No,NA,NA,Q92624,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_AQR.1.1.m.9127,-0.000903657003713501,No,NA,NA,O60306,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ARALYDRAFT_472154.1.1.m.29819,0.00569312885859755,No,NA,NA,Q9FSG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ARC1A.1.1.m.56262,0.00198173892186275,No,NA,NA,Q92747,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_ARC1A.1.1.m.56263,0.00378143148099224,No,NA,NA,Q1JP79,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARF2.1.3.m.10738,0.000135230098956971,No,NA,NA,P84082,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF4.1.2.m.8401,-0.0050233709899457,No,NA,NA,P51644,NA,NA,NA,Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF6.1.2.m.3974,0.00696219137671023,No,NA,NA,P62332,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARGI.1.2.m.3263,0.00276007980319427,No,NA,NA,P49900,NA,NA,NA,arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ARH.2.2.m.25884,0.00958303286945006,No,NA,NA,Q801G1,NA,NA,NA,cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_ARHG7.3.5.m.37182,-0.000603853591532751,No,NA,NA,O55043,NA,NA,NA,cell cortex [GO:0005938]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; astrocyte cell migration [GO:0043615]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_ARHGAP12B.1.2.m.36731,0.00111714466953172,No,NA,NA,Q8C0D4,NA,NA,NA,cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis; engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGAP8.1.1.m.25503,-0.00141594279081201,No,NA,NA,P85298,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGEF3.1.1.m.13898,-0.00763270113564205,No,NA,NA,Q9N0A8,NA,NA,NA,cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_ARI2.1.1.m.34963,-0.0214799842540514,No,NA,NA,O76924,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARI4B.1.1.m.56056,0.00302520294562167,No,NA,NA,Q9JKB5,NA,NA,NA,nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ARID3A.1.1.m.55743,0.0186629297431446,No,NA,NA,Q5XGD9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ARIP4.3.3.m.33366,0.0105497776088721,No,NA,NA,A4IHD2,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_ARL6.1.2.m.29833,0.00489810661132535,No,NA,NA,Q5M9P8,NA,NA,NA,axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ARL6IP1.1.1.m.13877,0.00372603328025145,No,NA,NA,Q9JKW0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038],NA,NA,NA
CHOYP_ARL8A.1.1.m.12151,0.000635338445423167,No,NA,NA,Q6P8C8,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],NA,NA,NA
CHOYP_ARMC6.1.1.m.28786,-0.0031108236615496,No,NA,NA,Q8BNU0,NA,NA,NA,cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_ARMC9.1.1.m.57265,-0.00675495650635113,No,NA,NA,Q5R629,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_ARNT.1.1.m.19078,0.00532864721979348,No,NA,NA,O15945,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ARP2.1.1.m.43520,0.000988739571110271,No,NA,NA,Q5BL41,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ARP3.1.1.m.6867,0.00378267663975264,No,NA,NA,Q5R8R1,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],NA,NA,NA
CHOYP_ARP6.1.1.m.17920,0.000513826492165991,No,NA,NA,Q9GZN1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338],NA,NA,NA
CHOYP_ARP8.1.1.m.10729,0.00725670443999975,No,NA,NA,D2I1E3,NA,NA,NA,centrosome [GO:0005813]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_ARPC2.1.1.m.50573,0.00357934347717637,No,NA,NA,Q3MHR7,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARPC4.2.2.m.35677,0.00119931252615833,No,NA,NA,P59999,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein binding; bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARRB.1.2.m.25932,0.00205043785673602,No,NA,NA,Q4R562,NA,NA,NA,clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARRD.6.1.1.m.9470,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ARRD3.2.2.m.64983,0.00818746509556533,No,NA,NA,Q7TPQ9,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ASB3.1.1.m.51103,0.0213770916937917,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_ASCC1.1.1.m.39863,0.00836348811916054,No,NA,NA,Q9D8Z1,NA,NA,NA,neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC2.1.1.m.34978,0.00531828350354868,No,NA,NA,Q9H1I8,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC3.1.1.m.51755,-0.0113650368476979,No,NA,NA,F1NTD6,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent helicase activity [GO:0008026]; nucleic acid binding [GO:0003676]; cell proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508],NA,NA,NA
CHOYP_ASGR2.3.4.m.47793,0.00261076966003958,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_ASK1.1.2.m.586,0.00639887320789534,No,NA,NA,Q6ZN16,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186],NA,NA,NA
CHOYP_ASM.1.1.m.21521,0.00414321979580736,No,NA,NA,Q04519,NA,NA,NA,endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_ASMTL.1.1.m.20115,0.0002943039038314,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_ASNA.1.1.m.52208,0.00202695310845282,No,NA,NA,B0WEV5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048],NA,NA,NA
CHOYP_ASPH.1.2.m.35319,-0.00240139130742646,No,NA,NA,Q8BSY0,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021],NA,NA,NA
CHOYP_ASPM.1.4.m.6650,0.0297730968411536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASSY.2.4.m.43713,0.00358941972534905,No,NA,NA,Q66I24,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ASUN.1.1.m.6333,0.00470347511557262,No,NA,NA,Q9NVM9,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_AT1.1.1.m.66793,-0.00621897839872119,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_AT10A.1.1.m.56662,0.0115890277465007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AT1A.1.1.m.18017,0.000151233962939387,No,NA,NA,Q6RWA9,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391],NA,NA,NA
CHOYP_AT5F1.1.1.m.12896,-0.00116915801266332,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ATC1.1.1.m.5160,0.000171997897169019,No,NA,NA,Q7PPA5,NA,NA,NA,integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATC1.1.1.m.5161,-0.0105157709838411,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ATE1.1.3.m.6901,-0.00504825509070692,No,NA,NA,Q9Z2A5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598],NA,NA,NA
CHOYP_ATG2A.1.1.m.57169,0.00777474323052492,No,NA,NA,Q96BY7,NA,NA,NA,extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422],NA,NA,NA
CHOYP_ATG3.1.1.m.25570,0.00327795086126413,No,NA,NA,Q5I0S6,NA,NA,NA,cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ATG7.1.1.m.34175,0.00213198708845102,No,NA,NA,Q9D906,NA,NA,NA,axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell development [GO:0055013]; cellular homeostasis [GO:0019725]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; suppression by virus of host autophagy [GO:0039521],NA,NA,NA
CHOYP_ATIC.1.1.m.17816,-0.00247121066537705,No,NA,NA,P31335,NA,NA,NA,cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_ATP13A.1.1.m.10161,0.000391361905662422,No,NA,NA,Q9EPE9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATP2B3.1.1.m.6573,-0.0064218018720231,No,NA,NA,Q16720,NA,NA,NA,extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-transporting ATPase activity [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_ATP5B.1.1.m.22321,0.00318172600470021,No,NA,NA,Q05825,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5C1.1.1.m.16222,-0.000197354471377593,No,NA,NA,O01666,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5H.1.1.m.22927,-0.001914881387934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATP6AP1.1.1.m.18150,-0.00613808646902857,No,NA,NA,Q15904,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; Rab GTPase binding [GO:0017137]; transporter activity [GO:0005215]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_ATP7A.1.1.m.23099,-0.0112234423362267,No,NA,NA,P70705,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper-exporting ATPase activity [GO:0004008]; copper-transporting ATPase activity [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_ATPA.1.1.m.50245,-0.000935888551040276,No,NA,NA,P80021,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; plasma membrane [GO:0005886]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ATPB.1.1.m.21960,-0.00240342531709085,No,NA,NA,Q25117,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_ATRIP.1.1.m.15992,0.00575341029238196,No,NA,NA,Q8WXE1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; interstrand cross-link repair [GO:0036297],NA,NA,NA
CHOYP_ATRX.1.1.m.14705,-0.00870628109793026,No,NA,NA,Q7YQM4,NA,NA,NA,condensed nuclear chromosome; centromeric region [GO:0000780]; nuclear chromosome; telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ATS10.1.1.m.43473,0.00212089493748671,No,NA,NA,Q8TE60,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331],NA,NA,NA
CHOYP_ATS16.2.4.m.14579,0.0202572328979614,No,NA,NA,Q8TE57,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS2.1.2.m.39791,0.00540395235311859,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS20.2.2.m.52571,0.00295626027419168,No,NA,NA,O15072,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],NA,NA,NA
CHOYP_ATS6.3.3.m.56109,-0.0145987733540049,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATXN10.1.1.m.33209,-0.00774092685834195,No,NA,NA,Q5FVB0,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_AUHM.1.2.m.28847,-0.0162178667854978,No,NA,NA,F1LU71,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_AUHM.2.2.m.44102,-0.000455685526665197,No,NA,NA,Q3TLP5,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_BACH1.3.17.m.6935,0.00651627872095498,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BACH1.8.17.m.18006,-0.0015755767914791,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BACOIKO003_21.1.1.m.44123,0.00262207692591081,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAG1.2.2.m.60616,0.00436978773325364,No,NA,NA,Q99933,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_BAG3.1.1.m.15160,0.0212275112356189,No,NA,NA,O95429,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; regulation of cellular response to heat [GO:1900034]; ruffle assembly [GO:0097178]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BAG6A.1.1.m.25802,-0.00646918811320493,No,NA,NA,A3KPW9,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BAI1.1.2.m.4434,-0.011525714339424,No,NA,NA,Q9HAR2,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_BAP18.1.1.m.48944,-0.00480943006605038,No,NA,NA,Q9DCT6,NA,NA,NA,cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_BAP31.1.1.m.62939,-0.00475312025468556,No,NA,NA,Q5R8H3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BARBAKC583_0145.1.1.m.10555,0.000399946945030334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAT1.4.4.m.32273,-0.0157126799886224,No,NA,NA,P82251,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_BAX.1.1.m.30787,0.0021696098899618,No,NA,NA,O02703,NA,NA,NA,BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],NA,NA,NA
CHOYP_BAZ1A.1.1.m.9485,-0.00930403763344549,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BAZ1B.1.1.m.24480,-0.00799239255102417,No,NA,NA,Q9UIG0,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BBOV_II003210.5.13.m.30678,0.00692988924748675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BBS4.1.1.m.50943,0.00280427456822119,No,NA,NA,Q96RK4,NA,NA,NA,BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BBS5.1.1.m.56560,0,No,NA,NA,Q7ZWB7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],NA,NA,NA
CHOYP_BCAS0157.2.2.m.53484,0.00080177638305658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BCAS3.1.1.m.6968,-0.00554123812246962,No,NA,NA,Q9H6U6,NA,NA,NA,cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148],NA,NA,NA
CHOYP_BCAT1.1.1.m.54127,-0.000841070807498314,No,NA,NA,Q5EA40,NA,NA,NA,mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099],NA,NA,NA
CHOYP_BCKD.2.2.m.60038,-0.00777559562088924,No,NA,NA,O14874,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; phosphorylation [GO:0016310],NA,NA,NA
CHOYP_BCL3.1.2.m.56007,0.0124964552824277,No,NA,NA,P20749,NA,NA,NA,Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein binding; bridging [GO:0030674]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus; translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BCL3.2.2.m.57485,-0.00674555032386518,No,NA,NA,Q9WTK5,NA,NA,NA,Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; aging [GO:0007568]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; lymph node development [GO:0048535]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; rhythmic process [GO:0048511]; spleen development [GO:0048536],NA,NA,NA
CHOYP_BCL7A.1.1.m.29528,0.00312339244756179,No,NA,NA,Q9CXE2,NA,NA,NA,,NA,NA,NA
CHOYP_BDH2.1.2.m.30737,0.000804434537825166,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDH2.2.2.m.57286,-0.0144242052496981,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDHB.1.1.m.9128,-0.0110421397762945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BGAL.2.2.m.41942,0.00232588596165936,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BH13620.1.1.m.41020,-0.0082464828688779,No,NA,NA,P24928,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription; termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription; DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BICD2.1.1.m.9177,-0.0135029834027795,No,NA,NA,Q8BR07,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032],NA,NA,NA
CHOYP_BICRD.1.1.m.11088,0.000300177968693805,No,NA,NA,Q8SWR2,NA,NA,NA,,NA,NA,NA
CHOYP_BIG1.1.3.m.6444,0.00758523593012707,No,NA,NA,G3X9K3,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG1.3.3.m.34442,0.000800572762880365,No,NA,NA,Q9Y6D6,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG3.1.1.m.51447,-0.00697268858966364,No,NA,NA,Q5TH69,NA,NA,NA,integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_BIG3.1.1.m.51448,0.00775957343192704,No,NA,NA,Q9Z2W1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_BIR7B.2.2.m.60973,-0.0131514974174604,No,NA,NA,P41436,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BIRA.1.1.m.18343,0.00204245171214521,No,NA,NA,P0CI75,NA,NA,NA,ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BIRC6.1.2.m.51516,-0.00405070536013959,No,NA,NA,Q9NR09,NA,NA,NA,endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BIRC7.3.5.m.22702,-0.00614634106429898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BL1S2.1.1.m.11618,-0.00252790407330213,No,NA,NA,Q66KB9,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]; gamma-tubulin binding [GO:0043015]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455],NA,NA,NA
CHOYP_BLIMP.1.1.1.m.55502,-0.00011888297504318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BLMH.1.1.m.66065,-0.000811942384443422,No,NA,NA,Q13867,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BLOC1S4.1.1.m.22903,0.000589981332484366,No,NA,NA,Q8VED2,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_BLVRA.1.1.m.17904,-0.0146462989794258,No,NA,NA,Q9CY64,NA,NA,NA,cytosol [GO:0005829]; biliverdin reductase activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BM1_00205.2.4.m.5170,0.00188552721092702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_05690.1.1.m.23253,0.00468536660183359,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_24035.1.1.m.40152,0.00151795732420025,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BM1_57400.5.7.m.58033,0.0157549241286806,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_BM8F.1.2.m.3009,0.0176994156069521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM8F.2.2.m.35731,0.0158518759957589,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BMS1.1.1.m.17619,-0.0115940638337275,No,NA,NA,Q14692,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BN6_64710.1.1.m.52168,-0.0114619112862278,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_BOP1.1.1.m.66373,-0.00762799136533946,No,NA,NA,A0JMQ0,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_BPHL.1.1.m.55822,0.0132268839169561,No,NA,NA,Q8R164,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BPTF.1.1.m.25244,0.00207419580618521,No,NA,NA,Q9W0T1,NA,NA,NA,NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of JAK-STAT cascade [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of Notch signaling pathway [GO:0045747]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAF.2.3.m.21192,-0.0145909325835671,No,NA,NA,P15056,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive; alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542],NA,NA,NA
CHOYP_BRAFLDRAFT_100614.1.1.m.31700,0.00570413354534845,No,NA,NA,Q92636,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_100695.1.1.m.47761,0.00366741584929465,No,NA,NA,Q2T9T0,NA,NA,NA,phosphatase binding [GO:0019902],NA,NA,NA
CHOYP_BRAFLDRAFT_101346.1.1.m.1028,-0.0015917447027446,No,NA,NA,Q6PDY2,NA,NA,NA,mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_102226.1.1.m.48829,-0.0069799846615838,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_102424.4.6.m.51652,0.000531116957492174,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_103544.1.1.m.38439,0.0143536496180925,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_104092.10.11.m.53767,-0.0211759445394205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_104160.1.1.m.29524,0.00127299012909312,No,NA,NA,Q91Z53,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_BRAFLDRAFT_104267.1.1.m.52332,-0.00805711621448791,No,NA,NA,Q5ZK69,NA,NA,NA,proteasome complex [GO:0000502],NA,NA,NA
CHOYP_BRAFLDRAFT_104472.1.1.m.16220,0.00199733785240794,No,NA,NA,Q6P963,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_BRAFLDRAFT_104488.3.3.m.2973,-0.0099633601907296,No,NA,NA,Q9Y535,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384],NA,NA,NA
CHOYP_BRAFLDRAFT_105037.1.1.m.17483,-0.000357391702048775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_105238.1.1.m.18657,-0.00116446502003057,No,NA,NA,Q9H269,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion; non-autophagic [GO:0032889]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.10.14.m.46985,-0.0067706762289251,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62780,-0.010848588867128,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.4.14.m.5053,0.00882397984611014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_107506.1.1.m.15759,0.0207663073281488,No,NA,NA,Q29M42,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_108193.2.2.m.37878,0.00810725727408864,No,NA,NA,Q86VX2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription; DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.2.5.m.31493,-0.0197749296735066,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.3.5.m.34514,0.0106258693572452,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.4.5.m.45892,-0.0136727863194488,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_109077.1.1.m.7494,0,No,NA,NA,Q6CEJ6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_109340.1.1.m.30107,0.00561227073077419,No,NA,NA,Q60769,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein self-association [GO:0043621]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573],NA,NA,NA
CHOYP_BRAFLDRAFT_109688.1.1.m.59704,0.0162213914841987,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_BRAFLDRAFT_113534.1.1.m.10828,0.00405594903899125,No,NA,NA,Q03161,NA,NA,NA,carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; cellular carbohydrate metabolic process [GO:0044262],NA,NA,NA
CHOYP_BRAFLDRAFT_113552.1.1.m.29171,0.00119999741646726,No,NA,NA,Q1W374,NA,NA,NA,cytoplasm [GO:0005737]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_BRAFLDRAFT_113596.1.1.m.53557,-0.00511831355057482,No,NA,NA,A4IGP0,NA,NA,NA,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53398,0.000438072860136515,No,NA,NA,Q9D8W5,NA,NA,NA,cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53400,-1.00117862100992e-05,No,NA,NA,Q7ZUB2,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_113892.1.1.m.44055,-0.00598858022558972,No,NA,NA,P48508,NA,NA,NA,glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_114006.1.1.m.49056,-0.00150146380099012,No,NA,NA,Q6GNT9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_114106.1.1.m.28307,0.000276403425216806,No,NA,NA,P54921,NA,NA,NA,glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; positive regulation of ATPase activity [GO:0032781]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_114158.1.1.m.24733,0.00609788743453585,No,NA,NA,Q5R9J9,NA,NA,NA,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; dendrite development [GO:0016358]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114204.1.1.m.15168,0.00969119228948262,No,NA,NA,A6QP05,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_114379.1.1.m.57424,0.00140299438204798,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_BRAFLDRAFT_114488.1.1.m.6260,-0.00197511203639146,No,NA,NA,Q9UNX4,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_114510.1.1.m.52252,0.00478347277650549,No,NA,NA,Q0VFM0,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114633.1.1.m.49577,-0.0238737905047551,No,NA,NA,Q62348,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697],NA,NA,NA
CHOYP_BRAFLDRAFT_114709.1.1.m.17347,0.0159821644994447,No,NA,NA,Q8IW92,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_114843.2.2.m.57232,-0.00148793348558133,No,NA,NA,Q7TP17,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_114859.1.1.m.37271,0.00920695344463553,No,NA,NA,Q15119,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.1.5.m.6859,0.000414982962131829,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35626,0.0111861627308062,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35627,-0.00021185508428236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_114978.1.1.m.43775,0.00318256285897844,No,NA,NA,Q5IFJ8,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_BRAFLDRAFT_115029.1.2.m.8365,0.0140545902612272,No,NA,NA,Q95NI4,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_115040.1.1.m.28389,-0.000236856607965851,No,NA,NA,Q8VC30,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; glycolytic process through fructose-1-phosphate [GO:0061625]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_BRAFLDRAFT_115113.1.2.m.31023,0.00127662222765815,No,NA,NA,Q99417,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_115208.1.1.m.52467,0.0062080828695763,No,NA,NA,A4IIL4,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_115265.1.1.m.5158,-0.00164266784862915,No,NA,NA,Q5R792,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; cellular homeostasis [GO:0019725]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; negative regulation of apoptotic process [GO:0043066]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_BRAFLDRAFT_115608.1.1.m.25984,0.000377823842598391,No,NA,NA,Q4R502,NA,NA,NA,mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_115611.1.1.m.33392,0.00784402359222516,No,NA,NA,Q9DCN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_BRAFLDRAFT_115639.1.1.m.11373,-0.00674523176678043,No,NA,NA,Q9D287,NA,NA,NA,centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_115687.1.1.m.4876,0.0040643886833724,No,NA,NA,O57476,NA,NA,NA,cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_115743.1.1.m.61177,0.000606933574559833,No,NA,NA,Q9WTP6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060],NA,NA,NA
CHOYP_BRAFLDRAFT_115771.2.2.m.30817,-0.00311991326067475,No,NA,NA,Q0MQI9,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_BRAFLDRAFT_115951.1.1.m.22622,0.0066686158380313,No,NA,NA,P17276,NA,NA,NA,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571],NA,NA,NA
CHOYP_BRAFLDRAFT_116041.1.1.m.3962,0.000438508151099055,No,NA,NA,Q5I0D1,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_116053.1.1.m.63017,-0.0136580599167479,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_116088.2.2.m.27531,-0.00698491022477542,No,NA,NA,Q9H0A8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_116394.1.1.m.57079,0.000112295642132768,No,NA,NA,Q6NRT5,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_BRAFLDRAFT_116913.1.1.m.43886,-0.00107774410870092,No,NA,NA,Q4QQQ7,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_116988.1.3.m.3947,0.0176938486466913,No,NA,NA,P56941,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BRAFLDRAFT_117028.1.1.m.26596,-0.0232767280467411,No,NA,NA,Q96LR7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117068.1.1.m.36193,0.00059272256439003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117083.3.3.m.59001,-0.0177144215281059,No,NA,NA,Q0VB26,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117106.1.1.m.49365,-0.00180277192662463,No,NA,NA,Q0V8F1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117157.1.3.m.7944,-0.0165931137602164,No,NA,NA,Q502W6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117158.2.2.m.42430,0.0078002243901058,No,NA,NA,Q9JKR5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome membrane [GO:0055038]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_117187.2.4.m.3553,0.0116470274559155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117216.1.1.m.25201,-0.0215492689819054,No,NA,NA,Q9JMD3,NA,NA,NA,cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],NA,NA,NA
CHOYP_BRAFLDRAFT_117231.1.1.m.4966,-0.00504477184099662,No,NA,NA,P36956,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; enzyme activator activity [GO:0008047]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_117263.1.1.m.28027,-0.00488137469904857,No,NA,NA,Q53T59,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; negative regulation of autophagy [GO:0010507]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_117275.1.1.m.9900,0.00450497596585884,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117282.2.6.m.13259,8.07373594105213e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117283.2.2.m.37544,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117284.5.7.m.53216,0.00489783815532381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117292.1.1.m.19637,0.00319880633735574,No,NA,NA,P53352,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412],NA,NA,NA
CHOYP_BRAFLDRAFT_117315.1.2.m.7247,0.000650552933500404,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.1.2.m.12413,-0.0108450324782605,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.2.2.m.31681,-0.0234766040223151,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117560.1.1.m.18467,-0.0128714592317042,No,NA,NA,Q3U829,NA,NA,NA,AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117612.1.1.m.28286,0.000867862371529167,No,NA,NA,P38024,NA,NA,NA,cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_BRAFLDRAFT_117629.2.2.m.31330,-0.00904598504261232,No,NA,NA,Q8CE72,NA,NA,NA,ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_BRAFLDRAFT_117631.1.1.m.45793,-0.0144215168203239,No,NA,NA,Q99P25,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_117675.1.1.m.33772,0.0164239004386531,No,NA,NA,Q4V847,NA,NA,NA,nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_BRAFLDRAFT_117737.1.1.m.4255,0.00769603282944718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117750.1.1.m.12162,0.00374998837680912,No,NA,NA,Q7L0X2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27127,0.00444045688090131,No,NA,NA,Q86IV5,NA,NA,NA,extracellular region [GO:0005576]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; multicellular organism development [GO:0007275]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of glucose-6-phosphatase activity [GO:0032114]; regulation of glycolytic process [GO:0006110]; response to UV-C [GO:0010225],NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27128,0.0162311781808796,No,NA,NA,Q6P823,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_BRAFLDRAFT_117821.1.1.m.16201,-0.00984751414734137,No,NA,NA,O88384,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_BRAFLDRAFT_117849.1.3.m.2806,0.00484376102311629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.2.3.m.4489,-0.000854207233977401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.3.3.m.5503,0.00657913840193494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117858.2.3.m.48274,-0.0013285977541942,No,NA,NA,Q8K2Z2,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395],NA,NA,NA
CHOYP_BRAFLDRAFT_117858.3.3.m.61651,-0.00831729653852224,No,NA,NA,Q5PPV2,NA,NA,NA,motile cilium [GO:0031514]; cell projection organization [GO:0030030],NA,NA,NA
CHOYP_BRAFLDRAFT_117875.1.1.m.48427,-0.000946808665783756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117937.1.1.m.18686,0.00160805246746757,No,NA,NA,Q6DBY2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion; centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_117940.1.1.m.59223,0,No,NA,NA,Q00808,NA,NA,NA,GTP binding [GO:0005525],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.1.3.m.22767,-0.00523522946454896,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.2.3.m.49156,-0.00240396371538792,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_118043.1.1.m.26278,0.00183580039727481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118054.1.1.m.18488,0.010095177007319,No,NA,NA,Q888A4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on NAD(P)H; oxygen as acceptor [GO:0050664],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.2.6.m.3049,-0.00436822870358741,No,NA,NA,Q6PGL7,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.6.6.m.45150,-0.0137604900517274,No,NA,NA,Q80X08,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118103.1.1.m.41767,0.00307534976351646,No,NA,NA,O14523,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid transporter activity [GO:0005548]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],NA,NA,NA
CHOYP_BRAFLDRAFT_118108.1.1.m.58962,5.01129966035622e-05,No,NA,NA,Q90ZE4,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053],NA,NA,NA
CHOYP_BRAFLDRAFT_118210.1.1.m.51280,-0.00603355982664743,No,NA,NA,B9FAF3,NA,NA,NA,kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_118250.1.1.m.11178,0.0170725842060709,No,NA,NA,O95295,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein-containing complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_118260.1.1.m.13621,-0.000517374477481721,No,NA,NA,Q5R6L5,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265],NA,NA,NA
CHOYP_BRAFLDRAFT_118294.2.2.m.15439,-0.00137836604259265,No,NA,NA,Q9R064,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_118310.1.1.m.8287,-0.00101414340101734,No,NA,NA,P46461,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_118365.1.1.m.44334,-0.0115610651627852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.1.3.m.29148,-0.00127466272687556,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.2.3.m.29362,-0.00265592746821786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.3.3.m.30322,5.39864110979987e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118430.2.2.m.44188,0.00694240537700261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118500.1.1.m.46374,-0.00239475576003752,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.3.8.m.35521,0.00259041416167964,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.6.8.m.55199,8.48269903332941e-05,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.8.8.m.61819,-0.00582196093055014,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118545.2.2.m.54585,0.00510987538921446,No,NA,NA,A0JPH4,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.2.5.m.17419,0.00651631129380845,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.4.5.m.26803,-5.20904325982076e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118619.2.2.m.4663,-0.00882737435934623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118645.1.1.m.30629,-0.0103571133137515,No,NA,NA,M4YFG7,NA,NA,NA,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_118680.1.1.m.14225,0.00326264854615076,No,NA,NA,Q9CZT4,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_118709.2.4.m.41225,0.00754563782550387,No,NA,NA,O15050,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118709.3.4.m.52468,-0.00736913954482326,No,NA,NA,Q8BV79,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118718.1.1.m.14739,0.00444677805596945,No,NA,NA,O75594,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; neutrophil degranulation [GO:0043312]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714],NA,NA,NA
CHOYP_BRAFLDRAFT_118735.1.1.m.6990,0.0166490441811877,No,NA,NA,Q5RKZ7,NA,NA,NA,molybdopterin synthase complex [GO:0019008]; 4 iron; 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3';8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_BRAFLDRAFT_118736.1.1.m.17458,-0.00298189075300789,No,NA,NA,Q8IYD8,NA,NA,NA,FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],NA,NA,NA
CHOYP_BRAFLDRAFT_118756.1.2.m.16721,0.00605722497179619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118772.1.1.m.59465,-0.0110786043990798,No,NA,NA,A2RT91,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_118789.2.3.m.59829,0.0012273889177755,No,NA,NA,P52758,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity; producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; platinum binding [GO:1904012]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; xenon atom binding [GO:1904013]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_118790.1.1.m.29970,0.000581689791142018,No,NA,NA,Q9C6B9,NA,NA,NA,cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphatidylcholine biosynthetic process [GO:0006656],NA,NA,NA
CHOYP_BRAFLDRAFT_118793.1.1.m.20795,0.00455039185744279,No,NA,NA,A4IFB6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_118803.1.1.m.14069,-0.0203308365418476,No,NA,NA,Q9HCD5,NA,NA,NA,actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],NA,NA,NA
CHOYP_BRAFLDRAFT_118819.1.2.m.29565,-0.00711174400075212,No,NA,NA,O75460,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing; via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_118961.1.1.m.8363,-0.0166820837075589,No,NA,NA,Q5RF36,NA,NA,NA,CIA complex [GO:0097361]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_119035.1.3.m.6973,-0.00153907258824033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119036.1.1.m.18576,-0.0203861199217155,No,NA,NA,Q8R3P7,NA,NA,NA,centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_119350.1.1.m.50169,-0.00149832391739818,No,NA,NA,Q5ZKD7,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; ATP binding [GO:0005524]; ATP-dependent 5'-3' RNA helicase activity [GO:0032575]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition; RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011],NA,NA,NA
CHOYP_BRAFLDRAFT_119363.1.1.m.41627,-0.00198106811984188,No,NA,NA,Q6KAR6,NA,NA,NA,exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_119367.1.1.m.59963,0.00575503437299773,No,NA,NA,Q3UWM4,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_119424.1.1.m.15350,0.00782859968648606,No,NA,NA,Q6DJK9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119484.2.3.m.60445,-0.0131905754768093,No,NA,NA,B5DF93,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290],NA,NA,NA
CHOYP_BRAFLDRAFT_119491.1.1.m.58761,-0.0145641549459911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119549.1.1.m.56597,-0.00874451928502927,No,NA,NA,Q5BK43,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119616.1.1.m.31670,0.00112417676478118,No,NA,NA,P30841,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_BRAFLDRAFT_119617.1.1.m.50138,0.000108849128412004,No,NA,NA,Q2YDR3,NA,NA,NA,integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_119774.4.4.m.33349,-0.00460095442103972,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_119799.1.1.m.23765,0.00193466381483616,No,NA,NA,P30044,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_119901.1.1.m.7089,-0.00858997980589022,No,NA,NA,P49916,NA,NA,NA,cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair; DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair; DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45319,0.0179038112238022,No,NA,NA,B0DOB4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; non-motile cilium [GO:0097730]; negative regulation of canonical Wnt signaling pathway [GO:0090090],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45320,-0.00142806374384025,No,NA,NA,Q9CR41,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_119955.1.1.m.16485,-0.00495862296308319,No,NA,NA,Q6NU94,NA,NA,NA,nucleus [GO:0005634]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_BRAFLDRAFT_119982.1.1.m.62398,0.00595768623283615,No,NA,NA,O95243,NA,NA,NA,chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_BRAFLDRAFT_120041.1.1.m.6386,-0.0118672905340373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120058.1.1.m.9895,0.00336636439116386,No,NA,NA,Q8WWB3,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_BRAFLDRAFT_120093.2.2.m.51468,0.00300372714973312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120139.4.5.m.50713,-0.00609434275422484,No,NA,NA,Q60997,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; extracellular matrix structural constituent [GO:0005201]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_120431.1.1.m.49038,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120433.1.1.m.66614,-0.0173831683113218,No,NA,NA,Q5BJ68,NA,NA,NA,integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_BRAFLDRAFT_120586.1.1.m.41856,-0.0132677727679219,No,NA,NA,Q9ULC5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],NA,NA,NA
CHOYP_BRAFLDRAFT_120588.1.1.m.22993,-0.0109778174622725,No,NA,NA,Q9JMB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_120607.1.3.m.8455,-0.00530435680666406,No,NA,NA,Q6Q759,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement [GO:0003351],NA,NA,NA
CHOYP_BRAFLDRAFT_120767.1.1.m.16005,0.00848798913475219,No,NA,NA,Q8K1J5,NA,NA,NA,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156],NA,NA,NA
CHOYP_BRAFLDRAFT_120826.1.1.m.56321,0.00101919575191593,No,NA,NA,A1A4L0,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_120908.1.1.m.5866,0.000367543802183545,No,NA,NA,Q865F7,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289]; hibernation [GO:0042750],NA,NA,NA
CHOYP_BRAFLDRAFT_120923.3.3.m.58916,0.000678595817625985,No,NA,NA,Q3B8G0,NA,NA,NA,zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_120970.1.1.m.63798,-0.00938106820970684,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_120990.1.18.m.2376,0.000338673600292293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120990.10.18.m.51025,-0.00690310914036034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120993.1.2.m.41307,0.0193273457841461,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_BRAFLDRAFT_121045.1.1.m.55827,-0.00990696296258194,No,NA,NA,Q5XM24,NA,NA,NA,extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_BRAFLDRAFT_121105.1.1.m.41883,-0.00416223358738731,No,NA,NA,Q32NR4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121138.1.1.m.787,0.00537832802198431,No,NA,NA,Q95KU9,NA,NA,NA,cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_121151.1.1.m.59381,0.00571842711928978,No,NA,NA,Q9Y5X3,NA,NA,NA,brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; macropinocytic cup [GO:0070685]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein heterodimerization activity [GO:0046982]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of renal sodium excretion [GO:0035815]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_121259.1.1.m.2411,0.000150518103440131,No,NA,NA,Q8BUV8,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583],NA,NA,NA
CHOYP_BRAFLDRAFT_121459.1.1.m.21810,0.000317403816896913,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121480.1.1.m.48790,0.00727831400021106,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_121507.1.2.m.30603,-0.00580031202091074,No,NA,NA,Q5TYW6,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37267,0.00136456520713587,No,NA,NA,V5YMB3,NA,NA,NA,dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37268,-0.00136066544837008,No,NA,NA,Q5R9R4,NA,NA,NA,postsynaptic density [GO:0014069]; ribosome [GO:0005840]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_121824.1.1.m.37419,-0.004009509098979,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121887.1.1.m.59668,0.00586919941381071,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_121902.1.1.m.64757,-0.00409487214383747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121927.1.1.m.47211,-0.00203822479452876,No,NA,NA,Q6ZTR5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122018.1.1.m.21774,-0.0132554267445433,No,NA,NA,O08658,NA,NA,NA,nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_BRAFLDRAFT_122376.1.1.m.49446,-0.00707827150333976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122381.3.4.m.23140,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122389.1.1.m.15498,-0.00567956478165233,No,NA,NA,Q11118,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; cell cycle [GO:0007049]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_122422.1.2.m.52874,0.000958160111839395,No,NA,NA,P51610,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein binding; bridging [GO:0030674]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription; DNA-templated [GO:0006355]; release from viral latency [GO:0019046],NA,NA,NA
CHOYP_BRAFLDRAFT_122572.1.1.m.29320,-0.0127034161739009,No,NA,NA,Q5PQ44,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122634.2.2.m.43678,0.00103258463033883,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_122687.1.1.m.47713,-0.0191415500041283,No,NA,NA,Q5XIA2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122791.1.6.m.8640,0.00702049150785285,No,NA,NA,Q9UIF8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_122807.1.1.m.3729,-2.64698767629072e-05,No,NA,NA,Q99MD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_122887.1.1.m.62170,0.0106302987023823,No,NA,NA,Q3ULZ2,NA,NA,NA,cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_BRAFLDRAFT_122922.1.1.m.17746,0.00688577520176004,No,NA,NA,Q9UHB4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_122927.1.1.m.51870,0.0117911641379713,No,NA,NA,Q66J69,NA,NA,NA,chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_BRAFLDRAFT_122970.1.1.m.52022,-0.0186117133836942,No,NA,NA,Q5VVH5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_123087.1.2.m.6329,0.0028222124491411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123087.2.2.m.27308,0.00331047366358727,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123202.1.1.m.17267,-0.00950924147731753,No,NA,NA,P08836,NA,NA,NA,cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],NA,NA,NA
CHOYP_BRAFLDRAFT_123291.1.1.m.11923,0.000394811088436896,No,NA,NA,B6CZ61,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_123298.1.1.m.483,-0.00465817907003364,No,NA,NA,P24386,NA,NA,NA,cytosol [GO:0005829]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; regulation of apoptotic process [GO:0042981]; small GTPase mediated signal transduction [GO:0007264]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123304.1.1.m.29231,-0.0108363924234823,No,NA,NA,Q6GQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_BRAFLDRAFT_123389.1.1.m.57156,-0.00611040846141607,No,NA,NA,Q05AL1,NA,NA,NA,cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_123397.1.1.m.42218,0.0039237283667323,No,NA,NA,Q8WXR4,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.1.2.m.28822,0.0294358920696248,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.2.2.m.50531,0.00993513963305198,No,NA,NA,Q9UIF3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_BRAFLDRAFT_123540.1.1.m.10582,-0.0216905174976972,No,NA,NA,Q4R5Y0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_123636.1.1.m.16162,0.00345556098059864,No,NA,NA,Q8C0J2,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_BRAFLDRAFT_123642.2.2.m.55471,0.00474280242743379,No,NA,NA,Q8N6T3,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_BRAFLDRAFT_123736.1.1.m.48671,-0.00126776197984265,No,NA,NA,A0A0R4IVV0,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; sprouting angiogenesis [GO:0002040],NA,NA,NA
CHOYP_BRAFLDRAFT_123741.1.1.m.31088,0.0010085202366345,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_123768.1.1.m.7223,0.00523976641960278,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_123909.1.1.m.24337,0.000300751903994161,No,NA,NA,Q3UYG8,NA,NA,NA,centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123969.1.1.m.15145,-0.00143446482037873,No,NA,NA,Q9QXT0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988],NA,NA,NA
CHOYP_BRAFLDRAFT_123986.1.1.m.47284,-0.00374221357653739,No,NA,NA,Q7ZY18,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_BRAFLDRAFT_124020.1.1.m.22574,0.00166225319718881,No,NA,NA,Q9HBK9,NA,NA,NA,cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.1.2.m.22812,0.0043543048683951,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.2.2.m.50286,-0.0196005908235873,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.1.6.m.5120,-0.0188556468356078,No,NA,NA,Q66IM5,NA,NA,NA,N-acyltransferase activity [GO:0016410]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.3.6.m.38212,-0.0140093308116246,No,NA,NA,P35543,NA,NA,NA,high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.5.6.m.41252,0.0125550926529516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124069.1.1.m.14145,-0.00255854945334178,No,NA,NA,Q4R6V2,NA,NA,NA,cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_BRAFLDRAFT_124130.2.3.m.30247,-0.00804441216868876,No,NA,NA,Q4R8M9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_124233.1.1.m.26105,0.00143035034099462,No,NA,NA,O43837,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124240.1.1.m.8573,0.00420559794115581,No,NA,NA,Q76NI1,NA,NA,NA,dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_BRAFLDRAFT_124260.1.1.m.8355,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124275.1.1.m.8900,-0.000357947855594165,No,NA,NA,P13086,NA,NA,NA,mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124284.1.1.m.33673,0.00450306562255854,No,NA,NA,Q3TNA1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.1.4.m.1812,-0.00349550054470025,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.3.4.m.48503,0.00139787028976244,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124523.1.1.m.18960,-0.000584542393909527,No,NA,NA,Q9CRA8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_BRAFLDRAFT_124526.1.1.m.25228,0,No,NA,NA,Q9BRS2,NA,NA,NA,cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_BRAFLDRAFT_124536.1.2.m.10835,-0.00637197015986569,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_BRAFLDRAFT_124611.1.1.m.34341,0.00263067480251775,No,NA,NA,Q6P9B9,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_BRAFLDRAFT_124637.1.1.m.26435,-0.011294607403552,No,NA,NA,Q68FK8,NA,NA,NA,actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription; termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_BRAFLDRAFT_124675.1.1.m.61945,0.00622443365341639,No,NA,NA,Q99JG7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_BRAFLDRAFT_124686.1.1.m.18409,0.000791168365038027,No,NA,NA,P00504,NA,NA,NA,cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114],NA,NA,NA
CHOYP_BRAFLDRAFT_124878.1.1.m.55561,0.0116669150043063,No,NA,NA,P35570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_124950.1.1.m.8139,-0.00613490048904794,No,NA,NA,Q8C156,NA,NA,NA,chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_124962.1.1.m.57433,-0.0122873000323409,No,NA,NA,O97490,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3843,0.00816217165521629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3844,-0.00469543590492548,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.2.5.m.4101,-0.00323437128324999,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.1.3.m.2939,-0.00381782393561387,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.2.3.m.13981,0.00358543719371557,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125073.1.1.m.1752,-0.0219046900858779,No,NA,NA,Q99P31,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398],NA,NA,NA
CHOYP_BRAFLDRAFT_125104.1.1.m.31139,-0.01222163944947,No,NA,NA,P51909,NA,NA,NA,cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BRAFLDRAFT_125119.1.1.m.57550,-0.000313514089788306,No,NA,NA,Q5F201,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_125234.2.2.m.19033,-0.00207233211662011,No,NA,NA,Q5T6F2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_125263.1.9.m.7394,-0.0168359003118769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125265.2.4.m.18968,-0.00935506582243953,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125270.1.1.m.2429,-0.00708971414948661,No,NA,NA,Q5TZ24,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_BRAFLDRAFT_125327.1.1.m.29699,0.0011923256950236,No,NA,NA,Q91YN5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_BRAFLDRAFT_125356.3.3.m.35009,-0.0192515288485113,No,NA,NA,Q3V0L5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125389.1.1.m.62938,-0.000888429626278342,No,NA,NA,Q5RFR0,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125403.1.1.m.30476,-0.0116724369750632,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_125405.1.1.m.5741,0.00860701788551349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125481.1.1.m.4369,-0.000801186913804549,No,NA,NA,Q9YGY3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_125501.1.1.m.30916,-0.00421036642050734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125516.1.1.m.13150,0.00818527365248687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125550.1.5.m.9080,-0.011072851590155,No,NA,NA,P11678,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_125634.1.1.m.14767,0.000708447741597295,No,NA,NA,Q9UI14,NA,NA,NA,cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022],NA,NA,NA
CHOYP_BRAFLDRAFT_125658.1.1.m.27104,0.00850781874895444,No,NA,NA,O00471,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_BRAFLDRAFT_125670.1.1.m.9555,-0.00384985985018059,No,NA,NA,Q96N23,NA,NA,NA,axoneme [GO:0005930]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125701.1.3.m.18477,-0.0011050669382857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125724.1.1.m.30781,0.0127108266177995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125729.1.1.m.50316,-0.0151216838156242,No,NA,NA,Q8BN59,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_BRAFLDRAFT_125731.1.1.m.6261,0.00210611880339527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125735.1.3.m.26333,-0.0146160173341342,No,NA,NA,P62313,NA,NA,NA,cytoplasm [GO:0005737]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_BRAFLDRAFT_125780.1.1.m.60450,-0.00157050340218718,No,NA,NA,Q9YH58,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_BRAFLDRAFT_125840.1.1.m.58396,0.00153516064155441,No,NA,NA,Q5RB02,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_BRAFLDRAFT_125880.1.3.m.7081,-0.00326956642164639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.3.3.m.26918,-0.0174756713652669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125998.1.1.m.63211,-0.0128516715737623,No,NA,NA,Q8NA69,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125999.1.1.m.24819,0.0195175597984259,No,NA,NA,Q7ZTY7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126058.1.1.m.1201,0,No,NA,NA,Q503Y4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_126152.2.2.m.42694,0.00413562744299844,No,NA,NA,Q7ZUN8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126227.1.1.m.24340,-0.00997105149650703,No,NA,NA,O94903,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; pyridoxal phosphate binding [GO:0030170],NA,NA,NA
CHOYP_BRAFLDRAFT_126338.1.1.m.59058,-0.00586581905684336,No,NA,NA,Q922C1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126352.2.2.m.64882,-0.0245752682987744,No,NA,NA,Q9NXG6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646],NA,NA,NA
CHOYP_BRAFLDRAFT_126371.3.3.m.66053,0.00131584768327197,No,NA,NA,Q5XJN2,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126378.2.2.m.11826,-0.00464527587445037,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126379.1.3.m.5102,0,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126411.1.1.m.49664,0.00300060369540723,No,NA,NA,Q96J94,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_BRAFLDRAFT_126506.1.1.m.60629,-0.0098919003357113,No,NA,NA,O02373,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration; open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process; polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.2.6.m.5075,-0.00426842788359342,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.6.6.m.54234,-0.00731592849944321,No,NA,NA,Q6P8U6,NA,NA,NA,extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_BRAFLDRAFT_126596.1.1.m.64385,-0.00499038651543026,No,NA,NA,Q8WV41,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],NA,NA,NA
CHOYP_BRAFLDRAFT_126603.1.1.m.31078,-0.000200147773691838,No,NA,NA,B2RY50,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_126700.1.2.m.17811,8.43556508204277e-05,No,NA,NA,G3V9R8,NA,NA,NA,nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367],NA,NA,NA
CHOYP_BRAFLDRAFT_126756.1.1.m.29611,-0.009535529480981,No,NA,NA,Q6ZMY6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126767.1.3.m.6394,-0.00289462935094916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126822.1.1.m.14626,-0.00145271427144943,No,NA,NA,O35815,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; RNA polymerase II regulatory region DNA binding [GO:0001012]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; histone H3 deacetylation [GO:0070932]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810],NA,NA,NA
CHOYP_BRAFLDRAFT_126826.1.1.m.14796,2.79155077362184e-05,No,NA,NA,Q0P4V4,NA,NA,NA,cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.1.3.m.24519,-0.0131629921658209,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.2.3.m.30577,-0.000894870323520936,No,NA,NA,Q3MHZ8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126923.1.1.m.5580,-0.0144629108063902,No,NA,NA,Q95LS7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_BRAFLDRAFT_126943.1.3.m.6839,-0.00691496507143328,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127028.1.1.m.18415,0.00178951265801191,No,NA,NA,Q9JLJ2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein homodimerization activity [GO:0042803]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.1.7.m.4586,-0.0168753174607812,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.2.7.m.5835,0.00187401376468681,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.3.7.m.15669,0.00114805657700904,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.4.7.m.28277,-0.0104552769541753,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.6.7.m.30727,-0.0107855593138981,No,NA,NA,Q62009,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.7.7.m.57708,-0.00126927934123099,No,NA,NA,P10675,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.1.2.m.2218,-0.00119230301241749,No,NA,NA,O08585,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.2.2.m.42594,0.00111312119881733,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_127105.1.1.m.21922,-0.000251613119449998,No,NA,NA,Q3ZC89,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_127252.1.1.m.16242,-0.00216966212253699,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_BRAFLDRAFT_127356.1.2.m.8691,0.00246158813642265,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_127466.1.1.m.62415,-0.00440698832879335,No,NA,NA,A6PWD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127486.1.1.m.57687,0,No,NA,NA,P58340,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_127497.1.1.m.35445,-0.00219355075529646,No,NA,NA,Q6DEJ5,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039],NA,NA,NA
CHOYP_BRAFLDRAFT_127510.1.1.m.48935,-0.0125875698541508,No,NA,NA,P00920,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission; GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903],NA,NA,NA
CHOYP_BRAFLDRAFT_127851.1.1.m.10499,-0.000355287522260857,No,NA,NA,P49020,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_128029.1.1.m.63515,0.00758493942984228,No,NA,NA,Q2TBS4,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344],NA,NA,NA
CHOYP_BRAFLDRAFT_128033.2.2.m.54293,-0.0176739028025962,No,NA,NA,Q70LM4,NA,NA,NA,isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000],NA,NA,NA
CHOYP_BRAFLDRAFT_128100.1.1.m.10153,-0.00355865523818882,No,NA,NA,P70279,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_128129.1.1.m.63237,-0.0027387808622321,No,NA,NA,Q96J01,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_BRAFLDRAFT_128345.1.1.m.9897,-0.00636472004972645,No,NA,NA,D6REC4,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_128432.1.1.m.8945,0.014233833163537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128459.1.3.m.21899,-0.00754844342238699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128460.1.2.m.7232,0.00252062385441029,No,NA,NA,Q7Z4L5,NA,NA,NA,ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_128562.2.4.m.33663,-0.0123449344271434,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_128749.1.1.m.56605,-0.00218883367036855,No,NA,NA,Q8HXW6,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_128799.1.1.m.29183,-0.00656537276925974,No,NA,NA,A8MXQ7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_128825.1.1.m.10785,-0.0092063364020259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128828.1.2.m.7356,-0.00572850292964522,No,NA,NA,Q2T9S4,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_BRAFLDRAFT_128878.1.1.m.42339,-0.000298894129672991,No,NA,NA,Q9EPB1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_128887.2.2.m.46965,-0.0164181221134763,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128944.1.2.m.19981,0.000390655716946489,No,NA,NA,Q6NVM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013],NA,NA,NA
CHOYP_BRAFLDRAFT_129004.15.15.m.60150,-0.0226906200764829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129034.1.1.m.17626,0.000354392613453863,No,NA,NA,Q6DF94,NA,NA,NA,centriole [GO:0005814]; spindle [GO:0005819]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_BRAFLDRAFT_129048.1.1.m.1769,0.0232483170574812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129063.1.1.m.15419,0.000368507231511273,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129074.1.1.m.25032,-0.00609189656301666,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_129108.1.2.m.2456,-0.0230009079044599,No,NA,NA,A6QLI0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_129234.1.1.m.10468,-0.000335280761628847,No,NA,NA,Q80Y14,NA,NA,NA,dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_BRAFLDRAFT_129259.1.1.m.9267,0.0017231223370043,No,NA,NA,Q03460,NA,NA,NA,amyloplast [GO:0009501]; 3 iron; 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054],NA,NA,NA
CHOYP_BRAFLDRAFT_129513.1.1.m.51276,-0.00082270664726927,No,NA,NA,O89000,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; dihydrouracil dehydrogenase (NAD+) activity [GO:0004159]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; NADH dehydrogenase activity [GO:0003954]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; aging [GO:0007568]; beta-alanine biosynthetic process [GO:0019483]; circadian rhythm [GO:0007623]; pyrimidine nucleobase catabolic process [GO:0006208]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_BRAFLDRAFT_129759.2.2.m.30082,-0.0130341709305144,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.1.2.m.24564,-0.000561792585810424,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.2.2.m.34895,0.00653594544383683,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129914.1.3.m.8213,-0.00764686895273606,No,NA,NA,Q8IYJ2,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_129932.1.1.m.30332,-0.0134875035807844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129967.1.4.m.4020,-0.00322914462057362,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.3.4.m.41916,0.0030843910708267,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.4.4.m.64315,0.00768886069816382,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_130097.1.1.m.12458,-0.00263096077873866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130131.1.1.m.11020,-0.0043186629925948,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_130395.1.1.m.38394,0.0072212380596673,No,NA,NA,Q6IR74,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_130685.1.1.m.63499,0.000151649847817223,No,NA,NA,Q9ULJ6,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_BRAFLDRAFT_130809.1.1.m.5127,0.0013540649560493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130974.1.1.m.28374,-0.000573443487822374,No,NA,NA,Q27245,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_BRAFLDRAFT_131134.3.3.m.16643,-0.00550456582478655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131151.3.4.m.57848,-0.000619542801899674,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131151.4.4.m.58019,-0.0111399794307301,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131216.1.1.m.8822,-0.00530221860278633,No,NA,NA,Q6P9I7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_131227.1.1.m.24973,-0.00856859277872244,No,NA,NA,Q5ZIT5,NA,NA,NA,cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_131414.1.1.m.9300,0.014540797231494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131608.1.1.m.44249,0.0145449481345539,No,NA,NA,Q8R3V6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_131621.1.1.m.56341,-6.56125494640674e-05,No,NA,NA,P46425,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_131834.1.1.m.29489,-0.0248799733383985,No,NA,NA,Q561R0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integrin activation [GO:0033622]; positive regulation of cell proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626],NA,NA,NA
CHOYP_BRAFLDRAFT_132233.1.4.m.13687,0.000578480930107655,No,NA,NA,Q6AYN9,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_BRAFLDRAFT_132336.1.1.m.26677,-0.0179047424249423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_132957.1.1.m.51287,0.000357153810651339,No,NA,NA,Q9GZQ3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_BRAFLDRAFT_133135.1.1.m.18788,-0.00779907671808846,No,NA,NA,Q8WYH8,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription; DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_BRAFLDRAFT_136434.1.1.m.33244,0.0142609211953388,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_140951.1.1.m.40225,0.0289638009969712,No,NA,NA,Q9FMR5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_150340.1.4.m.7435,0.0217813013140875,No,NA,NA,Q19QU3,NA,NA,NA,nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_151236.1.1.m.30653,-0.0187327386207454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_153908.1.2.m.1377,-0.000122444738848283,No,NA,NA,Q6ZT07,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_154839.1.1.m.13878,-0.00382081673763128,No,NA,NA,Q7SXE4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport; vesicle recycling within Golgi [GO:0000301],NA,NA,NA
CHOYP_BRAFLDRAFT_161161.1.1.m.39447,-0.0103628840196385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_165799.1.1.m.33332,0.000146192000965099,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_194931.1.1.m.46966,-0.0146034525788861,No,NA,NA,Q14790,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_BRAFLDRAFT_199108.1.2.m.24078,0.00157034127435791,No,NA,NA,O97902,NA,NA,NA,cell projection membrane [GO:0031253]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803],NA,NA,NA
CHOYP_BRAFLDRAFT_199346.1.3.m.11369,0.00739824397652529,No,NA,NA,Q96QF0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_200206.1.1.m.35419,0.00119396211679357,No,NA,NA,Q96AB6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_200527.1.1.m.601,0.00937837528376893,No,NA,NA,Q8JIS3,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_201924.1.1.m.30855,-0.0140336854936257,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_202318.1.1.m.4330,0.00344969375387157,No,NA,NA,Q5R7H0,NA,NA,NA,mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_202721.1.2.m.18687,0.013376479438914,No,NA,NA,Q9C005,NA,NA,NA,Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_BRAFLDRAFT_202783.1.2.m.21505,0.0201279972100285,No,NA,NA,C3ZQF9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653],NA,NA,NA
CHOYP_BRAFLDRAFT_203026.1.1.m.61263,0.000108892097673176,No,NA,NA,P97379,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_BRAFLDRAFT_203057.1.1.m.47437,0.00073345227191585,No,NA,NA,Q5ZLS8,NA,NA,NA,integrator complex [GO:0032039]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_BRAFLDRAFT_203393.1.2.m.16760,-0.0130852828100997,No,NA,NA,Q15291,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; methylated histone binding [GO:0035064]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; histone H3-K4 methylation [GO:0051568]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.1.2.m.10,-0.0204553865284658,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.2.2.m.20185,0.00270928294289877,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_204357.1.1.m.62329,0.00315823568963043,No,NA,NA,P17141,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_204501.1.1.m.910,-0.00425888196948417,No,NA,NA,Q91YR5,NA,NA,NA,methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.1.2.m.27864,0.00437067181440487,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.2.2.m.63327,0.00179410413468201,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204871.1.1.m.66069,-0.00246849075742528,No,NA,NA,Q4PM12,NA,NA,NA,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.1.2.m.1690,-0.0051717157657843,No,NA,NA,P48147,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_205095.2.2.m.62915,-0.000579339194361418,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_206799.1.23.m.3242,-0.00896781921330226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60961,0.00179364209493517,No,NA,NA,Q9Y2V2,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902]; intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.5.11.m.19273,-0.00289790377116208,No,NA,NA,Q9Y383,NA,NA,NA,nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.6.11.m.30690,0.00146709087790756,No,NA,NA,P50429,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_208090.1.1.m.45354,0.000842930111653368,No,NA,NA,Q61371,NA,NA,NA,acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_BRAFLDRAFT_208117.3.3.m.56788,-0.0124943297329622,No,NA,NA,P55196,NA,NA,NA,cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_208160.1.2.m.4498,-0.000998339983745036,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.18.21.m.59194,-0.00762976158180528,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.5.21.m.21756,0.00792746981272756,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.10.20.m.53518,0.00437899549948206,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.6.20.m.36168,-0.0175934108853415,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.1.32.m.14239,-0.0102965388191688,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.11.32.m.42955,-0.0154683640525366,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.18.32.m.58763,0.000678747396552994,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.22.32.m.59131,0.000827336393506608,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.25.32.m.60144,-0.0223584729504651,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.27.32.m.61232,0.00855700636911831,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.29.32.m.61624,-0.00775036525666839,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.30.32.m.61782,-0.0119860280773124,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22687,0.00707480652490371,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22689,-0.0163853604411697,No,NA,NA,P62278,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.8.32.m.36574,-0.00654633376363671,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61941,0.00154473078958286,No,NA,NA,Q26619,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; cGMP-mediated signaling [GO:0019934],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61942,-0.0104889194464289,No,NA,NA,C9JJ37,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_209304.2.2.m.63768,0.00845698992367288,No,NA,NA,Q9QYI4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_209933.1.1.m.29283,0.0203363760536728,No,NA,NA,Q8N2R8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_210874.1.1.m.28596,0.00495129093635062,No,NA,NA,P20351,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; compound eye pigmentation [GO:0048072]; kynurenine metabolic process [GO:0070189]; ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_BRAFLDRAFT_211853.1.1.m.18681,-0.00307759914030575,No,NA,NA,Q1JQA5,NA,NA,NA,extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.1.11.m.20083,-0.0135592023305085,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.9.11.m.60590,-0.0178775133409297,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212438.1.1.m.29117,-0.0158571483573132,No,NA,NA,Q08DF7,NA,NA,NA,mitochondrial matrix [GO:0005759]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_BRAFLDRAFT_214346.1.1.m.56462,-0.01779593010146,No,NA,NA,Q00988,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; electron transporter; transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.1.2.m.42797,0.00434673970021198,No,NA,NA,O14841,NA,NA,NA,cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.2.2.m.59996,0.000301322799564378,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_214790.1.1.m.15955,-0.0072226398365612,No,NA,NA,Q4QR86,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_BRAFLDRAFT_215087.1.1.m.66618,0.00246561891065982,No,NA,NA,Q5ZL74,NA,NA,NA,apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis; engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_215208.1.1.m.40012,-0.00913123870587979,No,NA,NA,Q0UI56,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_215283.1.1.m.1467,0.00131182694921897,No,NA,NA,Q68EZ3,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246],NA,NA,NA
CHOYP_BRAFLDRAFT_215361.1.1.m.55455,0.00103716242989585,No,NA,NA,Q3SZH7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],NA,NA,NA
CHOYP_BRAFLDRAFT_215413.1.1.m.2004,0.0124652573685355,No,NA,NA,Q3KRG3,NA,NA,NA,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60401,-0.00680456017766605,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60405,-0.00581389804369668,No,NA,NA,Q9H0Z9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell cycle [GO:0007049]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; mRNA processing [GO:0006397]; negative regulation of cell proliferation [GO:0008285]; regulation of myotube differentiation [GO:0010830]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_216204.1.1.m.30654,-0.00238723390855302,No,NA,NA,P26697,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_216893.1.1.m.18940,-0.00889958163519199,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_217332.2.2.m.51240,0.0102633514599456,No,NA,NA,P70665,NA,NA,NA,lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682],NA,NA,NA
CHOYP_BRAFLDRAFT_217424.2.2.m.44576,0.00759990991082869,No,NA,NA,O08590,NA,NA,NA,cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902],NA,NA,NA
CHOYP_BRAFLDRAFT_217516.1.1.m.18628,-0.00301138124254075,No,NA,NA,P56518,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_218889.2.2.m.58058,-0.00411710888768041,No,NA,NA,P28749,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40577,0.00721552086641019,No,NA,NA,Q5RC46,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40578,0.0162490295253384,No,NA,NA,Q91V57,NA,NA,NA,ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_BRAFLDRAFT_219160.1.1.m.58567,0.000647227735742986,No,NA,NA,Q7ZXF1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_220284.1.1.m.29545,0.00262824693700313,No,NA,NA,A2TJ54,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; mannose binding [GO:0005537]; glycosylation [GO:0070085]; positive regulation of GTP binding [GO:1904426]; retrograde transport; endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_BRAFLDRAFT_221105.1.2.m.172,0.0133808425378216,No,NA,NA,Q9D2Z4,NA,NA,NA,cysteine-type peptidase activity [GO:0008234]; NEDD8-specific protease activity [GO:0019784],NA,NA,NA
CHOYP_BRAFLDRAFT_221105.2.2.m.18318,0.00948526798435125,No,NA,NA,Q8N0U4,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_221115.1.1.m.28512,0.00445121652682077,No,NA,NA,Q2M389,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_221294.2.2.m.52722,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221898.1.2.m.28353,-0.00340673495380461,No,NA,NA,Q68CZ1,NA,NA,NA,axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_BRAFLDRAFT_223290.2.2.m.30918,-0.00807791787320703,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.1.2.m.30136,-0.00517362181294787,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.2.2.m.38659,0.00145645812364986,No,NA,NA,Q28F51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_223476.1.1.m.30983,0.00491582992270207,No,NA,NA,O35125,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_223573.1.1.m.4526,0.0109526850584634,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223623.1.1.m.11202,0.00416849343062782,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_223894.1.1.m.7024,-0.00297539498140655,No,NA,NA,Q9H9Y6,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression; epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.1.3.m.26136,0.0124442465229562,No,NA,NA,Q64516,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to ethanol [GO:0045471]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.3.3.m.52906,0.0284628410116636,No,NA,NA,Q0IID9,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.18.18.m.65591,-0.000191730269355765,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.3.18.m.20799,0.0112110207205059,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_BRAFLDRAFT_224716.1.2.m.41344,0.00267198171612172,No,NA,NA,Q6NSW5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_225253.1.1.m.9264,-0.0010569619792287,No,NA,NA,O75694,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_225290.1.1.m.5737,0.0148807160883371,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_226345.1.1.m.55555,0.00506103297475459,No,NA,NA,Q9BXB4,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890],NA,NA,NA
CHOYP_BRAFLDRAFT_226416.1.1.m.56984,-0.000552718833874266,No,NA,NA,Q9H939,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.1.3.m.1062,0.00569828359305776,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.3.3.m.53203,-0.000302519357485129,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226942.1.1.m.49751,-4.07476779302316e-05,No,NA,NA,Q9UHJ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_227287.1.1.m.14669,0.00970726561775605,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_227771.1.2.m.60606,0.00851012816019643,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_228853.1.1.m.9833,-0.00092165702760488,No,NA,NA,Q6TH15,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_230143.1.1.m.15015,-0.00929972433463153,No,NA,NA,Q1RMU2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_230181.1.1.m.61583,0.000600642143007181,No,NA,NA,Q8NCC3,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_BRAFLDRAFT_232705.1.2.m.13912,-0.0170254181685426,No,NA,NA,A7SG73,NA,NA,NA,cytoplasm [GO:0005737]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],NA,NA,NA
CHOYP_BRAFLDRAFT_233674.1.1.m.66738,0.0031351545247085,No,NA,NA,A5PLK2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_234513.1.1.m.9581,-0.0105801890298603,No,NA,NA,Q95KG9,NA,NA,NA,Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085],NA,NA,NA
CHOYP_BRAFLDRAFT_234854.2.2.m.58013,-0.00924320168437666,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_BRAFLDRAFT_235412.2.2.m.58139,0.00820682754629107,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.2.6.m.17168,0.017823612372228,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.3.6.m.29228,0.0215393368908299,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_237339.1.1.m.15256,0.00936510906867977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_238139.1.1.m.12224,0,No,NA,NA,Q6DGP2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_239751.2.3.m.36889,-0.00442068073054986,No,NA,NA,Q28J59,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_240825.1.1.m.43452,0.0147333360339212,No,NA,NA,Q63186,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_240864.1.1.m.24434,0.00836885862581745,No,NA,NA,Q5RID7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_240914.2.3.m.29586,0.0141859633717606,No,NA,NA,Q96P44,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_BRAFLDRAFT_241287.1.1.m.5544,0.0022628101677193,No,NA,NA,F1NUK7,NA,NA,NA,axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560],NA,NA,NA
CHOYP_BRAFLDRAFT_241400.1.1.m.44544,0.00656833845663311,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_241420.1.1.m.61408,0.00191244645089731,No,NA,NA,Q8CG72,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451],NA,NA,NA
CHOYP_BRAFLDRAFT_241726.22.22.m.52736,0.0105685396947095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_241726.4.22.m.3766,-0.0116687493373225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_244533.1.2.m.40480,0.000770846300433863,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_244533.2.2.m.53951,-0.0016640697952225,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_245349.1.1.m.45479,-0.00889173606111084,No,NA,NA,Q6PBA8,NA,NA,NA,motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_246510.1.1.m.27433,-0.0165973570444198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_246978.1.1.m.6916,-0.00661475288090752,No,NA,NA,Q32KU3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_247007.1.1.m.15096,-0.0113979960878933,No,NA,NA,O14618,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; metal ion transport [GO:0030001]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_BRAFLDRAFT_247063.1.1.m.17671,-0.00597893440926191,No,NA,NA,Q80UM7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_BRAFLDRAFT_249141.1.1.m.6974,0.0121128487927322,No,NA,NA,Q7ZVC9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_251578.1.1.m.15566,-0.00210100017599978,No,NA,NA,Q9V535,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing; via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition; DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_251779.1.2.m.6830,0.00527921534149527,No,NA,NA,Q8CGS6,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_BRAFLDRAFT_251802.1.1.m.66483,0.00133543493712582,No,NA,NA,Q2HJF4,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],NA,NA,NA
CHOYP_BRAFLDRAFT_255736.1.1.m.62027,-0.0117110686203677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_258021.1.1.m.6099,-0.0171894790925405,No,NA,NA,Q2VLG6,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_259692.1.1.m.44099,0.000736673442843129,No,NA,NA,Q3T0V9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],NA,NA,NA
CHOYP_BRAFLDRAFT_259734.1.1.m.23051,-0.0176594769267982,No,NA,NA,Q5R5M0,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743],NA,NA,NA
CHOYP_BRAFLDRAFT_259980.1.1.m.17608,-0.0068808529514213,No,NA,NA,Q8CF89,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_260197.1.1.m.8081,-0.00569256260496571,No,NA,NA,O43402,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_260828.1.1.m.16250,-0.00165941247761228,No,NA,NA,Q9D2V5,NA,NA,NA,spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_BRAFLDRAFT_260946.1.2.m.54464,-0.00928764924654823,No,NA,NA,O69060,NA,NA,NA,dioxygenase activity [GO:0051213],NA,NA,NA
CHOYP_BRAFLDRAFT_261406.1.1.m.46291,-0.013897163794675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_261932.1.1.m.23690,-0.00120242002264556,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_BRAFLDRAFT_261940.2.2.m.53422,0.00652128142727556,No,NA,NA,F1NZI4,NA,NA,NA,cell wall [GO:0005618]; cytosol [GO:0005829]; alpha;alpha-trehalase activity [GO:0004555]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]; trehalose catabolic process [GO:0005993],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65564,0.000637792749466526,No,NA,NA,Q99JW2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65565,-0.00297848296837837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59010,0.00743734582997663,No,NA,NA,O95995,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; negative regulation of cell proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526],NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59011,-0.0100195662011397,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_BRAFLDRAFT_263840.1.1.m.51673,-0.00406423590744268,No,NA,NA,A2BFC9,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.1.2.m.5174,0.000530269020541448,No,NA,NA,Q58DU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.2.2.m.7063,-0.00207621615785911,No,NA,NA,P27085,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_BRAFLDRAFT_264304.1.1.m.35625,0.00928601723289303,No,NA,NA,Q6DF57,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_BRAFLDRAFT_264316.1.1.m.29655,-0.0167452657358234,No,NA,NA,Q08C33,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_264461.1.1.m.51481,0.0120867709282948,No,NA,NA,Q3V0Q6,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.1.3.m.58969,-0.013657838507755,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.3.3.m.64003,-0.0168945414772815,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.3.7.m.10791,-0.00175240609316983,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.6.7.m.52336,0.00411369296166195,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.7.7.m.62510,0,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265613.1.2.m.14785,0.00178494708951036,No,NA,NA,Q8BMB3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_265991.1.1.m.58765,-0.00265179864786972,No,NA,NA,Q9NXS2,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_BRAFLDRAFT_266349.1.1.m.9217,-0.00103874415951055,No,NA,NA,Q3ULD5,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24880,0.00101723697872431,No,NA,NA,Q2KI24,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24881,5.82197522024249e-05,No,NA,NA,P62494,NA,NA,NA,axon [GO:0030424]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular cholesterol transport [GO:0032367]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_BRAFLDRAFT_268308.1.1.m.17043,0.00972352975363419,No,NA,NA,P00378,NA,NA,NA,mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_BRAFLDRAFT_268354.1.1.m.57510,0.000951246850093571,No,NA,NA,Q3ZBL4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_268591.1.1.m.59744,-0.0181203975842777,No,NA,NA,Q54728,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35239,0.0019438887417895,No,NA,NA,Q6GN02,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35240,0.00523453264729804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_269194.1.1.m.53515,-0.0113849841678245,No,NA,NA,Q2PZI1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_BRAFLDRAFT_269209.1.1.m.4681,0.00344215095123119,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_270293.1.3.m.8709,-0.0104228476977787,No,NA,NA,P02720,NA,NA,NA,cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_BRAFLDRAFT_270300.1.1.m.59680,-0.000590549028147969,No,NA,NA,Q99L13,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_BRAFLDRAFT_270517.1.1.m.27028,-0.0190478762039327,No,NA,NA,B0CM26,NA,NA,NA,cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_270672.1.1.m.25768,2.60217255234065e-05,No,NA,NA,Q9Y617,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_BRAFLDRAFT_271463.1.1.m.62869,-0.0049536409806139,No,NA,NA,Q5JVL4,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],NA,NA,NA
CHOYP_BRAFLDRAFT_272416.1.1.m.56641,-0.000156260103089845,No,NA,NA,P43487,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_273508.1.4.m.5528,0.000324972900018233,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_BRAFLDRAFT_273832.1.1.m.56325,-0.00200116696914335,No,NA,NA,Q0MQI4,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron; 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_BRAFLDRAFT_274539.3.3.m.49552,-0.013247730190916,No,NA,NA,Q86TN4,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_274974.1.1.m.56783,-0.00247155512735163,No,NA,NA,Q6DED0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_BRAFLDRAFT_275083.2.2.m.66604,0.00195161541840747,No,NA,NA,Q8AVY1,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_275293.1.1.m.16192,-0.00106568295458177,No,NA,NA,A4QNM5,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_275517.1.1.m.9720,-0.0159250066061742,No,NA,NA,Q2HJ56,NA,NA,NA,chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_275527.1.1.m.12579,0.00207116009435547,No,NA,NA,Q7ZX96,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_275580.2.2.m.40924,0.0288025020091161,No,NA,NA,Q8QZR1,NA,NA,NA,mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_275667.1.1.m.17353,-0.00441732345009988,No,NA,NA,Q9P2H3,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_275724.1.1.m.54178,0.00242245031751041,No,NA,NA,Q93008,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; regulation of circadian rhythm [GO:0042752]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.1.2.m.15360,-0.000552863533158261,No,NA,NA,Q5E951,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.2.2.m.62313,-0.0115825668270087,No,NA,NA,Q5E951,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275793.1.1.m.9519,0.00974666623676455,No,NA,NA,Q9H3N1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_275870.1.1.m.12895,0.000469502336142418,No,NA,NA,P36993,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_276131.1.1.m.46672,-0.0025142705501834,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_BRAFLDRAFT_276226.1.2.m.21725,-0.000515955229291984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_276226.2.2.m.64449,-0.0070718904403878,No,NA,NA,Q5R806,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_BRAFLDRAFT_276229.1.1.m.37508,0.00404520646172355,No,NA,NA,Q5ZL12,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_276474.1.1.m.6793,-0.00228526593982453,No,NA,NA,A1L259,NA,NA,NA,peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_BRAFLDRAFT_276592.1.1.m.8046,-0.0113356768444644,No,NA,NA,Q8NI36,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_276662.1.1.m.52846,0.00161882016561728,No,NA,NA,P60522,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_276868.1.1.m.27780,0.00171538212357388,No,NA,NA,Q3U487,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_276908.1.1.m.28793,-1.69655043542008e-05,No,NA,NA,O54774,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation; exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport; postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.1.2.m.3095,-0.0150953495403442,No,NA,NA,Q32LQ6,NA,NA,NA,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.2.2.m.18714,0.000189429958269593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_277269.1.1.m.51636,-0.0150147097620254,No,NA,NA,A6H611,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.2.3.m.57496,-0.00534411847643368,No,NA,NA,O43432,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.3.3.m.62602,-0.00278146804389839,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_277528.1.1.m.10120,-0.00453946048430753,No,NA,NA,Q9H0C1,NA,NA,NA,intracellular [GO:0005622]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_277744.1.2.m.5416,0.00316249851415085,No,NA,NA,P98073,NA,NA,NA,brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12736,-0.00196174484600948,No,NA,NA,P07953,NA,NA,NA,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2;6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2;6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12737,-0.000877759412166085,No,NA,NA,Q567B1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport; ER to cytosol [GO:1904265]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_278091.1.1.m.7340,-0.0140820615397784,No,NA,NA,O15067,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493],NA,NA,NA
CHOYP_BRAFLDRAFT_278625.1.2.m.53120,7.43486644559916e-05,No,NA,NA,Q9H3P7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_BRAFLDRAFT_278777.1.1.m.1970,0.00917152788096748,No,NA,NA,Q04281,NA,NA,NA,nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_278832.1.1.m.13624,-0.00926235698565686,No,NA,NA,P07872,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.1.5.m.13792,-0.00758958473748593,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.2.5.m.16457,0.0265630146027987,No,NA,NA,Q9FWW9,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.3.5.m.38481,0.00816653467995313,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.5.5.m.48881,-0.00952127559268857,No,NA,NA,Q9C8U0,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278938.1.1.m.38684,0.0147867693051569,No,NA,NA,Q5R605,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; gene silencing [GO:0016458]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vacuolar transport [GO:0007034]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_279143.1.1.m.50630,0.000470071323047105,No,NA,NA,Q5PQR5,NA,NA,NA,fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_279226.1.1.m.24471,-0.00117705111611495,No,NA,NA,Q91642,NA,NA,NA,cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_279360.1.1.m.11115,0.00225372164513393,No,NA,NA,O35345,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_BRAFLDRAFT_279625.1.1.m.51890,0.00601628262167832,No,NA,NA,P41636,NA,NA,NA,4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698],NA,NA,NA
CHOYP_BRAFLDRAFT_279668.1.1.m.21404,-0.000173616025335624,No,NA,NA,Q9CQP2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription; DNA-templated [GO:0006355]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_279789.3.3.m.48128,-7.77365597189806e-05,No,NA,NA,Q26481,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_279923.1.1.m.65663,7.20137671330415e-07,No,NA,NA,P84169,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_279937.1.1.m.49979,-0.00769735226993803,No,NA,NA,Q9QXN5,NA,NA,NA,cytoplasm [GO:0005737]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310],NA,NA,NA
CHOYP_BRAFLDRAFT_279949.1.1.m.54415,-0.00688968789476299,No,NA,NA,Q9NXB0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271],NA,NA,NA
CHOYP_BRAFLDRAFT_279978.1.1.m.30960,0.00169808258273978,No,NA,NA,Q9D3W1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280249.1.1.m.26508,-0.00173480834681154,No,NA,NA,Q5PPV3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280343.1.1.m.41317,0.011143984042777,No,NA,NA,Q9CQC8,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609],NA,NA,NA
CHOYP_BRAFLDRAFT_280861.1.2.m.5389,-2.2708166716416e-05,No,NA,NA,P12815,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_BRAFLDRAFT_281070.1.1.m.1319,0.00849813029249688,No,NA,NA,Q9Y2Q3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; signaling receptor binding [GO:0005102]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_281217.1.1.m.15677,-0.000827244085447611,No,NA,NA,P40112,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_281480.1.1.m.22697,-0.00121954858001066,No,NA,NA,Q8IXY8,NA,NA,NA,cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BRAFLDRAFT_281490.1.1.m.53995,-0.00359702717541112,No,NA,NA,Q8NFH3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA export from nucleus [GO:0006406]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.2.8.m.5909,0.000288845864896316,No,NA,NA,Q6RY07,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.5.8.m.25278,-0.0181789162891757,No,NA,NA,Q6RY07,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281658.1.1.m.6266,0.00124678494213796,No,NA,NA,O93257,NA,NA,NA,Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription; DNA-templated [GO:0045892]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_281754.1.1.m.27604,0.00123365033289411,No,NA,NA,Q92506,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_BRAFLDRAFT_282065.1.2.m.590,-0.000171251589788531,No,NA,NA,Q6PBY7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_282105.1.2.m.43460,-0.00258454717715226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_282135.1.1.m.55919,-0.0151010754291993,No,NA,NA,Q9HAB8,NA,NA,NA,cytosol [GO:0005829]; phosphopantothenate--cysteine ligase activity [GO:0004632]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],NA,NA,NA
CHOYP_BRAFLDRAFT_282200.1.1.m.18115,-0.00735707042390604,No,NA,NA,P79101,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snoRNA 3'-end processing [GO:0031126]; snoRNA splicing [GO:0034247]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_BRAFLDRAFT_282752.2.2.m.17526,-0.00978086248925843,No,NA,NA,Q8VDT1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_BRAFLDRAFT_283093.1.1.m.15039,-0.00340994042758335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_283789.1.1.m.40987,-0.00674694908417582,No,NA,NA,E2RQ08,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_BRAFLDRAFT_283981.1.1.m.7732,-0.00315392769173721,No,NA,NA,Q9YHY6,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_284130.1.1.m.27065,0.00998052026633873,No,NA,NA,P90893,NA,NA,NA,membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_284242.1.1.m.13711,0.000209625385663155,No,NA,NA,Q9D4P0,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_284412.1.1.m.37396,0,No,NA,NA,Q05932,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],NA,NA,NA
CHOYP_BRAFLDRAFT_284508.1.1.m.4587,-0.0094004573837596,No,NA,NA,Q9NR33,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3 acetylation [GO:0043966],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.1.3.m.284,-0.00123989206091408,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.2.3.m.15867,0.00118514064434739,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.3.3.m.26954,0.0081185750591256,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284784.1.1.m.12397,0.0106655534122021,No,NA,NA,Q6P632,NA,NA,NA,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_BRAFLDRAFT_284846.2.2.m.60100,-0.0130494606207187,No,NA,NA,Q8VHE0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; protein transporter activity [GO:0008565]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane; translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8607,0.00982221987355308,No,NA,NA,Q99J62,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8608,-0.000577869844863758,No,NA,NA,P41900,NA,NA,NA,nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TFIIF-class transcription factor complex binding [GO:0001096]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_BRAFLDRAFT_285193.1.1.m.63396,-0.0106540847042224,No,NA,NA,Q9CWZ7,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; SNARE complex [GO:0031201]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_285264.1.1.m.52913,-0.00547463420996006,No,NA,NA,O95861,NA,NA,NA,cytosol [GO:0005829]; 3'(2');5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_285738.1.1.m.21025,0.000653087580393681,No,NA,NA,O95394,NA,NA,NA,cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_BRAFLDRAFT_285971.1.1.m.18286,-0.023956505861876,No,NA,NA,Q6GPV5,NA,NA,NA,metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_286243.1.1.m.11085,-0.0153675107703515,No,NA,NA,Q9HD45,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_BRAFLDRAFT_287019.1.1.m.36911,-0.000815741911712003,No,NA,NA,Q4QQW8,NA,NA,NA,lysosomal lumen [GO:0043202]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_BRAFLDRAFT_287353.1.1.m.46293,0.00177035541880622,No,NA,NA,A6QR56,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620],NA,NA,NA
CHOYP_BRAFLDRAFT_287356.1.1.m.25008,-0.0135577801910089,No,NA,NA,Q7ZWY2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_287444.3.5.m.17688,-0.000536569380134305,No,NA,NA,Q6RVV4,NA,NA,NA,chloroplast inner membrane [GO:0009706]; calmodulin binding [GO:0005516]; oxidoreductase activity [GO:0016491]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_287716.1.1.m.51443,0.00633000521291674,No,NA,NA,P51464,NA,NA,NA,argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_BRAFLDRAFT_287844.1.1.m.63253,-0.009673535923397,No,NA,NA,Q6P2Y2,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_290492.1.1.m.21887,0.0088600621996702,No,NA,NA,Q9BPW9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_BRAFLDRAFT_291364.1.1.m.47990,-0.0104565215329895,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_BRAFLDRAFT_57028.1.1.m.55583,0.000102172584119827,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_57175.1.1.m.7616,0.017883205898681,No,NA,NA,P60027,NA,NA,NA,core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.3.5.m.23440,0.000403328248568024,No,NA,NA,O43805,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.5.5.m.54727,0.00166849480345022,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_57258.1.3.m.43523,0.00114995684684727,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_57258.2.3.m.48328,-0.00033729838494709,No,NA,NA,Q53FA7,NA,NA,NA,cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_57395.1.1.m.9938,0.000865606611695147,No,NA,NA,O75521,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_57407.1.1.m.28838,-0.0231003233529507,No,NA,NA,O88741,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_57459.1.1.m.61613,-0.00529662237169364,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_57552.1.1.m.8199,-0.0041445875012699,No,NA,NA,Q9R1C7,NA,NA,NA,cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.3.10.m.31620,0.00354311326074391,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.6.10.m.45495,-0.00986839589654704,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.8.10.m.49717,-3.4725514890401e-05,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_58035.2.2.m.65814,-0.0129309248749742,No,NA,NA,Q6DQX6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_58194.1.1.m.27050,-0.00092051958227077,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_BRAFLDRAFT_58684.1.1.m.13006,-0.00334529798971967,No,NA,NA,Q13367,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; transporter activity [GO:0005215]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892],NA,NA,NA
CHOYP_BRAFLDRAFT_59014.1.1.m.59709,0.000383158671898961,No,NA,NA,Q99NB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],NA,NA,NA
CHOYP_BRAFLDRAFT_59647.1.1.m.25700,-0.00670733478583718,No,NA,NA,Q4QRK0,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_59863.1.1.m.24545,-0.000184011801498633,No,NA,NA,O70439,NA,NA,NA,azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22201,-0.0112062010588276,No,NA,NA,Q3SX11,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22202,0.0202087979225381,No,NA,NA,Q8NC51,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.2.3.m.33251,-0.00851021111771103,No,NA,NA,Q63340,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_60329.1.1.m.18239,-0.000975442108517775,No,NA,NA,Q6GM65,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]; cellular response to lipopolysaccharide [GO:0071222]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_BRAFLDRAFT_60331.1.1.m.34512,-0.00557335710955017,No,NA,NA,Q8BS45,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.5.14.m.37733,0.0147607493915293,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.8.14.m.44214,0.0150255538374357,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61507.1.1.m.52347,0.000588104099916269,No,NA,NA,Q9WTP7,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; protein homooligomerization [GO:0051260]; UTP metabolic process [GO:0046051],NA,NA,NA
CHOYP_BRAFLDRAFT_61845.1.1.m.37831,-0.00295630246020234,No,NA,NA,P56597,NA,NA,NA,sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_62156.1.1.m.47958,-0.00172447909245922,No,NA,NA,Q10725,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_BRAFLDRAFT_63199.1.5.m.9045,-0.0158446263186748,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63199.2.5.m.21288,-0.00509902597730654,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.1.2.m.28725,0.00211927610106483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.2.2.m.46528,8.22382949450862e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63397.6.8.m.48804,-0.011125738623158,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_63459.2.3.m.27933,-0.00375341823498044,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_63471.1.1.m.25619,0.0213340192656429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63652.1.1.m.8021,-0.0135380980454375,No,NA,NA,Q4R9E0,NA,NA,NA,integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_63676.1.1.m.37146,-0.00835346586864802,No,NA,NA,Q6P3R8,NA,NA,NA,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],NA,NA,NA
CHOYP_BRAFLDRAFT_63907.1.1.m.14584,-0.00137626426951109,No,NA,NA,Q9P2J5,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; negative regulation of autophagy [GO:0010507]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; protein targeting to lysosome [GO:0006622]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_BRAFLDRAFT_64071.9.35.m.13313,0.00486512215609155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_64737.1.1.m.40499,-0.00224375610568757,No,NA,NA,Q9C0B0,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_BRAFLDRAFT_64948.1.1.m.17321,-0.0104790972892621,No,NA,NA,B9EJR8,NA,NA,NA,cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_BRAFLDRAFT_64962.1.1.m.59737,0.00174243011376516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65137.1.1.m.64534,0.0101511331891326,No,NA,NA,A2AIW0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_BRAFLDRAFT_65518.1.1.m.29803,0.0221243236631105,No,NA,NA,Q6P3Z3,NA,NA,NA,DNA binding [GO:0003677]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_BRAFLDRAFT_65562.1.1.m.14267,0.00947011070755415,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_65681.1.1.m.445,-0.00651721672707947,No,NA,NA,Q9P0W8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_65711.1.1.m.18159,0.0108279702980595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65861.1.1.m.24624,-0.00661806273080482,No,NA,NA,Q8NDI1,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_65994.1.1.m.40535,0.0089788350204758,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_BRAFLDRAFT_66204.1.3.m.2589,0.00402912026248828,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_66627.1.1.m.40620,-3.6345967002773e-05,No,NA,NA,P49696,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438],NA,NA,NA
CHOYP_BRAFLDRAFT_66688.1.2.m.2447,-0.00681220432026798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_66688.2.2.m.10883,-0.00195989289386351,No,NA,NA,O43345,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_66705.1.1.m.47148,-0.00778630225871788,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_BRAFLDRAFT_67226.1.1.m.38034,0.00999562781060469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67258.9.18.m.34120,0.00764157882530972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67261.1.2.m.16694,0.0126475537184606,No,NA,NA,P86179,NA,NA,NA,cell [GO:0005623]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; galactose binding [GO:0005534]; melibiose binding [GO:1903777]; protein homodimerization activity [GO:0042803]; rhamnose binding [GO:0033296],NA,NA,NA
CHOYP_BRAFLDRAFT_67264.4.6.m.42082,0.01353102992044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67459.2.2.m.56116,3.75568288742974e-05,No,NA,NA,Q8BK67,NA,NA,NA,chromosome; centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_BRAFLDRAFT_67483.1.1.m.55096,-0.00142424505338785,No,NA,NA,Q9JJP6,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; aging [GO:0007568]; cell proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.1.2.m.16093,0.00887249537527558,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.2.2.m.34594,-0.00569877072844896,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_67662.1.1.m.3006,6.3353601835945e-05,No,NA,NA,O81884,NA,NA,NA,cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853],NA,NA,NA
CHOYP_BRAFLDRAFT_67696.3.3.m.54584,-0.00879283635877429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67741.2.2.m.37743,0.00763686063251218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67911.1.1.m.4174,-0.009233540282789,No,NA,NA,Q8L970,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_BRAFLDRAFT_67999.1.1.m.44535,0.0171750334466004,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_BRAFLDRAFT_68004.1.1.m.24323,0.000364816834335623,No,NA,NA,O93610,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_BRAFLDRAFT_68242.2.3.m.26345,-0.00403093101567974,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_68488.1.1.m.58466,-0.00991970566304444,No,NA,NA,Q32L27,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936],NA,NA,NA
CHOYP_BRAFLDRAFT_68592.1.1.m.53611,0.00738272839800686,No,NA,NA,O13016,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_BRAFLDRAFT_68766.4.4.m.38248,-0.0127321813851612,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_68867.1.1.m.4095,-0.0136799969765793,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_68915.2.7.m.3908,0.010495765832453,No,NA,NA,O08762,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.1.3.m.16606,0.00276269942292295,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.2.3.m.28554,0,No,NA,NA,A1L4H1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intracellular [GO:0005622]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of interleukin-8 secretion [GO:2000483],NA,NA,NA
CHOYP_BRAFLDRAFT_68934.1.2.m.57609,-0.0217433685112043,No,NA,NA,Q5XI68,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_68997.1.1.m.56357,-0.00941833539747375,No,NA,NA,P39429,NA,NA,NA,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_69005.1.1.m.26462,0.00126022927976862,No,NA,NA,Q2HJH1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_69120.3.3.m.40386,0.0204922146856667,No,NA,NA,G8HTB6,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_69134.2.13.m.10914,0.0251818036027721,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_BRAFLDRAFT_69505.3.4.m.52485,-2.71797805812925e-05,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_69729.1.1.m.683,-0.00859275121797025,No,NA,NA,B2ZZS9,NA,NA,NA,nucleolus [GO:0005730]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; pharynx development [GO:0060465]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538],NA,NA,NA
CHOYP_BRAFLDRAFT_69798.11.22.m.42042,0.000428857072695532,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70742.1.1.m.8525,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70868.1.1.m.55081,-0.00289914219266353,No,NA,NA,Q9H1J1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_BRAFLDRAFT_70886.1.1.m.53762,-0.00219175093479395,No,NA,NA,Q96P53,NA,NA,NA,early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_BRAFLDRAFT_70987.2.2.m.58284,-0.0059517810343852,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_BRAFLDRAFT_71030.1.1.m.31477,-0.00097766382332297,No,NA,NA,A2A3L6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_71616.2.3.m.27171,-0.0118114175392503,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_71629.1.1.m.65970,-0.00974782453594222,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72035.1.1.m.48832,-0.00248549513428608,No,NA,NA,Q5R630,NA,NA,NA,clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_72273.1.2.m.34499,-0.0112555760035112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72357.1.1.m.59063,-0.00993149473597167,No,NA,NA,Q5VYX0,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_72541.1.2.m.13652,0.0075509325616878,No,NA,NA,Q5ZL00,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_BRAFLDRAFT_72611.1.1.m.61108,0.000628183168046546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72748.1.1.m.27724,0.00119553664800279,No,NA,NA,Q00285,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_BRAFLDRAFT_73177.1.1.m.61488,-0.00535573446041069,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_73486.1.1.m.16417,0.0134367462294261,No,NA,NA,Q93099,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1;2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_73991.2.2.m.60726,0.00707512042083596,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.1.5.m.2740,0.00167712229620906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74063.2.5.m.9454,0.00427121248658368,No,NA,NA,Q9IBG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.4.5.m.43367,-0.00804403607146782,No,NA,NA,Q3U492,NA,NA,NA,extracellular space [GO:0005615]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513],NA,NA,NA
CHOYP_BRAFLDRAFT_74469.3.3.m.53818,-0.00539097296052264,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74594.1.3.m.1187,-0.00196577792165272,No,NA,NA,Q6GMV2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.2.3.m.1285,0.00720616433917298,No,NA,NA,Q6GPQ4,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.3.3.m.1992,0.000277205277990714,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74861.1.1.m.16599,0.00795294512905513,No,NA,NA,Q96IG2,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse; modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.1.9.m.3545,0.00409449348921144,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.3.9.m.37096,-0.0024787704878374,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74874.5.9.m.47033,-0.0108748496611789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74879.1.6.m.21111,-0.00054587862576281,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74879.3.6.m.24658,-0.0214747540817111,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_75094.1.2.m.24898,0.00425932172130622,No,NA,NA,Q7Z7G8,NA,NA,NA,protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_75616.1.2.m.9949,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_75632.1.1.m.60676,-0.00472167745824373,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_75707.1.1.m.8533,-0.00433070431758194,No,NA,NA,Q7Z5J8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_75823.1.2.m.2870,-0.00681361863424142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76126.1.1.m.8736,-0.00970324137313906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76176.1.1.m.55550,-0.00526822628390477,No,NA,NA,Q8NE28,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_BRAFLDRAFT_76402.1.5.m.22765,-0.000437813686537531,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76662.3.3.m.61577,-0.0241549667209843,No,NA,NA,Q6ZV70,NA,NA,NA,plasma membrane [GO:0005886]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_76728.1.1.m.17486,0.000786901624212676,No,NA,NA,Q6P8G1,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_76825.1.1.m.2818,-0.00138874657272832,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_76885.1.1.m.20259,-0.00266873562531481,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_76943.1.1.m.58001,0.00863717302835644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_77063.1.1.m.8252,-0.00845836239262967,No,NA,NA,Q8D3M4,NA,NA,NA,2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_BRAFLDRAFT_77132.1.2.m.5217,0.000783321914325765,No,NA,NA,Q9UNH7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular [GO:0005622]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_77225.1.2.m.29845,0.0192752163492506,No,NA,NA,P04988,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; hyperosmotic response [GO:0006972]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_77483.1.1.m.56627,-0.00825443133649609,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_78229.1.1.m.52210,0.020348137317859,No,NA,NA,Q9P2K2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_BRAFLDRAFT_79044.2.2.m.62650,-0.00149859246446714,No,NA,NA,B0BNE5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],NA,NA,NA
CHOYP_BRAFLDRAFT_79377.5.30.m.21330,0.000435591704340216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_79602.1.1.m.42298,0.0205492798337131,No,NA,NA,Q8IVI9,NA,NA,NA,cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999],NA,NA,NA
CHOYP_BRAFLDRAFT_79734.1.1.m.15409,0.0251764900464495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80039.1.1.m.2568,0.00156052373691586,No,NA,NA,Q6PDL0,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.1.3.m.18963,-0.00038732089297314,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.3.3.m.30251,-0.000374306660467056,No,NA,NA,P98092,NA,NA,NA,carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_80394.4.9.m.33604,-0.00620999657524002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80432.2.2.m.18322,0.0053765370748855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80496.1.10.m.12618,-0.0101234768285887,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.3.10.m.22837,0.00437531791281312,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.6.10.m.29014,-0.00570584872052593,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.8.10.m.49028,-0.0118349754573821,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80577.2.6.m.24330,-0.0095389863479839,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_80919.1.1.m.62047,-0.0166241867591213,No,NA,NA,Q8C0R9,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_80934.1.2.m.23714,-0.00225482496074869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_81321.3.10.m.34305,0.00577198870797613,No,NA,NA,P41241,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.5.10.m.45062,0.00111490591993022,No,NA,NA,O22558,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chloroplast organization [GO:0009658],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.6.10.m.48025,0.00743521071928737,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_BRAFLDRAFT_81322.1.2.m.17860,0.0224119807564505,No,NA,NA,B2IZD3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.2.3.m.30348,-0.0068041865130161,No,NA,NA,A0A1P8AWH8,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.3.3.m.30607,-0.00821867176043091,No,NA,NA,O80596,NA,NA,NA,endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81509.1.1.m.31565,-0.00168918492921456,No,NA,NA,Q9BDK2,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_BRAFLDRAFT_81532.1.1.m.58865,0.0159848550012411,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_BRAFLDRAFT_81609.1.1.m.94,0.00872513938670205,No,NA,NA,Q9Y6N5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221],NA,NA,NA
CHOYP_BRAFLDRAFT_81733.1.1.m.213,-0.00935583602572659,No,NA,NA,A4IHY1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; proteasome core complex assembly [GO:0080129],NA,NA,NA
CHOYP_BRAFLDRAFT_82353.1.1.m.13454,-6.99015422563628e-06,No,NA,NA,Q9D4D4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802],NA,NA,NA
CHOYP_BRAFLDRAFT_82426.1.20.m.8067,-0.00711827835798327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_82868.3.5.m.48837,0.000652871098921227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_83096.1.1.m.27011,0.000959430767767813,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_83552.1.1.m.55255,0.000763249954065887,No,NA,NA,Q704S8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine metabolic process; CoA-linked [GO:0019254]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_BRAFLDRAFT_84207.2.2.m.36438,-0.00771148806205974,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84237.1.1.m.1879,-0.0133756245015205,No,NA,NA,Q9BQG0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription; DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_84245.2.2.m.53621,0.00746961233168012,No,NA,NA,Q9NQG7,NA,NA,NA,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_BRAFLDRAFT_84494.2.5.m.30751,-0.0146122701611102,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.3.5.m.41159,0.000231337729516002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.4.5.m.44543,0.0154019154564752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84664.1.7.m.3969,0.0103227087965279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84838.3.6.m.42355,-0.0111394331633113,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_84941.1.1.m.53224,-0.0147739140634203,No,NA,NA,Q3SZE9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_BRAFLDRAFT_85170.1.1.m.8699,0.0101566649856432,No,NA,NA,Q69Z89,NA,NA,NA,microtubule [GO:0005874]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_BRAFLDRAFT_85206.1.1.m.49234,-0.0107868887772124,No,NA,NA,F5H4B4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_85506.1.1.m.54726,0.00515371447861034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.15.23.m.46769,-0.000866637041324238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.17.23.m.55470,-0.0133687841748232,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_85511.3.23.m.14160,-0.00875489127159526,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.10.10.m.45430,0.00511521472848919,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.3.10.m.26597,0.00645540284127803,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.6.10.m.30553,-0.0221741666864674,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_85822.1.1.m.10102,0.000346119315372178,No,NA,NA,Q9CWK3,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_85994.3.10.m.7126,-0.000314407932099599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85994.7.10.m.36866,0.0222214735302826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86052.1.1.m.25460,-0.00644897506729377,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_BRAFLDRAFT_86765.1.1.m.54066,0.000598517128443954,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27107,-0.00145814099013252,No,NA,NA,E9PV24,NA,NA,NA,blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; blood coagulation; common pathway [GO:0072377]; blood coagulation; fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein-containing complex assembly [GO:0034622]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27108,0.000573146312337065,No,NA,NA,Q20758,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_86827.2.4.m.9197,0.00305951208017589,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.3.4.m.27276,0.000224678544153411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.4.4.m.61859,-0.0160202523899027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86846.1.3.m.13594,-0.00277663455356396,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86846.3.3.m.53453,0.00540197808410096,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86890.2.4.m.23914,0.0113620201621431,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_87283.1.1.m.46768,-0.0108376194421897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87294.6.6.m.64622,-0.0131247007707047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87336.4.9.m.23926,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87429.1.1.m.43808,-0.00877491564778601,No,NA,NA,Q1RLX4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_87630.1.1.m.30352,0.0229852489405195,No,NA,NA,O43174,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_BRAFLDRAFT_87634.1.1.m.39992,0.00921376124035383,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87662.1.1.m.5474,-0.00233818868414276,No,NA,NA,P17560,NA,NA,NA,N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_BRAFLDRAFT_87806.1.1.m.28308,-0.0021545519635408,No,NA,NA,Q6EV69,NA,NA,NA,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_88012.1.1.m.12815,-0.00163492263972647,No,NA,NA,P82861,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203],NA,NA,NA
CHOYP_BRAFLDRAFT_88018.1.1.m.50147,-0.00930728803986181,No,NA,NA,O35474,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_BRAFLDRAFT_88218.8.8.m.64733,0.00063987062724348,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_88219.1.5.m.37187,-0.000360542418123496,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.10.22.m.35410,-0.0234961225913468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88223.5.22.m.23899,0.00768380780417111,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.9.22.m.34933,-0.0223815221192832,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_88224.2.11.m.3212,0.0210485053730269,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88506.1.1.m.64174,-0.0178810159184468,No,NA,NA,Q3SX22,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_88566.3.11.m.5108,-0.00646849469395534,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_88570.1.2.m.55232,-0.00241908912045621,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88583.1.1.m.56300,-0.0066797716702859,No,NA,NA,Q5SSH7,NA,NA,NA,calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_88596.1.2.m.24206,-0.0088750472473746,No,NA,NA,Q95LU3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_89105.1.1.m.2234,0.010170123854322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89330.1.1.m.23864,-0.00638946506545371,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89362.1.1.m.49683,-0.00441846424679334,No,NA,NA,A2VDN6,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_89535.1.1.m.6232,-0.0106093637076863,No,NA,NA,Q8C4B4,NA,NA,NA,ciliary transition zone [GO:0035869]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_89536.1.1.m.26678,-0.00236304480123903,No,NA,NA,Q96QT6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BRAFLDRAFT_89744.1.1.m.29497,-0.0163638127094014,No,NA,NA,O88280,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_BRAFLDRAFT_89746.1.2.m.29425,-0.0112106094644214,No,NA,NA,Q9R172,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060],NA,NA,NA
CHOYP_BRAFLDRAFT_89869.1.3.m.28871,-0.00888977164321419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89869.3.3.m.37644,0.00686818410860346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89870.1.1.m.15447,0.0121661481131699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89920.1.1.m.13963,0.00186917367639225,No,NA,NA,O15213,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59629,0.0143049056985621,No,NA,NA,Q7TQE6,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; brain development [GO:0007420]; neuronal signal transduction [GO:0023041],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59630,-0.000541456778823081,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.1.3.m.5717,0.000506327009280054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.3.3.m.49198,-0.00738159683261996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90098.1.4.m.3841,-0.00218191150876771,No,NA,NA,Q5M8Z0,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90098.4.4.m.28113,-0.00115129553455052,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90187.1.1.m.30393,-0.0032183662749566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90196.2.2.m.42787,-0.00876793978094217,No,NA,NA,B0JZG0,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904],NA,NA,NA
CHOYP_BRAFLDRAFT_90332.3.4.m.18933,-0.000230147112140438,No,NA,NA,Q8C6K9,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_90405.1.1.m.44167,-0.00557372932385127,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_BRAFLDRAFT_90471.1.2.m.30257,-0.00147263926567728,No,NA,NA,Q9JLQ0,NA,NA,NA,cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_BRAFLDRAFT_90679.1.1.m.33411,0.00532064124797313,No,NA,NA,O18783,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_BRAFLDRAFT_90706.2.2.m.29119,-0.0113191567921286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90929.1.1.m.54454,-0.00702775374789672,No,NA,NA,E9QAM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_90953.1.1.m.48786,0.00125360171050971,No,NA,NA,P51570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_BRAFLDRAFT_91062.1.1.m.77,-0.00388323891644086,No,NA,NA,Q6XZF7,NA,NA,NA,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi stack [GO:0005795]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_BRAFLDRAFT_91068.1.1.m.9955,-0.0166178706132635,No,NA,NA,Q58DT5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547],NA,NA,NA
CHOYP_BRAFLDRAFT_91316.1.1.m.46558,0.00646751605425694,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.1.10.m.20278,0.0085887918779281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.10.10.m.59301,0.00329003404399863,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.5.10.m.37054,-0.000100228052405036,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.7.10.m.56158,0.0154613434252858,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91394.1.1.m.16068,-0.00706741278096419,No,NA,NA,Q9CQF9,NA,NA,NA,lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],NA,NA,NA
CHOYP_BRAFLDRAFT_91441.1.1.m.47971,0.00249001939571933,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.1.11.m.28449,-0.00985709145298575,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.4.11.m.45350,0.0152199777139592,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.6.11.m.49144,0.00400994792160761,No,NA,NA,Q8BV66,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.8.11.m.58992,-0.000589410241410647,No,NA,NA,Q8TCB0,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615],NA,NA,NA
CHOYP_BRAFLDRAFT_91695.1.1.m.31423,-0.011447855475238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91870.3.3.m.62762,-0.0100579330367418,No,NA,NA,P17178,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; vitamin D3 25-hydroxylase activity [GO:0030343]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_BRAFLDRAFT_92024.1.1.m.49813,-0.000811889279592465,No,NA,NA,O08746,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_BRAFLDRAFT_92063.1.2.m.677,0.0135659000075563,No,NA,NA,Q5ZKI4,NA,NA,NA,early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92084.1.1.m.10643,-0.00697679478959933,No,NA,NA,Q8VCY6,NA,NA,NA,nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_92365.3.3.m.51160,0.00489244015493868,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_92367.1.4.m.29492,0.00755412772648937,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_92398.1.2.m.15178,-0.0195436402296962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_92410.1.1.m.36946,-0.000853605965685331,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_92601.1.1.m.56157,0.00173438013048547,No,NA,NA,Q5R7R6,NA,NA,NA,Golgi membrane [GO:0000139]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92908.1.1.m.36182,0.0137918001842018,No,NA,NA,Q80YA7,NA,NA,NA,cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_93030.1.1.m.29276,0.0131414491111608,No,NA,NA,Q62261,NA,NA,NA,axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_BRAFLDRAFT_93247.1.1.m.7558,-0.00764479676909046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93411.1.3.m.13317,-0.000708718189005286,No,NA,NA,O95049,NA,NA,NA,bicellular tight junction [GO:0005923]; nucleus [GO:0005634]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_93411.3.3.m.54402,0.00518081024362224,No,NA,NA,O97758,NA,NA,NA,bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277],NA,NA,NA
CHOYP_BRAFLDRAFT_93856.2.6.m.20593,0.0184932181086573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93876.1.1.m.8885,-0.00827767666337987,No,NA,NA,Q9NPF5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471],NA,NA,NA
CHOYP_BRAFLDRAFT_94906.1.1.m.59345,0.00135554848087963,No,NA,NA,P90994,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein deglycase activity [GO:0036524]; cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation; glyoxal removal [GO:0106046]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; protein deglycation; glyoxal removal [GO:0036529]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BRAFLDRAFT_95073.3.9.m.27326,0.00571521174447156,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95739.1.2.m.53575,0.00517856419640391,No,NA,NA,P70193,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_BRAFLDRAFT_95739.2.2.m.57592,0.00889821015045768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95868.1.2.m.56034,0.00553051861583346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96254.1.1.m.47860,0.00248635004833326,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96598.1.1.m.54770,0.00879575777070988,No,NA,NA,Q62283,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_BRAFLDRAFT_97410.1.3.m.34739,0.0112524984653692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_97676.1.1.m.62102,-0.00971187485476596,No,NA,NA,Q8N1B4,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_97881.1.1.m.46581,-8.42637948753716e-05,No,NA,NA,O75182,NA,NA,NA,autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_BRAFLDRAFT_98499.1.1.m.5718,0.0108509185850184,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.3.7.m.46571,0.0145003735258997,No,NA,NA,Q8N2S1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.4.7.m.53694,-0.00134496680549707,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.5.7.m.58200,0.0274448223173147,No,NA,NA,P98133,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; negative regulation of osteoclast development [GO:2001205]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59350,0.00370907598782659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59351,0.000521554949468664,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.7.7.m.65348,-0.00337961047382985,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98895.2.2.m.39575,-0.000973034247669612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98992.1.1.m.62815,-0.00157505832133427,No,NA,NA,P08503,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; protein homotetramerization [GO:0051289]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_BRAFLDRAFT_99018.1.1.m.14650,0.00172257667217611,No,NA,NA,P55567,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BRAFLDRAFT_99073.1.1.m.18282,0.0114239417431118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99083.1.1.m.11705,0.00200579515412391,No,NA,NA,Q9DAK2,NA,NA,NA,cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_99539.1.1.m.55866,0.00823516257163475,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99630.3.9.m.20020,0.000164987779004113,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.5.9.m.36500,-0.00659163206926466,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.9.9.m.62562,0.00593254220478787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99641.1.1.m.63666,0.0051369353067438,No,NA,NA,Q2T9I5,NA,NA,NA,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_BRAFLDRAFT_99974.1.1.m.25083,0.0143396299678883,No,NA,NA,Q9HAY6,NA,NA,NA,cytosol [GO:0005829]; beta-carotene 15;15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238],NA,NA,NA
CHOYP_BRAP.1.1.m.47862,0.0148582183815047,No,NA,NA,Q7Z569,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_BRCA2.1.2.m.17660,3.80133748532252e-05,No,NA,NA,Q6AZL2,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_BRCC3.1.1.m.66615,0.00268493787146027,No,NA,NA,B5X8M4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_BRD4.1.1.m.55245,-0.00806738707863785,No,NA,NA,Q91Y44,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRD8.1.1.m.244,0.00257783424813387,No,NA,NA,Q8R3B7,NA,NA,NA,mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_BRX1.1.1.m.30421,0.00959655061829722,No,NA,NA,Q3SZZ0,NA,NA,NA,nucleolus [GO:0005730]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_BT3L4.1.1.m.2144,-0.00154435867359728,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_BTAF1.2.2.m.55086,-0.0107913943937905,No,NA,NA,O14981,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BTKL.1.1.m.55270,0.000603078107082524,No,NA,NA,Q14BI2,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_BTKL.1.1.m.55271,0.00221736038327589,No,NA,NA,P42680,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BTRC.1.1.m.816,-0.00616045853338329,No,NA,NA,Q9Y297,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; snoRNA binding [GO:0030515]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BTZ.1.1.m.45914,-0.000633863613186012,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BUCC.1.2.m.10972,0.0268480724586287,No,NA,NA,P20481,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_BUD31.3.3.m.64519,0.00948956929736747,No,NA,NA,Q962X9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BUP1.1.1.m.13641,-0.00180399698142171,No,NA,NA,Q9UBR1,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; metal ion binding [GO:0046872]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_BZW1.1.1.m.44089,-0.00275356747716686,No,NA,NA,Q5ZLT7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_C102A.1.1.m.23591,0.00252313067335449,No,NA,NA,A0JNH6,NA,NA,NA,myosin complex [GO:0016459]; motor activity [GO:0003774],NA,NA,NA
CHOYP_C124A.1.1.m.61913,-0.00759812197956278,No,NA,NA,Q68EY7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_C19L1.1.1.m.13954,0.000979823344825341,No,NA,NA,Q5RGJ5,NA,NA,NA,,NA,NA,NA
CHOYP_C1QL2.19.32.m.29743,-0.0186639317932957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL2.32.32.m.64434,-0.00195961310821318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4.7.10.m.49245,0.0123685830003101,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4L.3.7.m.5967,0.0223103474797197,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_C1QL4L.3.7.m.5968,0.0236521321157409,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1QL4L.6.7.m.26358,-0.00459378103987412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT3.4.8.m.22821,0.00938399701605524,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT4.2.5.m.28767,0.00765202059825398,No,NA,NA,Q8R066,NA,NA,NA,extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469],NA,NA,NA
CHOYP_C1QT4.3.5.m.46406,-0.00235952991016877,No,NA,NA,Q4ZJM9,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1TC.1.1.m.28294,0.00198586003102351,No,NA,NA,P27653,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_C2CD5.1.1.m.9675,0.00575958679896107,No,NA,NA,Q28BX9,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340],NA,NA,NA
CHOYP_C2D1.1.1.m.8807,-0.00222446578711233,No,NA,NA,Q9VKJ9,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; multivesicular body organization [GO:0036257]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_C3ORF38.1.1.m.59043,0.0120829674540422,No,NA,NA,Q5JPI3,NA,NA,NA,nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_C43BP.1.1.m.62099,0.000325140457700804,No,NA,NA,Q6VVX2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermembrane ceramide transfer activity [GO:0120017]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ER to Golgi ceramide transport [GO:0035621],NA,NA,NA
CHOYP_CA050.1.2.m.10226,-0.0080421180419576,No,NA,NA,Q5PQ76,NA,NA,NA,,NA,NA,NA
CHOYP_CA14.1.1.m.30677,-0.017832723500308,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_CA2.1.1.m.27846,-0.00602408263773132,No,NA,NA,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAB32.1.1.m.52444,-0.0168432057583861,No,NA,NA,P41044,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],NA,NA,NA
CHOYP_CAD1.2.2.m.61448,0,No,NA,NA,Q6X862,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_CAD89.1.1.m.14552,-0.0166816352116178,No,NA,NA,Q9VAF5,NA,NA,NA,apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305],NA,NA,NA
CHOYP_CADM3.4.4.m.45272,-0.0151275927273831,No,NA,NA,Q7ZXX1,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60662,0.000225680415790717,No,NA,NA,Q0P5A1,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_CADN.2.3.m.19237,-0.000565894732637791,No,NA,NA,O15943,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_CAH1.1.2.m.24247,-0.00966731651416584,No,NA,NA,P83299,NA,NA,NA,cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAH2.1.1.m.42306,0.00289145665447072,No,NA,NA,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAHD1.5.6.m.53893,0.00621354485422815,No,NA,NA,Q5VU97,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_CAL6303_3579.1.1.m.59031,0.00169889980137804,No,NA,NA,P28034,NA,NA,NA,caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; lignin biosynthetic process [GO:0009809],NA,NA,NA
CHOYP_CAL7507_4591.1.1.m.49532,0.0113721248195894,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CALCR.1.6.m.856,0,No,NA,NA,O08893,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_CALM.11.50.m.28106,-0.0160185830719383,No,NA,NA,Q8STF0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.15.50.m.30007,1.35282540955721e-05,No,NA,NA,Q9LIK5,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.22.50.m.31010,-0.00383935657422239,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.31.50.m.48469,-0.0109897394482024,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CALM.32.50.m.48894,0,No,NA,NA,O16305,NA,NA,NA,cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.35.50.m.49987,-0.0039789323025803,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.42.50.m.56135,0.00593061599966686,No,NA,NA,P0DP35,NA,NA,NA,calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.44.50.m.56751,-0.000359774017451057,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.45.50.m.57163,-0.000420969491613571,No,NA,NA,O96102,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.49.50.m.63320,-0.00296209805992061,No,NA,NA,P02595,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.50.50.m.67046,0.00360578255437171,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.7.50.m.12029,0.00340971744219952,No,NA,NA,Q7T3T2,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALMB.1.1.m.41570,-0.00598968596579768,No,NA,NA,P05932,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALRL.2.3.m.42463,0.0202866550661674,No,NA,NA,O42602,NA,NA,NA,integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852],NA,NA,NA
CHOYP_CALUB.1.2.m.57842,-0.00115405424552721,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALUB.2.2.m.58007,0.00362900812073027,No,NA,NA,Q6XLQ7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALX.1.1.m.12010,0.00118927589719105,No,NA,NA,Q5R440,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CAMK4.1.1.m.30431,0.00137240194956792,No,NA,NA,Q16566,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42242,-0.00658420297154865,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42243,-0.00484293653519724,No,NA,NA,P80404,NA,NA,NA,4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094],NA,NA,NA
CHOYP_CAN8.1.2.m.21091,-0.00594879633134162,No,NA,NA,O35920,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAOG_00801.1.2.m.1579,0.00222314260919225,No,NA,NA,Q9D9B4,NA,NA,NA,melanocyte differentiation [GO:0030318],NA,NA,NA
CHOYP_CAOG_01182.1.1.m.8019,-0.00838524924820162,No,NA,NA,Q717B4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CAOG_01521.1.1.m.28103,0.0009951409595925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_02976.1.2.m.41292,0.000319268339088675,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_02976.2.2.m.56777,-0.00648729236331672,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_03463.1.1.m.16746,0.00445351647416305,No,NA,NA,Q6P1C6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_CAOG_04006.1.1.m.5403,-0.00448509327191589,No,NA,NA,Q5JI69,NA,NA,NA,cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; L-threonine 3-dehydrogenase activity [GO:0008743]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]; protein homotetramerization [GO:0051289]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_CAOG_04643.2.2.m.50992,-0.0140858987847666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_04686.2.2.m.28117,0.0227180441590911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_05733.1.2.m.29878,0.0103372974973131,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAP.1.2.m.22123,-0.0199249288327291,No,NA,NA,P40122,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010],NA,NA,NA
CHOYP_CAPLA.1.2.m.51979,0.00175161102677634,No,NA,NA,P12370,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification; imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040],NA,NA,NA
CHOYP_CAPSLB.1.1.m.58887,0.00103517800851595,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CAPZB.1.1.m.5762,-0.00172940114488531,No,NA,NA,Q5XI32,NA,NA,NA,actin filament [GO:0005884]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_CARNS1.1.6.m.2227,0.00196893134907464,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.2.6.m.3531,-0.00943042113228433,No,NA,NA,Q9BT30,NA,NA,NA,mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],NA,NA,NA
CHOYP_CARNS1.4.6.m.40244,-0.0188731978183058,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.5.6.m.63614,-0.0105640555704207,No,NA,NA,Q80TZ9,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CASP10.4.7.m.45631,-0.0114814554226402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP10.5.7.m.49889,-0.000448487002854698,No,NA,NA,Q92851,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_CASP2.5.5.m.35953,-0.000899984360612015,No,NA,NA,P29594,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485],NA,NA,NA
CHOYP_CASP3.1.3.m.23354,0.0125229401884437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP3.2.3.m.24896,0.00881455429558112,No,NA,NA,P70677,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CASP7.11.23.m.26574,-0.0230663878991506,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.16.23.m.50828,-0.000167256990387692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.17.23.m.52767,-0.00484566371538701,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.18.23.m.52787,-0.00519264468569794,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_CASP7.2.23.m.5415,-0.00993163822655586,No,NA,NA,P55214,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_CASP7.21.23.m.63852,-0.0112730628803655,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.22.23.m.66704,-0.000377846016714223,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.8.23.m.23670,0.00117036256897449,No,NA,NA,O89094,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630],NA,NA,NA
CHOYP_CASP7.9.23.m.25523,-0.0109071731964005,No,NA,NA,P55210,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAT.1.1.m.57038,0.00122539371157544,No,NA,NA,P00432,NA,NA,NA,peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aminoacylase activity [GO:0004046]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; response to hydrogen peroxide [GO:0042542]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.1.3.m.11120,0.0215824354284596,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATA.2.3.m.18454,0.00522160821060146,No,NA,NA,P04040,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity; acting on peroxide as acceptor [GO:0016684]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.3.3.m.21642,0.00136137594699805,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATB.1.2.m.5440,-0.000568599543902835,No,NA,NA,A1E295,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790],NA,NA,NA
CHOYP_CATL1.1.1.m.56906,0.0157583506986773,No,NA,NA,P25782,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_CATS.1.1.m.45218,-0.00776590163428135,No,NA,NA,O60911,NA,NA,NA,apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CB044.1.1.m.53539,-0.00101680969466048,No,NA,NA,Q5RFV8,NA,NA,NA,,NA,NA,NA
CHOYP_CBG09799.1.1.m.44038,-0.0074682612585381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11254.1.1.m.9107,-0.000864173948870499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11292.1.1.m.12957,0.00265508901868129,No,NA,NA,Q8ISH7,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_CBG18730.1.1.m.2611,-0.0175638088961107,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_CBG20816.1.1.m.49333,0.00755683788361819,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG22657.2.2.m.28802,-0.0121239405936379,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBLN3.1.2.m.29253,-0.0241258585315498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBP.2.4.m.11401,0.00133760137040847,No,NA,NA,Q6JHU9,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; peroxisome proliferator activated receptor binding [GO:0042975]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to UV [GO:0034644]; histone acetylation [GO:0016573]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; regulation of transcription; DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_CBPC1.1.1.m.30713,-7.33976101048663e-05,No,NA,NA,Q5REG1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; mRNA splicing; via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_CBPQ.1.1.m.58629,-0.0148775801361681,No,NA,NA,Q6GQ29,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CBR.GLY.5.1.1.m.26441,-0.00260901156819665,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44681,0.0082228961893845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44682,0.0062847767316569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBS.2.2.m.65898,0.000178904292927323,No,NA,NA,Q91WT9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; cysteine synthase activity [GO:0004124]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel size [GO:0050880]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_CBWD1.1.1.m.6825,-0.0102488456652932,No,NA,NA,Q8IUF1,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_CBX1.1.4.m.5390,0.00140863254991049,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CBX1.3.4.m.27106,0.0185125061683363,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CC136.1.1.m.64302,-0.0243199826035376,No,NA,NA,Q01844,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CC171.1.1.m.55237,0.0036801195728065,No,NA,NA,E9Q1U1,NA,NA,NA,,NA,NA,NA
CHOYP_CC1G_13336.1.3.m.23079,-0.00532954670903249,No,NA,NA,O94581,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrial respiratory chain complex IV assembly [GO:0033617],NA,NA,NA
CHOYP_CCAR1.1.1.m.25430,-0.00444954642266157,No,NA,NA,Q641G3,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; cell cycle [GO:0007049]; regulation of transcription; DNA-templated [GO:0006355]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_CCD22.1.1.m.6639,0.00346739979811449,No,NA,NA,A7RNG8,NA,NA,NA,cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060],NA,NA,NA
CHOYP_CCD53.1.1.m.6684,0.00775204799868044,No,NA,NA,Q5RGJ6,NA,NA,NA,WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_CCD73.1.2.m.21485,-0.020504459014252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CCDC146.1.1.m.11347,0,No,NA,NA,Q8IYE0,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_CCDC150.1.1.m.58800,0.0107903540418175,No,NA,NA,Q8NCX0,NA,NA,NA,,NA,NA,NA
CHOYP_CCDC6.1.1.m.13918,0.0203592700636834,No,NA,NA,Q16204,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],NA,NA,NA
CHOYP_CCHCR1.1.1.m.59142,-0.0117328986571027,No,NA,NA,Q566U4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_CCHL.2.2.m.66608,-0.00908934705925986,No,NA,NA,Q5F339,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063],NA,NA,NA
CHOYP_CCKAR.4.6.m.43964,-0.00885744736219071,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_CCNB.2.2.m.16936,-0.00738605145986897,No,NA,NA,Q5XIK8,NA,NA,NA,phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_CCNL1.1.2.m.9018,0.00824925962711169,No,NA,NA,Q6GN15,NA,NA,NA,nuclear speck [GO:0016607]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription; DNA-templated [GO:0006355]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CD033.1.1.m.25350,-0.0206538481781942,No,NA,NA,Q8BGN2,NA,NA,NA,,NA,NA,NA
CHOYP_CD109.1.2.m.7033,0.00116417067893662,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_CD11B.1.1.m.51509,0.000611659885447176,No,NA,NA,P21127,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CD36_40650.1.1.m.47015,0.00612463003574877,No,NA,NA,O35601,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_CDC14A.1.1.m.18068,-0.00864304973821105,No,NA,NA,Q9UNH5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cell proliferation [GO:0008283]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_CDC23.1.1.m.6463,-0.0139365507908586,No,NA,NA,A1A4R8,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],NA,NA,NA
CHOYP_CDC42.1.11.m.324,0.00163052188572868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60002,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60004,0.000279314476145192,No,NA,NA,Q29HY3,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CDC5L.1.1.m.25107,-0.00487387833239337,No,NA,NA,O08837,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mRNA splicing; via spliceosome [GO:0000398]; regulation of transcription; DNA-templated [GO:0006355]; signal transduction involved in DNA damage checkpoint [GO:0072422],NA,NA,NA
CHOYP_CDC73.1.1.m.36157,0.0244124092478859,No,NA,NA,Q5ZLM0,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone modification [GO:0016570]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK13.1.1.m.59965,-0.00724691179946617,No,NA,NA,Q9NYV4,NA,NA,NA,chromosome [GO:0005694]; cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; fibrillar center [GO:0001650]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK5.1.1.m.25495,-0.00854144491322046,No,NA,NA,P49615,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex development [GO:0021695]; cerebellar cortex formation [GO:0021697]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission; glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission; dopaminergic [GO:0001963]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; telencephalon development [GO:0021537]; visual learning [GO:0008542],NA,NA,NA
CHOYP_CDO1.1.4.m.26663,0.00121217173037183,No,NA,NA,Q6NWZ9,NA,NA,NA,cysteine dioxygenase activity [GO:0017172]; iron ion binding [GO:0005506]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CDPK5.1.1.m.6214,0.00107922325721144,No,NA,NA,P04630,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CDPKM.1.1.m.58179,0.000177865670368641,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CE112.1.2.m.11508,0.0100456066795674,No,NA,NA,Q8N8E3,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120],NA,NA,NA
CHOYP_CE120.1.2.m.19214,-0.00245069528041084,No,NA,NA,Q8N960,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],NA,NA,NA
CHOYP_CEBPZ.1.1.m.12869,-0.00411312981561272,No,NA,NA,P53569,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_CECR2.2.3.m.13613,-0.00232521962758631,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CECR2.3.3.m.59311,-0.007270294290765,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CED1.20.29.m.45054,0.00808644483681876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.22.29.m.48193,0.00898795627286047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.26.29.m.53629,0,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CED1.9.29.m.29470,-0.00980900802202456,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CEG1A.1.6.m.815,0.00604346414284387,No,NA,NA,Q6NRL1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CEL.2.3.m.27351,0.0020537367916064,No,NA,NA,P07882,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; zymogen granule [GO:0042588]; carboxylic ester hydrolase activity [GO:0052689]; glycosphingolipid binding [GO:0043208]; lysophospholipase activity [GO:0004622]; neurexin family protein binding [GO:0042043]; protein-containing complex binding [GO:0044877]; retinyl-palmitate esterase activity [GO:0050253]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CELA1.1.3.m.14531,-0.0185668306723293,No,NA,NA,P00773,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CELA1.2.3.m.27287,-0.0106396804378483,No,NA,NA,Q7SIG3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4263,0.0213873614577228,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_Y64G10A.7.3.4.m.53262,0.00862263355423794,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CELF2.2.4.m.22506,1.36715974744535e-05,No,NA,NA,Q6P0B1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELR2.3.8.m.29505,0.000146308433800779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CENPJ.1.1.m.49318,-0.00461943846461679,No,NA,NA,Q569L8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_CENTRIN.1.1.m.59526,0.0142292096658319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CEP164.1.1.m.40330,-0.0114393861012301,No,NA,NA,Q9UPV0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP192.1.2.m.7869,-0.00326907841793561,No,NA,NA,Q8TEP8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CEP290.1.1.m.58767,-0.00420166020908538,No,NA,NA,O15078,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP350.1.1.m.4119,0.00285345956245354,No,NA,NA,E9Q309,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_CEP63.2.2.m.35716,0.000174677931438662,No,NA,NA,Q86X83,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CEP76.1.1.m.6264,-0.00422467711479572,No,NA,NA,Q28DH9,NA,NA,NA,centriole [GO:0005814]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_CEP89.1.2.m.14339,0.00730169884290182,No,NA,NA,Q9CZX2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_CERS6.1.1.m.5214,0.00827637270165302,No,NA,NA,Q9D6K9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_CETN1.1.3.m.15199,-0.00514621693058739,No,NA,NA,Q9R1K9,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; centriole replication [GO:0007099]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; nucleotide-excision repair [GO:0006289]; regulation of centrosome duplication [GO:0010824]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CF106.1.1.m.14354,-0.00881156794814987,No,NA,NA,Q3TT38,NA,NA,NA,autophagosome [GO:0005776]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_CG057.1.1.m.45912,-0.0204218418343655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG14207.1.1.m.41523,0.00309215014740747,No,NA,NA,Q9EPF3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CG17147.1.1.m.28107,7.35509559642725e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG34417.1.2.m.18203,-0.000618597194993407,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_CG42749.1.1.m.30138,0.000356415672378252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGD4_750.1.1.m.29180,0.00120514673798134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGL.1.2.m.31960,0.00214364587335601,No,NA,NA,Q60HG7,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272],NA,NA,NA
CHOYP_CH60.1.1.m.26967,0.000448550091206541,No,NA,NA,O02649,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_CHCHD1.1.1.m.25210,0.0250694716572335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHD2.1.1.m.36132,-0.00800016397952064,No,NA,NA,B6ZLK2,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_CHD5.2.2.m.28708,-0.000163478789856688,No,NA,NA,D3ZD32,NA,NA,NA,heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; H3K27me3 modified histone binding [GO:0061628]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis; exchange of chromosomal proteins [GO:0035093]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_CHD7.2.2.m.14418,0.000278610342756973,No,NA,NA,Q8BYH8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_CHER.1.1.m.63350,0.00100053407125259,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_CHERP.1.1.m.22401,0.0101117660759422,No,NA,NA,Q8CGZ0,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CHGG_10233.1.1.m.39238,0.00292439529417804,No,NA,NA,Q4I963,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_CHI1.1.1.m.40259,0.00754942297547704,No,NA,NA,H2A0L4,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_CHKA.1.1.m.25454,0.0101237234456892,No,NA,NA,Q9Y259,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_CHL1.2.2.m.65829,-0.0147919155140125,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHM2A.1.1.m.59752,-0.00102185287047933,No,NA,NA,Q7ZW25,NA,NA,NA,ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CHM4B.1.1.m.19057,0.00329589059271037,No,NA,NA,Q5XGW6,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034],NA,NA,NA
CHOYP_CHMP3.1.1.m.65684,0.0118110726067079,No,NA,NA,Q8CGS4,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; multivesicular body [GO:0005771]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036],NA,NA,NA
CHOYP_CHMP5.1.1.m.66827,-0.00583613423350677,No,NA,NA,Q4QQV8,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755],NA,NA,NA
CHOYP_CHMP7.1.1.m.15221,-0.00163016783388152,No,NA,NA,Q7T0X5,NA,NA,NA,ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; protein transporter activity [GO:0008565]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468],NA,NA,NA
CHOYP_CHRD1.1.1.m.42143,0.00485356154196774,No,NA,NA,Q7T3F7,NA,NA,NA,metal ion binding [GO:0046872]; regulation of centrosome duplication [GO:0010824],NA,NA,NA
CHOYP_CHRO_0413.1.2.m.16023,-0.0157094189885504,No,NA,NA,A6QLH5,NA,NA,NA,3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process; exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467],NA,NA,NA
CHOYP_CHS.2.1.1.m.37794,-0.00182228056352405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHS1.1.4.m.4755,-0.00874643888995462,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHS2.1.1.m.63783,0.00636936558632944,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHSS2.1.1.m.19314,0.00805145819152142,No,NA,NA,Q6IQX7,NA,NA,NA,cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity; transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206],NA,NA,NA
CHOYP_CHTOP.1.1.m.35404,-0.0025693712173402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CIAO1.1.1.m.48324,-0.00193723980655289,No,NA,NA,A7RWD2,NA,NA,NA,CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_CIC.1.2.m.57436,0.0197630460267902,No,NA,NA,Q96RK0,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; social behavior [GO:0035176],NA,NA,NA
CHOYP_CIR1.1.2.m.16126,-0.00501130245374996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CIR1A.1.1.m.11568,-0.0213062706738818,No,NA,NA,Q969X6,NA,NA,NA,90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of transcription; DNA-templated [GO:0006355]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_CISD2.1.1.m.26823,-0.0120951632991811,No,NA,NA,C1C524,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; autophagy of mitochondrion [GO:0000422]; multicellular organism aging [GO:0010259]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_CISY.1.1.m.36666,-0.000223788953868654,No,NA,NA,Q7ZVY5,NA,NA,NA,mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; response to activity [GO:0014823]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CKAP5.1.1.m.10679,-0.00549436380992833,No,NA,NA,Q14008,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CKLF4.1.1.m.55295,-0.00701605166441206,No,NA,NA,Q8IZR5,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_CLAP1.4.6.m.39950,0.00640279909540944,No,NA,NA,A1A5G0,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023],NA,NA,NA
CHOYP_CLAP1.6.6.m.57823,0.00969973312096454,No,NA,NA,Q7Z460,NA,NA,NA,basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_CLASR.1.2.m.27688,0,No,NA,NA,Q5HZB6,NA,NA,NA,nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CLC10.2.5.m.4673,0.000713149999237141,No,NA,NA,Q66S03,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_CLCN3.1.1.m.21245,-0.0118904087284431,No,NA,NA,P51791,NA,NA,NA,apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; ion channel activity [GO:0005216]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transport [GO:0006811]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis; engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission; GABAergic [GO:0051932]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401],NA,NA,NA
CHOYP_CLCN7.2.3.m.47039,0.00789915616778213,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLCN7.3.3.m.51894,-0.00641067512153937,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLEC10A.3.3.m.27236,-0.000548984828388049,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_CLEC17A.1.1.m.28486,-0.000505619914172954,No,NA,NA,Q6ZS10,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CLH1.2.2.m.22327,0.000881352215209425,No,NA,NA,P49951,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_CLK2.1.1.m.3082,0.00113623517335646,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_CLP1.1.1.m.11641,0.0072955247890619,No,NA,NA,Q5ZJL4,NA,NA,NA,cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CLPB.1.3.m.14233,0.000519122980970165,No,NA,NA,Q60649,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605],NA,NA,NA
CHOYP_CLPT1.1.1.m.50172,0,No,NA,NA,Q2NL17,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CLPX.1.2.m.12748,-0.0242397414850624,No,NA,NA,Q5U2U0,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLPX.2.2.m.49273,-0.000185429989632904,No,NA,NA,Q9JHS4,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLSTN1.1.1.m.55323,-0.00634924317691517,No,NA,NA,O94985,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_CLU.1.1.m.8566,-0.00244775575746895,No,NA,NA,Q17N71,NA,NA,NA,cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312],NA,NA,NA
CHOYP_CML1.1.1.m.30763,-0.0107085280991566,No,NA,NA,P0DH96,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CML8.1.1.m.37436,-0.0122148231087778,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CN166.1.1.m.14529,-0.00227028235835583,No,NA,NA,Q5R8I2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CNA1.1.1.m.65403,0.00114935528543478,No,NA,NA,P63329,NA,NA,NA,calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; Z disc [GO:0030018]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],NA,NA,NA
CHOYP_CNDP2.1.4.m.11722,0.00784208705418677,No,NA,NA,Q96KP4,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750],NA,NA,NA
CHOYP_CNDP2.3.4.m.30467,0.00447418793344405,No,NA,NA,Q9D1A2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CNDP2.4.4.m.56870,-0.0129407572262494,No,NA,NA,Q5R432,NA,NA,NA,cytoplasm [GO:0005737]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],NA,NA,NA
CHOYP_CNE_1C34780.3.3.m.30615,-0.0106145235381579,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CNOT1.1.1.m.12104,0.000453354534837042,No,NA,NA,Q6ZQ08,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; protein domain specific binding [GO:0019904]; protein-containing complex scaffold activity [GO:0032947]; retinoic acid receptor binding [GO:0042974]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT2.1.2.m.47530,-0.00620551275489855,No,NA,NA,Q9NZN8,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT3.1.1.m.62322,-0.00817428083639343,No,NA,NA,Q8K0V4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription; DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT7.1.2.m.7497,-0.0081213097040961,No,NA,NA,Q60809,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509],NA,NA,NA
CHOYP_CNOT7.2.2.m.35718,-0.00336596758067627,No,NA,NA,Q8CHS8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_CNTN5.4.5.m.44639,-0.0183434065364497,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTN6.1.2.m.781,-0.0124895633886168,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTRL.1.1.m.8381,0.00857546978210961,No,NA,NA,A2AL36,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; mitotic cell cycle [GO:0000278]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_CNTROB.1.1.m.11584,-0.00409641747582024,No,NA,NA,Q8CB62,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_CO1A1.1.1.m.32133,0.00767519105279987,No,NA,NA,Q30D77,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_CO2A1.1.1.m.62996,8.16014356909809e-05,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_CO4A1.1.2.m.36472,-0.00945621028415501,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CO4A2.1.2.m.14631,-0.016921026993826,No,NA,NA,P08120,NA,NA,NA,basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; oviduct morphogenesis [GO:0035848]; post-embryonic digestive tract morphogenesis [GO:0048621],NA,NA,NA
CHOYP_CO5A2.1.1.m.28030,-0.0139088606064789,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_CO6A3.2.5.m.39533,0.011698589033784,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_CO6A3.3.5.m.39796,-0.0104974976904311,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_CO6A5.1.6.m.5838,0.00126699515894843,No,NA,NA,A8TX70,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CO6A5.1.6.m.5840,-0.00115034758166541,No,NA,NA,P27080,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857],NA,NA,NA
CHOYP_CO9A1.1.1.m.62338,0.0109034542282833,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_COCA1.3.6.m.49360,-0.00516946453269229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COG2.1.2.m.12604,-0.00313204380546114,No,NA,NA,Q14746,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_COG3.1.1.m.35921,0.00360960184502137,No,NA,NA,Q96JB2,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COG5.1.1.m.13833,0.00494000910785804,No,NA,NA,Q9UP83,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG6.1.1.m.57008,-0.00554774966979784,No,NA,NA,Q9Y2V7,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG8.1.1.m.10907,0.0215052537386997,No,NA,NA,Q96MW5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COIL.1.1.m.18070,-0.00858910361425901,No,NA,NA,Q09003,NA,NA,NA,sphere organelle [GO:0071601],NA,NA,NA
CHOYP_COL4A4.1.1.m.30919,-0.0247737207896182,No,NA,NA,Q5UQ13,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_COL6A6.1.2.m.39071,0.00704939211074969,No,NA,NA,A3DC27,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose binding [GO:0030248]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_contig_000003.m.1,0.00990212311431433,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000121.m.127,0.00948516448609888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000227.m.218,-0.000405218906818416,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000437.m.416,-0.0188250437857261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001114.m.1165,-0.00155001201022249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001129.m.1188,-0.000688711318290517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001251.m.1283,0.0125782595824786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001305.m.1337,-0.00808832429411839,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001413.m.1466,-0.00997153167827391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001477.m.1562,0.00555779990749446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001544.m.1660,0.00109802883728702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001740.m.1863,-0.00025511207639108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001932.m.2147,-0.00269867641798902,No,NA,NA,Q09575,NA,NA,NA,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_002228.m.2410,0.0211361882659049,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002245.m.2431,-0.00388158522164323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002279.m.2484,0.00778774027498939,No,NA,NA,Q5RA22,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_contig_002305.m.2519,-0.0142049929525984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002327.m.2549,0.00402506784122965,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_002369.m.2605,-0.00123847302167351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002558.m.2814,0.00644691410426659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002568.m.2819,0.00464459330360771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002597.m.2856,-0.0115247447788143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002691.m.2966,-0.0106971394768269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002715.m.2994,-0.0125150736493045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002718.m.2999,0.00179554862776585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002734.m.3017,-0.0156077521000297,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002762.m.3056,-0.0110295437630647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002806.m.3116,0.00838820895181723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002826.m.3144,0.00169334732511953,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002896.m.3210,0.00801660261451538,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002989.m.3291,-0.00882076642432225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002999.m.3300,0.000335491848000635,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003050.m.3358,0.00114499636353466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003161.m.3509,0.00790016513002933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003213.m.3589,0.00777627734140017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003275.m.3667,-0.00183399043203977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003319.m.3735,-0.0238956448824109,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003356.m.3782,-0.00778397383786446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003460.m.3916,0.00964737003294613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003549.m.4007,-0.000291618367213487,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003595.m.4058,0.00185911971939845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003670.m.4147,0.0150335455680964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003695.m.4176,-0.0082598524054337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003840.m.4375,0.010730633524606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003882.m.4416,0.0043721840094705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003956.m.4511,-0.00295299246159588,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004011.m.4571,0.00914487670390375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004045.m.4615,-0.0204618875528328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004193.m.4802,0.00928445535417076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004202.m.4814,0.00858870255591087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004338.m.4955,-0.0224092985454842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004401.m.5025,0.0105445187652412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004461.m.5117,-0.00803059295145075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004474.m.5130,-0.0243283881975705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004504.m.5173,-0.000626095255289002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004513.m.5183,0.0088965965707039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004572.m.5255,0.00846035599409112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004594.m.5279,0.000493169512490368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004609.m.5296,0.00645490346324135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004652.m.5338,-0.0123340627196986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004705.m.5404,-0.0138216746303909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004751.m.5446,-0.0106591514001985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004756.m.5453,0.00453139844085873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004795.m.5507,0.000352827695107741,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004820.m.5529,0.0117666181312808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004853.m.5555,0.0188579098277572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004890.m.5604,-0.0221671388267977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004925.m.5642,0.0159710032436239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004972.m.5699,0.00359008152786414,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004987.m.5716,-0.0133283903517575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004993.m.5721,0.0180590783666597,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005134.m.5869,0.0212778639992553,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005454.m.6186,-0.0120831509395053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005583.m.6332,0.000463022002584391,No,NA,NA,P21399,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_contig_005590.m.6345,-0.00610727403040354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005659.m.6448,0.00176695753004848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005830.m.6680,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005858.m.6708,0.0125853597418528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005908.m.6759,-0.0135867147402637,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005913.m.6764,-0.00717589332906929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006063.m.6910,0.000514358466131084,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006084.m.6928,-0.00452555250379151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006293.m.7131,-0.0117447571291733,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006299.m.7138,-0.00986646227554839,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_contig_006359.m.7206,-0.0101870057975009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006364.m.7211,-0.00181593559430675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006560.m.7472,-0.010642205705823,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006640.m.7557,0.0116321937960002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006758.m.7690,-0.00105192130428043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006775.m.7711,-0.00789433093207199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007032.m.8066,2.2192869598106e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007082.m.8119,0.0245168921335453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007115.m.8183,-0.0249534596851185,No,NA,NA,Q58DT4,NA,NA,NA,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_contig_007164.m.8244,0.00574754461639093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007754.m.8963,0.000358702585522537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007998.m.9259,-0.016627134409827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008002.m.9263,-0.0181100816983824,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008016.m.9273,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008030.m.9291,-0.00754287273865962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008101.m.9378,0.020081593210023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008102.m.9380,0.0201093333813684,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008114.m.9394,-0.0103883058377658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008181.m.9453,-0.00955315888219475,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008261.m.9575,-0.0193124719786394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008262.m.9576,3.74261659172257e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008307.m.9640,0.000164972739529964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008503.m.9899,-0.00401236500525488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008795.m.10231,0.00365209658361989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008923.m.10388,-0.0107846923737729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008926.m.10391,0.0140418563284905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008975.m.10444,-0.00672106111957269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009196.m.10701,0.00745276686711327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009315.m.10833,0.0235373389395199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009651.m.11212,-0.0108022710304018,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009697.m.11280,0.0113889622061116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009806.m.11429,0.0107203164601804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009817.m.11438,-0.021465639709735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009870.m.11509,0.000947375266435121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009887.m.11524,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010011.m.11666,0.0291707720215217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010181.m.11866,-0.0179550485642192,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010226.m.11916,0.00607623783446237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010233.m.11921,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010276.m.11960,-0.00480833617214319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010354.m.12065,0.00905419913872599,No,NA,NA,Q9CRB3,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_contig_010487.m.12180,-0.0148415966694165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010532.m.12231,0.00746967481704312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010639.m.12333,-0.00141795156869412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010659.m.12347,0.0243269748354132,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010674.m.12365,-0.0146419701299384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010687.m.12382,-0.0170663260548959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010861.m.12544,-0.0198770783423651,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011170.m.12887,0.00846472295629312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011268.m.13012,-0.0189256481413474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011571.m.13308,-0.0198306950572025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012045.m.13814,-0.00421269044338368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012068.m.13831,-0.00256220986091244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012079.m.13839,0.00343876061486861,No,NA,NA,P74897,NA,NA,NA,,NA,NA,NA
CHOYP_contig_012255.m.14080,-0.000397684242922511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012395.m.14264,-0.00499875615864594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012437.m.14312,0.0108533656816487,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012819.m.14744,-0.00986394085763241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012962.m.14885,0.00361280138483438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013437.m.15402,0.0256058606615859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013551.m.15499,-0.0236535209097042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013622.m.15553,0.000214361801648739,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013738.m.15666,0.0138498926326389,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013751.m.15674,0.00227170875148215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013806.m.15731,0.004377696657014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014109.m.16087,0.010024791266411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014152.m.16145,0.00158899688787239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014279.m.16311,0.0135063812045016,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014296.m.16345,0.000432983128517794,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014354.m.16426,0.00376332455452797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014357.m.16429,0.000173770637569345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014469.m.16593,-0.00965756652874355,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014479.m.16604,0.0193890986219531,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014529.m.16671,-0.0177473828449406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014863.m.17135,-0.0118730124165381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014867.m.17143,0.0161108533825831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014877.m.17157,-0.000877875450725993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014947.m.17245,0.00264087439886048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014958.m.17266,-0.0100934509183277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015023.m.17360,0.0104423510710151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015209.m.17650,0.0114185482379975,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015341.m.17864,0.000112515831705971,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015391.m.17937,0.00337248868404821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015430.m.17979,-0.0168338521879138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015439.m.17989,0.0105135172986334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015543.m.18138,0.0133685496768584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015692.m.18358,0.0166797388664208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015712.m.18387,0.00467457883366403,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015857.m.18578,0.0112394930892943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015918.m.18639,-0.0129149657318162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015923.m.18643,-0.00566800523465066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015931.m.18654,0.0106604148388478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016010.m.18750,-0.00449938867833398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016017.m.18760,0.0216131848993717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016020.m.18768,0.0178884950487918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016370.m.19270,0.0176645405994235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016405.m.19312,-0.0086702670483847,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016540.m.19484,0.014014431027096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016554.m.19499,0.0082596563386115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016567.m.19514,0.0140020712248787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016589.m.19530,-0.00216438802080366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016628.m.19586,-0.0077643912083474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016637.m.19603,0.0216076340376901,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016752.m.19715,0.0206472691092257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016762.m.19724,-0.0135727070458539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017060.m.20058,-0.00288512851498037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017672.m.20677,-0.0152167451350338,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017941.m.21005,0.00493770805451984,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_018098.m.21196,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018118.m.21239,-0.0089126938667788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018645.m.21889,0.0147735312602079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018676.m.21920,-0.0039107776862542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018822.m.22082,0.00367371656986046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018956.m.22217,0.0064671197953876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018978.m.22243,-0.00816603082618071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019122.m.22406,0.000207877897051165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019189.m.22478,-0.0104310836165266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019238.m.22546,-0.0104841722666461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019263.m.22580,-0.0194914961608408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019436.m.22745,-0.00143710404301893,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019571.m.22867,0.021854801275199,No,NA,NA,A0MSJ1,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_019914.m.23170,0.00935020542967872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020023.m.23276,-0.000642186590725701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020370.m.23576,-0.00979529794932172,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020390.m.23600,0.000321700299944269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020392.m.23606,-0.0174496916892083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020442.m.23651,-0.0100576578877823,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021278.m.24464,0.0088732493154289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021455.m.24647,-0.00712103308744289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021478.m.24670,0.00771494529199232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021494.m.24691,0.00796339179630425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021632.m.24849,0.000314568417887905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021664.m.24884,0.0107812695711402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021811.m.25040,0.00020437557116431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021858.m.25098,0.0180376079830845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022142.m.25369,0.0047917796909042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022641.m.25871,0.00575184952556501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022643.m.25874,-0.00407335330766646,No,NA,NA,Q96HC4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_022826.m.26063,-0.00936344903337086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022851.m.26077,-0.0106619032161622,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_contig_022855.m.26082,-0.017028192196282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022863.m.26088,-0.0104590605768313,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023043.m.26235,0.0166550642309765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023172.m.26349,-0.00975281844316611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023259.m.26467,-0.0101414057164018,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023399.m.26635,-0.00232395731053048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023445.m.26685,0.0221463314643799,No,NA,NA,Q66HG4,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_contig_023474.m.26716,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023538.m.26787,-0.00352394046110822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023655.m.26913,-0.0182389030852196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023660.m.26915,0.000299394618806204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023673.m.26924,0.00212882351859653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023675.m.26925,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023710.m.26965,0.0023624473679436,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023723.m.26983,0.000455734111036162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023724.m.26984,0.0021831816001453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023752.m.27015,0.00179543750138271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023763.m.27021,0.0192608372349768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023792.m.27044,0.0141982292919572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023811.m.27063,0.00527396319842308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023814.m.27068,0.0101718896135301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023887.m.27194,0.00415153546443595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023888.m.27197,-0.0135992717231641,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023932.m.27233,0.011532231014568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023945.m.27245,-0.0154722001994855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023964.m.27264,-9.37266457615523e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024012.m.27306,-0.0143762354587679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024035.m.27331,0.00520165295681602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024046.m.27342,-0.0161067330241854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024156.m.27442,-0.0093940820564342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024166.m.27453,-0.0222285857875817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024175.m.27461,0.00778276575602605,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024218.m.27505,-0.0071169248114325,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024219.m.27509,-0.0207447062498457,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024342.m.27673,0.0153692255989491,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024357.m.27696,-0.0104528773473371,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024372.m.27722,-0.00310484162732961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024418.m.27769,-0.00403230254306436,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024424.m.27774,-0.0215517324122718,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_contig_024498.m.27853,-0.0151055072739216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024504.m.27855,-0.00363562431379783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024582.m.27943,-0.0154133639611411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024602.m.27966,0.0134620336892577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024605.m.27976,-0.0115644825354705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024653.m.28033,-0.000370692484162814,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024662.m.28044,0.0113008397320499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024665.m.28048,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024679.m.28057,0.0251283408178606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024697.m.28081,-0.00287600604928337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024706.m.28101,0.0231829481633982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024730.m.28114,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024739.m.28119,-0.0152781686737828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024742.m.28122,0.00257604000762991,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024846.m.28258,0.00733621107469262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024858.m.28270,0.017429768779477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024935.m.28365,0.00895739610571616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025014.m.28472,-0.011288212074559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025032.m.28479,0.0011515418602373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025058.m.28495,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025076.m.28535,-0.0193559608330442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025149.m.28635,-0.000270723969485882,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025167.m.28650,0.0171351374891532,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025192.m.28699,-0.0120728892747134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025210.m.28720,7.34410062029887e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025272.m.28780,-0.0131009829081075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025311.m.28826,-0.0153568943096586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025377.m.28903,0.000253846281035183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025391.m.28934,-0.0125695216967431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025398.m.28945,0.00264812831859585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025411.m.28960,-0.0144165928883576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025422.m.28978,-0.0105410461733179,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025639.m.29255,-0.00841991550371858,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_contig_025679.m.29295,-0.0137014896851055,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025684.m.29301,-5.71520006622073e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025702.m.29329,-0.0151980027471065,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025725.m.29348,0.0162718231417316,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025810.m.29463,-0.0192672372436191,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025827.m.29484,-0.00776909969778153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025861.m.29521,-0.0102494687325641,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025865.m.29527,-0.00165502453056703,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025897.m.29562,0.00158014903606127,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025962.m.29619,0.02992796889715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026106.m.29754,-0.0152725439102498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026129.m.29781,-0.0152093931087516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026140.m.29796,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026147.m.29805,0.000317876451799162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026238.m.29873,0.000973124156712438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026328.m.29985,-0.00500465248699161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026389.m.30064,-0.0132497260437253,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026398.m.30077,-0.0139665395043943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026477.m.30166,-0.0123157820564521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026494.m.30182,-0.0150674258858473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026567.m.30260,0.00209281366258771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026627.m.30320,0.0248508331497715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026644.m.30335,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026676.m.30376,-0.0113424841444693,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026679.m.30379,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026684.m.30387,0.0114699962357983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026696.m.30395,0.00339128829964056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026700.m.30399,-0.01359197332168,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_026723.m.30427,-0.0182464443694623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026816.m.30541,-0.00912106155539458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026852.m.30581,0.0106339535064569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026871.m.30597,0.00808517964131951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026910.m.30632,0.000186863947114056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026915.m.30635,-0.00261555954221845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026949.m.30663,0.00263769303660669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026959.m.30676,-0.0120503201937085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026975.m.30698,-0.0102705356499021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027060.m.30790,0.00137080044672295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027196.m.30937,0.0227414828119131,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027213.m.30953,-0.00889791113849729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027260.m.31007,0.00381718131133227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027304.m.31034,-0.0193753775982904,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027327.m.31055,-0.0163560838770098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027342.m.31071,-0.00955513676275959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027379.m.31113,-0.015336428717083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027593.m.31285,0.00864659010124997,No,NA,NA,O42350,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_contig_027703.m.31406,0.0114636426218651,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027730.m.31434,0.013759857952447,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027976.m.31727,0.00424563448679696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028013.m.31792,0.00383328866284399,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028016.m.31798,0.0089358714561374,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028143.m.32002,-0.00909222348168025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028227.m.32131,0.00891445511762616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028345.m.32285,-0.00692139004430296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028370.m.32304,-0.0060480852898097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028488.m.32431,-0.00865958574886911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028566.m.32498,-0.0108940276091747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028737.m.32661,0.0123058207434701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029139.m.33073,-0.0110615687010526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029222.m.33159,0.011945276878917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029279.m.33207,0.0100936110255458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029445.m.33401,0.000107086642273043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029710.m.33698,-0.0108541484004172,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030340.m.34527,0.00668508444817177,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030366.m.34550,0.0110671304362923,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030528.m.34754,-0.00874884355940605,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030621.m.34884,-0.023667121091363,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_contig_030692.m.34979,-0.000948301594462321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030744.m.35041,0.0176637837834781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030748.m.35048,-0.00648652589899297,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030819.m.35130,-0.0099795042530364,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030869.m.35200,0.0247679886233831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030888.m.35216,0.00471673538074821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030959.m.35312,-0.00209434512895125,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031003.m.35364,-0.0143098763748674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031126.m.35509,-0.0149056882821671,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031244.m.35665,-0.00858628986652718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031272.m.35693,-5.60355053483398e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031279.m.35700,0.00950569909855927,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031433.m.35919,0.00843827470934698,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031485.m.35969,0.0107700722803985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031486.m.35972,0.00772707399208299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031630.m.36105,-0.012935127664483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031802.m.36287,0.00646225356097615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031987.m.36469,-0.0100713300642428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032098.m.36603,0.00838281301792106,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032567.m.37185,-0.0166973939740624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032576.m.37192,0.00050974695527415,No,NA,NA,Q8CI51,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_032616.m.37244,-0.00641327821604671,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032666.m.37309,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032690.m.37333,-0.00797380260384565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032916.m.37612,0.0100592993098314,No,NA,NA,P49446,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],NA,NA,NA
CHOYP_contig_032947.m.37658,-0.0223714932550308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033072.m.37776,0.0091236853767516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033090.m.37804,0.0185293302228731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033147.m.37856,-0.00878765436851243,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033179.m.37880,0.0166529193979747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033285.m.37973,-0.0217444462234689,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033346.m.38026,-0.0111608698189426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033356.m.38032,0.00703182525243437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033663.m.38288,0.0104235323980595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033822.m.38452,0.00121929530260366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033899.m.38537,0.00682296854393319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033976.m.38613,0.00765723324277769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034345.m.39015,0.0119232559358961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034390.m.39050,0.000219535491063526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034410.m.39066,0.0186298449152108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034686.m.39375,0.000356538945475471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034695.m.39383,-0.0213989638292667,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034750.m.39458,0.004506655088398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034847.m.39553,0.00480069088585348,No,NA,NA,P95896,NA,NA,NA,amidase activity [GO:0004040]; indoleacetamide hydrolase activity [GO:0043864],NA,NA,NA
CHOYP_contig_034890.m.39584,0.00943399190255911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034934.m.39632,-0.016311190843943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034987.m.39710,0.0249607771949191,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035123.m.39896,-0.00942562910846609,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035291.m.40069,-0.000117456291271003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035372.m.40130,-0.00241366531106964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035380.m.40136,0.00460065990862949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035493.m.40257,0.00735578917396551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035545.m.40311,0.0157796374029612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035578.m.40341,-0.00204524175608075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035767.m.40509,0.00406874084015044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035951.m.40680,0.0104074100704518,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036103.m.40829,0.0256593571459257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036280.m.40985,-0.0148032769537696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036283.m.40992,-0.0217019388673117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036657.m.41264,0.0123768252818209,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036790.m.41410,0.00864525718723993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036886.m.41498,0.0143281246864634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036899.m.41515,-0.0230808899888383,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036935.m.41573,0.000388383023933087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036974.m.41637,0.00210508108714976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037000.m.41674,0.0185016827521399,No,NA,NA,A0A1I9LN01,NA,NA,NA,integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845],NA,NA,NA
CHOYP_contig_037038.m.41727,0.0266531421709663,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037561.m.42354,0.00703176577173354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037644.m.42447,0.0219293654127259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037727.m.42549,-0.00874697894226872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037785.m.42603,-0.000180928382495153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037938.m.42800,0.0110561119546319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037956.m.42826,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037959.m.42830,-0.00208825106807793,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038058.m.42964,-0.0136842578591417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038126.m.43051,-0.0128767345467893,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038160.m.43103,-0.000269634497234489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038218.m.43194,-0.00324141812930625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038370.m.43386,0.00231225492173835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038408.m.43447,-0.0192708713936542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038478.m.43530,0.0248714660817234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038486.m.43547,0.0184589877752131,No,NA,NA,Q9BXM0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; axon ensheathment [GO:0008366]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_contig_038513.m.43619,0.026000491322044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038579.m.43695,0.0101307426809565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038691.m.43809,-0.0244845045474869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038703.m.43817,0.000400483109001887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038765.m.43871,-0.0117878965848813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038766.m.43872,4.38771464415093e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038806.m.43911,0.0057285738204147,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038817.m.43926,-0.00759500670474509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038859.m.43982,0.00111330924760313,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038869.m.43996,0.0243597851283461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038921.m.44081,0.00964020122989162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038946.m.44119,0.0116027556536515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039058.m.44237,0.0281703641652807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039068.m.44246,0.000137125303755161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039097.m.44266,-0.0100620572784958,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039100.m.44268,0.0209825558329395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039169.m.44357,0.0079132324781241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039283.m.44494,-0.00190920885608118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039285.m.44499,8.68220681787822e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039330.m.44540,0.015055660691805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039363.m.44567,-3.77878115066281e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039366.m.44569,0.0162330865457162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039460.m.44676,-0.00460128868104182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039465.m.44679,0.010194156554107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039575.m.44801,0.001897180585761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039595.m.44817,-0.0160767948309525,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039638.m.44850,0.0104328347607551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039715.m.44911,0.0126505292297664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039741.m.44927,0.00655910240498698,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039966.m.45203,0.0011640805394508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040048.m.45313,-0.00862157341402313,No,NA,NA,P04323,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_040334.m.45722,0.00626932361138257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040433.m.45856,-0.0156224583486504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040481.m.45927,0.0182627361963705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040503.m.45959,0.0116805997736026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040577.m.46077,-0.0169520587765348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040623.m.46145,0.0201815547510972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040750.m.46306,-0.00142307585656764,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040887.m.46494,-0.000153128078308494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040962.m.46595,0.00134671265376756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040975.m.46616,-0.00068083243944952,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_040978.m.46621,-0.0145296619007116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041025.m.46710,-0.0140109537898278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041068.m.46778,0.0131693175515513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041073.m.46786,0.00762596043645161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041193.m.46961,0.0214430831211943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041218.m.46991,-0.00194339225030989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041298.m.47095,0.0131924531592965,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041336.m.47149,0.00995478336664082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041380.m.47215,-0.00712610104857431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041554.m.47492,0.0186685099408778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041605.m.47590,-0.00191267957839993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041673.m.47688,0.0125271399608309,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041706.m.47739,-0.00987816233030868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041712.m.47757,-0.00757096947821718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041717.m.47768,-0.00853835522092103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041765.m.47848,0.00525056886612007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041782.m.47874,-0.0203926688086445,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041876.m.48001,-0.00873515046286114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041950.m.48134,-0.00540386989835606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041958.m.48141,0.00444916546540379,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042054.m.48295,-0.00307828779323017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042130.m.48414,-0.00731280118339314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042244.m.48592,0.0132081322422485,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042249.m.48611,-0.0118521314725502,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042362.m.48774,-0.00765781581038054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042378.m.48796,0.0109374062182834,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042449.m.48875,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042540.m.49007,0.0114468068165585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042557.m.49033,0.00673307503546314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042616.m.49103,0.00661278281609534,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042690.m.49166,-0.0118998625607634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042697.m.49175,0.0118752586858014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042766.m.49278,-0.00933445992243062,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042815.m.49366,-0.00868574626080986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042864.m.49442,0.00689015707889701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042901.m.49495,0.011758074533573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043041.m.49677,-0.0149946141345216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043053.m.49693,-0.00945047351576775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043057.m.49706,-0.000561443236675519,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043072.m.49721,0.00357176787668301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043212.m.49892,0.0052663700570197,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043231.m.49931,0.000354501300062851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043238.m.49940,0.00434694236818075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043301.m.50018,-0.0193438503751166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043488.m.50266,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043510.m.50295,0.000456886237830997,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043813.m.50619,0.0031526661469266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043818.m.50622,0.000772744305001487,No,NA,NA,Q5TZA2,NA,NA,NA,actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365],NA,NA,NA
CHOYP_contig_043845.m.50665,-0.0114019554214615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043862.m.50684,0.00474772365870479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043874.m.50696,0.012635095313303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043898.m.50728,0.00942657792262482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043909.m.50738,-0.00976647915064947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044225.m.51129,-0.0102652355214401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044310.m.51269,0.00707150298297045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044503.m.51534,0.0093439364297638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044612.m.51675,-0.000796501154105629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044629.m.51700,0.017302234331994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044640.m.51719,-0.0020349586638478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044678.m.51771,-0.00984038481266199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044692.m.51797,-0.0187486526243703,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044795.m.51952,0.00786067829647797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044824.m.51993,0.0100076468829787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045072.m.52344,-0.00914151699314492,No,NA,NA,Q3ZBG9,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; response to interferon-beta [GO:0035456],NA,NA,NA
CHOYP_contig_045193.m.52491,-0.0170317805317937,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045205.m.52522,-0.00246875198966776,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045248.m.52574,-0.0019564946021325,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045427.m.52825,0.0162753886193043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045550.m.53021,0.00181517081367151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045552.m.53024,-0.02204966407486,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045655.m.53199,-0.00158727268564148,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045662.m.53210,-0.0120617070385419,No,NA,NA,Q14686,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription; initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725],NA,NA,NA
CHOYP_contig_045946.m.53656,-0.0113949712781013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046319.m.54200,0.0178134054188743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046503.m.54505,0.00796337356822214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046530.m.54559,0.000150710930823601,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046551.m.54588,-0.00175108981825628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046706.m.54827,-0.0179902373985714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046854.m.55054,-0.0152729229194748,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046883.m.55107,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047016.m.55305,0.00950933302390829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047066.m.55375,-0.00999926032761071,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_contig_047135.m.55497,9.52438134786149e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047190.m.55575,0.0185681006734157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047214.m.55631,-0.00048800487440348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047294.m.55755,0.00850070526360234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047333.m.55799,0.00815729037100149,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047394.m.55871,0.0076821220655986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047449.m.55959,0.00767150131327702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047498.m.56019,0.00926193189089675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047569.m.56118,-0.000365720488697631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047668.m.56271,0.00641172456670738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047685.m.56291,-0.0126221406012429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047707.m.56320,0.00897675953288138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047731.m.56360,-0.0236986045266669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047828.m.56501,-0.00907576078296119,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047907.m.56621,0.0091561580020009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047908.m.56622,0.00569672308089469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047916.m.56635,0.00643166348587393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047982.m.56715,0.00451059307642426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048122.m.56947,-0.00761625205196858,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048134.m.56964,-0.0139984931667467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048148.m.56980,0.0102750354965857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048267.m.57131,-0.0108076894626498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048274.m.57147,0.0197349492676645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048277.m.57151,0.00647108639038685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048369.m.57273,-0.00282214754278277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048457.m.57397,-0.000231384587027172,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048495.m.57473,0.0153439088868143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048541.m.57541,0.00420375202581795,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048603.m.57625,-0.00567217293437408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048626.m.57669,-0.00708209051756363,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048667.m.57735,-0.024237770651726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048706.m.57793,-0.0214643995473465,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048721.m.57810,0.0175821451516495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048781.m.57879,0.0113269887414587,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048887.m.57987,-0.000596376211523994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048930.m.58050,-0.0151613646625685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048973.m.58107,-0.00405765743789556,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048994.m.58122,0.0182314483777205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049099.m.58219,0.0117014433185437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049136.m.58269,-0.00724054578242309,No,NA,NA,Q8N7X0,NA,NA,NA,calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825],NA,NA,NA
CHOYP_contig_049345.m.58557,-0.00329760282885576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049353.m.58568,-0.00376193145635489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049367.m.58596,0.000418856379317601,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049413.m.58667,6.28618746889587e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049619.m.58908,-0.00468160960128818,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050044.m.59512,-0.0118396191776298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050158.m.59641,-0.0113260108531214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050222.m.59713,0.00874282180671012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050253.m.59761,-7.39488339375793e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050301.m.59822,-0.00986182828978562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050355.m.59899,0.00758022029990709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050388.m.59942,0.0151614750157086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050483.m.60085,-0.0136186945833527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050507.m.60115,0.00800915067358406,No,NA,NA,Q6H236,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_contig_050515.m.60136,-0.0112451408899506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050645.m.60289,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050710.m.60376,0.0097018651410664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050842.m.60581,-0.0088781408275442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050863.m.60613,0.000426005638609723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050942.m.60734,-0.00490863317854386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051171.m.61058,0.0189028040240616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61184,-0.00913765545845285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61185,-0.0123737341379661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051311.m.61287,0.0195804464717511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051346.m.61337,0.015236630508024,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051433.m.61487,-0.00875612153771007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051534.m.61634,0.0158277966103536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051787.m.61994,-0.000198223599524614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051794.m.62013,-0.00806613809994168,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051943.m.62221,-0.00339512095883417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052015.m.62309,-0.00715331438578649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052081.m.62393,0.0210505103648996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052083.m.62396,0.00146669599149527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052147.m.62461,0.0193875395482543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052383.m.62773,0.00917863664919305,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052396.m.62799,0.00241837871508519,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052416.m.62821,0.0290099958930118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052441.m.62852,-0.00618682406866169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052658.m.63135,-0.0060935294304244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052729.m.63227,0.0151717158005941,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052748.m.63243,-0.0109681783035521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052993.m.63573,-0.0117692216182805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053017.m.63597,0.00951284907229075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053024.m.63605,0.0278378395024805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053133.m.63737,-0.00686313928459607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053329.m.63915,0.0215294205233322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053371.m.63972,-0.00108394833045614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053582.m.64175,0.00114263255690434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053627.m.64220,-0.00654923285681891,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053683.m.64287,0.0178972758266116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053687.m.64290,0.000473431989524092,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053787.m.64362,0.0132734116659096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053977.m.64571,0.00386749095380024,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053989.m.64582,-0.00211957601854511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053995.m.64585,0.00203412130240294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054223.m.64734,-0.0115863693909417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054409.m.64895,0.00521403501944911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054622.m.65176,0.009553180514117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054868.m.65463,0.0126624108141709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054901.m.65508,0.0266207708319887,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_contig_055102.m.65741,-0.0160981996658496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055303.m.65981,-0.0160427345718761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055359.m.66029,-0.0107085280991566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055404.m.66082,-0.00822704783595055,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055406.m.66084,0.0137877771362877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055822.m.66445,0.00846793614007578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055842.m.66464,0.000300130816753686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055984.m.66583,-0.0007276388198831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056008.m.66602,-0.00336797077744779,No,NA,NA,P51958,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_contig_056033.m.66621,-0.00524191472661542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056499.m.66997,-0.00805749061060178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COPA.1.1.m.31888,0.0004241044446171,No,NA,NA,Q27954,NA,NA,NA,COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPA.1.1.m.31889,-0.0075957503321691,No,NA,NA,Q9JLR1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_COPB.1.1.m.16988,0.00118359223793587,No,NA,NA,P23514,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPB2.1.1.m.11046,0.000140027146615199,No,NA,NA,P35606,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_COPD.1.1.m.37389,-0.00104358455799356,No,NA,NA,Q5ZL57,NA,NA,NA,COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPD.1.1.m.37390,0.000632263005369727,No,NA,NA,Q9DCM4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_COPE.1.1.m.48265,-0.00286693939204366,No,NA,NA,Q5ZIK9,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPG2.1.1.m.60836,-4.55188663273827e-05,No,NA,NA,Q9I8E6,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_COQ4.1.1.m.6843,-0.0218039480296983,No,NA,NA,Q16FT5,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_CORIN.2.2.m.40858,0.00882794736885382,No,NA,NA,Q9Y5Q5,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050],NA,NA,NA
CHOYP_COX1.1.15.m.3193,0.00267215258913967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.5.15.m.24406,-0.000809489888561775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.6.15.m.25748,-0.000657704362812212,No,NA,NA,Q9BYJ9,NA,NA,NA,cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948],NA,NA,NA
CHOYP_COX5B.1.3.m.20245,0.00873210579100112,No,NA,NA,Q710D6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_COX5B.3.3.m.38557,0.000641618096252321,No,NA,NA,P00428,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_CP080.1.1.m.24911,-0.00150342493311905,No,NA,NA,Q8BTU1,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],NA,NA,NA
CHOYP_CP096.1.1.m.35853,-0.00144449398550287,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_CP2BA.1.1.m.38084,0.0128786852616072,No,NA,NA,O46658,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_CP3AO.1.1.m.63459,0.000303258895055935,No,NA,NA,P51538,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; female pregnancy [GO:0007565]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_CP4F2.1.1.m.7803,-0.0134009727203568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPE.1.1.m.53041,-0.00590749468324979,No,NA,NA,P37892,NA,NA,NA,extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CPIB.2.3.m.44557,0.0117959735949788,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIB.3.3.m.46138,-0.00660181697340445,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIPJ_CPIJ000723.1.1.m.7190,-0.0132659152601406,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CPIPJ_CPIJ001623.1.1.m.19531,0.00286736388914041,No,NA,NA,Q9UMY4,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_CPIPJ_CPIJ003599.1.1.m.61267,-0.00605381909865937,No,NA,NA,Q9NRH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_CPIPJ_CPIJ003871.1.1.m.147,-5.31139661644297e-05,No,NA,NA,P49024,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; vinculin binding [GO:0017166]; cell-matrix adhesion [GO:0007160]; response to muscle stretch [GO:0035994],NA,NA,NA
CHOYP_CPIPJ_CPIJ004440.1.1.m.62518,-0.000605903559376097,No,NA,NA,Q9HC07,NA,NA,NA,early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751],NA,NA,NA
CHOYP_CPIPJ_CPIJ004536.3.3.m.52790,0.0119321800811716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ004840.1.1.m.3309,0.00241043890058006,No,NA,NA,Q5EA45,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ005489.1.1.m.43655,2.27379363910888e-05,No,NA,NA,P13668,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.1.4.m.5854,-0.00581963626843454,No,NA,NA,P48166,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.3.4.m.30316,-0.0084767191873946,No,NA,NA,Q6GL69,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.4.4.m.64973,-0.0115474142950181,No,NA,NA,Q4V886,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CPIPJ_CPIJ007907.1.1.m.45771,-0.00180470193350802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ008112.1.1.m.51524,0.00110028779212294,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CPIPJ_CPIJ008190.1.1.m.21761,0.0204695867580975,No,NA,NA,Q7ZUH5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ008492.1.1.m.6934,0.0102407281956513,No,NA,NA,P83565,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761],NA,NA,NA
CHOYP_CPIPJ_CPIJ011304.2.2.m.43130,0.00680488541361076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ011346.2.2.m.44999,-0.00724197668131887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ012408.1.1.m.10724,-0.00134690004134569,No,NA,NA,Q6PV61,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_CPIPJ_CPIJ015079.1.1.m.39675,-0.00880078006554515,No,NA,NA,P42029,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; protein-containing complex binding [GO:0044877]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ016910.1.1.m.62713,-0.00590588657106908,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_CPNE8.2.2.m.58380,0.000171856122603071,No,NA,NA,Q78ZA7,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_CPSF1.1.1.m.27767,-0.00964686602717502,No,NA,NA,Q10569,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF2.1.1.m.13908,-0.0220441757619019,No,NA,NA,O35218,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF5.1.2.m.59012,0.00173928069164551,No,NA,NA,Q7T3C6,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_CPT1A.1.1.m.53985,-0.017115811672414,No,NA,NA,Q9R0P6,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_CPT2.1.1.m.16349,0.00210474515229352,No,NA,NA,P23786,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_CPVL.1.2.m.2978,0.0112644026422954,No,NA,NA,Q9H3G5,NA,NA,NA,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CPVL.2.2.m.62669,-0.00108695277392839,No,NA,NA,Q9H3G5,NA,NA,NA,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CRADD.1.2.m.27800,-0.0108298498795473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_01395.2.2.m.44269,-0.00208818383477524,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_CRE_02254.1.1.m.12455,0.00160261543666869,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CRE_06881.1.1.m.62783,0.00880625161462148,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_13958.1.1.m.31239,-0.011724980819406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_16884.1.1.m.28203,0.0130708015009817,No,NA,NA,Q19673,NA,NA,NA,copper ion binding [GO:0005507]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; another compound as one donor; and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438],NA,NA,NA
CHOYP_CRE_18961.1.1.m.30942,0.0118358596435684,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_CRE_20365.1.3.m.20889,0.0127143324639493,No,NA,NA,Q21828,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850],NA,NA,NA
CHOYP_CRE_21950.1.1.m.55,-0.00777160327469404,No,NA,NA,Q9VZW5,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],NA,NA,NA
CHOYP_CRE_25145.1.1.m.8177,-0.0100326833840368,No,NA,NA,Q9D9T0,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_CRE_29942.1.1.m.48587,-0.0117118671281095,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CRE.DIG.1.1.1.m.26794,0.00468279005843629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.GST.7.1.1.m.30139,-0.0125082181035912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.HIM.4.1.1.m.55343,0.00229063609514427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.1.3.m.20277,0.0089794070527342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.3.3.m.61234,-0.00535196488745499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CREM.1.1.m.12267,0.0042201902527959,No,NA,NA,P79145,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRI9333_2800.1.1.m.5332,0.000623792640921139,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRIM1.1.3.m.5078,0.00410071255531772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRIM1.2.3.m.5811,0.0211303828539108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRLF3.1.2.m.8760,-0.000584299415211412,No,NA,NA,Q568M3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_CRNL1.1.1.m.2792,-0.0221125858328416,No,NA,NA,Q9BZJ0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_CRYAB.1.5.m.2659,0.00170764873156999,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYAB.5.5.m.49919,0.00156157537430965,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYM.1.1.m.8544,0.00790027677558688,No,NA,NA,O54983,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-NH2 group of donors; NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],NA,NA,NA
CHOYP_CRYZ.2.2.m.65927,0.000117853495361421,No,NA,NA,Q08257,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_CS066.1.3.m.44165,-0.00192736939583181,No,NA,NA,Q32L09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342],NA,NA,NA
CHOYP_CS081.1.1.m.48577,0.000203041296837161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CSAD.1.1.m.40056,-0.00175058174761551,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CSK.1.1.m.55145,0.000775724191324953,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_CSK21.1.2.m.19313,-0.00741730844943713,No,NA,NA,P21868,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSK2B.1.1.m.37285,-0.000889624618698619,No,NA,NA,P28021,NA,NA,NA,protein kinase CK2 complex [GO:0005956]; metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSKI2.1.1.m.29327,-0.0093349943793945,No,NA,NA,Q8VHK2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CSKP.1.2.m.20832,0.00559940936801464,No,NA,NA,O14936,NA,NA,NA,actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_CSN2.1.1.m.28636,-0.00269174424307763,No,NA,NA,Q6IR75,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CSN3.1.1.m.10996,-0.0019701302395125,No,NA,NA,Q6P2U9,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CSN4.1.1.m.18561,-0.000609513307540573,No,NA,NA,O88544,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSN5.1.1.m.52330,0.0011029925547746,No,NA,NA,Q6PC30,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein deneddylation [GO:0000338]; vestibular receptor cell development [GO:0060118],NA,NA,NA
CHOYP_CSN8.1.1.m.14798,-0.0224994159449747,No,NA,NA,Q6GQA6,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSPA_C15740.1.1.m.59258,-0.00333022226748212,No,NA,NA,Q27237,NA,NA,NA,cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; response to heat [GO:0009408],NA,NA,NA
CHOYP_CSPP1.11.14.m.54546,-0.00753541517166084,No,NA,NA,Q1MSJ5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],NA,NA,NA
CHOYP_CSTA.1.3.m.6422,-0.0135369915105436,No,NA,NA,P80416,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_CSTF3.1.1.m.10636,0.00584197629690905,No,NA,NA,Q12996,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; RNA 3'-end processing [GO:0031123]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_CTBL1.1.1.m.22983,0.00195164897507382,No,NA,NA,O62703,NA,NA,NA,nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CTBS.1.1.m.54468,-0.00779141850097248,No,NA,NA,Q8R242,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_CTK2.3.3.m.51999,0.00638380629918588,No,NA,NA,P20480,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CTL2.1.2.m.3858,0.00073990328793799,No,NA,NA,Q642H9,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412],NA,NA,NA
CHOYP_CTND2.1.1.m.12206,-0.000550179412410031,No,NA,NA,P98203,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CTR1.2.4.m.39987,-0.0151500029395072,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_CTR9.1.1.m.18832,0.00986671286550198,No,NA,NA,Q4QR29,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_CTRA.1.2.m.26705,-0.00734783254787977,No,NA,NA,P80646,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_CTRL.1.1.m.48654,0.00126196494152412,No,NA,NA,P35003,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CTSL2.1.2.m.2936,-0.000227919637268913,No,NA,NA,Q9GL24,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CTTN.1.1.m.22042,-0.000617755226736887,No,NA,NA,Q14247,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_CTU2.1.1.m.43200,0.000544388803373639,No,NA,NA,Q6DC53,NA,NA,NA,cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_CTXA.1.2.m.31637,-0.0164774900111563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CUL1.1.1.m.13087,-0.00364570004099912,No,NA,NA,Q9WTX6,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUL2.1.1.m.59278,-0.017650749102289,No,NA,NA,Q9D4H8,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CUL3B.1.1.m.61643,0.00272089721559944,No,NA,NA,Q6GPF3,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_CUL3B.1.1.m.61644,-0.0174892840441979,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_CUL4B.1.1.m.6652,0.001317405581494,No,NA,NA,Q13619,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUX1.1.2.m.10448,-0.0116924655658072,No,NA,NA,Q13948,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_CWC22.1.1.m.29270,-0.00525199722544251,No,NA,NA,Q9VJ87,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_CX6A2.1.1.m.47963,-0.000974760183313994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYB5.1.2.m.2195,-0.00253544482411935,No,NA,NA,P56395,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_CYC.1.5.m.5663,-0.000204851475621746,No,NA,NA,Q6QLW4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CYH1.1.1.m.66676,0.00674334395981721,No,NA,NA,Q15438,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CYIIB.2.2.m.64544,0.00161599811923369,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CYIIB.2.2.m.64545,0.01728857677463,No,NA,NA,Q11212,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_CYPL.1.1.m.25000,0.001297521134591,No,NA,NA,Q9D0W5,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_CYT5.1.1.m.29960,-0.0142792774912985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYT5.1.1.m.29962,-0.00529355898613606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYTA.1.1.m.10540,-0.00734665204331016,No,NA,NA,P01040,NA,NA,NA,cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; protein binding; bridging [GO:0030674]; structural molecule activity [GO:0005198]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_CYTB.1.6.m.7874,0.019981268893958,No,NA,NA,Q6DRC3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_CZH5ORF51.1.1.m.25147,-0.00900526657541548,No,NA,NA,A8Y5U1,NA,NA,NA,,NA,NA,NA
CHOYP_D39U1.1.1.m.29364,0.000454090938102933,No,NA,NA,Q17QH8,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_DAB2.1.1.m.22396,0.00124077918371832,No,NA,NA,P98081,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_DANA_GF10165.1.1.m.59230,5.70168790246271e-05,No,NA,NA,Q68FA2,NA,NA,NA,,NA,NA,NA
CHOYP_DANA_GF10776.1.1.m.18533,-0.00397696648177911,No,NA,NA,Q2TBS2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_DANA_GF14191.1.1.m.11942,0.00167058620772754,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF15280.1.2.m.4538,0.0022904584664958,No,NA,NA,Q5ZHW4,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44177,-0.00318723057856751,No,NA,NA,Q66KY3,NA,NA,NA,response to metal ion [GO:0010038],NA,NA,NA
CHOYP_DANA_GF16638.1.1.m.10255,-0.0059285818516551,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DANA_GF18010.1.1.m.6864,-0.00186941515402174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF20914.1.1.m.14747,0.00465286203594301,No,NA,NA,O76902,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_DANA_GF24303.1.1.m.33639,0.0151185442485839,No,NA,NA,P17671,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis; chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle; chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993],NA,NA,NA
CHOYP_DAR1.2.4.m.29583,-0.0149338280062891,No,NA,NA,Q9GZT4,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069],NA,NA,NA
CHOYP_DARS2.1.1.m.43847,0.0218969332689541,No,NA,NA,A6QPU5,NA,NA,NA,mitochondrial matrix [GO:0005759]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145],NA,NA,NA
CHOYP_DBP2.2.2.m.55820,-0.0135098377931054,No,NA,NA,Q59LU0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DBT.1.1.m.4866,-0.00269232333472623,No,NA,NA,P11181,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_DC1I2.1.3.m.25743,-0.00652191861887846,No,NA,NA,O88487,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; protein-containing complex binding [GO:0044877]; microtubule-based movement [GO:0007018]; negative regulation of neuron projection development [GO:0010977],NA,NA,NA
CHOYP_DC1I2.2.3.m.54049,0.0128016247431938,No,NA,NA,Q0III3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DCA15.1.1.m.11376,-0.00617221621970308,No,NA,NA,A2BDA5,NA,NA,NA,protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCAF7.1.1.m.51583,-0.000873749940784207,No,NA,NA,P61963,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCDC2.3.7.m.36589,-0.00109168334965276,No,NA,NA,Q5DU00,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; visual learning [GO:0008542],NA,NA,NA
CHOYP_DCNL4.1.2.m.36826,-0.00253475462787824,No,NA,NA,Q8CCA0,NA,NA,NA,nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_DCTN1.2.2.m.40900,0.00202708820402237,No,NA,NA,Q14203,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport; endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517],NA,NA,NA
CHOYP_DCTN2.1.1.m.1084,-0.000321653744675951,No,NA,NA,Q99KJ8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; cell proliferation [GO:0008283]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_DCTN4.1.1.m.29541,0.00487163677893917,No,NA,NA,Q9UJW0,NA,NA,NA,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097],NA,NA,NA
CHOYP_DCUP.1.1.m.7527,-0.00571300258595375,No,NA,NA,P06132,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_DD19A.1.1.m.57641,-0.00101364149714186,No,NA,NA,Q3ZBV2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DDB_G0275195.1.1.m.47584,-0.0126973735583933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DDB1.1.1.m.59135,-0.00141167029673021,No,NA,NA,Q805F9,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein binding; bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; WD40-repeat domain binding [GO:0071987]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DDX1.1.1.m.46908,-0.0123020209721535,No,NA,NA,Q90WU3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DDX10.1.1.m.17783,-0.0102272076685445,No,NA,NA,Q9D7V9,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_DDX18.1.2.m.12567,-0.0169111976855345,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX18.2.2.m.51768,-0.00142061917858978,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX21.1.2.m.3695,-0.0173519429628258,No,NA,NA,Q99MJ9,NA,NA,NA,nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX23.1.1.m.20195,-0.00262833441032961,No,NA,NA,Q9BUQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_DDX23.1.1.m.20196,0.016405918540863,No,NA,NA,Q6DF67,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_DDX24.1.1.m.6330,-0.0114703562375659,No,NA,NA,Q9GZR7,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_DDX3Y.1.1.m.3679,-0.00352699200177992,No,NA,NA,P24346,NA,NA,NA,ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX41.1.1.m.16719,0.00087590380944675,No,NA,NA,Q91VN6,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DDX42.2.2.m.54450,0.00306322706675057,No,NA,NA,Q7ZY47,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX46.1.1.m.52473,-0.00531404381697215,No,NA,NA,Q4TVV3,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621],NA,NA,NA
CHOYP_DDX58.1.9.m.822,-0.00858908224303348,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.7.9.m.58168,-0.0207079213134637,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.9.9.m.62757,0.000414863401188446,No,NA,NA,O95786,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032],NA,NA,NA
CHOYP_DECR2.1.2.m.29687,0.00116785435338414,No,NA,NA,Q6NV34,NA,NA,NA,peroxisome [GO:0005777]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_DEK.1.1.m.40646,-0.000273384597351667,No,NA,NA,Q6AXS3,NA,NA,NA,contractile fiber [GO:0043292]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032],NA,NA,NA
CHOYP_DENND4A.1.1.m.342,-0.00263539928815839,No,NA,NA,Q7Z401,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_DEP1A.1.1.m.50111,0.0108787731311025,No,NA,NA,Q803Q4,NA,NA,NA,GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44727,-0.00159552285899647,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44730,-0.015946639312505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_00978.1.1.m.17875,0.00317794165457673,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_05420.1.1.m.25051,-0.000423176742462792,No,NA,NA,O42646,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_DFA_06569.1.1.m.9782,-0.0078573221772775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFER_5601.1.1.m.49215,-0.0155163991926946,No,NA,NA,Q8J0I9,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; glucan endo-1;6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; polysaccharide metabolic process [GO:0005976]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_DFPA.1.1.m.29402,-0.00201687061717742,No,NA,NA,Q7SIG4,NA,NA,NA,calcium ion binding [GO:0005509]; diisopropyl-fluorophosphatase activity [GO:0047862],NA,NA,NA
CHOYP_DGKD.2.2.m.9520,-0.0104057850487617,No,NA,NA,Q16760,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DGKZA.1.2.m.29620,0.0115078049941577,No,NA,NA,O08560,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_DGRI_GH10893.1.1.m.27211,-0.00491748762559383,No,NA,NA,Q6DGW9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983],NA,NA,NA
CHOYP_DGRI_GH12278.1.1.m.5056,-0.0027773152224025,No,NA,NA,Q9Y2S2,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640],NA,NA,NA
CHOYP_DGRI_GH13197.1.1.m.35578,-0.00592266169435315,No,NA,NA,O17482,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_DGRI_GH14833.1.1.m.14206,-0.00735700410836711,No,NA,NA,Q9VUJ0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH14972.1.1.m.64210,-0.00282776293694163,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_DGRI_GH15313.1.1.m.5763,0.00308275136506054,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DGRI_GH15575.1.1.m.49170,0.00291734821428118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DGRI_GH19122.1.1.m.1378,0.0190476720973677,No,NA,NA,Q2TBK2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH20300.1.1.m.57587,-0.00435240802021155,No,NA,NA,Q63ZH8,NA,NA,NA,,NA,NA,NA
CHOYP_DGRI_GH22804.1.1.m.12160,-0.0040765026084291,No,NA,NA,Q9HCB6,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954],NA,NA,NA
CHOYP_DGRI_GH22876.2.3.m.54068,0,No,NA,NA,Q761V0,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_DGRI_GH23100.1.1.m.44142,-0.000381206277900448,No,NA,NA,O60500,NA,NA,NA,cell projection [GO:0042995]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_DGRI_GH24618.1.2.m.1995,-0.00613854261758465,No,NA,NA,Q7KVW5,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],NA,NA,NA
CHOYP_DHB12.1.1.m.62534,0.00886112383377066,No,NA,NA,Q28IU1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_DHB14.1.1.m.13441,-0.00763926090987094,No,NA,NA,Q9MYP6,NA,NA,NA,cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_DHB4.1.2.m.13985,-0.00405851333052048,No,NA,NA,P51659,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],NA,NA,NA
CHOYP_DHB4.2.2.m.19618,-0.00677276876902624,No,NA,NA,P97852,NA,NA,NA,peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_DHC6.1.1.m.22887,-0.015869683279149,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHE4.1.1.m.48536,0.000608144704000645,No,NA,NA,P00367,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350],NA,NA,NA
CHOYP_DHPS.1.1.m.55870,0.0195605041998358,No,NA,NA,P49366,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; spermidine metabolic process [GO:0008216]; translation [GO:0006412],NA,NA,NA
CHOYP_DHR.1.1.1.m.43819,-0.0086093550920874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHR11.2.2.m.36445,-0.0113979960878933,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_DHSAB.1.1.m.25026,-0.00071943199817001,No,NA,NA,Q801S2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSB.1.1.m.3993,-0.00111620114026681,No,NA,NA,P21912,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSO.1.2.m.5409,-0.00324806719856377,No,NA,NA,P27867,NA,NA,NA,extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHSO.2.2.m.29745,0.00169542475892824,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHTK1.1.1.m.8425,0.00666002931658936,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DHX15.2.2.m.62441,0.00302960303057798,No,NA,NA,O43143,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_DHX57.2.2.m.45703,0.0101883638815753,No,NA,NA,Q9R0X0,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914],NA,NA,NA
CHOYP_DHX8.2.3.m.55112,-0.0114968346949462,No,NA,NA,Q14562,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390],NA,NA,NA
CHOYP_DHX8.2.3.m.55114,0.00117647043581012,No,NA,NA,P38542,NA,NA,NA,nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DI3L2.1.1.m.61980,0.0139440361996929,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_DIAP2.1.1.m.25706,0.00085853904780581,No,NA,NA,Q9Z207,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DIAPH1.1.1.m.55416,0.002174644520359,No,NA,NA,O70566,NA,NA,NA,actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_DICER.1.3.m.9936,-0.00545460258946351,No,NA,NA,Q9VCU9,NA,NA,NA,cytoplasm [GO:0005737]; micro-ribonucleoprotein complex [GO:0035068]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle; embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_DICPUDRAFT_147269.1.1.m.34818,0.0139837576705955,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_DICPUDRAFT_81027.1.1.m.5425,-0.00561816999382512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DICPUDRAFT_93011.1.1.m.30650,-0.00312146208401452,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_DIS3.1.1.m.6724,-0.00833204139106948,No,NA,NA,Q9CSH3,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DJC13.1.1.m.46117,-0.000981723894665784,No,NA,NA,O75165,NA,NA,NA,azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],NA,NA,NA
CHOYP_DKC1.1.1.m.10978,-0.00891748054254352,No,NA,NA,Q9ESX5,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_DLAT.1.1.m.64812,-0.000145562986082476,No,NA,NA,Q19749,NA,NA,NA,mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_DLDH.1.1.m.31018,0.00191468907461489,No,NA,NA,P09623,NA,NA,NA,acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077],NA,NA,NA
CHOYP_DLGP1.3.3.m.44296,0.00199197679243367,No,NA,NA,O14490,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_DLL1.1.1.m.4589,0.00721716923900865,No,NA,NA,P78504,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],NA,NA,NA
CHOYP_DLL4.1.1.m.40197,0.0143590658475916,No,NA,NA,D3ZHH1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; pericardium morphogenesis [GO:0003344]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DLP.1.1.m.31353,0.00328358925789598,No,NA,NA,Q5GN48,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; zinc ion binding [GO:0008270]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],NA,NA,NA
CHOYP_DLP1.1.1.m.40279,-0.0244379200893098,No,NA,NA,Q86YH6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_DMBT1.11.34.m.22620,-0.000181700912069496,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.13.34.m.27666,0.0015264317154024,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.15.34.m.29008,-0.00695836765558427,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_DMBT1.3.34.m.3602,0.00148519316870586,No,NA,NA,Q86VB7,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_DMOJ_GI11203.1.1.m.24977,0.000989504776919205,No,NA,NA,Q9VXK0,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_DMOJ_GI12418.1.1.m.49398,-0.0167882459186912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.1.3.m.5732,0.00946335203798455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.2.3.m.20888,-0.00930356845068854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17052.1.1.m.4566,-0.00586137604570417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17690.1.1.m.48369,0.00976435153467868,No,NA,NA,B7YZV4,NA,NA,NA,extracellular space [GO:0005615]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3';5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8902,-0.0163202146114049,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18925.1.1.m.37775,-0.000747528481759378,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_DMOJ_GI19977.1.1.m.66449,0.0131084422761124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.1.2.m.12269,0.00939442449599259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.2.2.m.30988,-0.00526806481823315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAH12.2.3.m.32353,-0.00805310510656097,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH12.3.3.m.63246,0.0057339719734837,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH5.1.2.m.56799,0.00132605055002716,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH5.2.2.m.61452,-0.00528361534899688,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH6.2.3.m.21512,-0.0106804140611657,No,NA,NA,Q9C0G6,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.1.2.m.19685,-0.00681573464311364,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.2.2.m.46648,-0.00426523354317351,No,NA,NA,Q8WXX0,NA,NA,NA,axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAJ.11.1.1.m.18882,0.00139548305828533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAJB6B.1.2.m.1265,0.01103652586577,No,NA,NA,O35723,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_DNAL1.1.1.m.11822,-0.00184351959241223,No,NA,NA,Q05A62,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNER.1.1.m.28378,0.000364324909637208,No,NA,NA,Q07008,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DNJA2.2.2.m.51791,0.000437377499546739,No,NA,NA,Q2HJ94,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408],NA,NA,NA
CHOYP_DNJA3.1.1.m.15026,-0.0228495247700996,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_DNJC2.1.1.m.8941,-0.001721410433872,No,NA,NA,Q7TQ20,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_DNJC3.1.1.m.52309,0.0024124403475858,No,NA,NA,Q27968,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]; cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_DNJC5.1.1.m.52453,-0.00961003879613475,No,NA,NA,P56101,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_DNJC7.1.1.m.8987,-0.0042915460667269,No,NA,NA,Q99615,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_DNJC9.1.1.m.12688,-0.00421341903479256,No,NA,NA,Q91WN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DNLI1.1.2.m.19123,0,No,NA,NA,P51892,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DNMT1.1.1.m.54990,-0.0169249857758217,No,NA,NA,Q92072,NA,NA,NA,nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_DNPH1.1.1.m.28418,0.00127739985641655,No,NA,NA,Q80VJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],NA,NA,NA
CHOYP_DOCK1.2.2.m.61345,0.00337916749993363,No,NA,NA,Q14185,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis; engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_DOCK3.1.2.m.49353,0.000179260308853406,No,NA,NA,Q8N1I0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK7.1.3.m.1197,-0.000997548101603668,No,NA,NA,Q96N67,NA,NA,NA,axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK9.1.2.m.7649,-0.00149385269914502,No,NA,NA,Q9BZ29,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOME.2.2.m.62360,-0.00824676563200512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DP13A.2.3.m.10746,0.0033747527272575,No,NA,NA,Q9UKG1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; vesicle membrane [GO:0012506]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; regulation of glucose import [GO:0046324]; regulation of protein localization to plasma membrane [GO:1903076]; signal transduction [GO:0007165]; signaling [GO:0023052],NA,NA,NA
CHOYP_DPER_GL17438.1.1.m.11680,0.000136275470777481,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_DPER_GL17448.1.1.m.54836,-0.000733177053169789,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_DPER_GL24378.1.1.m.64285,0.022098325042701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.1.2.m.885,0.0075856280727163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.2.2.m.17886,0.00596691390728842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPF2.1.2.m.6678,-0.00211917022248775,No,NA,NA,Q61103,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DPOLB.1.1.m.15375,-0.0180496878889796,No,NA,NA,O57383,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DPOLZ.1.1.m.49299,0.00321656871685902,No,NA,NA,Q61493,NA,NA,NA,nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 4 iron; 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],NA,NA,NA
CHOYP_DPSE_GA10259.1.1.m.36297,-0.0125623918558907,No,NA,NA,Q6NW29,NA,NA,NA,,NA,NA,NA
CHOYP_DPSE_GA10675.1.1.m.23860,0.0038314879036991,No,NA,NA,Q23023,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_DPSE_GA15574.1.1.m.62967,0.00144436039796234,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DPSE_GA16367.1.1.m.22618,0.00110968055106949,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_DPSE_GA17283.3.3.m.59446,0.0183723336261771,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DPSE_GA19599.1.1.m.64309,-0.00143924549281884,No,NA,NA,P58365,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_DPSE_GA25136.1.1.m.66680,0,No,NA,NA,Q8MRC9,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_DPSE_GA27121.1.1.m.6089,0.00360125055446345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA28568.3.9.m.19206,-0.00588864338915177,No,NA,NA,Q8TCU4,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; alpha-actinin binding [GO:0051393]; ciliary basal body-plasma membrane docking [GO:0097711]; endosomal transport [GO:0016197]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of stress fiber assembly [GO:0051492],NA,NA,NA
CHOYP_DPSE_GA28568.5.9.m.33670,-0.000727402064871829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA30097.1.1.m.24050,0.00205202019546201,No,NA,NA,Q5R8Z6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_DPSE_GA30464.1.1.m.65390,0.00671309124940873,No,NA,NA,Q3T094,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity; acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813],NA,NA,NA
CHOYP_DPY19L3.1.1.m.7532,-0.00604591558005414,No,NA,NA,Q71B07,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_DRE2.2.2.m.41479,-0.00587084348185586,No,NA,NA,Q5EAC7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_DRG1.1.1.m.28901,0.00341356841179306,No,NA,NA,P32234,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_DRG2.1.1.m.14009,-0.00872641079275186,No,NA,NA,P55039,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DRPR.1.2.m.58255,-0.00684493986606398,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DRPR.2.2.m.62931,5.32077705508666e-05,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DS.1.1.m.62106,0.000573231187463455,No,NA,NA,Q24292,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_DSCAM.3.3.m.65848,0.0018634368886635,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSEC_GM10209.1.1.m.49171,0.00857285097342174,No,NA,NA,P27701,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_DSEC_GM12928.1.1.m.11933,-0.00176059818375505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSEC_GM19691.1.1.m.30070,0.00408660899368862,No,NA,NA,P19803,NA,NA,NA,cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_DSEC_GM21767.1.1.m.63020,-0.00783314393987754,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSIM_GD11682.1.1.m.30804,-0.00385502349891378,No,NA,NA,Q8WTC1,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412],NA,NA,NA
CHOYP_DSIM_GD13062.1.1.m.3175,0.00753620352722248,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_DSIM_GD13354.1.1.m.6235,-0.0062920683963926,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_DSIM_GD25210.1.1.m.29275,0,No,NA,NA,Q5XIS2,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226],NA,NA,NA
CHOYP_DSPP.5.8.m.37255,-0.00304926172737822,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_DSPP.6.8.m.47723,-0.00659247119707826,No,NA,NA,Q80WT5,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein transporter activity [GO:0008565]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_DSPP.8.8.m.65419,0.015804624473295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSRAD.1.4.m.4228,-0.00736560039498173,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.2.4.m.5410,-0.0102165384061249,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.3.4.m.24850,0.027264070272675,No,NA,NA,Q99MU3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],NA,NA,NA
CHOYP_DTNBP1.1.1.m.66644,0.0199008145518353,No,NA,NA,Q96EV8,NA,NA,NA,axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_DTX3.3.3.m.64703,-0.00525862217283011,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DTX3L.2.4.m.51200,-0.000769551981406657,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_DUOX1.1.4.m.14284,0.0292730043568934,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DUOX1.1.4.m.14285,0.000126831723972838,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.2.4.m.33964,0.00179671034825059,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.3.4.m.34160,0.00940475449155047,No,NA,NA,Q9VQH2,NA,NA,NA,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_DUOX1.4.4.m.44613,-0.00302255784052724,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_DVIR_GJ11008.1.1.m.11917,-0.000647267647971019,No,NA,NA,P20073,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DVIR_GJ11267.1.1.m.29991,0.00300389269448356,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_DVIR_GJ13593.1.1.m.18124,0.0107618324831174,No,NA,NA,P37193,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998],NA,NA,NA
CHOYP_DVIR_GJ14588.1.1.m.25420,-0.00521069599403507,No,NA,NA,Q8IZ73,NA,NA,NA,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455],NA,NA,NA
CHOYP_DVIR_GJ17679.2.3.m.46443,-0.00520888806891851,No,NA,NA,A2RU49,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554],NA,NA,NA
CHOYP_DVIR_GJ20612.1.1.m.14542,0.0274637851264422,No,NA,NA,Q291A0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DVIR_GJ21252.1.1.m.10086,0.00233217060240388,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_DVIR_GJ22204.1.1.m.17270,0.00223391548558325,No,NA,NA,Q642M9,NA,NA,NA,D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity [GO:0047115],NA,NA,NA
CHOYP_DVIR_GJ23521.1.1.m.2757,-0.00301358392436903,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_DVL.2.2.m.40553,-0.0158262630215561,No,NA,NA,Q6DKE2,NA,NA,NA,cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DWIL_GK10341.1.1.m.21304,-0.0193716485444755,No,NA,NA,Q3ZBX6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK10525.1.1.m.56074,-9.20379579651662e-05,No,NA,NA,P15330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; defense response [GO:0006952]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; ectodermal cell fate specification [GO:0001715]; gastrulation involving germ band extension [GO:0010004]; germ cell migration [GO:0008354]; heart development [GO:0007507]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; plasmatocyte differentiation [GO:0042387]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_DWIL_GK11849.1.1.m.12344,0.00459809670212998,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK12566.1.1.m.26720,-0.00590663746353709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK15715.1.1.m.52399,0.00608847664342178,No,NA,NA,Q924N4,NA,NA,NA,axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573],NA,NA,NA
CHOYP_DWIL_GK17319.1.1.m.58968,-0.00349692749872728,No,NA,NA,Q90879,NA,NA,NA,nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_DWIL_GK23042.1.1.m.38792,0.0038469895417725,No,NA,NA,Q92539,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_DWIL_GK24328.1.1.m.16490,0.0115328309778626,No,NA,NA,Q32PI6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK25045.1.2.m.9225,0.00386062887578128,No,NA,NA,Q8WQA4,NA,NA,NA,apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150],NA,NA,NA
CHOYP_DWIL_GK25256.1.1.m.7275,0.00047950822812591,No,NA,NA,Q8MV48,NA,NA,NA,endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_DX39B.2.3.m.18241,-3.5846745382351e-05,No,NA,NA,Q5RE47,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_DYAK_GE11656.1.2.m.34706,-0.00898550372074677,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DYAK_GE21870.1.1.m.28467,-0.00758631755255041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25081.2.3.m.43232,0.00639212602491586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25484.1.1.m.6273,0.0106620835759103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYH1.1.1.m.46156,-0.00824542005352482,No,NA,NA,E9Q8T7,NA,NA,NA,axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_DYH2.1.1.m.28905,-0.00437484250549277,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYH8.2.2.m.45091,0.00386803493128643,No,NA,NA,Q91XQ0,NA,NA,NA,dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DYHC.1.3.m.10664,-0.00312717635154596,No,NA,NA,P23098,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYHC1.1.1.m.2432,0.00215523550900879,No,NA,NA,Q14204,NA,NA,NA,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_DYHC2.2.2.m.31941,-0.000798361571577605,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DYN1.2.3.m.30771,-0.00267651687069022,No,NA,NA,P21575,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; clathrin-dependent endocytosis [GO:0072583]; endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_DYNLL2.2.2.m.37356,0.00181411600354614,No,NA,NA,Q78P75,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_E_R_.1.1.m.63122,0.0142191419034911,No,NA,NA,Q93104,NA,NA,NA,cell cycle [GO:0007049]; positive regulation of Notch signaling pathway [GO:0045747]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_E2F4.1.1.m.25398,-0.00595875102688787,No,NA,NA,Q6DE14,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_E41L3.2.2.m.57999,-0.000566134094563644,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_EATER.1.1.m.30042,0.00100263262947957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EBNA1BP2.1.1.m.63216,-0.00926866101505979,No,NA,NA,Q9D903,NA,NA,NA,nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ECD.1.1.m.61798,0.00269951905782414,No,NA,NA,O95905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ECH1.1.1.m.29110,-0.00327184713378036,No,NA,NA,Q62651,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3;5-delta2;4-dienoyl-CoA isomerase activity [GO:0051750]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHM.1.1.m.38462,0.00021698604602271,No,NA,NA,Q8BH95,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHVI_0367.2.2.m.16808,0.00466665518347945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECM29.1.1.m.48083,-0.00644053186501613,No,NA,NA,Q6PDI5,NA,NA,NA,centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein-containing complex scaffold activity [GO:0032947]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ECMB.1.3.m.2566,0.00385947154377821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECR.1.1.m.28368,0.0149550316085675,No,NA,NA,P49880,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; ecdysone binding [GO:0035100]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076],NA,NA,NA
CHOYP_EDEM1.1.1.m.12175,0.00354244383883548,No,NA,NA,Q925U4,NA,NA,NA,aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport; ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],NA,NA,NA
CHOYP_EDI_002780.1.1.m.31041,-0.013254639836602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDI_048910.1.2.m.31504,0.00222811148355522,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDRF1.2.2.m.45353,-0.00153039795770191,No,NA,NA,Q5R9R1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_EEA1.1.1.m.9573,0.0029431088616326,No,NA,NA,Q8BL66,NA,NA,NA,axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_EEF1A.2.3.m.20692,-0.00146562998913086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF1A.3.3.m.37430,0.0035499323106122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF2.1.2.m.44023,-0.00937808133838886,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EEF2.1.2.m.44025,-0.000161159949840364,No,NA,NA,Q8WZA0,NA,NA,NA,beta-catenin binding [GO:0008013]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_EF.1A.6.9.m.43621,0.0179618891169389,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF.1A.9.9.m.63037,-0.00134067689066978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF1A.2.4.m.50858,0.00125615717132616,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A.3.4.m.63413,0.00480852458464317,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_EF1A.3.4.m.63416,0.000448425405755359,No,NA,NA,P54353,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059],NA,NA,NA
CHOYP_EF1A.4.4.m.65743,-0.0134870896271811,No,NA,NA,Q92630,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_EF1A2.1.3.m.30022,-0.0229847870974886,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A2.2.3.m.37043,0.0119467556441248,No,NA,NA,P27634,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.1.7.m.26504,-0.000685187374582868,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.2.7.m.30853,-0.00985629871919532,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.3.7.m.35082,0.00948516448609888,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.1.3.m.12909,0.000740381454212963,No,NA,NA,P63100,NA,NA,NA,cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_EF1G.2.3.m.50676,0.00044763889433468,No,NA,NA,P29694,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.3.3.m.63510,0.000333745152670216,No,NA,NA,P12261,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF2.1.5.m.1541,-0.00734640062648474,No,NA,NA,P24156,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_EF2.4.5.m.30185,-0.0106537546939158,No,NA,NA,Q05086,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; positive regulation of protein ubiquitination [GO:0031398]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_EF2.4.5.m.30186,0.000392213300386962,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39855,-0.00680706133275904,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39856,-0.000743329180256486,No,NA,NA,Q7QC84,NA,NA,NA,mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],NA,NA,NA
CHOYP_EFCAB1.1.1.m.43342,0.00274310827666608,No,NA,NA,Q3KQ77,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFCAB7.1.1.m.17862,-0.0142483582502037,No,NA,NA,Q6DCF6,NA,NA,NA,ciliary membrane [GO:0060170]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFGM.1.1.m.16632,-0.00151576117023919,No,NA,NA,Q7Q1K8,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125],NA,NA,NA
CHOYP_EFHD2.1.1.m.22844,0.00119771038940101,No,NA,NA,Q4FZY0,NA,NA,NA,membrane raft [GO:0045121]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFTS.2.2.m.66393,0.00050670893714674,No,NA,NA,Q17PI0,NA,NA,NA,mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EGF1.1.2.m.46366,-0.000515947230757717,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EGFR.1.3.m.30285,0.0270614258213068,No,NA,NA,P0CY46,NA,NA,NA,integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_EGFR.2.3.m.61781,-0.00896569012621331,No,NA,NA,Q01279,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body; internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; receptor-mediated endocytosis [GO:0006898]; regulation of cell proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060],NA,NA,NA
CHOYP_EHI_072050.2.8.m.16931,0.00280967111987827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.5.8.m.47580,-0.00718791010640884,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.7.8.m.61373,0.000611664218802813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_153670.1.2.m.21885,-0.0174267013754346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHMT2.1.1.m.263,-0.00852731031082237,No,NA,NA,Q9H9B1,NA,NA,NA,chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_EIF1A.1.1.m.30303,-0.00306258992250539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF1A.1.1.m.30304,-0.0179244568472647,No,NA,NA,Q0V9J5,NA,NA,NA,nucleus [GO:0005634]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_EIF1B.1.3.m.29107,-0.0047806980812181,No,NA,NA,P42678,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_EIF2A.1.1.m.12752,-0.00465444120143326,No,NA,NA,Q5ZKC1,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_EIF3B.1.1.m.12232,-0.00123199224830034,No,NA,NA,P55884,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF3C.1.1.m.7991,1.7426977146207e-05,No,NA,NA,Q6PFQ2,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3E.1.1.m.27167,-0.00443821843760009,No,NA,NA,Q641X8,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3G.1.1.m.29464,-0.00245982053089011,No,NA,NA,Q6DRC4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3I.1.1.m.56504,-0.0022972606448789,No,NA,NA,B5FZ19,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3K.1.1.m.59650,-0.00194103113164988,No,NA,NA,Q28C65,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3L.1.1.m.7542,-0.000228680885974162,No,NA,NA,Q5F428,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF4BB.1.1.m.51065,-0.000147180128232951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF4BB.1.1.m.51066,0.000285141064403419,No,NA,NA,Q8BGD9,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; postsynapse [GO:0098794]; ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_EIF4H.3.3.m.57962,0.00102160279167033,No,NA,NA,Q15056,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953]; translational initiation [GO:0006413]; viral process [GO:0016032],NA,NA,NA
CHOYP_EIF5A.1.3.m.22684,-0.00246991269249529,No,NA,NA,P10160,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452],NA,NA,NA
CHOYP_EIN_155680.4.6.m.52358,0.00559106737085966,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_155680.6.6.m.56323,0.00484462444786205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_201030.1.3.m.20334,0.016167149422717,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_ELDP2.1.2.m.39081,0.00638747408155227,No,NA,NA,B3A0R6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELDP2.2.2.m.40194,0.00419261470381152,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELMO1.1.1.m.59285,-0.00110412922998093,No,NA,NA,Q96JJ3,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_ELOB.1.1.m.56270,0.00218122826085046,No,NA,NA,P62870,NA,NA,NA,elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ELOC.1.1.m.1299,-0.000190581080866113,No,NA,NA,P83941,NA,NA,NA,elongin complex [GO:0070449]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ELOV4.3.3.m.64203,-0.0086373488375521,No,NA,NA,Q9JLJ4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation; monounsaturated fatty acid [GO:0034625]; fatty acid elongation; polyunsaturated fatty acid [GO:0034626]; fatty acid elongation; saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ELP1.2.2.m.29114,-0.00794937126005118,No,NA,NA,O95163,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; immune response [GO:0006955]; positive regulation of cell migration [GO:0030335]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ELP2.1.1.m.18394,0.0061028695117131,No,NA,NA,Q05AM5,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_EMAL1.1.1.m.58030,-0.000201729150591703,No,NA,NA,O00423,NA,NA,NA,cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405],NA,NA,NA
CHOYP_EMAL6.1.1.m.6370,-0.00113071798245427,No,NA,NA,Q6ZMW3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_EMC2.2.2.m.21018,-0.012388226566289,No,NA,NA,Q6TGY8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_ENGASE.1.1.m.54655,-0.0157411580796877,No,NA,NA,Q8BX80,NA,NA,NA,cytosol [GO:0005829]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_ENO.1.2.m.7680,-0.0189537227542103,No,NA,NA,Q5ZK62,NA,NA,NA,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],NA,NA,NA
CHOYP_ENO.1.2.m.7681,0.00183521883701264,No,NA,NA,O02654,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ENOPH.1.4.m.8576,0.00632216395709666,No,NA,NA,Q69ZR9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ENOPH.3.4.m.51956,-0.0016797529656427,No,NA,NA,Q0VD27,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2;3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_ENOX2.1.1.m.7197,-0.00885055040689779,No,NA,NA,Q8TC92,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_ENPEP.1.1.m.12765,-0.00727060861469001,No,NA,NA,P50123,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ENPL.3.4.m.39476,-0.00372344447118445,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPL.4.4.m.47194,0.000695341624472762,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPP3.1.1.m.13519,0.0100856482177087,No,NA,NA,J3SBP3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; toxin activity [GO:0090729]; immune response [GO:0006955],NA,NA,NA
CHOYP_ENS.1.3.m.25925,0.00535692426331757,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ENTPD4.1.1.m.15533,0.0138747859021185,No,NA,NA,Q28CF8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_EP15R.1.1.m.14260,0.00133868313292407,No,NA,NA,Q9UBC2,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_EPN2.1.1.m.23660,0.0028032449570477,No,NA,NA,Q9Z1Z3,NA,NA,NA,clathrin coat of endocytic vesicle [GO:0030128]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_EPN4.2.3.m.66030,0.0235233701276346,No,NA,NA,A7Z035,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPRS.1.1.m.35443,-0.0032283308011896,No,NA,NA,Q8CGC7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_EPS.8.1.1.m.17522,0.00347015088824002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ER.1.2.m.14189,-0.0102970339133508,No,NA,NA,P81559,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor activity [GO:0030284]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ERD22.1.1.m.12383,0.0225346825486467,No,NA,NA,Q6PEH1,NA,NA,NA,cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ERF1.1.1.m.37539,-0.000610483374667926,No,NA,NA,Q9GR88,NA,NA,NA,cytoplasm [GO:0005737]; translation release factor activity [GO:0003747],NA,NA,NA
CHOYP_ERF1.1.1.m.37540,-0.00145728183088105,No,NA,NA,P81004,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308],NA,NA,NA
CHOYP_ERF3A.1.1.m.57282,-0.00163892800452674,No,NA,NA,Q8R050,NA,NA,NA,cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; translation [GO:0006412],NA,NA,NA
CHOYP_ERGI1.1.1.m.9684,0.00715689116219853,No,NA,NA,Q969X5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ERL2B.1.1.m.187,0.000799228855543845,No,NA,NA,Q6DKC0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ERP44.1.1.m.3853,-0.000977641924226155,No,NA,NA,Q3T0L2,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_ERR3.1.1.m.25316,0.00827754969394189,No,NA,NA,P62510,NA,NA,NA,nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription; DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_ES1.1.1.m.66406,0.00407096187750675,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_ESF1.1.1.m.15088,-0.0123006064382218,No,NA,NA,Q3V1V3,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EST1A.1.1.m.59161,0.00427038476495455,No,NA,NA,P61406,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_ETFD.1.1.m.6881,-0.00249215442640975,No,NA,NA,Q921G7,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_EVI1.1.1.m.62064,-0.00451537033942499,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_EVL.1.1.m.57134,0.0114723310843135,No,NA,NA,P70460,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_EXC6B.1.1.m.38489,1.84885577397243e-05,No,NA,NA,Q9Y2D4,NA,NA,NA,exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_EXOC1.1.2.m.60,-0.0069308868234549,No,NA,NA,Q9NV70,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032],NA,NA,NA
CHOYP_EXOC2.1.3.m.360,0.000419122450304132,No,NA,NA,Q96KP1,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535],NA,NA,NA
CHOYP_EXOC4.1.2.m.4421,0.0113043480454849,No,NA,NA,Q62824,NA,NA,NA,cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],NA,NA,NA
CHOYP_EXOS7.1.1.m.3323,-0.00723605889521071,No,NA,NA,Q15024,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOS9.1.1.m.12468,0.0211800128753408,No,NA,NA,Q5XJQ5,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; AU-rich element binding [GO:0017091]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOSC10.1.1.m.39774,-0.0178435302786867,No,NA,NA,Q01780,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EXOSC2.1.1.m.9530,-0.012913446691241,No,NA,NA,Q2KID0,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EZH2.1.1.m.47916,-0.00110585957869282,No,NA,NA,Q28D84,NA,NA,NA,ESC/E(Z) complex [GO:0035098]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; negative regulation of gene expression; epigenetic [GO:0045814]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_F10A1.2.4.m.11805,-0.00707978636654023,No,NA,NA,Q5ZLF0,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F172A.2.2.m.58797,-0.00536110840183911,No,NA,NA,Q3TNH5,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_F179B.1.1.m.45817,0.00461616325518755,No,NA,NA,Q8BMI3,NA,NA,NA,early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_F188B.1.1.m.8460,0.015582454010274,No,NA,NA,Q3UQI9,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],NA,NA,NA
CHOYP_F48E3.8.1.1.m.46349,0.0083167573318928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_F91A1.1.1.m.52980,-0.00570841352759576,No,NA,NA,Q3UVG3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_FA13A.1.2.m.296,0.00013240293413649,No,NA,NA,Q8HYW0,NA,NA,NA,,NA,NA,NA
CHOYP_FA13A.1.2.m.297,0.00982331045287008,No,NA,NA,Q6TH47,NA,NA,NA,cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536],NA,NA,NA
CHOYP_FA49B.1.1.m.294,0.000430738526856011,No,NA,NA,Q9NUQ9,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding; via antigen binding groove [GO:0023030]; platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916],NA,NA,NA
CHOYP_FA63B.1.1.m.52872,-0.00703071750869624,No,NA,NA,Q2KI23,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_FA65A.1.1.m.24019,0.00555533768148986,No,NA,NA,Q96MK2,NA,NA,NA,,NA,NA,NA
CHOYP_FAAA.1.1.m.7653,0.000508143267225104,No,NA,NA,A5PKH3,NA,NA,NA,cytosol [GO:0005829]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_FABP.1.2.m.51611,-0.00138187806263147,No,NA,NA,O01814,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_FABP2.1.2.m.5800,0.011356863894592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FABP6.1.2.m.49858,0.000631593076890626,No,NA,NA,O01812,NA,NA,NA,lipid binding [GO:0008289],NA,NA,NA
CHOYP_FABP7.1.2.m.22674,-0.00760737204161478,No,NA,NA,Q09139,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FABP7.2.2.m.29096,0.00770407693059154,No,NA,NA,Q09139,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FACE1.1.1.m.13875,5.63044536548131e-05,No,NA,NA,Q80W54,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription; DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229],NA,NA,NA
CHOYP_FAF1.1.1.m.35621,0.000209313595219744,No,NA,NA,Q9UNN5,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_FAF1.1.1.m.35623,0.0157224394868802,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_FAF2.1.1.m.54271,0.0229306218994971,No,NA,NA,P30568,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_FAIM1.1.1.m.36651,0.00908375953198012,No,NA,NA,Q0IIF6,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_FAM122B.1.1.m.7361,0.0126456155773864,No,NA,NA,Q5ZLN7,NA,NA,NA,protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436],NA,NA,NA
CHOYP_FAM193A.1.1.m.66343,0.00805092066400338,No,NA,NA,P78312,NA,NA,NA,,NA,NA,NA
CHOYP_FAM50.1.1.m.17123,0.00709084070418463,No,NA,NA,Q9VAY7,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_FANCJ.1.1.m.17513,-0.00433934616976319,No,NA,NA,Q3YK19,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_FARP2.1.1.m.9404,0.0060290462297107,No,NA,NA,Q91VS8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_FAS2.1.1.m.41201,0.00292074581228149,No,NA,NA,P13596,NA,NA,NA,glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794],NA,NA,NA
CHOYP_FASN.3.4.m.60278,-0.0161791472700085,No,NA,NA,P12276,NA,NA,NA,cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH; A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100],NA,NA,NA
CHOYP_FAT1.2.4.m.36735,0.00012447397234165,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FAT1.4.4.m.63315,-0.0108475432025422,No,NA,NA,Q6V0I7,NA,NA,NA,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_FAT4.8.10.m.44748,-0.00169124329503369,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FBLN2.1.1.m.25187,0.00465265974144492,No,NA,NA,P37889,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_FBX22.1.1.m.35385,-0.00255381086679321,No,NA,NA,Q5RE08,NA,NA,NA,Z disc [GO:0030018],NA,NA,NA
CHOYP_FBX42.1.1.m.11569,-0.0015946954242494,No,NA,NA,Q6PDJ6,NA,NA,NA,,NA,NA,NA
CHOYP_FBX9.1.1.m.49865,0.00621533804346666,No,NA,NA,Q3ZBT2,NA,NA,NA,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_FCHO2.1.1.m.46242,0.00636645382464045,No,NA,NA,Q3UQN2,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_FCL.1.1.m.13504,-0.000759734462973441,No,NA,NA,Q8K3X2,NA,NA,NA,coenzyme binding [GO:0050662]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3;5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; T cell mediated cytotoxicity [GO:0001913],NA,NA,NA
CHOYP_FGD1.1.2.m.11030,0.0155763844944702,No,NA,NA,P98174,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_FGFR2.1.3.m.20151,0.01010734034742,No,NA,NA,Q03142,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640],NA,NA,NA
CHOYP_FGFR2.2.3.m.53947,0,No,NA,NA,Q8JG38,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; cell proliferation in midbrain [GO:0033278]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract development [GO:0048565]; midbrain development [GO:0030901]; positive regulation of cell proliferation [GO:0008284]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FGL1.1.6.m.30450,-0.000565179345872237,No,NA,NA,Q9R045,NA,NA,NA,extracellular space [GO:0005615],NA,NA,NA
CHOYP_FHOD3.2.2.m.44837,0.00206004131972433,No,NA,NA,Q2V2M9,NA,NA,NA,striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FIBP.1.1.m.36402,-0.00865758654004406,No,NA,NA,Q9JI19,NA,NA,NA,endomembrane system [GO:0012505]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134],NA,NA,NA
CHOYP_FKBP12.1.1.m.32709,0.0193119480652947,No,NA,NA,Q9Z2I2,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],NA,NA,NA
CHOYP_FKBP13.1.1.m.43694,-0.00380155089518451,No,NA,NA,Q9Y680,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP14.1.1.m.7244,0.00980165906473989,No,NA,NA,P59024,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP1AA.1.1.m.26101,0.000346970240182359,No,NA,NA,O42123,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],NA,NA,NA
CHOYP_FKBP4.1.1.m.15147,0.00204140805646429,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_FL2D.1.1.m.62439,0.00111098328692108,No,NA,NA,Q7SXL7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_FLELI_3104.1.1.m.46432,-0.000818005948584489,No,NA,NA,Q30NT6,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity; alcohol group as acceptor [GO:0016773]; 1;6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254],NA,NA,NA
CHOYP_FLNA.1.6.m.11089,-0.00205962764251569,No,NA,NA,Q80X90,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNA.2.6.m.11845,0.0294675389576834,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FLNA.6.6.m.37383,0.0132114403615699,No,NA,NA,Q80X90,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNC.2.5.m.37450,-0.00382532834523265,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.3.5.m.38669,0.0171138269723537,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.5.5.m.40834,0.000895740795595132,No,NA,NA,D3ZHA0,NA,NA,NA,costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_FLOT1.1.2.m.21435,0.00897396152692024,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FLOT1.2.2.m.59727,-0.00384818998662133,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FMRF.1.4.m.26285,0.0119655991768185,No,NA,NA,P08021,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_FMRF.4.4.m.62077,-0.0162163589564069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRP.1.2.m.37742,-0.00345838669048334,No,NA,NA,Q5XI81,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_FND2.1.4.m.8542,-0.000921675950994941,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.3.4.m.40482,0.0069336367251855,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.4.4.m.44570,0.0208202358140281,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FNTA.1.1.m.40996,-0.00215135033298987,No,NA,NA,P49354,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_FNTB.1.1.m.45546,0.00609255654934275,No,NA,NA,P49355,NA,NA,NA,protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060],NA,NA,NA
CHOYP_FOCAD.2.2.m.52366,-0.00607316997093419,No,NA,NA,Q5VW36,NA,NA,NA,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_FOXF1.1.1.m.4194,-0.00795503734314335,No,NA,NA,Q61080,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841],NA,NA,NA
CHOYP_FOXK2.1.1.m.56318,-0.000763003733913415,No,NA,NA,Q7ZX03,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; magnesium ion binding [GO:0000287]; sequence-specific DNA binding [GO:0043565]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_FOXN2_3.1.1.m.8518,0.00160904819245131,No,NA,NA,Q33BP8,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_FREM1.1.1.m.55119,0.015211678952204,No,NA,NA,Q5H8C1,NA,NA,NA,basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094],NA,NA,NA
CHOYP_FREM2.1.1.m.31430,-0.0024207957143657,No,NA,NA,Q9GV77,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FRIS.10.11.m.66055,0.0285000758397056,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.6.11.m.44036,-0.00266030893372787,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.9.11.m.53958,-0.00398078156961572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FRIY.1.1.m.5052,0.00381072212850944,No,NA,NA,P42578,NA,NA,NA,cell [GO:0005623]; extracellular region [GO:0005576]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRM4B.1.1.m.2249,0.000773648077490495,No,NA,NA,Q8BIE6,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding; bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_FRRS1.2.3.m.41025,-0.00139856902377381,No,NA,NA,A4QP81,NA,NA,NA,integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_FUCL1.1.1.m.28893,0,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_FUCO.1.2.m.58756,-0.00959935243330058,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO.2.2.m.58905,0.00913170648763888,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO2.1.1.m.64139,0.00896107952637231,No,NA,NA,Q9BTY2,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; cellular protein metabolic process [GO:0044267]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_FUK.1.1.m.17020,0.000989986025756356,No,NA,NA,Q8N0W3,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350],NA,NA,NA
CHOYP_FUMH.2.2.m.55401,-0.00751026823656435,No,NA,NA,O17214,NA,NA,NA,mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_FUT2.4.5.m.54048,0.00839973378366336,No,NA,NA,Q28113,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_FUT8.1.1.m.9231,-0.0110149640115456,No,NA,NA,Q659X0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_FUTSC.1.4.m.10187,0.000131966538219413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.3.4.m.18545,-0.00107950146457322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.4.4.m.59503,0.00269737907862223,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FYN.1.1.m.44312,0.00104377086520929,No,NA,NA,Q9CPW4,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; endosome [GO:0005768]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_FYNA.1.1.m.63901,0.00797511511471052,No,NA,NA,P00523,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; connexin binding [GO:0071253]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; progesterone receptor signaling pathway [GO:0050847]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FYV1.1.1.m.41923,0.00755941364925574,No,NA,NA,Q9Z1T6,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_FZD7A.1.1.m.29589,-0.00804091588156948,No,NA,NA,Q9I9M5,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_G6PD.1.2.m.38380,0.0181154458709579,No,NA,NA,P05370,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_G6PD.2.2.m.46923,-0.00115788363932186,No,NA,NA,P05370,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_GABPA.1.1.m.15077,0.0105197784533639,No,NA,NA,Q06546,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; mitochondrion organization [GO:0007005]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_GACZ.1.1.m.42619,-0.00413772292423588,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GADL1.1.1.m.14433,0.00732306456724331,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_GAK.1.1.m.7017,0.00232997215282337,No,NA,NA,O14976,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_GALK2.1.2.m.5222,0.00305156959254584,No,NA,NA,Q5XIG6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose catabolic process via UDP-galactose [GO:0033499],NA,NA,NA
CHOYP_GALNS.1.1.m.66165,-0.00511647505513522,No,NA,NA,Q32KH5,NA,NA,NA,lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890],NA,NA,NA
CHOYP_GALT1.1.1.m.33853,2.60335026241421e-05,No,NA,NA,Q29121,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_GALT2.1.1.m.54493,-0.00908713725714223,No,NA,NA,Q10471,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GAR1.1.2.m.9449,-0.00466424217008985,No,NA,NA,Q9CY66,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nuclear chromosome; telomeric region [GO:0000784]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_GATA1.1.2.m.16576,-0.0135731008509185,No,NA,NA,P52168,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; digestive tract development [GO:0048565]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_GATAD1.1.1.m.50020,0.00299651355393831,No,NA,NA,Q1L8G7,NA,NA,NA,I band [GO:0031674]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_GATC.1.2.m.2975,-0.00156028554236124,No,NA,NA,C3XVM1,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450],NA,NA,NA
CHOYP_GBB.2.2.m.35274,-0.00379962234094855,No,NA,NA,Q17902,NA,NA,NA,nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_GBLP.3.7.m.20931,-0.000326722271382784,No,NA,NA,O42249,NA,NA,NA,ribosome [GO:0005840]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_GBLP.6.7.m.57427,0.00136791263353234,No,NA,NA,Q9W2N0,NA,NA,NA,actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; microtubule-based movement [GO:0007018]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_GCC2.1.1.m.17251,-0.00056385129539567,No,NA,NA,Q8CHG3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_GCKR.1.1.m.51743,0.000332213715783182,No,NA,NA,Q91754,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; fructose-6-phosphate binding [GO:0070095]; carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; negative regulation of glucokinase activity [GO:0033132],NA,NA,NA
CHOYP_GCN1L.1.1.m.1352,-0.00101779415713876,No,NA,NA,E9PVA8,NA,NA,NA,cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_GCP2.1.1.m.23103,0.00560614982837987,No,NA,NA,Q921G8,NA,NA,NA,centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_GCSP.1.1.m.46644,0.00025040975260418,No,NA,NA,P23378,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],NA,NA,NA
CHOYP_GCST.1.1.m.16047,0.00180667853992519,No,NA,NA,P48728,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],NA,NA,NA
CHOYP_GCY.2.4.m.33243,-0.0105620817484352,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GD1L1.1.1.m.11963,-0.00913272946314083,No,NA,NA,A6QQZ0,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_GDAP2.1.1.m.57049,0.00743505287363465,No,NA,NA,A7T167,NA,NA,NA,,NA,NA,NA
CHOYP_GDE.1.1.m.54948,-0.0057447677564522,No,NA,NA,P35573,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1;6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_GDS1B.1.1.m.52257,0.000315224817532112,No,NA,NA,Q5PPZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_GEK.1.1.m.4939,0.00213528634767948,No,NA,NA,O54874,NA,NA,NA,actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_GELS2.2.2.m.30443,0.00198132655242368,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_GEMIN5.2.2.m.59078,0.00312231148620937,No,NA,NA,Q8BX17,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],NA,NA,NA
CHOYP_GEPH.1.2.m.49093,-0.00437700667620124,No,NA,NA,Q9NQX3,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],NA,NA,NA
CHOYP_GFM2.1.1.m.18396,-0.0139195670832395,No,NA,NA,A6QNM2,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_GGPPS.1.1.m.12124,-0.000367809167768239,No,NA,NA,O95749,NA,NA,NA,cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540],NA,NA,NA
CHOYP_GIGA2.1.1.m.44916,0.0151947132813882,No,NA,NA,P86785,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA3.1.1.m.42774,0.0181288665470129,No,NA,NA,P86786,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.1.3.m.10521,0.0116782462885641,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.2.3.m.41265,0.00907082286171758,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.3.4.m.17227,0.0088965965707039,No,NA,NA,P86788,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.4.4.m.39598,-0.0100713300642428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GIGA6.1.1.m.38687,0.00736257267858621,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GIMA4.4.7.m.42250,0.00246747186955929,No,NA,NA,Q8K3K9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_GINS3.1.1.m.18574,-0.0191270291674996,No,NA,NA,Q9CY94,NA,NA,NA,nucleoplasm [GO:0005654]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_GIPC1.1.1.m.60630,0.000316537805292333,No,NA,NA,Q9Z254,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GIT1.1.2.m.26059,0.00388017628904976,No,NA,NA,Q9Y2X7,NA,NA,NA,calyx of Held [GO:0044305]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GKAP1.1.1.m.18792,0.0105468188036212,No,NA,NA,Q6NWC9,NA,NA,NA,Golgi apparatus [GO:0005794]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GLB1L2.1.1.m.5029,0.0221547388738123,No,NA,NA,Q3UPY5,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_GLCM.2.3.m.40511,0.0143103937638199,No,NA,NA,P17439,NA,NA,NA,extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_GLIPR1L1.1.1.m.41745,0.00418641172308496,No,NA,NA,Q7T141,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_GLMN.1.1.m.17085,-0.0067954908725098,No,NA,NA,Q8BZM1,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression; epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_GLNA.1.5.m.1591,0.0101646038237279,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4133,0.00218547222655719,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4134,-0.0208831342385705,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GLO1.1.1.m.32382,-0.000724834900501102,No,NA,NA,Q6P7Q4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GLOD5.1.1.m.25831,-0.0116578266697276,No,NA,NA,Q502D1,NA,NA,NA,,NA,NA,NA
CHOYP_GLRX2.1.1.m.19246,-0.0123815609648878,No,NA,NA,Q5RC53,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_GLRX3.1.1.m.63529,-0.000318355843281823,No,NA,NA,Q28ID3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_GLT13.2.2.m.10604,0.010979082553623,No,NA,NA,O08912,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GM2A.2.3.m.19346,0.00100510987531213,No,NA,NA,Q60648,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_GMCLL.1.1.m.15031,0.000331608251178936,No,NA,NA,Q96IK5,NA,NA,NA,nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_GMDS.1.1.m.28602,-0.00196891461646581,No,NA,NA,Q8K0C9,NA,NA,NA,cytoplasm [GO:0005737]; GDP-mannose 4;6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_GMEB1.1.1.m.8284,-0.00391486821122966,No,NA,NA,O88873,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GMFB.2.2.m.54955,0.000630539664595939,No,NA,NA,Q5R6P6,NA,NA,NA,actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316],NA,NA,NA
CHOYP_GMPAA.1.1.m.1432,0.00169630180754654,No,NA,NA,Q6GMK8,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_GMPR2.1.1.m.63274,0.000216765073685919,No,NA,NA,Q9P2T1,NA,NA,NA,cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_GNA1.1.1.m.39198,0.00159051002869887,No,NA,NA,Q9VAI0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetylglucosamine biosynthetic process [GO:0006045]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GNAI.1.1.m.26096,0.00897519319724944,No,NA,NA,P30682,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAO.1.1.m.37355,-0.00578592285350579,No,NA,NA,P30683,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAQ.1.1.m.20698,-0.00961007009999536,No,NA,NA,O15975,NA,NA,NA,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNAS.3.3.m.55756,0.0107504887551584,No,NA,NA,P30684,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNBPB3.1.1.m.55379,0.0031822781467284,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_GNPI2.1.1.m.55897,-0.000302624509402304,No,NA,NA,A4IHW6,NA,NA,NA,cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GOGB1.1.2.m.26408,0.00588030172400107,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOGB1.2.2.m.66418,0.0119989965495853,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOLGA4.1.3.m.4761,0.00325853465154398,No,NA,NA,Q91VW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773],NA,NA,NA
CHOYP_GOLGA4.3.3.m.55461,0.00372144340616021,No,NA,NA,Q13439,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_GOLI4.2.4.m.15493,0.0113354407133146,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLI4.3.4.m.29146,0.00738759974510432,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLP3.1.1.m.52389,-0.00114919450631102,No,NA,NA,Q9VQ93,NA,NA,NA,cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport; vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053],NA,NA,NA
CHOYP_GPAT4.1.1.m.56178,-0.0078833051131067,No,NA,NA,Q5R6J7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_GPC6.1.1.m.64926,0.000630046856848262,No,NA,NA,Q9R087,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_GPCP1.1.1.m.11490,0.00219842323704831,No,NA,NA,Q9NPB8,NA,NA,NA,cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_GPDA.1.2.m.6967,-0.00102475150343673,No,NA,NA,O35077,NA,NA,NA,cytosol [GO:0005829]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH metabolic process [GO:0006734]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821],NA,NA,NA
CHOYP_GPDA.2.2.m.30755,0.000142296595228143,No,NA,NA,Q27928,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650],NA,NA,NA
CHOYP_GPM6A.1.1.m.41817,0.0247958553355753,No,NA,NA,P35803,NA,NA,NA,integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_GPMA.1.1.m.35689,0.000708727853138118,No,NA,NA,Q54NE6,NA,NA,NA,cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_GPN3.1.2.m.6649,0.000274437309873964,No,NA,NA,O15145,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_GPR98.4.5.m.21296,0.0201061201876976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GPSM2.1.1.m.58301,-0.0224713935275063,No,NA,NA,P81274,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_GPSM2.1.1.m.58302,-0.000892315593351731,No,NA,NA,O42387,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_GPX3.1.2.m.24838,0.00726948639017373,No,NA,NA,G9JJU2,NA,NA,NA,glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX4.A.1.1.m.257,0.00603906416853234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GR101.3.3.m.43507,-0.00592588713806209,No,NA,NA,P46023,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_GRAP1.1.1.m.45768,0.00883206812175499,No,NA,NA,Q8VD04,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158],NA,NA,NA
CHOYP_GRDN.1.5.m.12675,-0.00511886255218265,No,NA,NA,Q3V6T2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_GRIA3.1.1.m.44173,-0.00205062072750964,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_GRK5.1.1.m.6617,-0.0063565011285478,No,NA,NA,P43249,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GRM1.2.2.m.65835,-0.000261089556459048,No,NA,NA,Q14416,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_GRP75.1.1.m.11678,-6.49062468701091e-05,No,NA,NA,Q3ZCH0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_GRP78.2.5.m.33058,0.00192027940558418,No,NA,NA,Q16956,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_GSH1.1.1.m.8927,0.010447532549952,No,NA,NA,P19468,NA,NA,NA,cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],NA,NA,NA
CHOYP_GSHB.1.1.m.27512,-0.00201224668237299,No,NA,NA,Q5EAC2,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_GSK3B.1.1.m.62139,-0.00364634534178522,No,NA,NA,Q9WV60,NA,NA,NA,axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; Schaffer collateral - CA1 synapse [GO:0098685]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; integrin binding [GO:0005178]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hepatic stellate cell activation [GO:0035733]; hepatocyte apoptotic process [GO:0097284]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; maintenance of cell polarity [GO:0030011]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of TOR signaling [GO:0032007]; neuron projection development [GO:0031175]; neuron projection retraction [GO:0106028]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron projection development [GO:0010975]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to zinc ion [GO:0010043]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GSLG1.3.3.m.66468,-0.00434358200471001,No,NA,NA,Q61543,NA,NA,NA,extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330],NA,NA,NA
CHOYP_GSPATT00009499001.1.1.m.34366,-0.000795048771575034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GSPATT00037947001.1.1.m.24620,0.0257010756795371,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GST7.1.1.m.59335,-0.00485665986210878,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTO1.2.2.m.26202,-0.00260324261706217,No,NA,NA,Q9VSL3,NA,NA,NA,cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity; transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728],NA,NA,NA
CHOYP_GSTO2.1.1.m.36486,-0.00198792963582059,No,NA,NA,P78417,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTP1.1.2.m.29677,-0.00845852727979684,No,NA,NA,P19157,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; animal organ regeneration [GO:0031100]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione metabolic process [GO:0006749]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of neutrophil aggregation [GO:2000429]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of peroxidase activity [GO:2000469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; oligodendrocyte development [GO:0014003]; positive regulation of superoxide anion generation [GO:0032930]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to amino acid [GO:0043200]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to L-ascorbic acid [GO:0033591]; response to nutrient levels [GO:0031667]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_GSTP1.2.2.m.30099,-3.75928928008644e-05,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTS8.1.1.m.12434,0.0152782679547501,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_GSTUL.1.1.m.35986,-0.00292091738464035,No,NA,NA,Q9ZRW8,NA,NA,NA,chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; cellular response to water deprivation [GO:0042631]; glutathione metabolic process [GO:0006749]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]; toxin catabolic process [GO:0009407],NA,NA,NA
CHOYP_GSTZ1.1.1.m.56540,0.00433272242503688,No,NA,NA,Q9VHD2,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_GTPB1.1.1.m.66453,-0.0065949105510293,No,NA,NA,O08582,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_GTR1.1.1.m.25509,-0.00076289720326428,No,NA,NA,P27674,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; midbody [GO:0030496]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; cellular response to glucose starvation [GO:0042149]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_GUAA.1.1.m.18809,-0.0003649923556185,No,NA,NA,Q5RA96,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177],NA,NA,NA
CHOYP_GUAD.1.1.m.33511,-0.00137065015929365,No,NA,NA,Q5RAV9,NA,NA,NA,guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147],NA,NA,NA
CHOYP_GUK1.1.1.m.48140,0.000817472383611711,No,NA,NA,P15454,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163],NA,NA,NA
CHOYP_GULP1.1.1.m.44407,0.00629834717145407,No,NA,NA,Q32PV0,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; phagocytosis [GO:0006909],NA,NA,NA
CHOYP_GUN.1.2.m.26883,0.00210842092842613,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GUN.2.2.m.46462,0.00501760592041769,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GZF1.1.2.m.7747,-0.00213637176199918,No,NA,NA,P18737,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_H2AV.1.7.m.12182,-0.000851022193910449,No,NA,NA,Q5BJ65,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_H2BL3.1.1.m.16594,-0.022100704589786,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_H3.1.2.m.3829,-0.00224324035669955,No,NA,NA,P84239,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],NA,NA,NA
CHOYP_HAAF.11.13.m.44366,-0.0153908040143476,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HAAF.3.13.m.8849,-0.023999258941096,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HACE1.1.2.m.24806,0.000390382157998738,No,NA,NA,Q28BK1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HACL1.1.1.m.6578,-0.000565509359117637,No,NA,NA,Q9UJ83,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; signaling receptor binding [GO:0005102]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_HAND1.1.1.m.10874,0.0104170868264873,No,NA,NA,P57102,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],NA,NA,NA
CHOYP_HBS1L.1.2.m.14311,-0.00192147675586351,No,NA,NA,Q9Y450,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412],NA,NA,NA
CHOYP_HBX5.1.1.m.11081,0.00453597315151493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HD.1.1.m.56119,-0.00358930013874666,No,NA,NA,P42859,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; L-glutamate import [GO:0051938]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HEAT1.1.1.m.11228,-0.00391802859609032,No,NA,NA,Q7SY48,NA,NA,NA,90S preribosome [GO:0030686]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487],NA,NA,NA
CHOYP_HEATR3.1.1.m.33423,-0.00158506487972016,No,NA,NA,Q7Z4Q2,NA,NA,NA,cell [GO:0005623]; unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_HECD1.1.1.m.27759,0.00105373293614791,No,NA,NA,Q9ULT8,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_HELZ.2.2.m.43303,-0.00409671002931403,No,NA,NA,Q6NYU2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194],NA,NA,NA
CHOYP_HEM2.1.1.m.6789,0.00301360145503152,No,NA,NA,Q58DK5,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM3.1.1.m.28414,-0.00103929385414568,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM6.1.1.m.17205,-0.00828996305696919,No,NA,NA,Q9V3D2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process from glutamate [GO:0019353],NA,NA,NA
CHOYP_HERC1.2.2.m.51367,-0.0015288863782413,No,NA,NA,Q15751,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_HERC2.1.1.m.65153,0.00690519825130579,No,NA,NA,O95714,NA,NA,NA,centriole [GO:0005814]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_HES1.2.3.m.27001,-0.00955078201768665,No,NA,NA,Q90Z12,NA,NA,NA,nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501],NA,NA,NA
CHOYP_HEX.1.1.m.43068,0.000463093750757204,No,NA,NA,H2A0L6,NA,NA,NA,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],NA,NA,NA
CHOYP_HGFAC.1.1.m.5902,-0.00863039661345491,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HHEX.2.2.m.19527,0.000159634834808346,No,NA,NA,O88271,NA,NA,NA,basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_HIF1N.1.1.m.53726,0.0121152870814619,No,NA,NA,Q9NWT6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418],NA,NA,NA
CHOYP_HINT1.1.1.m.53526,0.00246660849829141,No,NA,NA,P80912,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_HIP1.1.1.m.31791,0.0123083074372474,No,NA,NA,O00291,NA,NA,NA,actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_HIRA.1.1.m.19212,0.00403375217440747,No,NA,NA,O42611,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_HMBS.1.1.m.31422,-0.00216025303550597,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HMCN1.19.44.m.39500,0.00486311314247854,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.23.44.m.42684,0.012425991419768,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.28.44.m.47379,0.0161504161264046,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.32.44.m.58935,-0.00624907781312761,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.33.44.m.58938,0.015453501828777,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_HMCN1.39.44.m.61047,-0.00849766929694929,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN1.5.44.m.7236,-0.0113239866932222,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN2.10.12.m.49343,-0.00877650820502063,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_HMCN2.11.12.m.51619,-0.00594687604143942,No,NA,NA,Q9W6R5,NA,NA,NA,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.3.12.m.26811,-0.00583136308546288,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_HMCN2.6.12.m.33452,0.00451307792395758,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.8.12.m.39297,-0.00592073858253085,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_HMCN2.9.12.m.44986,0.0110001429199169,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HN1L.2.2.m.9837,-0.00827270332028064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HNRPR.1.2.m.44125,0.00184075640523912,No,NA,NA,O43390,NA,NA,NA,axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_HNRPR.1.2.m.44126,0.0102417616654996,No,NA,NA,P07291,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_HOIL1.2.3.m.54310,0.0112688166728976,No,NA,NA,A9JTG5,NA,NA,NA,LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],NA,NA,NA
CHOYP_HOOK3.1.1.m.14456,-0.0101930887596136,No,NA,NA,Q86VS8,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031],NA,NA,NA
CHOYP_HOW.5.5.m.58452,0.00045197488624116,No,NA,NA,O01367,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of translation [GO:0006417]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_HPGD.1.3.m.50258,0.000418978824443126,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_HPRT.1.1.m.61881,-0.000150988865650456,No,NA,NA,P47959,NA,NA,NA,cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; GMP catabolic process [GO:0046038]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_HS12A.10.33.m.38139,0.0225801632963599,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.12.33.m.39763,-0.00615603882709128,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.14.33.m.41988,0.00354333224372659,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.20.33.m.55554,-0.0127895591201865,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.24.33.m.60051,-0.00384056100265993,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.25.33.m.60352,0.0147168721263839,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.10.14.m.59859,-0.0115909642202947,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.2.14.m.19896,-0.00965382256870733,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40600,-0.000724559097071367,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40601,0.00267585726283819,No,NA,NA,Q5EAE6,NA,NA,NA,death domain binding [GO:0070513]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507],NA,NA,NA
CHOYP_HS74L.1.1.m.24610,-0.000167187691741374,No,NA,NA,O95757,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HS90A.1.3.m.7725,0.00331961304231183,No,NA,NA,O14562,NA,NA,NA,cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_HS90A.3.3.m.28299,0.0140031339796212,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HS90A.3.3.m.28300,0.000733973435839974,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_HSC70.1.1.m.335,0.00785166514782968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSF1.2.2.m.38636,-0.00744037966140322,No,NA,NA,P38529,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cadmium ion [GO:0071276]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to heat [GO:0009408]; response to light stimulus [GO:0009416],NA,NA,NA
CHOYP_HSP21.4.1.1.m.8171,-0.00137638175215386,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_HSP70.1.1.m.61727,0.000165028776612163,No,NA,NA,P41827,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34782,0.00301544577330933,No,NA,NA,Q9U639,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34785,-0.00595444224629383,No,NA,NA,Q3T022,NA,NA,NA,ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_HSP7D.3.3.m.41778,0.0054432760683326,No,NA,NA,O18373,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide; water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cell proliferation [GO:0008284]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329],NA,NA,NA
CHOYP_HSP7E.1.1.m.13730,-0.00351321001418285,No,NA,NA,Q2YDD0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; cytoplasmic translation [GO:0002181]; protein refolding [GO:0042026]; regulation of translational fidelity [GO:0006450]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HSP90AA1.1.1.m.14867,0.00154877033705545,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HSPA12A.10.27.m.35252,0.0200389073785023,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.15.27.m.45635,0.0204054668230671,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.16.27.m.48207,0.0126389025777196,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.2.27.m.15188,-0.00935237337072079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSPA12A.21.27.m.57005,0.000324782255446845,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.5.27.m.21251,-0.00284737576801407,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.9.27.m.34375,-0.015780907008849,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12B.1.1.m.36165,0.00737007415736551,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPG2.1.4.m.1496,0.00596365378856809,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_HTF4.1.5.m.16262,-0.0064839913023718,No,NA,NA,Q99081,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_HTR2B.1.1.m.121,0.00783274181382952,No,NA,NA,P41595,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; serotonin receptor signaling pathway [GO:0007210]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_HTR5B.1.1.m.39330,-0.00744085742196355,No,NA,NA,A1A5F2,NA,NA,NA,cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_HTT.1.1.m.33803,-0.0138428946242082,No,NA,NA,P42858,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HUTH.1.1.m.30350,2.06828752775373e-05,No,NA,NA,P21213,NA,NA,NA,cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547],NA,NA,NA
CHOYP_HUWE1.1.2.m.566,-0.0020715296439438,No,NA,NA,Q7Z6Z7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HVCN1.1.4.m.8888,-0.00857455653054538,No,NA,NA,Q5F4C0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_HVCN1.2.4.m.29334,0.0081787366006935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HX1.1.1.m.23716,0.00862799789771607,No,NA,NA,Q8IWF2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_HXD3.1.1.m.40287,-0.000811102596286223,No,NA,NA,P50901,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_HYI.1.1.m.10528,-0.00993609037282472,No,NA,NA,Q7T3H9,NA,NA,NA,hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857],NA,NA,NA
CHOYP_HYOU1.1.3.m.163,0.00946297625450208,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_HYOU1.2.3.m.12568,0.00139782535483855,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_IARS.1.1.m.27559,-0.00121217879871938,No,NA,NA,P41252,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_IDE.1.3.m.8450,-0.00839559933815509,No,NA,NA,P35559,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],NA,NA,NA
CHOYP_IDHC.1.1.m.7041,0.000828195449819454,No,NA,NA,Q9Z2K9,NA,NA,NA,cytosol [GO:0005829]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_IDLC.1.1.m.63624,-0.00321426501733899,No,NA,NA,Q26630,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_IF122.2.2.m.59794,0.00727635224241961,No,NA,NA,A8WGF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_IF2A.1.1.m.13279,-0.00142978223360817,No,NA,NA,P68101,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; glial limiting end-foot [GO:0097451]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_IF2H.1.1.m.18253,-0.00105007800081407,No,NA,NA,C9WPN6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_IF4A3.1.1.m.30424,-0.0011051487261972,No,NA,NA,Q7ZVA6,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IF4E.1.1.m.56823,-0.00384843500164296,No,NA,NA,P48597,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_IF4G2.1.1.m.62766,-0.0017487515024265,No,NA,NA,Q62448,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_IF6.1.1.m.22685,0.000871458916733117,No,NA,NA,O55135,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054],NA,NA,NA
CHOYP_IFIH1.10.14.m.60393,-0.0157256699456367,No,NA,NA,Q8R5F7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein sumoylation [GO:0016925]; response to virus [GO:0009615],NA,NA,NA
CHOYP_IFIH1.3.14.m.24387,-0.0173309181215549,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.7.14.m.46974,-0.0118124857412011,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.9.14.m.54678,0.00419302636125312,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFT140.1.1.m.61053,-0.00341068690274816,No,NA,NA,E9PY46,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_IFT57.1.1.m.13249,-0.00530634275456682,No,NA,NA,Q5EA95,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_IKBZ.1.1.m.23083,0.00157700651110846,No,NA,NA,G5EDE9,NA,NA,NA,transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_IKZF.1.1.m.55498,-0.00680965573374031,No,NA,NA,A4IFJ6,NA,NA,NA,nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_IMA2.1.2.m.35753,0.00535573117741935,No,NA,NA,F4KF65,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; NLS-bearing protein import into nucleus [GO:0006607],NA,NA,NA
CHOYP_IMA2.2.2.m.49279,-0.0102099392451869,No,NA,NA,P52170,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IMDH3.1.1.m.51789,-0.00219851415636995,No,NA,NA,B0UXP9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183],NA,NA,NA
CHOYP_IMG5_109580.1.1.m.27791,-0.0111078522197788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMG5_163910.1.1.m.46747,0.0181724194371725,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.1.2.m.5157,-0.0217313143518657,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_INF2.3.5.m.13728,-0.0109286614758122,No,NA,NA,Q27J81,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_INO1A.1.1.m.91,-0.020101184941158,No,NA,NA,Q6DDT1,NA,NA,NA,cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_INO80.1.2.m.1270,0.00511851225709765,No,NA,NA,Q9ULG1,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription; DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914],NA,NA,NA
CHOYP_INSI2.1.1.m.59456,0.000690895958641222,No,NA,NA,P49230,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779],NA,NA,NA
CHOYP_INT11.1.1.m.29494,-0.00995138738671872,No,NA,NA,Q5ZIH0,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; hydrolase activity [GO:0016787]; regulation of RNA splicing [GO:0043484]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT2.1.1.m.52909,-0.00591037362887324,No,NA,NA,Q9H0H0,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INT6.1.1.m.13005,-0.00882005874161596,No,NA,NA,Q6PCM2,NA,NA,NA,actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT7.1.1.m.14480,-0.00569828132950567,No,NA,NA,Q5ZL91,NA,NA,NA,chromosome [GO:0005694]; integrator complex [GO:0032039]; cellular response to DNA damage stimulus [GO:0006974]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_INT9.1.1.m.11703,0.00300031499474751,No,NA,NA,Q9NV88,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INVS.2.6.m.8331,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IP6K1.1.1.m.54347,0.0083030480285322,No,NA,NA,Q9ESM0,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_IPO11.1.1.m.10815,-0.0242370197899282,No,NA,NA,Q9UI26,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_IPO5.1.1.m.25693,-0.000133403169775667,No,NA,NA,O00410,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_IPO7.1.1.m.16806,0.00215885427819258,No,NA,NA,Q9EPL8,NA,NA,NA,cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; innate immune response [GO:0045087]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IPO9.1.4.m.24013,0.00021487031872381,No,NA,NA,Q91YE6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_IQCA1.1.3.m.4290,-0.0143758446849367,No,NA,NA,Q86XH1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_IQGA1.1.1.m.47731,-0.000295105787040492,No,NA,NA,P46940,NA,NA,NA,actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_IRAK4.1.1.m.23405,0.00584354746366786,No,NA,NA,Q8R4K2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661],NA,NA,NA
CHOYP_IRF1.1.3.m.52606,-0.00188608140086644,No,NA,NA,Q8R4E0,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_IRF5.1.1.m.58123,-0.0181502369169169,No,NA,NA,Q90871,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_IRO.4.4.m.24034,0.0197927952666228,No,NA,NA,P54269,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCA1.1.2.m.17578,-0.000606286367402177,No,NA,NA,Q80W96,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; endocrine process [GO:0050886]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_ISCU.1.1.m.37414,-0.000204982177854103,No,NA,NA,Q9D7P6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]; protein-containing complex scaffold activity [GO:0032947]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_ISCW_ISCW000642.1.1.m.4065,0.0173810782329538,No,NA,NA,Q8WVN8,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_ISCW_ISCW000704.1.1.m.38250,-0.00305732580912414,No,NA,NA,Q08E52,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ISCW_ISCW001190.1.1.m.26579,0.0176807881594107,No,NA,NA,Q7ZV80,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW001487.2.2.m.61505,-0.00194389630469706,No,NA,NA,Q96DR7,NA,NA,NA,cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell morphogenesis [GO:0001886]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_ISCW_ISCW001592.1.2.m.20852,-0.00107240917716595,No,NA,NA,O75439,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_ISCW_ISCW003477.1.1.m.37800,0.000533090907192725,No,NA,NA,Q28619,NA,NA,NA,apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; protein-containing complex scaffold activity [GO:0032947]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_ISCW_ISCW003928.1.1.m.18079,-0.0180246397177623,No,NA,NA,Q6P5H6,NA,NA,NA,adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_ISCW_ISCW004420.1.8.m.5439,-0.0110074621819772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW004725.1.1.m.9722,0.00227552446147689,No,NA,NA,Q09506,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW005083.2.2.m.40343,-0.0100877401156865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW005292.1.1.m.11066,0.00187936342299837,No,NA,NA,Q9QXD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1;6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986],NA,NA,NA
CHOYP_ISCW_ISCW005596.1.1.m.60561,-0.00402614343475697,No,NA,NA,O94812,NA,NA,NA,cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission; GABAergic [GO:0032228]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW005651.1.1.m.49000,-0.00468284523180207,No,NA,NA,P42669,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_ISCW_ISCW005791.1.1.m.53514,-0.00129604352223476,No,NA,NA,P23880,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCW_ISCW005878.1.1.m.39374,-0.0181157673779057,No,NA,NA,Q9D773,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW006091.2.2.m.61313,-0.000225888117507926,No,NA,NA,Q503Y7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_ISCW_ISCW006277.2.2.m.66212,0.0157637909627951,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW006831.1.1.m.23820,-0.000418095158711309,No,NA,NA,Q9NTZ6,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ISCW_ISCW007151.1.2.m.41781,0.00932746870158654,No,NA,NA,Q6BEA0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_ISCW_ISCW007151.2.2.m.41979,-0.00392093579713929,No,NA,NA,Q9HCM2,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53689,0,No,NA,NA,Q99MK9,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53690,0.00176481172577029,No,NA,NA,Q9QXV3,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941],NA,NA,NA
CHOYP_ISCW_ISCW007303.1.1.m.42263,-0.0111397584567306,No,NA,NA,P41095,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_ISCW_ISCW008174.1.2.m.8360,-0.0172448832398672,No,NA,NA,O08740,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ISCW_ISCW008219.1.2.m.46822,0.000172693369517486,No,NA,NA,P08228,NA,NA,NA,axon cytoplasm [GO:1904115]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_ISCW_ISCW008555.1.1.m.40873,0.000795547923162653,No,NA,NA,Q8AXV0,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_ISCW_ISCW008596.2.2.m.44077,0.00212985491446552,No,NA,NA,Q3SZ76,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_ISCW_ISCW008669.1.1.m.20227,-0.0100664720846994,No,NA,NA,Q8BK35,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ISCW_ISCW009103.1.1.m.24140,0.00897612939186272,No,NA,NA,O70133,NA,NA,NA,actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription; termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_ISCW_ISCW009328.2.2.m.65633,0.0153726124171467,No,NA,NA,Q1L673,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; multicellular organism development [GO:0007275]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ISCW_ISCW010143.1.3.m.17397,-0.00891656342461522,No,NA,NA,Q9UBB5,NA,NA,NA,cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_ISCW_ISCW010143.3.3.m.61542,0.0019566690585335,No,NA,NA,P41236,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_ISCW_ISCW010532.1.4.m.11493,0.00193029318517095,No,NA,NA,Q9NL98,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW010532.2.4.m.35454,0.0113080746858795,No,NA,NA,Q9NL98,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW011108.1.1.m.13934,-0.00042317225310912,No,NA,NA,P62944,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin coat [GO:0030118]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; cargo receptor activity [GO:0038024]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; coronary vasculature development [GO:0060976]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_ISCW_ISCW011328.1.1.m.8861,0.014872685264831,No,NA,NA,Q6AXX4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_ISCW_ISCW011341.1.1.m.18728,-0.00509789312028186,No,NA,NA,B4NYV0,NA,NA,NA,nucleoplasm [GO:0005654]; conversion of ds siRNA to ss siRNA involved in RNA interference [GO:0033168]; defense response to Gram-negative bacterium [GO:0050829]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246],NA,NA,NA
CHOYP_ISCW_ISCW012010.1.1.m.27251,0.000616138449553557,No,NA,NA,P38117,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_ISCW_ISCW012036.1.1.m.27987,-0.00370911146416612,No,NA,NA,Q24297,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ISCW_ISCW012228.1.2.m.57884,-0.0110075812389588,No,NA,NA,Q3T100,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_ISCW_ISCW012232.1.1.m.38746,-0.0189571800348253,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3690,-0.0038407398509298,No,NA,NA,P53563,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of long-term synaptic depression [GO:1900452]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; synaptic vesicle recycling via endosome [GO:0036466],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3691,-0.00927521279524232,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ISCW_ISCW012442.1.1.m.8441,0.0137124178954087,No,NA,NA,Q5RBX7,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_ISCW_ISCW012623.1.1.m.26452,-0.000544119221835677,No,NA,NA,P49256,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ISCW_ISCW012957.1.2.m.51659,0.0126155158559823,No,NA,NA,Q9Y5K3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; phosphatidylcholine binding [GO:0031210]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013289.2.2.m.18741,-0.00507299683431253,No,NA,NA,O22703,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to cold [GO:0009409]; response to water deprivation [GO:0009414],NA,NA,NA
CHOYP_ISCW_ISCW013378.2.3.m.11858,-0.000208036779060794,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013378.3.3.m.20296,0.0035515277100496,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013556.1.1.m.26406,-0.00992537875652236,No,NA,NA,Q7T0M6,NA,NA,NA,nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333],NA,NA,NA
CHOYP_ISCW_ISCW013767.1.1.m.29335,0.000702615496072241,No,NA,NA,O08807,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013810.2.2.m.19882,-0.000123165162104768,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15838,-0.00104629203034223,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15839,0.00504442563652676,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014481.1.1.m.61217,0.00340596586827821,No,NA,NA,P56524,NA,NA,NA,A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression; epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW014579.2.2.m.5327,-0.00149143663142799,No,NA,NA,Q8VHF0,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW014726.5.5.m.47210,0.00693998907543543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW014880.1.1.m.27977,-0.00924705778874112,No,NA,NA,Q7L7X3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW015061.1.1.m.51,0.00399712188160462,No,NA,NA,O08662,NA,NA,NA,cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_ISCW_ISCW015295.1.1.m.22192,0.00434339454644115,No,NA,NA,O88986,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518],NA,NA,NA
CHOYP_ISCW_ISCW016148.3.6.m.54385,0.0176854460373768,No,NA,NA,P31674,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW016212.1.2.m.2539,-0.00220851892188817,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016212.2.2.m.46221,0.0071243894956726,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016254.2.5.m.38599,-0.0190644939602102,No,NA,NA,Q9W141,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ISCW_ISCW016289.1.1.m.12312,-0.00100538956755845,No,NA,NA,P57721,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071],NA,NA,NA
CHOYP_ISCW_ISCW016328.1.1.m.10256,0.00755784190065415,No,NA,NA,Q9R1C6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_ISCW_ISCW017188.1.1.m.23179,-0.00028367177444816,No,NA,NA,Q8WVM7,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; regulation of mitotic spindle assembly [GO:1901673],NA,NA,NA
CHOYP_ISCW_ISCW017350.1.1.m.11950,-0.00365953938508396,No,NA,NA,Q24537,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379],NA,NA,NA
CHOYP_ISCW_ISCW017474.1.1.m.18280,0.000435075301767608,No,NA,NA,Q4PJX1,NA,NA,NA,integral component of membrane [GO:0016021]; protein localization [GO:0008104],NA,NA,NA
CHOYP_ISCW_ISCW017519.1.2.m.935,0.00540414799261107,No,NA,NA,Q5R5V4,NA,NA,NA,focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_ISCW_ISCW017526.2.2.m.57044,-0.00620667734676762,No,NA,NA,Q9VZZ9,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification; embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293],NA,NA,NA
CHOYP_ISCW_ISCW017652.1.1.m.49306,-0.0189296092757358,No,NA,NA,Q32PI8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell proliferation [GO:0008283]; positive regulation of mitochondrial translation [GO:0070131],NA,NA,NA
CHOYP_ISCW_ISCW017655.1.1.m.22914,-0.000696352705301416,No,NA,NA,Q95WA0,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW017707.1.1.m.58329,0.00201821139077666,No,NA,NA,Q9Y2H1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],NA,NA,NA
CHOYP_ISCW_ISCW017709.1.1.m.30040,-0.00501992001015291,No,NA,NA,Q04757,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_ISCW_ISCW017872.2.2.m.60293,0.0136705832914748,No,NA,NA,P70365,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_ISCW_ISCW018108.1.1.m.43365,-0.00733876280169314,No,NA,NA,Q9C0D3,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_ISCW_ISCW018298.1.1.m.741,0.0199277193353387,No,NA,NA,Q12893,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of cell proliferation [GO:0008285]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ISCW_ISCW018425.1.1.m.35608,0.00537541853176205,No,NA,NA,P81623,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],NA,NA,NA
CHOYP_ISCW_ISCW018501.2.2.m.61797,-0.00250235816910128,No,NA,NA,Q5F452,NA,NA,NA,nuclear envelope [GO:0005635]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_ISCW_ISCW018536.1.1.m.56336,0.00262444883408167,No,NA,NA,Q8C0E2,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; protein transporter activity [GO:0008565]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW018656.1.1.m.51893,-0.0122444889724886,No,NA,NA,Q6PGW3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_ISCW_ISCW019027.2.2.m.66984,0.000986749837522213,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_ISCW_ISCW019130.1.2.m.10722,0.000865358601089669,No,NA,NA,Q3SZ90,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW019177.2.4.m.56600,-0.0146822290798004,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019177.4.4.m.63940,-0.0103901311678042,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019590.1.1.m.30707,0.00457804757023299,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_ISCW_ISCW019991.1.5.m.8713,-0.00326520280543523,No,NA,NA,Q6DFR2,NA,NA,NA,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ISCW_ISCW020028.1.1.m.57937,0.00667917672211319,No,NA,NA,Q9I7F7,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure; amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW020302.1.1.m.37564,-0.000585868052944908,No,NA,NA,Q17QJ7,NA,NA,NA,mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_ISCW_ISCW020550.2.2.m.18099,0.00207371642206532,No,NA,NA,O35796,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW021350.1.1.m.10332,-0.00219447465185435,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_ISCW_ISCW021457.1.1.m.31134,-0.00790406016151223,No,NA,NA,Q5XIH7,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription; DNA-templated [GO:0045892]; response to wounding [GO:0009611],NA,NA,NA
CHOYP_ISCW_ISCW021476.1.1.m.29578,-0.00884741826896834,No,NA,NA,Q66KE3,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_ISCW_ISCW021545.1.1.m.25379,0.0165725441243321,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13969,0.00949797617082679,No,NA,NA,Q5RE70,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13970,-0.00205456633832466,No,NA,NA,Q2KJG3,NA,NA,NA,cytoplasm [GO:0005737]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421],NA,NA,NA
CHOYP_ISCW_ISCW021601.2.2.m.20304,0.000644498498147963,No,NA,NA,Q6INR1,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732],NA,NA,NA
CHOYP_ISCW_ISCW022021.1.1.m.53168,0.00214702462640304,No,NA,NA,A2AVA0,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ISCW_ISCW022029.1.1.m.9014,-0.000781606762500695,No,NA,NA,P61258,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; mismatch repair [GO:0006298]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_ISCW_ISCW022189.1.1.m.8227,0.00189272277690378,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_ISCW_ISCW022609.1.1.m.26988,0.00899653368364334,No,NA,NA,P97521,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; carnitine transmembrane transport [GO:1902603],NA,NA,NA
CHOYP_ISCW_ISCW022842.1.1.m.5648,-0.00246679624089495,No,NA,NA,Q8VI63,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_ISCW_ISCW022925.1.2.m.61535,0.00362987936297631,No,NA,NA,Q9UEW8,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW023153.1.1.m.10480,0.0014937821796842,No,NA,NA,Q96GG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_ISCW_ISCW023180.1.2.m.31255,-0.0148318190111851,No,NA,NA,Q8WXF0,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_ISCW_ISCW023297.1.1.m.11833,-0.00508520469649561,No,NA,NA,Q9DCD2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing; via spliceosome [GO:0000398]; transcription; DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ISCW_ISCW023591.1.1.m.9921,0.014322133005141,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_ISCW_ISCW023973.1.2.m.6506,-0.00442497245975368,No,NA,NA,Q28F07,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ISL1.1.1.m.10993,0.00837654436504481,No,NA,NA,P61374,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription; DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524],NA,NA,NA
CHOYP_ISY1.1.1.m.53545,-0.00466360633382607,No,NA,NA,Q6AYB3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389],NA,NA,NA
CHOYP_ITA5.1.1.m.55930,-0.00881527268717028,No,NA,NA,P26009,NA,NA,NA,integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; integrin-mediated signaling pathway [GO:0007229]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_ITA7.1.1.m.1060,-0.0152700705409847,No,NA,NA,P23229,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877]; amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; skin development [GO:0043588],NA,NA,NA
CHOYP_ITB1.2.4.m.24270,-0.00612931191812442,No,NA,NA,O54890,NA,NA,NA,alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to drug [GO:0035690]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_ITB1.3.4.m.28565,0.00817105367624144,No,NA,NA,P11584,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth; open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration; cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ITB1B.1.1.m.59423,-0.00811614130457682,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_ITF2.1.1.m.1446,0.00239224715505944,No,NA,NA,Q62655,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ITIH3.1.3.m.21736,-0.0122584869168492,No,NA,NA,Q8N801,NA,NA,NA,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537],NA,NA,NA
CHOYP_ITPA.1.1.m.13655,-0.0206942362365967,No,NA,NA,A7RWC9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ITSN1.4.4.m.35131,0.00595493684800274,No,NA,NA,O42287,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_IVBI.2.2.m.67049,-0.010828029858557,No,NA,NA,Q90W98,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_IVD.1.2.m.5213,0.000601647255347055,No,NA,NA,Q9JHI5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IVD.2.2.m.14522,-0.00305152228452903,No,NA,NA,P34275,NA,NA,NA,plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IWS1.1.1.m.13972,-0.00880210087409046,No,NA,NA,Q3SWT4,NA,NA,NA,nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IWS1.1.1.m.13973,0.00907690163702415,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_JIP3.1.1.m.25162,0.000742036057568806,No,NA,NA,Q58A65,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; retrograde transport; endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_JNK.1.1.m.1540,-0.00496249013914152,No,NA,NA,P92208,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing; spreading of epidermal cells [GO:0035313],NA,NA,NA
CHOYP_K0020.1.1.m.1673,0.00149896976174856,No,NA,NA,Q562C7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835],NA,NA,NA
CHOYP_K11G12.5.1.1.m.55605,0.00954055305543174,No,NA,NA,Q9UBX3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709],NA,NA,NA
CHOYP_K1239.3.3.m.45453,-0.000706738379322516,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_K1468.1.1.m.24917,0.000858397657075268,No,NA,NA,Q6P6Y1,NA,NA,NA,recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_K1609.1.1.m.17775,0.00972186883850759,No,NA,NA,Q5ZJX5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020],NA,NA,NA
CHOYP_K6PF.1.1.m.46882,0.00189248181293174,No,NA,NA,P52034,NA,NA,NA,6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein complex oligomerization [GO:0051259]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_KAL1.1.1.m.60996,0.00596011215976768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KALRN.1.2.m.891,0.00629439740472419,No,NA,NA,O60229,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_KAPR.1.3.m.8246,-0.00239053834559032,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KAPR.2.3.m.56519,-0.00084103287400506,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KARG.11.11.m.50800,0.00180008933931567,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.2.11.m.2196,0.000741217676978553,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.3.11.m.2494,-0.0109203703889331,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.4.11.m.5401,0.0251572468192801,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.9.11.m.50527,0.01068977642439,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KAT3.1.1.m.49207,-0.00502342555151035,No,NA,NA,Q6YP21,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_KAT5.1.1.m.9015,0.0153250973621233,No,NA,NA,Q99MK2,NA,NA,NA,cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to X-ray [GO:0071481]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; response to heat [GO:0009408],NA,NA,NA
CHOYP_KAT6B.1.2.m.10955,0,No,NA,NA,Q8WML3,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_KAT8.1.1.m.28310,0.0135009541524022,No,NA,NA,Q9H7Z6,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_KBP.1.1.m.16212,-0.00282838981307733,No,NA,NA,Q0IIZ5,NA,NA,NA,cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KC1A.1.2.m.14719,0,No,NA,NA,Q8BK63,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1A.2.2.m.64030,-4.31595000904477e-05,No,NA,NA,P67963,NA,NA,NA,ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.1.3.m.12297,0.0151129610779591,No,NA,NA,Q06486,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.3.3.m.61498,0.00833875046735357,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_KC1G3.1.2.m.18974,-0.00803584953049507,No,NA,NA,Q62762,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KCIP4.1.1.m.46682,-0.00101750833645754,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCMF1.1.1.m.62675,-0.00257191614943289,No,NA,NA,Q9P0J7,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_KCP.10.13.m.44423,0.000337578701201942,No,NA,NA,Q3U515,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586],NA,NA,NA
CHOYP_KCP.3.13.m.17018,0.0029210986364139,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.6.13.m.26127,-0.00142264284261028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.8.13.m.40457,0.017457199305716,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_KCP.9.13.m.43409,0.0143109220644652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCY.1.1.m.29973,0.00680324496891219,No,NA,NA,Q7ZWE9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_KDEL1.1.1.m.62729,0.00266314120475241,No,NA,NA,Q6UW63,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242],NA,NA,NA
CHOYP_KDM1A.1.1.m.60229,0.00139571123930926,No,NA,NA,O60341,NA,NA,NA,DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing; via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_KDM1A.1.1.m.60230,0.012099929491203,No,NA,NA,Q9C0D0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_KDM1B.1.1.m.15843,-0.00584449965873411,No,NA,NA,Q8NB78,NA,NA,NA,nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349],NA,NA,NA
CHOYP_KDM2B.1.1.m.58689,-0.0199404209620948,No,NA,NA,Q8N9M1,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_KDM5A.1.1.m.51935,-0.00203487389275051,No,NA,NA,P29375,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_KHDR1.1.1.m.8878,-0.00144293401502971,No,NA,NA,Q0VFL3,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_KI11A.1.1.m.14576,0.000176968452045384,No,NA,NA,P52732,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KI16B.1.3.m.42636,0.0135202773172564,No,NA,NA,Q96L93,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_KI21A.1.2.m.43900,0.0149194898830012,No,NA,NA,Q9QXL2,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIAA1143.1.1.m.1249,-0.000831353141535122,No,NA,NA,Q8K039,NA,NA,NA,,NA,NA,NA
CHOYP_KIF2A.2.2.m.62686,0.00861478734746463,No,NA,NA,Q5ZKV8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KIF2A.2.2.m.62687,-0.000318790131081032,No,NA,NA,P49432,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_KIF2A.2.2.m.62688,-0.000933200623501859,No,NA,NA,Q8VEM8,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435],NA,NA,NA
CHOYP_KIF3A.1.1.m.51746,-0.0142262224129926,No,NA,NA,Q4R628,NA,NA,NA,centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.1.9.m.1032,0.00390038550891422,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.6.9.m.42394,0.0229944331457049,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIZ.1.1.m.57618,0,No,NA,NA,Q2M2Z5,NA,NA,NA,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KLC.2.3.m.40314,0.0030586773797178,No,NA,NA,P46825,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777],NA,NA,NA
CHOYP_KLH26.1.2.m.8792,-0.0115070856664633,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLH36.1.2.m.12244,0.00128057621701647,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLHDB.3.5.m.46662,0.00152373941872532,No,NA,NA,O94889,NA,NA,NA,,NA,NA,NA
CHOYP_KLHL24.1.4.m.8833,-0.000135587662343405,No,NA,NA,Q6TFL4,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312],NA,NA,NA
CHOYP_KLHL24.2.4.m.18433,-0.00409348809169888,No,NA,NA,Q8WZ60,NA,NA,NA,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_KLHL7.1.1.m.9444,-0.0104008144231281,No,NA,NA,F1LZ52,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_KLLA0E01035G.1.1.m.13451,0.00837999104259272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KMO.1.2.m.17496,-0.00581465448283338,No,NA,NA,Q1RLY6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; glomerular visceral epithelial cell development [GO:0072015]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_KNOP1.1.1.m.11909,0.000518875310685758,No,NA,NA,A5D7J3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_KPC1.1.2.m.30648,0.0129403077620447,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC1.2.2.m.37402,-0.00575836085003141,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC2.1.3.m.22368,0.0120654577400837,No,NA,NA,Q16975,NA,NA,NA,membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPCD3.1.1.m.10808,0.00899978062423103,No,NA,NA,O94806,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_KPOL_1058P4.2.2.m.61989,0.0023030606990052,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KPRB.1.1.m.17501,0.00333196774903382,No,NA,NA,O08618,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164],NA,NA,NA
CHOYP_KPYK.3.4.m.47446,-0.00531216443716591,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYK.4.4.m.48513,0.00844305806988938,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYM.1.1.m.33498,0.00100752001923897,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KRP95.1.1.m.13582,-0.00168068836998782,No,NA,NA,O15066,NA,NA,NA,axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_KS6A1.1.1.m.38386,0.00112417982653614,No,NA,NA,P51812,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_KS6A1.1.1.m.38387,-0.00217475299465978,No,NA,NA,Q07598,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385],NA,NA,NA
CHOYP_KS6A5.1.1.m.51330,-0.0150592030659612,No,NA,NA,Q5F3L1,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_KS6B1.1.1.m.8274,-0.0190932405997052,No,NA,NA,P67999,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_KSR2.1.1.m.9852,-0.000233559916923763,No,NA,NA,Q9D0F6,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_KTNA1.1.2.m.16373,0.0110464666078693,No,NA,NA,O61577,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122],NA,NA,NA
CHOYP_KTNA1.2.2.m.63437,0.00104396028268001,No,NA,NA,O08623,NA,NA,NA,aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912],NA,NA,NA
CHOYP_L1CAM.2.2.m.49542,0.0158186916291017,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LA.1.1.m.65962,-0.00275386453144694,No,NA,NA,P10881,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409],NA,NA,NA
CHOYP_LACB2.1.1.m.31957,0.0237232322636752,No,NA,NA,Q0V9A9,NA,NA,NA,mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502],NA,NA,NA
CHOYP_LACBIDRAFT_295117.3.10.m.29879,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LACH.1.1.m.62529,-0.00355978352739628,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LAMA2.1.1.m.10439,0.00284560079347615,No,NA,NA,Q60675,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of synaptic transmission; cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037],NA,NA,NA
CHOYP_LAMC1.1.1.m.36098,-0.00492144765579995,No,NA,NA,P11047,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LAMP1.2.3.m.16422,-0.000302381906540858,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAMP1.3.3.m.16600,-0.0110467746771692,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAR.1.2.m.30133,-0.016912253675038,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LARP4.1.1.m.14987,-0.00418268702520312,No,NA,NA,Q6A0A2,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_LC7L3.1.1.m.20705,-0.000476687753997118,No,NA,NA,Q5SUF2,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LCAZH_2403.1.1.m.47655,0.00620982868285169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LCP2.12.14.m.40093,0.0101916203226643,No,NA,NA,Q13094,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; platelet activation [GO:0030168]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LCP2.3.14.m.8968,-0.0242527121869114,No,NA,NA,Q60787,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LDB3.1.1.m.371,-0.0133229970918022,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LDBPK_300810.1.1.m.29406,0.00135142830735368,No,NA,NA,Q54I71,NA,NA,NA,adherens junction [GO:0005912]; basal cortex [GO:0045180]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; alpha-catenin binding [GO:0045294]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; culmination involved in sorocarp development [GO:0031154]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of bipolar cell polarity [GO:0061245]; Golgi localization [GO:0051645]; multicellular organism development [GO:0007275]; positive regulation of cytoskeleton organization [GO:0051495]; protein secretion [GO:0009306]; regulation of gene expression [GO:0010468]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk development [GO:0031150]; sorocarp stalk morphogenesis [GO:0036360],NA,NA,NA
CHOYP_LDLR.6.7.m.57984,-0.00201816175379052,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LECG.3.4.m.29627,0.0106721666419251,No,NA,NA,Q66S03,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_LEG4.1.1.m.22079,0.00936350702539893,No,NA,NA,P38486,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LEMD3.1.1.m.56975,0.0113977113018756,No,NA,NA,Q9Y2U8,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; angiogenesis [GO:0001525]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531],NA,NA,NA
CHOYP_LEO1.1.1.m.41626,-0.0087695832159615,No,NA,NA,Q6NYV9,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936],NA,NA,NA
CHOYP_LGR4.1.2.m.27343,0.000870598081331103,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LIAS.1.1.m.21693,-0.021287618997044,No,NA,NA,Q6GQ48,NA,NA,NA,mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_LIG4.1.1.m.6295,0.0152958931442296,No,NA,NA,Q8BTF7,NA,NA,NA,condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair; DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151],NA,NA,NA
CHOYP_LIGO2.1.2.m.3525,0.00107899192969979,No,NA,NA,Q80X72,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],NA,NA,NA
CHOYP_LIN9.1.1.m.12005,-0.0186423265441495,No,NA,NA,Q5TKA1,NA,NA,NA,nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LINJ_09_0950.1.1.m.64023,0.00941712602772565,No,NA,NA,P0CH27,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LIPA1.1.1.m.10892,0.00135339492574409,No,NA,NA,Q13136,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LIPB1.1.1.m.35961,-0.00653448992986653,No,NA,NA,Q8ND30,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular [GO:0005622]; presynapse [GO:0098793]; identical protein binding [GO:0042802],NA,NA,NA
CHOYP_LIPR1.2.3.m.4679,0.000168767977721008,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LIS1.1.1.m.56212,-0.00101099792093606,No,NA,NA,C3XVT5,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_LMBL3.1.1.m.14251,0.00110224671674266,No,NA,NA,E1C2V1,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_LMNB2.1.1.m.55999,0.000167484432403576,No,NA,NA,P08928,NA,NA,NA,cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis; actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_LMO7.1.1.m.27803,0.00947524600018325,No,NA,NA,Q9UPQ0,NA,NA,NA,cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_LNTL.1.1.2.m.10782,-0.00444981674587176,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_00377.2.4.m.54574,-0.00598779139971817,No,NA,NA,Q20930,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOAG_00625.1.1.m.34418,0.0116324592869328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_01021.1.4.m.1826,-0.000433118133979822,No,NA,NA,O01761,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOAG_05095.2.2.m.58023,-0.000116760871661445,No,NA,NA,Q9NJV4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOAG_05718.1.1.m.48540,0.0036452329946308,No,NA,NA,Q5R957,NA,NA,NA,chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOAG_05814.1.1.m.56611,-0.0101303039970755,No,NA,NA,Q9JLY7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100005182.1.1.m.53007,0.000506596707572633,No,NA,NA,Q9NUV9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC100007585.5.7.m.51610,0.0131499258511216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100008030.1.1.m.10817,0.000141773950522679,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100013725.1.2.m.12740,-0.00267858690848487,No,NA,NA,P07607,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cofactor binding [GO:0048037]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP metabolic process [GO:0046078]; immortalization of host cell by virus [GO:0019088]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_LOC100017222.1.1.m.19930,0.000285058541239783,No,NA,NA,Q6PGE4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100017224.1.1.m.26828,-0.000575140640138137,No,NA,NA,Q4VBV9,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100023660.1.1.m.30865,-0.0078833051131067,No,NA,NA,Q91766,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; regulation of insulin secretion [GO:0050796]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100024134.1.1.m.61877,0.00833192841587036,No,NA,NA,Q91ZW6,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329],NA,NA,NA
CHOYP_LOC100024935.1.1.m.2615,0.00161042948574823,No,NA,NA,Q95108,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662],NA,NA,NA
CHOYP_LOC100027252.1.1.m.30045,-0.0033576937663738,No,NA,NA,Q08623,NA,NA,NA,cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097],NA,NA,NA
CHOYP_LOC100027962.1.1.m.48278,-0.000739990180915331,No,NA,NA,Q8R146,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100028654.1.1.m.62088,0.00217495922372101,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100030437.1.3.m.5994,-0.0102053319934952,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100030710.2.4.m.13432,0.00206311941139677,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100030710.4.4.m.20819,-0.00666017118084041,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100049762.1.1.m.1777,0.000208586980147622,No,NA,NA,Q1HQF8,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100061302.1.1.m.47172,2.58104336524223e-05,No,NA,NA,Q96PY6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100068494.1.1.m.8733,0.000115361952273135,No,NA,NA,A5PKG7,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100072802.1.1.m.27280,-0.00810127618865697,No,NA,NA,Q3T0B6,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100079978.1.1.m.18519,0.000448084511645306,No,NA,NA,Q9WU56,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor transcription coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_LOC100080726.1.1.m.59048,0.000714640078975386,No,NA,NA,A0JPN4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100081619.1.1.m.33744,0.013167821090589,No,NA,NA,O70480,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of presynaptic endosome membrane [GO:0099067]; integral component of synaptic vesicle membrane [GO:0030285]; phagocytic vesicle [GO:0045335]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cellular response to interferon-gamma [GO:0071346]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; microtubule cytoskeleton organization [GO:0000226]; regulation of Golgi to plasma membrane protein transport [GO:0042996]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100081920.1.4.m.1772,-0.0216630554136457,No,NA,NA,Q28024,NA,NA,NA,heterotrimeric G-protein complex [GO:0005834]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; phosphate ion binding [GO:0042301]; cerebral cortex development [GO:0021987]; G protein-coupled receptor signaling pathway [GO:0007186]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100083076.1.1.m.35327,9.53003481019255e-05,No,NA,NA,A2RT67,NA,NA,NA,cytoplasm [GO:0005737]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_LOC100089326.1.1.m.19184,-0.00648201011446541,No,NA,NA,P70581,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_LOC100113561.1.1.m.37903,-0.000195422184818444,No,NA,NA,P31478,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_LOC100113671.1.1.m.18491,-0.00518754159618913,No,NA,NA,Q8R3G1,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100114159.1.1.m.53867,-0.000142271116678235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100114171.1.1.m.50280,-0.000561381987439021,No,NA,NA,O42254,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610],NA,NA,NA
CHOYP_LOC100114247.1.1.m.30717,-0.00115411138998081,No,NA,NA,Q99MN1,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription; DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100114310.1.2.m.39843,0.0107610163636887,No,NA,NA,Q01082,NA,NA,NA,axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64227,0.00139471313531045,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64228,-0.000306251425579102,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100114433.2.4.m.6343,0.00350473593771341,No,NA,NA,O14974,NA,NA,NA,A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100114636.1.1.m.11052,-0.000836861363427467,No,NA,NA,O43396,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100114736.1.1.m.18266,-0.00090025788588199,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC100115002.1.1.m.45844,-0.00301141839663215,No,NA,NA,Q9CX00,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_LOC100115298.1.1.m.39207,7.62383479752525e-05,No,NA,NA,P35604,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100115467.1.1.m.51329,-0.000694690942154631,No,NA,NA,P62323,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; histone pre-mRNA DCP binding [GO:0071208]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100115577.1.1.m.21791,0.000503291327732532,No,NA,NA,P12613,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100115776.1.1.m.24729,-0.0030063582432277,No,NA,NA,Q921I2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100115939.1.1.m.28155,-0.00424605834620991,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_LOC100116049.1.1.m.54372,-0.00978437295881518,No,NA,NA,Q7K556,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100116717.2.2.m.30034,-0.000790929913479741,No,NA,NA,Q9EPR2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_LOC100116719.1.1.m.58,-0.00451931372882885,No,NA,NA,A4FV97,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11654,-0.0130145207414572,No,NA,NA,O88665,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11655,-0.00253872862291694,No,NA,NA,Q6NWC6,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; mRNA binding [GO:0003729]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_LOC100117365.1.1.m.37817,0.0166739210659357,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100117425.1.1.m.1256,-0.00604287936004938,No,NA,NA,O77633,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to tumor necrosis factor [GO:0034612],NA,NA,NA
CHOYP_LOC100117775.2.2.m.59969,-0.0125546331554313,No,NA,NA,Q9Y2E4,NA,NA,NA,catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100117917.1.1.m.21225,0.000571417712137967,No,NA,NA,Q9DC48,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62637,0.0112962297726905,No,NA,NA,P53356,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62638,0.00926193189089675,No,NA,NA,P53013,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity; RNA binding [GO:0008135]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100118063.2.4.m.29108,-0.0217737191757051,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100118098.1.1.m.14795,-0.00313569521642463,No,NA,NA,Q5ZL33,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100118291.1.1.m.54817,0.00527913235028782,No,NA,NA,Q5M824,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100118354.1.4.m.27048,-0.00388095317209693,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118354.2.4.m.44636,-0.00517502987450946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118464.1.1.m.33259,0.00310566280604298,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100118502.1.1.m.57420,0.00238648097826507,No,NA,NA,Q9DCR2,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100118811.1.1.m.57633,-0.0154877483272814,No,NA,NA,P97526,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100119008.1.1.m.43229,-0.00121419777642967,No,NA,NA,H3ZPL1,NA,NA,NA,L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC100119086.1.1.m.55425,0.0181395932993766,No,NA,NA,P16591,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100119310.1.1.m.22031,0.00684837223687209,No,NA,NA,Q28727,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; bile acid:sodium symporter activity [GO:0008508]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100119310.1.1.m.22032,0.00286721173890225,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100119577.1.1.m.47861,-0.00647442394701588,No,NA,NA,Q60676,NA,NA,NA,cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100120123.1.1.m.12979,-0.00209510816743536,No,NA,NA,P54886,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; delta1-pyrroline-5-carboxylate synthetase activity [GO:0017084]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_LOC100120260.1.1.m.41887,-0.01145075112581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100120440.1.1.m.15371,0.00115538782084426,No,NA,NA,Q7TN29,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100120677.1.1.m.16799,-0.00678239403013326,No,NA,NA,A0JMK9,NA,NA,NA,CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100120994.1.1.m.54109,-0.0238369373087791,No,NA,NA,Q9TUP7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC100121360.1.1.m.56328,-0.00545686116057471,No,NA,NA,Q99315,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100121363.1.1.m.46369,0.0127265661423193,No,NA,NA,P97570,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832],NA,NA,NA
CHOYP_LOC100121425.1.1.m.10532,-0.0123085007643263,No,NA,NA,Q01617,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; snRNA stem-loop binding [GO:0035614]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206],NA,NA,NA
CHOYP_LOC100121687.1.1.m.57141,-0.00799621479790058,No,NA,NA,Q14202,NA,NA,NA,nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100121788.1.1.m.28436,0.00208267584812337,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_LOC100121969.1.1.m.52130,0.00596496381137195,No,NA,NA,Q5RAY1,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_LOC100121991.1.1.m.13778,0.0114751826608602,No,NA,NA,Q9NG98,NA,NA,NA,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100121999.3.4.m.54805,0.0224376650335173,No,NA,NA,O61122,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; hippo signaling [GO:0035329]; hyperosmotic response [GO:0006972]; positive regulation of cell division [GO:0051781]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of sorocarp development [GO:0031156]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100122037.1.1.m.12516,-0.00501721331456306,No,NA,NA,A2BHJ4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100122067.1.1.m.49811,-0.0111843631030258,No,NA,NA,Q9BYD6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100122208.1.1.m.58545,-0.00827048592172157,No,NA,NA,Q8CC21,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_LOC100122211.1.1.m.56146,-0.00397109236121329,No,NA,NA,Q920Q8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100122269.1.1.m.8408,0.00116301741341942,No,NA,NA,Q9KPS0,NA,NA,NA,DNA binding [GO:0003677]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100122293.2.2.m.61265,0.00489457497563489,No,NA,NA,Q96RU3,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_LOC100122438.2.2.m.60108,0.00849177268522022,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100122904.1.1.m.45984,0.00545234233515422,No,NA,NA,Q3TLI0,NA,NA,NA,cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100123075.1.1.m.8128,-0.00276779980308726,No,NA,NA,Q5RBH9,NA,NA,NA,cell cortex [GO:0005938]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100123216.1.1.m.28671,-0.00101176183184916,No,NA,NA,Q5RBL1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_LOC100123238.1.1.m.27155,-0.00352143753050879,No,NA,NA,Q8C1Z8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100123307.1.1.m.13647,0.0141327152299509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100123521.1.2.m.20656,0.0257241026708528,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123521.2.2.m.52492,0.00279257559876503,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123553.1.1.m.34041,-0.00572075490720011,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100123595.1.2.m.63353,-0.00721221206998934,No,NA,NA,O88874,NA,NA,NA,cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100123629.1.1.m.841,0.00716167281173373,No,NA,NA,P50464,NA,NA,NA,adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; sensory perception of mechanical stimulus [GO:0050954],NA,NA,NA
CHOYP_LOC100123667.1.1.m.22353,-0.00905599405592952,No,NA,NA,P97376,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100123810.2.2.m.52182,0.0048703011072141,No,NA,NA,Q7TSH8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100123890.1.1.m.11450,0.000780241316902014,No,NA,NA,B4JSC2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100136190.1.1.m.9460,-0.0103284582052817,No,NA,NA,Q67ER4,NA,NA,NA,nuclear speck [GO:0016607]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA processing [GO:0006397]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247],NA,NA,NA
CHOYP_LOC100142119.1.2.m.2339,0.0251174534715429,No,NA,NA,Q8R003,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100142249.1.1.m.55762,0.0263005116583537,No,NA,NA,P58283,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process; modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648],NA,NA,NA
CHOYP_LOC100145215.1.1.m.6904,-0.00974044042580308,No,NA,NA,P28285,NA,NA,NA,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210],NA,NA,NA
CHOYP_LOC100146233.1.1.m.36400,0.000280068541543676,No,NA,NA,Q0VH32,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983],NA,NA,NA
CHOYP_LOC100148223.1.1.m.10633,-0.00591253303404361,No,NA,NA,B7Z6K7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100150876.1.1.m.61100,-0.00221506303819998,No,NA,NA,Q96NN9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194],NA,NA,NA
CHOYP_LOC100158931.1.1.m.8283,0.00528952094334814,No,NA,NA,Q5RDQ2,NA,NA,NA,bicellular tight junction [GO:0005923]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_LOC100160077.1.1.m.62645,0.00503738496129961,No,NA,NA,Q62829,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100160385.1.2.m.40193,0.00861015344133823,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100160412.2.2.m.56352,0.00132023697855775,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC100161158.1.1.m.14383,0.00328805949856221,No,NA,NA,Q6NYU7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; uridine kinase activity [GO:0004849],NA,NA,NA
CHOYP_LOC100161360.1.1.m.65809,-0.00253929645750251,No,NA,NA,P23128,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328],NA,NA,NA
CHOYP_LOC100162380.1.1.m.23942,0.00929020194097582,No,NA,NA,Q5RH71,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100162439.1.1.m.19182,-0.00502863637368829,No,NA,NA,Q17RP2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100164363.1.1.m.61731,0.0043131521252231,No,NA,NA,P18155,NA,NA,NA,mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100164899.1.1.m.59665,-0.000145838282918543,No,NA,NA,Q8BGT5,NA,NA,NA,mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_LOC100165317.1.1.m.8504,0.00646783086745334,No,NA,NA,P27398,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165581.1.1.m.18008,-0.0117952023837601,No,NA,NA,Q5R4B2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741],NA,NA,NA
CHOYP_LOC100165685.1.1.m.13583,0.0170592499354653,No,NA,NA,O14639,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165703.1.1.m.48642,-0.00228603195527396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100166052.1.1.m.46867,0.00201766269456186,No,NA,NA,A2AAE1,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_LOC100166353.1.1.m.4625,-0.0102089989880901,No,NA,NA,Q2NL00,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_LOC100166368.1.1.m.44709,0.00127534671605372,No,NA,NA,Q63598,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491],NA,NA,NA
CHOYP_LOC100167728.1.2.m.2289,0.0029050213207981,No,NA,NA,Q3U1T9,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745],NA,NA,NA
CHOYP_LOC100168017.1.1.m.40316,-0.0177473828449406,No,NA,NA,Q26474,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100168209.1.1.m.26697,-0.00244320400211367,No,NA,NA,Q5XI42,NA,NA,NA,plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_LOC100168368.1.1.m.18551,-0.000153463404754937,No,NA,NA,P41778,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of cell proliferation [GO:0042127]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],NA,NA,NA
CHOYP_LOC100168569.1.2.m.11752,-0.00506917950452504,No,NA,NA,Q13188,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100168620.4.4.m.40081,-0.00310928492586657,No,NA,NA,Q0Q028,NA,NA,NA,extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100168796.1.1.m.4672,0.000796853270105395,No,NA,NA,Q60899,NA,NA,NA,synapse [GO:0045202]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_LOC100168945.1.1.m.37004,0.00107545775238023,No,NA,NA,P50395,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; myelin sheath [GO:0043209]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100169229.1.1.m.25981,-0.00337932986431777,No,NA,NA,Q7Z6B7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100169297.1.1.m.48433,0.00301467820684248,No,NA,NA,G5ECP4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100169460.1.1.m.41302,-0.0100203565139076,No,NA,NA,Q9UJZ1,NA,NA,NA,cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive; alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100174996.1.1.m.27300,0.00227985137808187,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.11.11.m.63958,-0.0118800515526143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.7.11.m.58378,-0.0118800515526143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175702.1.1.m.56240,0,No,NA,NA,A2RSX4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100175722.1.3.m.11427,-0.0168181272502944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175867.1.1.m.48982,-0.0025094660336184,No,NA,NA,P05099,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100175959.1.7.m.1896,0.00453530719535958,No,NA,NA,P90703,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100175959.4.7.m.28172,-0.00231174811090451,No,NA,NA,O61463,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100176099.1.1.m.40368,-0.0100241792537369,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC100176232.1.1.m.24645,-0.00231108681115944,No,NA,NA,Q5SSL4,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density; intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100176461.1.1.m.63236,-0.0133634499483465,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100176721.6.6.m.66056,0.0074728402470465,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100176799.1.1.m.3132,0.0142034038225101,No,NA,NA,Q60HE9,NA,NA,NA,lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC100177459.1.2.m.48730,-0.00117294056245946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100177679.1.1.m.54177,0.0219203942893638,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100177909.1.1.m.29356,-0.0218010158360348,No,NA,NA,Q8K3A0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC100178034.1.2.m.13282,0.000141774972633358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178081.1.1.m.56365,-0.00434521777269168,No,NA,NA,O18334,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100178400.1.1.m.4321,-0.0108214204123978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178700.1.1.m.37554,0.00822746448855268,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100178916.1.1.m.26391,-0.000172444770727657,No,NA,NA,Q3KQ80,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100179134.1.1.m.23870,-0.00772683664003766,No,NA,NA,Q6NXK5,NA,NA,NA,fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_LOC100179300.1.2.m.22734,-0.00170874572399913,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100179357.5.6.m.45322,0.00543993482326329,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179448.1.1.m.8298,0.000696440145618832,No,NA,NA,P23403,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100179516.1.2.m.45110,-0.0175771101988619,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179516.2.2.m.49937,-0.0146564733501325,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100180023.1.7.m.11060,0.00336276824542608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.4.7.m.33650,0.0108798212074743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.5.7.m.56825,0.000231559579808981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180543.1.1.m.4746,-0.016743971669117,No,NA,NA,Q90XD2,NA,NA,NA,mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine [GO:0033388]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100180636.1.1.m.66440,0.000198887194153052,No,NA,NA,Q8CEQ0,NA,NA,NA,ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100180716.1.2.m.860,0.00179372014968996,No,NA,NA,Q9IA76,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100180855.2.4.m.46097,0.00291921819943529,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100180855.4.4.m.66721,-0.011036234098241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180883.1.1.m.46611,-0.000704211193155985,No,NA,NA,Q9CQ66,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],NA,NA,NA
CHOYP_LOC100181095.1.1.m.8314,-0.003046826573729,No,NA,NA,Q9C093,NA,NA,NA,Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100181159.1.1.m.6127,-0.00828108720199764,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181343.1.1.m.59214,-0.00253602427161167,No,NA,NA,Q9VRV7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA binding [GO:0003729]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100181350.1.1.m.2782,-0.00529336253134912,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100181355.1.1.m.48652,0.014402107762447,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_LOC100181607.1.2.m.36709,0.00332856769070173,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181826.1.1.m.16288,-0.000444053204738323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181873.1.2.m.45633,-0.00705475916418854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100182131.1.1.m.26023,0.00452941963061648,No,NA,NA,Q3T0C9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100182237.2.2.m.33734,-0.00658820657914049,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC100182352.2.2.m.64092,0.00774446243884405,No,NA,NA,D3YXS5,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100182585.1.2.m.2597,0.000261685332189009,No,NA,NA,Q95M12,NA,NA,NA,lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],NA,NA,NA
CHOYP_LOC100182585.2.2.m.24665,-0.00459518279892649,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100183353.1.1.m.54920,-0.0103888228715024,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100183535.2.2.m.10350,0.000253199102606168,No,NA,NA,Q9LGZ2,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_LOC100183583.1.2.m.3863,-0.00280127366511339,No,NA,NA,Q9BXW7,NA,NA,NA,mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474],NA,NA,NA
CHOYP_LOC100183682.1.1.m.61630,-0.0137471734335911,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100183847.1.2.m.12797,-0.00123334363962275,No,NA,NA,P33316,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070],NA,NA,NA
CHOYP_LOC100184284.2.2.m.21644,-0.00593061159257125,No,NA,NA,Q5RJI4,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100184451.1.8.m.30146,0.0017353581308998,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100184874.1.1.m.41851,-0.00229383700612753,No,NA,NA,Q2L6K8,NA,NA,NA,extracellular region [GO:0005576]; signaling receptor binding [GO:0005102],NA,NA,NA
CHOYP_LOC100185060.2.2.m.18100,-0.010896811755234,No,NA,NA,Q91ZT9,NA,NA,NA,cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100185271.1.1.m.19210,0.0199536778914901,No,NA,NA,B9EJX3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185431.1.1.m.43063,0.000268150785122451,No,NA,NA,B1WB06,NA,NA,NA,extracellular region [GO:0005576]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100185443.1.1.m.60976,-0.00361655447501265,No,NA,NA,A7RR34,NA,NA,NA,apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100185472.1.1.m.66178,-0.024348812697186,No,NA,NA,Q810N6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185473.1.1.m.5316,-0.00798428682103516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100185549.1.6.m.31232,0.000840708148405665,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100185549.5.6.m.62694,0.00235522081423995,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185846.1.1.m.37884,0.00250342813950727,No,NA,NA,Q6TGV7,NA,NA,NA,regulation of actin filament-based process [GO:0032970],NA,NA,NA
CHOYP_LOC100186070.1.1.m.3415,0.0169590175374364,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7875,-0.00486484595718133,No,NA,NA,Q52KB5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7876,0.00105541151285956,No,NA,NA,Q3SYZ4,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422],NA,NA,NA
CHOYP_LOC100186276.4.5.m.12980,-0.00592846502553872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186299.6.6.m.52749,-0.000928249332633615,No,NA,NA,Q70FJ1,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; synaptic membrane [GO:0097060]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; protein-containing complex scaffold activity [GO:0032947]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of Golgi organization [GO:1903358]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100186360.1.2.m.50759,-0.0154979565466402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186361.3.3.m.66600,-0.000547869072775918,No,NA,NA,P47911,NA,NA,NA,A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_LOC100186692.1.1.m.7600,-0.00257694944741906,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC100186733.1.1.m.7066,-0.00326089446330574,No,NA,NA,Q5XIA9,NA,NA,NA,cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813],NA,NA,NA
CHOYP_LOC100186936.1.2.m.12235,-0.00442098819615958,No,NA,NA,Q6IE24,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100187037.1.1.m.55673,0.00729013398428034,No,NA,NA,Q0VAA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100187348.1.1.m.29904,-0.0100371718766765,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100197130.2.2.m.39076,0.00373403588195508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100197511.1.1.m.22053,0.0181502495933382,No,NA,NA,Q5R546,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_LOC100197876.1.1.m.45271,-0.00397865964679685,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100198049.1.1.m.13866,-0.0242192380509658,No,NA,NA,Q9CWP8,NA,NA,NA,cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of endothelial cell proliferation [GO:0001938],NA,NA,NA
CHOYP_LOC100199222.1.1.m.17588,-0.00446658627151384,No,NA,NA,P0AF48,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100199246.1.1.m.43478,0.01469379166879,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199379.1.2.m.59875,0,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC100199379.2.2.m.63866,0.0144068783059828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199505.1.2.m.19947,0.00188961610776543,No,NA,NA,P04114,NA,NA,NA,chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transporter activity [GO:0017127]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100199505.2.2.m.25542,-0.00526583576926466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199663.1.1.m.22109,-0.0105201324816768,No,NA,NA,P27659,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100199980.1.2.m.51259,-0.00214492903634798,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100199980.2.2.m.62743,0.00840939193777837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199980.2.2.m.62746,0.00338607544439179,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100200137.1.1.m.23041,-0.00786997571762721,No,NA,NA,P19208,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100200424.1.1.m.16669,-0.0118383345107132,No,NA,NA,Q1RMG8,NA,NA,NA,RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100201155.1.1.m.58066,-0.0131812478542333,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100202203.1.1.m.27309,-0.0112925478149255,No,NA,NA,P29145,NA,NA,NA,serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100202812.1.1.m.31203,-0.00780567510664197,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100204502.1.2.m.26864,0.00914014888152042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100206475.1.16.m.4004,0.0169364960039271,No,NA,NA,Q02079,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274],NA,NA,NA
CHOYP_LOC100206557.1.1.m.11857,0,No,NA,NA,P61315,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247],NA,NA,NA
CHOYP_LOC100207121.5.9.m.48175,-0.00564711061871179,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100207216.2.2.m.28185,-0.00931427566036735,No,NA,NA,Q5EB30,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100208023.1.8.m.8628,0.00034466128789153,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_LOC100208023.8.8.m.49917,0.00206129357007862,No,NA,NA,Q05909,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100208544.1.1.m.54499,-0.000483868394371324,No,NA,NA,P26779,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100210536.1.1.m.18414,0.00572484766296205,No,NA,NA,Q9CX34,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_LOC100210677.7.8.m.42871,0.00417811772428452,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100210677.8.8.m.43132,0.0134679219938313,No,NA,NA,Q700K0,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100211409.1.1.m.4742,0.00943725202658293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100211409.1.1.m.4743,0.00742855364501909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100212224.1.1.m.37724,0.00284927283231924,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100212386.1.2.m.33906,-0.00895166861636548,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100212698.1.1.m.5807,-0.00787531341877197,No,NA,NA,P38571,NA,NA,NA,fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100213495.2.2.m.51531,-0.0111082414503278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213558.1.1.m.45753,-0.000375886252878528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213744.7.19.m.33062,-0.0218741641078531,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100213744.9.19.m.37687,-0.00713909419482848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100215454.1.1.m.40627,0.0291470961474797,No,NA,NA,P43143,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100217869.1.2.m.29774,-0.00151718061545416,No,NA,NA,Q5U317,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100218754.1.1.m.60778,0.00363977115199331,No,NA,NA,Q14678,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100222629.1.1.m.9927,0.00958228972527135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100222774.1.1.m.56992,-0.000235125591093767,No,NA,NA,P61354,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100227090.1.1.m.1313,0.012748931982077,No,NA,NA,Q8QZZ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_LOC100232142.1.1.m.19194,0.00326547631731282,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_LOC100232691.1.1.m.15025,-0.0069355927921712,No,NA,NA,Q924T2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100261610.1.1.m.6374,0,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_LOC100313559.1.1.m.47009,0.000772366403065266,No,NA,NA,Q8VBW5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100313569.1.1.m.15201,0.000294849158097357,No,NA,NA,Q13948,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_LOC100313573.1.1.m.62977,-0.0134867658096604,No,NA,NA,O15182,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; half bridge of spindle pole body [GO:0005825]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; mitotic spindle pole body duplication [GO:1903087]; spindle pole body duplication [GO:0030474],NA,NA,NA
CHOYP_LOC100313589.1.1.m.31479,0.000261329288290407,No,NA,NA,Q9JLM8,NA,NA,NA,postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100313617.1.1.m.18024,0.00952353712989526,No,NA,NA,O75496,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC100313636.2.3.m.26350,0.00435440240232832,No,NA,NA,O88801,NA,NA,NA,apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; glutamate receptor binding [GO:0035254]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100313649.1.1.m.49801,-0.00304663077005696,No,NA,NA,Q9D5E4,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100313653.1.1.m.61188,-0.00375294273429625,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_LOC100313655.1.1.m.52035,-0.00771464371052785,No,NA,NA,O88368,NA,NA,NA,nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription; initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100313661.1.1.m.17706,0.000255769739921015,No,NA,NA,A6QLT2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100313664.1.1.m.37913,-0.00173424609881126,No,NA,NA,D3ZSZ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription; DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100313668.2.6.m.31487,0.004767577670697,No,NA,NA,Q24746,NA,NA,NA,nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; mesoderm development [GO:0007498]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360],NA,NA,NA
CHOYP_LOC100313676.1.2.m.2193,-0.0196874767571289,No,NA,NA,Q03017,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; transcription factor binding [GO:0008134]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063],NA,NA,NA
CHOYP_LOC100313691.1.1.m.290,0.00308843728758509,No,NA,NA,Q21086,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],NA,NA,NA
CHOYP_LOC100329062.1.2.m.10150,-0.00101790918868123,No,NA,NA,O88951,NA,NA,NA,basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100329062.2.2.m.39235,-0.00480809727206294,No,NA,NA,Q9CS74,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100329078.1.3.m.26927,-6.07990491751764e-05,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329078.2.3.m.30776,0.00183866181738752,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329955.1.1.m.11340,0.00827028750593964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.1.2.m.48676,0.0251765831078155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.2.2.m.53521,0.0119487313063602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100331324.2.3.m.40325,0.00463228065667138,No,NA,NA,P55210,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100332237.1.1.m.18128,0.0100828676756815,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100346427.1.1.m.44592,0.0124709078711386,No,NA,NA,Q9UH65,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100353582.2.2.m.63483,0.0109269083702484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100358262.2.3.m.28381,0.0134029890619184,No,NA,NA,P35244,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA damage response; detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; regulation of cell proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_LOC100366344.1.1.m.7458,-0.00587745456658343,No,NA,NA,Q8BJ64,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100366380.1.4.m.16838,-0.0137692694807305,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100366404.1.2.m.22137,-0.00692675747574054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366408.1.1.m.37601,-0.00401276659413585,No,NA,NA,Q38SD2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731],NA,NA,NA
CHOYP_LOC100366424.1.1.m.29609,-0.00131374199969071,No,NA,NA,Q9GKS9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3739,-0.0060050029124823,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3740,9.83435710858255e-05,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100366442.1.4.m.6288,-3.41408424460606e-05,No,NA,NA,Q5ZKK5,NA,NA,NA,centriole [GO:0005814]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10500,-0.00362235928768745,No,NA,NA,B2RW38,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10501,0.000889121421178301,No,NA,NA,Q9VZI3,NA,NA,NA,cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229],NA,NA,NA
CHOYP_LOC100366455.1.3.m.13543,-0.00642821415453655,No,NA,NA,P16152,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366455.2.3.m.25037,0.0003039026178474,No,NA,NA,Q9CXS4,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],NA,NA,NA
CHOYP_LOC100366455.3.3.m.28840,-0.0205834991318848,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366470.2.2.m.64705,0.0112164307809614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366482.1.1.m.9777,-0.00692404153343726,No,NA,NA,Q8T773,NA,NA,NA,cell [GO:0005623]; electron transfer activity [GO:0009055]; malate dehydrogenase activity [GO:0016615]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein disulfide oxidoreductase activity [GO:0015035]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100366486.1.1.m.15010,0.0115125747430123,No,NA,NA,Q6P9T8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366488.1.1.m.56518,-0.00116799867912626,No,NA,NA,Q7ZYG4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366489.1.1.m.21907,-4.08281478591213e-05,No,NA,NA,A8MWY0,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100366518.5.6.m.43397,0.00446345674476118,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_LOC100366536.3.3.m.51739,0.0284763393812167,No,NA,NA,Q13426,NA,NA,NA,cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; positive regulation of ligase activity [GO:0051351]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC100366575.1.1.m.29959,0.00825493661566932,No,NA,NA,Q9D3N2,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent outer dynein arm binding [GO:0120152]; dynein heavy chain binding [GO:0045504]; cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity; minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317],NA,NA,NA
CHOYP_LOC100366577.1.2.m.17884,0.00417349775186516,No,NA,NA,Q9NRG9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; fertilization [GO:0009566]; learning [GO:0007612]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100366606.1.2.m.47289,-0.00830648116834729,No,NA,NA,Q9Y238,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100366708.1.1.m.19335,-0.00147466772062582,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57449,-0.0123927676045529,No,NA,NA,Q0V9S9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57452,0.0116777624694797,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366734.1.1.m.47271,-0.00314384866533789,No,NA,NA,O35594,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366735.1.1.m.52023,-0.0205909563811913,No,NA,NA,Q86YS6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; Rab protein signal transduction [GO:0032482]; retrograde transport; plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_LOC100366754.1.1.m.49522,-0.000776505636913061,No,NA,NA,Q9HBI1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53708,-0.00785663422792309,No,NA,NA,Q9BYB0,NA,NA,NA,cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53709,0.00893930775130983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366766.1.1.m.56292,0.00315804105990257,No,NA,NA,P59083,NA,NA,NA,cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; regulation of actin cytoskeleton reorganization [GO:2000249],NA,NA,NA
CHOYP_LOC100366770.1.1.m.55784,-0.00844556692610986,No,NA,NA,Q6P3V7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366787.1.1.m.65795,0.00131902269383627,No,NA,NA,A8Y5T1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366797.1.3.m.20765,2.06658522829817e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366797.2.3.m.54046,0.00445782743277247,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366799.1.2.m.37253,0.00090501381802617,No,NA,NA,Q3ZBD7,NA,NA,NA,ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024],NA,NA,NA
CHOYP_LOC100366813.1.6.m.2829,0.000347353075654758,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366813.4.6.m.31116,-0.00104697627544293,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366857.1.1.m.38884,-0.00788206874963087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366862.1.1.m.62455,-0.000123917082449967,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366892.2.3.m.51427,0.0113301737463478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366906.1.1.m.61901,-0.000939552024773747,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100366918.1.1.m.31506,0.00169941255449968,No,NA,NA,P11717,NA,NA,NA,cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; kringle domain binding [GO:0036143]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366927.1.1.m.6140,-0.00408475855502934,No,NA,NA,P44121,NA,NA,NA,ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_LOC100366932.1.1.m.36598,-0.00448643041068438,No,NA,NA,Q86UY6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187],NA,NA,NA
CHOYP_LOC100366957.1.1.m.10938,0,No,NA,NA,Q9BGT1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366965.1.2.m.40982,0.00857167328590964,No,NA,NA,Q8C079,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604],NA,NA,NA
CHOYP_LOC100366987.2.2.m.61972,-0.00159676127259233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367001.1.1.m.55663,-0.00747619363863947,No,NA,NA,Q15650,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription; DNA-templated [GO:0006355]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100367006.2.2.m.17211,0.0099753426667676,No,NA,NA,Q80U87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367014.1.1.m.18505,-0.0233659228166091,No,NA,NA,Q08CA1,NA,NA,NA,cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_LOC100367051.1.1.m.13013,-0.00472835181314937,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100367053.1.1.m.18595,-0.00348011229695815,No,NA,NA,Q9UKZ1,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367064.1.1.m.52280,0.00376372814741566,No,NA,NA,Q08E40,NA,NA,NA,integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578],NA,NA,NA
CHOYP_LOC100367069.1.1.m.14484,0.000261192487055577,No,NA,NA,Q9UHX1,NA,NA,NA,cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100367071.1.1.m.27695,0.000313847091019838,No,NA,NA,Q02337,NA,NA,NA,matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100367084.12.22.m.48659,-0.00432888549627786,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.3.22.m.29143,0.000428543413722413,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.6.22.m.31842,-0.00392675787243208,No,NA,NA,Q9ULL1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1384,0.00597390208915098,No,NA,NA,Q9I7U4,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522],NA,NA,NA
CHOYP_LOC100367089.2.4.m.1910,0.014099585251857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367093.1.1.m.63664,-0.00167974002386147,No,NA,NA,Q90511,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100367144.1.1.m.34153,0.00582233877700662,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_LOC100367166.1.1.m.1262,0.00162274499109731,No,NA,NA,Q8BT14,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367201.2.2.m.61573,0.00210438456753166,No,NA,NA,P56812,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200],NA,NA,NA
CHOYP_LOC100367205.1.1.m.24472,-0.024861649333746,No,NA,NA,Q7Z4T9,NA,NA,NA,axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100367232.4.5.m.45036,-0.0100244828794167,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367237.1.2.m.43812,-0.00938435494309545,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367237.2.2.m.47349,0.0113764786541529,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367242.1.2.m.48297,3.74257218365961e-05,No,NA,NA,Q69Z37,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367266.1.1.m.10803,-0.00949558164936273,No,NA,NA,Q5R6Q2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100367291.1.1.m.51818,0.0192921806295874,No,NA,NA,O35963,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport; Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_LOC100367312.7.13.m.37565,-0.000485008131961475,No,NA,NA,Q90Z10,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100367326.1.1.m.56733,0.0172193996113551,No,NA,NA,P27447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100367352.1.1.m.27863,-0.01456739070596,No,NA,NA,Q4G0U5,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; calmodulin binding [GO:0005516]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100367353.1.1.m.32092,-0.00133571877020276,No,NA,NA,Q6BWA5,NA,NA,NA,cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796],NA,NA,NA
CHOYP_LOC100367356.1.1.m.29181,6.8782648433118e-05,No,NA,NA,A4D263,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367378.1.1.m.25783,0.000653403551626066,No,NA,NA,Q9UBV8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100367394.1.2.m.34992,0.00866603861603345,No,NA,NA,Q8N4P6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367405.1.2.m.10570,0.00770360516183882,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367414.1.7.m.21233,-0.0128446020683338,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100367421.1.1.m.66338,0.00220064157367583,No,NA,NA,Q5R514,NA,NA,NA,orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],NA,NA,NA
CHOYP_LOC100367423.1.1.m.23397,0.00699965716725933,No,NA,NA,H2MTR9,NA,NA,NA,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_LOC100367436.1.1.m.20579,0,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC100367460.1.1.m.62925,-0.00908976504339877,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100367470.1.1.m.51904,0.0037017363540157,No,NA,NA,Q4QQY7,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_LOC100367548.1.1.m.48434,0.00645210879057885,No,NA,NA,Q5ZKF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100367604.1.1.m.52334,-0.00306958068548716,No,NA,NA,Q9Y366,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100367612.1.1.m.37487,0.00294949674407762,No,NA,NA,Q5XI13,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100367640.1.1.m.22070,-0.0112177573202287,No,NA,NA,Q0IHY5,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367645.1.1.m.29695,-0.00254871470516049,No,NA,NA,P21839,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100367659.1.1.m.9232,-0.00451683322824255,No,NA,NA,A1L258,NA,NA,NA,extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_LOC100367705.1.1.m.9297,-0.00978641659216306,No,NA,NA,Q04859,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC100367718.1.1.m.8839,-0.00392132352221732,No,NA,NA,P84817,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipid [GO:0071396]; cellular response to peptide [GO:1901653]; cellular response to thapsigargin [GO:1904579]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to fluoride [GO:1902617]; response to hypobaric hypoxia [GO:1990910]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_LOC100367726.1.2.m.47322,-0.00213660081745589,No,NA,NA,P11498,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; biotin metabolic process [GO:0006768]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074],NA,NA,NA
CHOYP_LOC100367736.2.2.m.66862,-0.0127732782543283,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100367739.1.1.m.22741,-0.00263080798126028,No,NA,NA,Q9UL16,NA,NA,NA,cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367787.1.1.m.52250,0.00175086127362383,No,NA,NA,A8MV24,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367809.2.2.m.44174,0.00813735036643061,No,NA,NA,Q1HG43,NA,NA,NA,cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609],NA,NA,NA
CHOYP_LOC100367837.1.1.m.56015,-0.00089435344867551,No,NA,NA,Q5BJQ6,NA,NA,NA,mRNA cleavage stimulating factor complex [GO:0005848]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100367880.1.1.m.12770,-0.0113321265264913,No,NA,NA,Q9BXW4,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100367908.2.2.m.55212,0.00188592536250212,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100367949.2.3.m.55056,-0.0104928317520972,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367949.3.3.m.63228,0.00420841890240563,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367951.1.1.m.38662,-0.000852590131432129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367954.1.2.m.66390,0.00474935181830212,No,NA,NA,Q9Y426,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367956.2.2.m.62044,0.00869507503094778,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100367974.1.3.m.19352,-0.00429646275750522,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100368022.1.1.m.55588,-0.00417230270173144,No,NA,NA,Q16959,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100368053.1.1.m.25224,0.019038811363393,No,NA,NA,A1L271,NA,NA,NA,membrane [GO:0016020]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; signal transduction [GO:0007165]; swimming behavior [GO:0036269],NA,NA,NA
CHOYP_LOC100368072.1.1.m.52449,-0.00429302767627506,No,NA,NA,Q9P2G1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100368104.1.1.m.22554,-0.00868223837139278,No,NA,NA,Q8K1N2,NA,NA,NA,basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100368109.1.1.m.18734,0.0149899398567527,No,NA,NA,A6QQM4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100368117.1.1.m.27153,0.0230427374772058,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368128.1.1.m.9893,0.0077439966991956,No,NA,NA,Q3UPW2,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100368178.1.3.m.36490,0.00819818453519331,No,NA,NA,Q9BYK8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_LOC100368194.1.1.m.59989,-0.003470331650548,No,NA,NA,Q9CRB9,NA,NA,NA,cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; protein-containing complex scaffold activity [GO:0032947]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100368219.2.5.m.38385,-0.00186437942170559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368219.4.5.m.58416,-0.00197733225806812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368228.3.3.m.54183,-0.00440627359168043,No,NA,NA,Q9W391,NA,NA,NA,phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100368238.1.1.m.7505,0.0123731904055068,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100368251.3.6.m.40053,0.00728999692024535,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_LOC100368259.1.1.m.39485,-0.00104841356673281,No,NA,NA,Q9VFC8,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744],NA,NA,NA
CHOYP_LOC100368376.1.2.m.11023,-0.0154263383582774,No,NA,NA,Q3EC11,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_LOC100368394.1.2.m.22888,-0.00962489606705424,No,NA,NA,Q5T0N1,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100368410.2.2.m.44510,-0.00781283603897918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368416.1.1.m.58347,0.0190094509450248,No,NA,NA,Q8VHI3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],NA,NA,NA
CHOYP_LOC100368486.1.1.m.18263,0.0086061412566662,No,NA,NA,O95433,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781],NA,NA,NA
CHOYP_LOC100368495.1.1.m.9879,-0.00783197044964924,No,NA,NA,Q9BVG4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368521.3.3.m.41435,0.00813620993095576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368525.1.1.m.62480,-0.00917619963995658,No,NA,NA,Q3UGF1,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],NA,NA,NA
CHOYP_LOC100368576.1.1.m.45391,-0.000497014660248539,No,NA,NA,Q6DMN8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100368627.1.1.m.13820,-0.00524425850398718,No,NA,NA,Q15061,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368636.1.1.m.6631,-0.0038788479306068,No,NA,NA,Q3UY96,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082],NA,NA,NA
CHOYP_LOC100368639.1.1.m.56563,-0.00303959694954587,No,NA,NA,Q5PPY6,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100368658.1.1.m.16577,0.000338256295553546,No,NA,NA,P49139,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_LOC100368659.1.2.m.15836,-0.0124755566797619,No,NA,NA,P78316,NA,NA,NA,90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368661.1.1.m.60830,0.00230568675702874,No,NA,NA,Q5F464,NA,NA,NA,cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100368695.1.1.m.26746,0.00097468953627133,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100368715.1.3.m.31823,-0.0059498626339345,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100368803.1.1.m.12857,-0.0138932520602182,No,NA,NA,Q5JTW2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_LOC100368820.1.1.m.12090,-0.0211092472625372,No,NA,NA,Q4T2X8,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_LOC100368844.1.1.m.45290,0.00359028478992914,No,NA,NA,B0WYR6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48100,0.00546087224984663,No,NA,NA,Q9D2K4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48101,-0.000761478497440761,No,NA,NA,Q5GIS3,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100368866.1.1.m.6804,0.000165918544018587,No,NA,NA,Q24439,NA,NA,NA,mitochondrial proton-transporting ATP synthase; central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC100368885.1.1.m.7807,-0.00423733789634573,No,NA,NA,A0A0R4IFG5,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287],NA,NA,NA
CHOYP_LOC100368907.1.1.m.22004,0.00734559247178525,No,NA,NA,B5X7E4,NA,NA,NA,cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],NA,NA,NA
CHOYP_LOC100368913.1.1.m.25628,-0.00877304818474964,No,NA,NA,B0G143,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839],NA,NA,NA
CHOYP_LOC100368918.1.2.m.6229,0.00282499394718994,No,NA,NA,Q49AM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368924.1.1.m.5031,0.016087864670772,No,NA,NA,Q642C0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100368926.5.5.m.55016,-0.015805465035284,No,NA,NA,O00370,NA,NA,NA,metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100368938.2.2.m.53945,-0.00689189452342931,No,NA,NA,Q5M7G4,NA,NA,NA,cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100368976.1.1.m.1873,-0.00134572558747338,No,NA,NA,A0JNH9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],NA,NA,NA
CHOYP_LOC100368987.1.1.m.6182,0.000975387727802615,No,NA,NA,Q62165,NA,NA,NA,basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100369014.8.9.m.53287,-0.00621891766452185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369014.9.9.m.53367,0.0167963962358782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369017.1.1.m.27033,-0.00784988365205131,No,NA,NA,Q3V3N7,NA,NA,NA,axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100369022.1.1.m.62978,-0.0110971228207476,No,NA,NA,Q8N0W5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369031.1.1.m.19197,0.00230580034474873,No,NA,NA,Q9JK25,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule plus-end [GO:0035371]; ruffle [GO:0001726]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_LOC100369186.2.9.m.27904,0.00266896939616604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369232.1.1.m.58420,-0.00824727925038325,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_LOC100369237.3.3.m.48902,0.00397763830799471,No,NA,NA,Q3UHR0,NA,NA,NA,chromatin binding [GO:0003682],NA,NA,NA
CHOYP_LOC100369255.1.3.m.17623,-0.00216071308938446,No,NA,NA,Q9P1Z9,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100369259.1.1.m.7509,-0.00982170479239064,No,NA,NA,P23919,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_LOC100369270.1.1.m.27019,-0.0177481014679355,No,NA,NA,Q9VFR0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100369294.2.6.m.22959,-0.00736660128658725,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369294.3.6.m.24633,0.00201858388380264,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369302.1.3.m.6808,0.0141937395685681,No,NA,NA,Q008S8,NA,NA,NA,Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100369330.1.1.m.48177,-0.0114107041665455,No,NA,NA,Q3T0W7,NA,NA,NA,Atg12-Atg5-Atg16 complex [GO:0034274]; phagophore assembly site membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100369333.14.32.m.32582,-0.00713347066442219,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100369333.22.32.m.39414,-0.00744144875030289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369333.28.32.m.53859,0.0111519058484214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369340.1.1.m.51639,-0.00780227029093369,No,NA,NA,Q80ZX8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC100369350.2.6.m.42373,0.00425969401424644,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100369378.1.1.m.5391,0.00136913489052225,No,NA,NA,P02640,NA,NA,NA,actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100369384.1.1.m.47986,0.00758695185315419,No,NA,NA,Q9WTR0,NA,NA,NA,extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100369402.2.2.m.29002,0.000728711896470343,No,NA,NA,P45842,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100369411.1.1.m.1071,-0.0093086321896558,No,NA,NA,Q920N2,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781],NA,NA,NA
CHOYP_LOC100369421.1.2.m.17340,-0.0181422048392547,No,NA,NA,Q2TA16,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC100369444.1.1.m.18613,-0.00636860651118881,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369488.1.1.m.10559,-0.00919538846181171,No,NA,NA,Q6P0I8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_LOC100369524.1.1.m.8159,-0.000605248742145353,No,NA,NA,P48818,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100369566.1.1.m.41492,-0.0044783218998403,No,NA,NA,A1A5Q4,NA,NA,NA,motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100369570.1.1.m.25302,0.0188749879894992,No,NA,NA,Q8CIG9,NA,NA,NA,SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100369596.1.1.m.7021,-0.0024748816542714,No,NA,NA,Q8IZH2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075],NA,NA,NA
CHOYP_LOC100369608.1.3.m.11971,-0.0040826517944634,No,NA,NA,Q8IVV2,NA,NA,NA,stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100369620.1.1.m.13590,0.000829426476107946,No,NA,NA,Q5E9Z7,NA,NA,NA,RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100369657.2.2.m.45309,-0.0040620622080437,No,NA,NA,P19891,NA,NA,NA,cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],NA,NA,NA
CHOYP_LOC100369686.2.2.m.30008,0.00887546027333393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369689.1.1.m.28663,0.00022429693605663,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369695.1.1.m.26973,-0.00648200955584785,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100369721.1.1.m.17704,0.00137321033052934,No,NA,NA,Q5FW48,NA,NA,NA,aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_LOC100369745.1.1.m.18815,0.000201321808723307,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_LOC100369754.6.10.m.53352,0.000446723331981867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369791.1.2.m.8271,0.00449008692972296,No,NA,NA,Q14315,NA,NA,NA,costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC100369816.1.1.m.23060,-0.0122505362930772,No,NA,NA,Q6AXP4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369839.2.4.m.27857,0.00317309718776112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369879.3.3.m.59095,-0.00530485727046073,No,NA,NA,P32018,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100369901.1.2.m.9586,0.00730083104162836,No,NA,NA,Q8N6D5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369929.1.5.m.32680,-0.0097561634136537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369935.1.1.m.40124,-0.00598202181727236,No,NA,NA,Q96M32,NA,NA,NA,cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22656,-0.0148590994979816,No,NA,NA,Q00420,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22658,0.00288311113682874,No,NA,NA,B0BNA5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_LOC100369985.1.1.m.35628,0.0173555384296622,No,NA,NA,A6NNX1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370026.1.1.m.42957,-0.00265955508015271,No,NA,NA,Q8JFY9,NA,NA,NA,nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; snoRNA processing [GO:0043144],NA,NA,NA
CHOYP_LOC100370040.1.2.m.55411,0.0144975505689648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370040.2.2.m.55789,0.0161198194220599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370046.1.1.m.18329,-0.0124780140874795,No,NA,NA,Q9UET6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128],NA,NA,NA
CHOYP_LOC100370061.1.1.m.41505,0.00979952195943461,No,NA,NA,Q9DBB5,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100370071.1.1.m.46123,-0.000412505575799395,No,NA,NA,Q17GZ9,NA,NA,NA,nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100370080.1.1.m.14971,-0.000944880906438387,No,NA,NA,P36404,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_LOC100370113.2.2.m.56346,7.70473862378841e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370122.2.2.m.59310,-0.00933404078417213,No,NA,NA,Q6P2C0,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; electron transport chain [GO:0022900],NA,NA,NA
CHOYP_LOC100370136.1.1.m.2170,-0.00987570160428315,No,NA,NA,Q9BZE4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_LOC100370139.3.4.m.58156,-0.00121138378553621,No,NA,NA,Q32P85,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100370154.1.2.m.27385,-0.00937587747502585,No,NA,NA,Q13637,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100370167.1.1.m.15539,0.00266852596766697,No,NA,NA,O04469,NA,NA,NA,peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_LOC100370187.1.1.m.8872,-0.00683380825172436,No,NA,NA,Q07553,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370194.1.1.m.52469,-0.0199215331817433,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100370201.1.1.m.974,0.0180787713921401,No,NA,NA,Q8BFY6,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100370218.1.1.m.36701,-0.000403621214184477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370236.1.3.m.7766,-0.0073170155061064,No,NA,NA,Q9JKL7,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45834,-0.00109662348672191,No,NA,NA,P41824,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45836,-0.000355720156398747,No,NA,NA,Q13442,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370269.1.1.m.55713,-0.0128277216929029,No,NA,NA,Q640Q5,NA,NA,NA,P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_LOC100370323.1.1.m.62024,0.020250735504878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370330.1.1.m.10944,-0.00173505484448471,No,NA,NA,Q9NRY5,NA,NA,NA,purine nucleotide binding [GO:0017076],NA,NA,NA
CHOYP_LOC100370334.1.1.m.48934,-0.0162100014668963,No,NA,NA,Q54RV9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_LOC100370358.1.1.m.39703,-0.0210265342368509,No,NA,NA,D3ZY60,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100370401.1.1.m.15416,0.000336379045799803,No,NA,NA,P70195,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100370403.1.1.m.11269,0.00562305810465597,No,NA,NA,C6KFA3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],NA,NA,NA
CHOYP_LOC100370410.1.1.m.24212,-0.000490585639370433,No,NA,NA,Q96AT9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_LOC100370453.1.1.m.48521,-0.00997367776543669,No,NA,NA,Q0VFN8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_LOC100370463.1.1.m.30276,-0.00908578560103398,No,NA,NA,A6NJI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370478.2.2.m.16291,0.000846947371005362,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_LOC100370504.1.2.m.17506,-0.0129852367692498,No,NA,NA,Q95J53,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370516.1.1.m.29182,-0.00182396401655909,No,NA,NA,B1H1E4,NA,NA,NA,cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370520.1.1.m.12258,-0.000690788903955616,No,NA,NA,Q8R059,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10588,0.00701489252320135,No,NA,NA,Q494V2,NA,NA,NA,axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10589,0.0104406213287743,No,NA,NA,Q3SZ21,NA,NA,NA,nucleolar ribonuclease P complex [GO:0005655]; ribonuclease P activity [GO:0004526]; RNA binding [GO:0003723]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100370551.1.1.m.64375,-0.00283968706939295,No,NA,NA,Q568D2,NA,NA,NA,motile cilium [GO:0031514]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100370552.2.2.m.59438,0.00179603542429069,No,NA,NA,Q6AYD3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; ribosomal large subunit export from nucleus [GO:0000055]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100370583.1.1.m.56859,0.0217929119850113,No,NA,NA,Q05655,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_LOC100370588.15.19.m.60881,0.00106990698556267,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370600.1.1.m.29572,-0.0119848058513702,No,NA,NA,Q5ZID0,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_LOC100370603.1.1.m.51092,-0.0025145371487685,No,NA,NA,P40237,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100370625.2.3.m.26929,-0.0109474286857661,No,NA,NA,Q7Z2W4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100370637.1.2.m.12891,-0.00178893107593833,No,NA,NA,Q4R5S7,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100370662.1.3.m.5814,0.0128427369187246,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370665.1.1.m.29815,-0.00169964331107518,No,NA,NA,F6P3G4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370672.1.1.m.54509,-0.00752854654945666,No,NA,NA,Q505F5,NA,NA,NA,phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100370673.1.1.m.13161,-0.0114718915721433,No,NA,NA,Q9WV04,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801],NA,NA,NA
CHOYP_LOC100370684.1.2.m.61027,0.00793460413268684,No,NA,NA,Q6DCG4,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519],NA,NA,NA
CHOYP_LOC100370705.1.2.m.30943,0.0108111227661305,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370705.2.2.m.55449,0.00233419436725846,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370716.1.1.m.35654,-0.00409547114559934,No,NA,NA,Q9H0E3,NA,NA,NA,nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100370738.1.1.m.30463,-0.0118743691158871,No,NA,NA,P51910,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100370747.1.1.m.28315,-0.000294352980082602,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100370750.2.2.m.52391,0.00117912737964214,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100370790.1.1.m.9845,0.00078309449579833,No,NA,NA,Q9Z336,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100370821.2.2.m.45409,0.00932039188566384,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370838.1.1.m.18679,-0.0210366183149204,No,NA,NA,Q8N9H8,NA,NA,NA,3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100370844.1.2.m.30341,-0.00556648800446712,No,NA,NA,A6NI56,NA,NA,NA,early endosome [GO:0005769],NA,NA,NA
CHOYP_LOC100370879.1.1.m.53699,-0.00581619347039974,No,NA,NA,P49754,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion; non-autophagic [GO:0042144],NA,NA,NA
CHOYP_LOC100370896.4.4.m.56380,0.000629990054458793,No,NA,NA,Q54QQ1,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-substrate adhesion [GO:0031589]; cellular response to nutrient [GO:0031670]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of STAT cascade [GO:1904894]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of sorocarp development [GO:0031156]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100370897.5.5.m.39218,0.00154747831567268,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370900.1.1.m.20012,-0.000852793985438697,No,NA,NA,Q5W041,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100370907.1.3.m.3187,0.00231671010076208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370907.3.3.m.36832,0.00789859548812999,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100370909.1.1.m.30849,-0.00210378788410297,No,NA,NA,Q9JID1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of protein metabolic process [GO:0051246],NA,NA,NA
CHOYP_LOC100370910.1.1.m.13897,-0.0091971668385199,No,NA,NA,Q5R7X9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598],NA,NA,NA
CHOYP_LOC100370913.1.1.m.19909,-0.00157556888154692,No,NA,NA,O15084,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208],NA,NA,NA
CHOYP_LOC100370941.1.1.m.59883,-0.0155092641925132,No,NA,NA,Q6ZNA5,NA,NA,NA,integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370957.1.1.m.22435,0.00794716049620402,No,NA,NA,Q8N0Z6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_LOC100370976.1.2.m.17764,0.00919028442384221,No,NA,NA,Q6IQY5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100370989.2.2.m.37995,0.00524912107374645,No,NA,NA,P62489,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100371005.1.2.m.2526,-0.000147979423650001,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100371022.1.1.m.51315,0.00466953316827383,No,NA,NA,Q8K2K6,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_LOC100371039.1.1.m.18908,-0.020378382954001,No,NA,NA,Q64261,NA,NA,NA,centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100371043.3.5.m.24649,0.00881828309950189,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371058.3.3.m.36497,-0.00212542267459494,No,NA,NA,Q58DA1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; cilium-dependent cell motility [GO:0060285]; negative regulation of microtubule depolymerization [GO:0007026],NA,NA,NA
CHOYP_LOC100371059.1.1.m.25395,0.00709533084620423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371074.1.1.m.36435,0.0153476351286039,No,NA,NA,Q5R573,NA,NA,NA,GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC100371085.1.1.m.44789,-0.0146246606959056,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100371099.1.1.m.20282,-0.0174121626626469,No,NA,NA,Q5M7F8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371127.1.1.m.23427,0.00532221513718004,No,NA,NA,Q96S38,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100371143.1.1.m.27046,0,No,NA,NA,Q66IC8,NA,NA,NA,cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100371148.1.1.m.47147,-0.00950799498658813,No,NA,NA,Q8TDX7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC100371168.1.1.m.54022,-0.00413959378231549,No,NA,NA,H3BNL1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371176.1.1.m.33995,-0.00575519524025211,No,NA,NA,Q58CP0,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100371209.1.1.m.49090,-0.012162777108026,No,NA,NA,A5PLI4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100371218.2.3.m.38221,0.0069191257476423,No,NA,NA,Q8TEW0,NA,NA,NA,adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100371228.1.4.m.6670,0.00846220955458366,No,NA,NA,P14381,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371232.1.1.m.25817,-0.0020755468307824,No,NA,NA,Q6P8E9,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622]; maturation of LSU-rRNA [GO:0000470]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371236.1.1.m.62865,-0.000492299214809966,No,NA,NA,P35623,NA,NA,NA,cytosol [GO:0005829]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100371248.1.2.m.10238,0.000583424473722352,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_LOC100371248.2.2.m.48460,0.00137363118596967,No,NA,NA,Q9H2M3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]; sulfur amino acid metabolic process [GO:0000096],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63117,0.00143993220314652,No,NA,NA,Q8XBI9,NA,NA,NA,cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63118,0.00889377073879193,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100371254.1.1.m.1838,-0.00136833385605381,No,NA,NA,Q6PAM1,NA,NA,NA,cytoplasm [GO:0005737]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100371275.1.1.m.46896,-0.00486420596286102,No,NA,NA,Q93034,NA,NA,NA,Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371304.1.1.m.47915,-0.0151831216726296,No,NA,NA,Q8TBZ9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371319.1.1.m.10776,0.00209234449680009,No,NA,NA,Q23445,NA,NA,NA,COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_LOC100371319.1.1.m.10777,0.000227323176213878,No,NA,NA,Q9CQV5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100371332.1.6.m.7760,-0.00615603256745609,No,NA,NA,Q28864,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596],NA,NA,NA
CHOYP_LOC100371339.1.1.m.4513,-0.020337529851508,No,NA,NA,P51910,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100371354.1.1.m.47130,0.0017588688494465,No,NA,NA,Q92576,NA,NA,NA,metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100371361.1.1.m.9282,0.017140171837555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371374.1.1.m.46502,-0.00568557948008846,No,NA,NA,B0SJT4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_LOC100371390.1.1.m.8047,0.00165373311664839,No,NA,NA,Q99700,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_LOC100371429.1.1.m.13499,0.00256932319128511,No,NA,NA,P09849,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100371430.1.1.m.61181,0.0101772118892064,No,NA,NA,Q01460,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_LOC100371435.1.1.m.6503,0,No,NA,NA,E5RJM6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371443.1.1.m.15017,-0.0120203771557595,No,NA,NA,Q66I67,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371457.1.1.m.12814,-0.00772655126807552,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100371468.2.2.m.53875,0.00222953961198384,No,NA,NA,Q15058,NA,NA,NA,cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371500.1.7.m.4423,-0.00192329850649974,No,NA,NA,Q8R151,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100371503.1.1.m.62767,0.00887546027333393,No,NA,NA,Q91W67,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371557.1.1.m.57537,0.000391511170434213,No,NA,NA,Q9VXK6,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100371571.1.1.m.2417,0.000284883615338299,No,NA,NA,Q3TLD5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100371575.1.1.m.10551,-0.00330117202199612,No,NA,NA,P43307,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_LOC100371590.1.1.m.64405,-0.0165363320622078,No,NA,NA,Q2YDN4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371597.1.1.m.3330,0.0175054987376333,No,NA,NA,A7RX26,NA,NA,NA,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],NA,NA,NA
CHOYP_LOC100371628.1.1.m.35401,-0.0107675536063388,No,NA,NA,Q9CPW7,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371637.1.1.m.7833,-0.002821087928465,No,NA,NA,Q9D024,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100371650.1.1.m.4398,-0.00598866963978634,No,NA,NA,Q6IQ20,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100371654.1.1.m.14188,-0.00937008372988309,No,NA,NA,Q9R0M5,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100371677.1.1.m.122,-0.0001500686222023,No,NA,NA,O46037,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100371695.1.1.m.10063,-0.000346854944657752,No,NA,NA,Q9SF85,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371721.1.1.m.23143,-0.018354111630984,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100371750.2.2.m.64949,-0.00294555902554691,No,NA,NA,P07942,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371756.1.1.m.24048,0.00653519441231495,No,NA,NA,Q26626,NA,NA,NA,kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100371761.1.1.m.57462,0.00495357199757853,No,NA,NA,Q6P2W7,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100371830.5.6.m.55811,-0.00730285394034584,No,NA,NA,O73853,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371831.1.1.m.11775,0.00667888696603555,No,NA,NA,O88327,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100371845.3.3.m.62472,-0.000752095382201966,No,NA,NA,P57103,NA,NA,NA,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_LOC100371875.1.1.m.29467,0.00140574125370914,No,NA,NA,P85971,NA,NA,NA,cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_LOC100371881.1.2.m.3634,0.0133329613582086,No,NA,NA,E9PVX6,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],NA,NA,NA
CHOYP_LOC100371885.1.1.m.9427,-0.00327358686530001,No,NA,NA,O61492,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593],NA,NA,NA
CHOYP_LOC100371909.1.1.m.30745,-0.00118645435300207,No,NA,NA,Q9D180,NA,NA,NA,cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100371965.3.4.m.28742,-0.0196226389147537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371977.1.1.m.21628,0.00235691885935023,No,NA,NA,Q5U312,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371983.1.3.m.2863,-0.000227384368471455,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371983.2.3.m.48879,-0.00365598348986173,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371994.1.1.m.50098,0.00120382399191435,No,NA,NA,Q29RI9,NA,NA,NA,methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_LOC100372012.1.1.m.36569,-0.00738685449226059,No,NA,NA,O14513,NA,NA,NA,microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019],NA,NA,NA
CHOYP_LOC100372020.1.1.m.59998,-0.00659594296124561,No,NA,NA,Q8BVV7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],NA,NA,NA
CHOYP_LOC100372028.1.1.m.22341,-0.0145013595013275,No,NA,NA,Q62717,NA,NA,NA,cell junction [GO:0030054]; dense core granule [GO:0031045]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079],NA,NA,NA
CHOYP_LOC100372071.1.1.m.14107,0.00331657031813704,No,NA,NA,O14662,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372110.1.1.m.11437,0.00232590938342167,No,NA,NA,O00400,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100372131.1.2.m.36461,0.00141130205500967,No,NA,NA,Q14117,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212],NA,NA,NA
CHOYP_LOC100372150.1.1.m.7059,0.00351326264457065,No,NA,NA,P28289,NA,NA,NA,actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694],NA,NA,NA
CHOYP_LOC100372183.1.1.m.31741,-0.0220002758904836,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100372197.3.3.m.56377,-0.00205669193671272,No,NA,NA,O35161,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of neurotransmitter secretion [GO:0046928]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372219.1.1.m.11590,-0.0216583809871595,No,NA,NA,Q92125,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],NA,NA,NA
CHOYP_LOC100372221.2.2.m.48004,0.0156028626196811,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100372236.1.4.m.16991,0.00783639365704602,No,NA,NA,Q6ITT3,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100372239.1.1.m.50390,-0.00739514973728306,No,NA,NA,Q0VFZ6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372241.1.1.m.9935,0.00346430552542492,No,NA,NA,Q9Z265,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription; DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428],NA,NA,NA
CHOYP_LOC100372245.1.1.m.60270,-0.023730190735043,No,NA,NA,Q9NUJ3,NA,NA,NA,microtubule [GO:0005874],NA,NA,NA
CHOYP_LOC100372287.1.1.m.10381,-0.0232967018192843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372290.2.2.m.40459,-0.00957187224446102,No,NA,NA,Q5E960,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100372298.1.1.m.19547,-0.000489247753453288,No,NA,NA,Q8VDC1,NA,NA,NA,autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],NA,NA,NA
CHOYP_LOC100372311.1.1.m.6654,0.00794478272057546,No,NA,NA,Q6ZUK4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100372339.1.2.m.5168,-0.000194753896986952,No,NA,NA,Q5ZMH1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100372340.1.3.m.9116,0.000923745960675695,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372340.3.3.m.59986,-0.00780581962134216,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372341.1.1.m.46956,-0.0133162671963871,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100372342.1.1.m.63404,-0.00119651152236124,No,NA,NA,P40423,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport; nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length; open tracheal system [GO:0035159]; spiracle morphogenesis; open tracheal system [GO:0035277]; tube formation [GO:0035148]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372388.1.1.m.26623,0.000325390213360479,No,NA,NA,Q3UVV9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.4.8.m.31087,-0.00707297568593891,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.6.8.m.56267,-0.00941934223142988,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372393.1.1.m.12043,-0.00229330929471878,No,NA,NA,P49116,NA,NA,NA,nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100372454.1.1.m.56045,0.0162907025365055,No,NA,NA,Q7ZYC4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_LOC100372467.1.1.m.42336,0.00584179293888224,No,NA,NA,Q8WXA3,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC100372473.2.5.m.35440,-0.0176974498832698,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372473.4.5.m.48798,0,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21010,0.0140556751445417,No,NA,NA,P23727,NA,NA,NA,cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex; class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21011,0.00573944268650188,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_LOC100372482.1.1.m.61581,0.0215291170030578,No,NA,NA,Q63HQ0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting; trans-Golgi to endosome [GO:0048203],NA,NA,NA
CHOYP_LOC100372487.1.1.m.39712,0.0123732299444756,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10260,-0.0063301983947594,No,NA,NA,Q5FWT1,NA,NA,NA,tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10261,-0.00158754389806408,No,NA,NA,Q5RE15,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome regulatory particle [GO:0005838]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100372505.2.2.m.26614,-0.014351220542163,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100372560.1.1.m.25500,0.0251711931862,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_LOC100372582.1.2.m.8558,-0.000515533126835062,No,NA,NA,Q6IQ97,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100372601.1.1.m.13567,0.000164675792726344,No,NA,NA,D2H8V8,NA,NA,NA,centrosome [GO:0005813]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],NA,NA,NA
CHOYP_LOC100372607.1.1.m.49009,-0.000573728836747953,No,NA,NA,Q32KV4,NA,NA,NA,apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; intraciliary transport particle [GO:0030990]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100372616.2.3.m.5692,0.0156909178338913,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372626.1.2.m.8346,0.0114337032624059,No,NA,NA,Q5T9S5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372693.1.1.m.16279,0.000535932349783752,No,NA,NA,P13804,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_LOC100372698.1.1.m.18674,-0.006498057122016,No,NA,NA,Q8BTK5,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100372703.1.1.m.29633,0.00032999888706346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372716.5.10.m.31370,-0.00586474907553668,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372803.1.2.m.18615,-0.011413221953164,No,NA,NA,Q5RDU7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100372845.1.3.m.7734,-0.0193357301004495,No,NA,NA,Q497Q6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372867.1.1.m.18083,0.00136060419904948,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372879.1.3.m.18886,-0.024778637642509,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100372881.1.1.m.4636,-0.00346492137877354,No,NA,NA,Q29RK9,NA,NA,NA,metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330],NA,NA,NA
CHOYP_LOC100372889.1.2.m.37506,-0.0135908848815595,No,NA,NA,P54001,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_LOC100372889.2.2.m.57965,0.00177671548793707,No,NA,NA,Q7ZU45,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_LOC100372921.2.2.m.56247,-0.00816685216180298,No,NA,NA,Q69ZM6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090],NA,NA,NA
CHOYP_LOC100372922.1.1.m.12888,-0.00649378294477262,No,NA,NA,P54254,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100372926.1.3.m.29881,0.00542156989538379,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372926.2.3.m.61794,-0.00298134893720608,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372942.1.1.m.31119,0.00263479895150539,No,NA,NA,Q28XE2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913],NA,NA,NA
CHOYP_LOC100372945.2.2.m.47110,0.00236917282458139,No,NA,NA,Q810B6,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100372955.1.1.m.18209,-0.0127051825571647,No,NA,NA,Q14181,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_LOC100372966.1.1.m.18755,0.0105712355508455,No,NA,NA,Q08DB5,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372967.1.1.m.16378,-0.00982670794139013,No,NA,NA,Q58EM4,NA,NA,NA,protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020],NA,NA,NA
CHOYP_LOC100372990.1.1.m.15018,-0.0248751619788689,No,NA,NA,Q62186,NA,NA,NA,integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784],NA,NA,NA
CHOYP_LOC100373045.1.1.m.16825,-0.00127322586932672,No,NA,NA,P18288,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19986,-0.00387648791880941,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19987,0.00184610791235295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373083.2.2.m.26841,-0.00625451072466021,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373090.1.1.m.52283,0.00708956727261373,No,NA,NA,Q1LWJ6,NA,NA,NA,lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336],NA,NA,NA
CHOYP_LOC100373100.3.4.m.51137,-0.00615605671325367,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373100.4.4.m.65650,-0.00693604581185207,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373136.1.1.m.6977,-0.00952475393947902,No,NA,NA,Q5XJS5,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100373138.1.1.m.23491,0.000606034453622437,No,NA,NA,O75886,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_LOC100373141.1.1.m.11194,-0.00200542663738923,No,NA,NA,Q99K28,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC100373146.1.2.m.13310,-0.0198137240955809,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373146.2.2.m.27802,0.00243536990454759,No,NA,NA,Q6ZUG5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373169.1.1.m.15573,0.010391956145166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373170.1.1.m.10994,0.000781070861758594,No,NA,NA,O57590,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100373178.1.1.m.61012,-0.00975610262892494,No,NA,NA,A7E3W5,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_LOC100373186.1.1.m.58981,0.0295442949085951,No,NA,NA,Q6AXK4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_LOC100373240.1.1.m.28382,-0.0120174219877584,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_LOC100373287.1.1.m.36226,-0.00842292615439866,No,NA,NA,Q96DI7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100373289.1.2.m.7904,-0.00749410144504666,No,NA,NA,Q9CPT5,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC100373317.1.1.m.16740,-0.0182477395652579,No,NA,NA,Q5HZP1,NA,NA,NA,nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100373327.1.13.m.13252,-0.00301634681191989,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373327.2.13.m.16978,0.00718079023595185,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373339.1.1.m.5653,0.00464265647648381,No,NA,NA,Q5RKJ1,NA,NA,NA,actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373351.1.3.m.49572,0.00217375956122523,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373351.2.3.m.58893,0.00303209118473955,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373353.1.1.m.50175,-0.000688349341651215,No,NA,NA,Q0IIF7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373374.1.1.m.7546,0.000799658514953846,No,NA,NA,Q3ZCL5,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100373421.1.1.m.38932,-0.00696933868182532,No,NA,NA,A0JPP8,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_LOC100373427.1.1.m.49648,0.00715540759400878,No,NA,NA,Q8NHP6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; neutrophil degranulation [GO:0043312]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023],NA,NA,NA
CHOYP_LOC100373429.1.1.m.10007,0.00527206961344777,No,NA,NA,F1P4W9,NA,NA,NA,integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100373444.22.79.m.26109,0.00748121678419424,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.23.79.m.27899,0.0241423341858875,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.44.79.m.39021,-0.0134283310279068,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373444.59.79.m.54129,-0.00375542163361991,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.63.79.m.59147,0.0109182848591252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.7.79.m.3209,0.00327825979704035,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.72.79.m.60850,0.00732190222065828,No,NA,NA,A4IF63,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.8.79.m.3255,0.00361718623483736,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373454.1.1.m.59681,0,No,NA,NA,Q32LJ3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373457.1.1.m.27685,0.000914554413227178,No,NA,NA,A0MTA1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628],NA,NA,NA
CHOYP_LOC100373461.1.2.m.30015,0.00578266508027493,No,NA,NA,Q0VC16,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipoprotein transporter activity [GO:0042954]; cargo loading into COPII-coated vesicle [GO:0090110]; cargo loading into vesicle [GO:0035459]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373484.1.1.m.8540,-0.00194220021424249,No,NA,NA,Q96EQ0,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; TRC complex [GO:0072380]; protein-containing complex scaffold activity [GO:0032947]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100373488.1.1.m.10129,0.00632963374879127,No,NA,NA,P10088,NA,NA,NA,dioxygenase activity [GO:0051213]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; 2;4-dichlorophenoxyacetic acid catabolic process [GO:0046300],NA,NA,NA
CHOYP_LOC100373492.1.1.m.24527,-0.0124506190711543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373522.5.5.m.54028,-0.0076494814741387,No,NA,NA,Q95230,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373569.1.1.m.280,-0.0130416979703966,No,NA,NA,Q96D46,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding; bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100373584.1.1.m.6647,-0.0226059528006342,No,NA,NA,Q7ZYA5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_LOC100373590.1.1.m.51920,-0.000427177458010716,No,NA,NA,P47758,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_LOC100373606.1.1.m.29757,-0.00322332742809002,No,NA,NA,Q6GM78,NA,NA,NA,cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345],NA,NA,NA
CHOYP_LOC100373653.3.3.m.56289,-0.000152260290957753,No,NA,NA,P97411,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496],NA,NA,NA
CHOYP_LOC100373656.1.1.m.57144,-0.00862918883887951,No,NA,NA,Q5F356,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100373657.1.1.m.10366,0.0227758743336115,No,NA,NA,Q96B26,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_LOC100373670.1.1.m.2427,-0.00208385700268302,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373694.1.1.m.11753,-0.00491482064466554,No,NA,NA,P0CB97,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100373728.1.1.m.59746,-0.0170180436140305,No,NA,NA,Q8TC84,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100373809.1.2.m.35126,-0.0144254079567883,No,NA,NA,Q8C761,NA,NA,NA,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373842.2.4.m.5139,-0.0129360002810944,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373842.4.4.m.40731,0.0135565990297655,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373864.1.2.m.16543,-0.00147669023680642,No,NA,NA,P12955,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373864.2.2.m.55132,-0.0142689328832368,No,NA,NA,P12955,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373888.8.9.m.60548,-0.010294693646117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373888.9.9.m.66033,-0.00774723713354081,No,NA,NA,P29590,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of protein localization to chromosome; telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100373892.1.2.m.44404,0.0217246523644127,No,NA,NA,Q9CZC8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373892.2.2.m.55838,0.00109584526620584,No,NA,NA,Q8VCA8,NA,NA,NA,dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373898.1.1.m.24900,0.00457681956071173,No,NA,NA,Q86VH2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100373917.1.1.m.43876,-0.00655850661565486,No,NA,NA,Q5F457,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100373945.1.1.m.53450,-0.00882855743414834,No,NA,NA,Q5EA50,NA,NA,NA,endosome membrane [GO:0010008],NA,NA,NA
CHOYP_LOC100373956.1.1.m.10987,-0.000603941804273195,No,NA,NA,A5D989,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_LOC100373985.1.1.m.9302,0.0179032720582121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373990.1.1.m.6259,-0.00157105899571602,No,NA,NA,B4F7A7,NA,NA,NA,centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; protein import into nucleus; translocation [GO:0000060]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100374036.1.1.m.65939,0.00911494424564727,No,NA,NA,Q28IV8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100374062.1.1.m.22586,-0.0183954139735198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374077.1.1.m.5922,0.00242256032459414,No,NA,NA,Q5T1M5,NA,NA,NA,actin filament [GO:0005884]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100374096.1.1.m.8052,-0.00543974509829405,No,NA,NA,Q8TBP0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100374116.1.1.m.37009,0.00850979497172862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374155.1.1.m.56570,0.00636406174037806,No,NA,NA,Q08BC4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374249.1.1.m.58296,-0.00899183768282842,No,NA,NA,Q4G0X9,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement [GO:0003351]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],NA,NA,NA
CHOYP_LOC100374249.1.1.m.58297,-0.0170411655820367,No,NA,NA,O14770,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100374268.1.1.m.58983,-0.000271015352202214,No,NA,NA,Q6P877,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100374272.3.6.m.53440,0.00553658077648692,No,NA,NA,O00222,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission; glutamatergic [GO:0051966]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100374272.5.6.m.57085,-0.00101634047713138,No,NA,NA,Q9QYS2,NA,NA,NA,astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission; glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_LOC100374272.6.6.m.62213,-4.09405954668276e-05,No,NA,NA,Q5RDQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196],NA,NA,NA
CHOYP_LOC100374274.2.3.m.27036,-0.0055031656391415,No,NA,NA,Q54BA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374277.1.3.m.16275,-0.00720189160260532,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374277.2.3.m.23204,-0.00331117722609836,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374280.1.1.m.17385,0.025745953211304,No,NA,NA,A0A1D3PCM3,NA,NA,NA,mitochondrion [GO:0005739]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344],NA,NA,NA
CHOYP_LOC100374307.1.1.m.29504,-0.00642989412002255,No,NA,NA,Q5RDZ2,NA,NA,NA,cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374320.1.1.m.54274,-0.00157819526669167,No,NA,NA,P21369,NA,NA,NA,metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365],NA,NA,NA
CHOYP_LOC100374338.1.1.m.44584,-0.00165511012059315,No,NA,NA,P42620,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; oxidoreductase activity; acting on a sulfur group of donors; quinone or similar compound as acceptor [GO:0016672],NA,NA,NA
CHOYP_LOC100374345.1.2.m.11328,-0.0087952196745828,No,NA,NA,Q8BHJ9,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100374358.1.1.m.59032,-8.6238225981963e-06,No,NA,NA,Q5ZLW3,NA,NA,NA,Golgi apparatus [GO:0005794]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC100374370.1.1.m.56335,-0.00256584570015356,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374422.1.2.m.26376,-0.00965546772088151,No,NA,NA,Q8IVF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100374446.1.1.m.29971,-0.00168770672456457,No,NA,NA,Q9H0I3,NA,NA,NA,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100374467.1.1.m.31786,-0.0079565482731995,No,NA,NA,Q4R7Y8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100374491.1.1.m.6498,-0.00342337544846595,No,NA,NA,Q0V9R4,NA,NA,NA,axoneme [GO:0005930]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100374495.1.1.m.55368,-0.00377979866092796,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100374522.1.1.m.66943,-0.0129718356058861,No,NA,NA,Q9DAM1,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100374527.1.1.m.55214,4.86744918106165e-06,No,NA,NA,O97593,NA,NA,NA,kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100374535.2.3.m.26026,0.00340982779085824,No,NA,NA,O44441,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]; negative regulation of nucleotide metabolic process [GO:0045980],NA,NA,NA
CHOYP_LOC100374535.3.3.m.31001,8.67753188726817e-05,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_LOC100374537.1.1.m.27241,0.00831074300135549,No,NA,NA,Q19269,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100374573.1.1.m.24523,-0.0014446186535091,No,NA,NA,P31689,NA,NA,NA,cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response; detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21988,8.64987739834225e-05,No,NA,NA,P34714,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21989,-0.0139503389271018,No,NA,NA,Q9D0C1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100374651.1.4.m.28869,0.000570628586215152,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374651.3.4.m.52010,-0.00685128249279899,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374662.1.6.m.7038,-0.017014888626251,No,NA,NA,Q496A3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374676.1.1.m.61638,0,No,NA,NA,Q9BZ19,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374685.1.1.m.16061,0.0128896838411591,No,NA,NA,Q5M8Z2,NA,NA,NA,cytosol [GO:0005829]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; mitochondrion [GO:0005739]; GPI anchor biosynthetic process [GO:0006506],NA,NA,NA
CHOYP_LOC100374693.1.1.m.62043,0.00737335122429676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374703.1.1.m.28348,-0.00432871480306805,No,NA,NA,Q8IV36,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]; response to brefeldin A [GO:0031001],NA,NA,NA
CHOYP_LOC100374741.27.83.m.24541,0.00736344023265478,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374741.30.83.m.32433,0.0104555817056104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.38.83.m.33463,0.00768897957909026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.49.83.m.42424,0.0104706923732788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.54.83.m.47294,0.017661647530533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.61.83.m.53306,0.00236473551960547,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.70.83.m.60164,0.00940952183123074,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.72.83.m.60196,-0.0141580504793086,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.79.83.m.63217,-0.00617561233021774,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100374742.1.2.m.209,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374747.1.1.m.54969,-0.00222931169753551,No,NA,NA,Q9NZQ3,NA,NA,NA,cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100374754.1.1.m.32299,-0.00635987243043204,No,NA,NA,Q8R0G9,NA,NA,NA,condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; somite development [GO:0061053],NA,NA,NA
CHOYP_LOC100374772.1.4.m.30631,-0.00248220051292607,No,NA,NA,Q9JIX0,NA,NA,NA,DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100374785.2.3.m.34677,-0.0139535572831287,No,NA,NA,Q8IYW2,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294],NA,NA,NA
CHOYP_LOC100374808.1.1.m.29300,0.00325208555046566,No,NA,NA,B1H283,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100374819.2.7.m.48237,-0.00785761070252828,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100374839.1.1.m.63735,0.0167153935166434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374845.1.1.m.49323,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374849.1.4.m.16004,0.0123975565911639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374909.1.2.m.4076,-0.0126261913640001,No,NA,NA,P91254,NA,NA,NA,glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374909.2.2.m.57748,0.00232924505544431,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374912.1.1.m.51922,-0.00599163613463112,No,NA,NA,P52556,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167],NA,NA,NA
CHOYP_LOC100374960.1.1.m.25267,-0.011579306792686,No,NA,NA,Q8NHH9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100374962.1.1.m.28954,0.00296749684280636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.12.16.m.47308,0.0079367090331143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.15.16.m.58657,0.00067713387898835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.1.16.m.21258,-0.00743086868233176,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.4.16.m.24874,0.0199617013546989,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100374995.1.3.m.34198,-0.00496301108729115,No,NA,NA,Q1LUT1,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087],NA,NA,NA
CHOYP_LOC100374995.2.3.m.59062,-0.00665812752948806,No,NA,NA,Q7ZXT3,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932],NA,NA,NA
CHOYP_LOC100375012.1.1.m.11931,0,No,NA,NA,Q6NXP6,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100375022.1.1.m.3033,-0.00329369163450886,No,NA,NA,P14685,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100375029.3.10.m.11445,0.000211548159620413,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375065.1.1.m.7678,0.00202256388073639,No,NA,NA,Q9BVG8,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC100375089.1.1.m.1341,0.000611018985904383,No,NA,NA,Q3MHN0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100375122.1.1.m.52296,-0.00451800533783968,No,NA,NA,Q9D581,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100375141.1.1.m.12655,0.0218538138404238,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100375168.1.1.m.23641,0.00190611583757272,No,NA,NA,Q59E55,NA,NA,NA,nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription; DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription; DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100375191.1.2.m.9220,-0.00806318763133897,No,NA,NA,Q86YF9,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375194.5.7.m.46447,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375204.2.2.m.21490,0.00578188954705124,No,NA,NA,Q6NVL7,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100375204.2.2.m.21491,-0.02251415037276,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375219.1.1.m.30268,0.0038907582598275,No,NA,NA,Q9H4K1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100375219.1.1.m.30269,-0.0159955444070196,No,NA,NA,Q9DAN9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100375230.1.1.m.52612,-0.0174101994580241,No,NA,NA,Q96M69,NA,NA,NA,acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375232.1.2.m.2686,0.00789152202932647,No,NA,NA,Q9Y2F9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008],NA,NA,NA
CHOYP_LOC100375265.2.2.m.11396,0.00972341993891839,No,NA,NA,Q9UBQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100375266.1.1.m.6535,-0.00377257397518213,No,NA,NA,Q9D5R3,NA,NA,NA,centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; Golgi apparatus [GO:0005794]; cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_LOC100375293.2.2.m.58888,-0.0147024382025443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375314.1.1.m.19446,0.00666441743023,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100375322.1.1.m.22016,0.00464097202645926,No,NA,NA,Q74FW6,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100375324.1.1.m.45919,0.000290886223920679,No,NA,NA,Q96S44,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],NA,NA,NA
CHOYP_LOC100375342.2.3.m.30827,-0.00796041302652835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375342.3.3.m.40363,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375357.1.1.m.46425,0.0208110884844141,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_LOC100375367.1.1.m.10761,-0.0108144906948414,No,NA,NA,O60231,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375395.1.2.m.3613,0.00570761676909186,No,NA,NA,Q9LJN4,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1;4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_LOC100375405.1.1.m.48387,-0.0010250289037039,No,NA,NA,Q9JI92,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_LOC100375419.1.1.m.60972,0.00155651848579393,No,NA,NA,O54786,NA,NA,NA,cytosol [GO:0005829]; lipid droplet [GO:0005811]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deoxyribonuclease inhibitor activity [GO:0060703]; protein binding involved in protein folding [GO:0044183]; protein domain specific binding [GO:0019904]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242],NA,NA,NA
CHOYP_LOC100375427.1.1.m.6282,0.00183214185484631,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_LOC100375467.1.1.m.42789,-0.00878708212687764,No,NA,NA,Q04721,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription; DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100375473.1.1.m.9062,0.0102345590698739,No,NA,NA,Q4R6T7,NA,NA,NA,cell projection organization [GO:0030030],NA,NA,NA
CHOYP_LOC100375476.1.1.m.33187,-0.000175079425213831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375481.1.1.m.4496,-0.00977914699566114,No,NA,NA,Q9VY28,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100375491.1.1.m.11693,-0.00694394210404889,No,NA,NA,Q61909,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100375514.2.6.m.12927,0.0258078812227388,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27488,0.0122707675264615,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27489,-0.00312747960712623,No,NA,NA,Q9JJW6,NA,NA,NA,cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375551.2.2.m.63719,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375622.1.1.m.55637,0.00368480182854626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375647.1.2.m.39652,0.000101113916807294,No,NA,NA,P78329,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377],NA,NA,NA
CHOYP_LOC100375650.1.1.m.51555,-0.00981609573433575,No,NA,NA,Q98SP7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877],NA,NA,NA
CHOYP_LOC100375678.1.1.m.51537,0.000191749462290492,No,NA,NA,P70541,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100375699.1.2.m.19738,0.00170519413986456,No,NA,NA,Q9TU19,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375733.1.1.m.66021,0.00584730940995424,No,NA,NA,P54961,NA,NA,NA,hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC100375747.1.1.m.36999,-0.00686787645386184,No,NA,NA,Q9P209,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-tubulin complex localization [GO:0033566]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_LOC100375776.1.3.m.8907,0.00956844446343955,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_LOC100375784.2.6.m.7640,-0.00751452924180185,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.3.6.m.12285,0.00868323580735523,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.4.6.m.27594,0.0112577989955656,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375791.1.1.m.18116,0.00975730027250596,No,NA,NA,Q6AY40,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302],NA,NA,NA
CHOYP_LOC100375797.1.3.m.4166,-0.00613991062609493,No,NA,NA,Q01262,NA,NA,NA,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; cellular amino acid biosynthetic process [GO:0008652],NA,NA,NA
CHOYP_LOC100375820.1.1.m.62640,0.00675174812267298,No,NA,NA,Q924T7,NA,NA,NA,CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100375831.1.1.m.24502,-0.000101239674004596,No,NA,NA,Q810J8,NA,NA,NA,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100375838.1.1.m.39473,-0.00599599265227413,No,NA,NA,Q8K4L0,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100375877.1.1.m.16493,-0.00599209731710548,No,NA,NA,Q9H0A0,NA,NA,NA,membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391],NA,NA,NA
CHOYP_LOC100375888.1.1.m.18951,-0.00942187082073504,No,NA,NA,Q8K370,NA,NA,NA,mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity; acting on the CH-CH group of donors [GO:0016627],NA,NA,NA
CHOYP_LOC100375890.1.1.m.10490,-0.00434180479615144,No,NA,NA,Q8CHP8,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_LOC100375897.1.2.m.14439,-5.2800921428547e-05,No,NA,NA,Q4KMD7,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_LOC100375913.1.1.m.9170,-0.00157993389515093,No,NA,NA,Q0IHI3,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100375943.1.1.m.9395,0.00640015578564435,No,NA,NA,P57772,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100375954.4.6.m.32949,0.00339798340629366,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100375955.1.1.m.9940,0.0029987534180964,No,NA,NA,Q5F415,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; embryonic brain development [GO:1990403]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100376045.1.1.m.30010,0.00706712372247456,No,NA,NA,Q96CN5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100376049.1.1.m.10489,-0.00183503862280884,No,NA,NA,Q5VWJ9,NA,NA,NA,phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376067.3.3.m.62990,0.0150812285123533,No,NA,NA,O93310,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; nuclear chromosome [GO:0000228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_LOC100376096.1.1.m.62366,-0.00974870704133375,No,NA,NA,A1A4V9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376151.1.1.m.21094,-3.32268005500036e-05,No,NA,NA,Q7Z5K2,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100376162.1.1.m.48261,-0.00225217447581916,No,NA,NA,P39098,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; glycoprotein metabolic process [GO:0009100]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585],NA,NA,NA
CHOYP_LOC100376187.1.2.m.22539,-0.000133362616171546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376187.1.2.m.22540,0.00199744588625591,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376187.2.2.m.55240,0.0140070606237726,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376214.9.11.m.53354,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376250.1.1.m.46061,-0.00179767448014978,No,NA,NA,Q5E9X5,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376265.3.4.m.22693,0.00426288568211843,No,NA,NA,B5X3C1,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376265.4.4.m.28000,0.00839086617290285,No,NA,NA,Q5SNX7,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30521,-0.0108618204274052,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30522,-0.000208766256585348,No,NA,NA,Q8HZM5,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC100376274.7.7.m.64553,0.000546557622219331,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100376289.1.1.m.60023,0.00212299274756819,No,NA,NA,Q5RHH4,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC100376296.1.1.m.36837,-0.00812655088978547,No,NA,NA,Q96MY1,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100376308.1.1.m.60595,0.0125141844358025,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100376325.1.2.m.1959,-0.0216174523199768,No,NA,NA,Q9NWU2,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell proliferation [GO:0008284]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100376387.1.1.m.9565,0.00385295663518728,No,NA,NA,O43818,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100376426.1.3.m.28097,-0.0115577497712423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376426.3.3.m.65900,-0.0128962169103323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376429.1.1.m.24844,-0.0215873839308644,No,NA,NA,Q0VCN3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100376442.1.1.m.40651,0.00765847660627597,No,NA,NA,A7S8T5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376457.1.2.m.11537,-0.00213135501521423,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_LOC100376457.2.2.m.51737,0.00234098614638322,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_LOC100376500.1.1.m.36606,-0.00182276015975528,No,NA,NA,Q08E38,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LOC100376608.2.4.m.47059,0.00735226708139365,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100376608.3.4.m.51379,-0.00700327510229783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376610.3.3.m.19687,-0.00715984409955053,No,NA,NA,Q61656,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; alternative mRNA splicing; via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription; DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069],NA,NA,NA
CHOYP_LOC100376688.1.8.m.12067,-0.00132141253824932,No,NA,NA,P84175,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100376708.2.2.m.19660,-0.000116132283029785,No,NA,NA,P28668,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]; glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_LOC100376733.1.1.m.12140,0.0019648090845305,No,NA,NA,Q803V5,NA,NA,NA,cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376759.2.2.m.59482,-0.00701869679073783,No,NA,NA,Q8WXX7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; embryonic viscerocranium morphogenesis [GO:0048703]; forebrain neuron development [GO:0021884]; innate vocalization behavior [GO:0098582]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_LOC100376802.2.2.m.60631,0.00235116284693399,No,NA,NA,O76537,NA,NA,NA,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; peptidoglycan catabolic process [GO:0009253],NA,NA,NA
CHOYP_LOC100376807.1.1.m.22568,0.0181762712731791,No,NA,NA,Q96DY2,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100376827.1.1.m.60291,-0.0046047858780697,No,NA,NA,Q5RBM1,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_LOC100376857.1.7.m.30171,-0.0165685287413063,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376857.4.7.m.47467,-0.00357861051026356,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376863.1.1.m.65235,-0.00103715854659652,No,NA,NA,Q04446,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1;4-alpha-glucan branching enzyme activity [GO:0003844]; 1;4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977],NA,NA,NA
CHOYP_LOC100376864.2.4.m.20389,-0.012536960613125,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376880.1.1.m.475,-0.0125913919502918,No,NA,NA,P70531,NA,NA,NA,dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637],NA,NA,NA
CHOYP_LOC100376902.1.1.m.20390,-0.00414378400094183,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100376908.1.4.m.112,0.0132709701839239,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100376932.1.1.m.12642,0.000172062767223263,No,NA,NA,Q63569,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_LOC100376984.1.1.m.15840,-0.000892032760697446,No,NA,NA,Q5U2Q3,NA,NA,NA,nuclear body [GO:0016604]; hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377001.1.2.m.10821,0.000827778987005432,No,NA,NA,A2T7G9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100377001.2.2.m.52324,-0.00955766873822346,No,NA,NA,Q9Z2G9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765],NA,NA,NA
CHOYP_LOC100377024.2.2.m.63302,-0.00265641265822634,No,NA,NA,E9Q7R9,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm motility [GO:0097722],NA,NA,NA
CHOYP_LOC100377034.1.1.m.6251,0.00196398936558665,No,NA,NA,Q6GNL7,NA,NA,NA,cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-; formyl- and related transferase activity [GO:0016742]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],NA,NA,NA
CHOYP_LOC100377054.1.1.m.8489,0.000805586713223365,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100377058.1.1.m.22299,0.000500740263904667,No,NA,NA,M0R2J8,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100377066.1.2.m.18381,0.0112527594201374,No,NA,NA,Q9EQ06,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100377077.1.1.m.9907,-0.00568090982661488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377089.1.2.m.5892,-0.00339707325193062,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100377100.1.1.m.51994,-0.000754535039212829,No,NA,NA,Q86WU2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457],NA,NA,NA
CHOYP_LOC100377119.1.1.m.44037,-0.00640763145246364,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377154.3.4.m.52896,-0.00521667415532433,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377160.2.2.m.55835,0.00272251052622234,No,NA,NA,P50867,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid biosynthetic process [GO:0008652]; cysteine biosynthetic process from serine [GO:0006535],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37698,-0.0191658218329246,No,NA,NA,Q969V4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37699,0.023473436685099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377184.1.1.m.16090,-0.0024393955457156,No,NA,NA,Q9DB15,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; positive regulation of transcription; DNA-templated [GO:0045893]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100377195.1.2.m.28624,-0.0134586848219953,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100377200.1.2.m.19811,0.00350654704982972,No,NA,NA,Q8R2K1,NA,NA,NA,fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857]; female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665],NA,NA,NA
CHOYP_LOC100377220.1.1.m.36306,-0.00727005677982065,No,NA,NA,Q6AX59,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100377233.1.1.m.30409,0.00160630743060788,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC100377235.1.2.m.30935,-0.00129301046582722,No,NA,NA,Q2KIR1,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100377243.1.1.m.6500,-0.00422781509023511,No,NA,NA,Q8T880,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377244.1.2.m.31458,-0.00970388883392392,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377267.1.1.m.49876,0.000325453633764324,No,NA,NA,A2BG43,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009],NA,NA,NA
CHOYP_LOC100377311.6.14.m.34688,-0.00649093014321374,No,NA,NA,Q8C525,NA,NA,NA,protein-containing complex binding [GO:0044877],NA,NA,NA
CHOYP_LOC100377323.1.1.m.23683,-0.00805110353244764,No,NA,NA,D4GU72,NA,NA,NA,dTDP-glucose 4;6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232],NA,NA,NA
CHOYP_LOC100377347.1.1.m.11235,0.0143198427060959,No,NA,NA,Q80Y83,NA,NA,NA,axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100377362.1.1.m.10266,0.000519193385885975,No,NA,NA,Q99LM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921],NA,NA,NA
CHOYP_LOC100377364.1.2.m.4828,-0.000613086304648577,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100377364.2.2.m.52803,0.00426077798116416,No,NA,NA,Q9NRC6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100377378.1.1.m.64418,-0.00279888513267366,No,NA,NA,Q32TF8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377381.1.2.m.29868,-0.00654620379328288,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377381.2.2.m.49035,-0.00286922948928959,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377392.3.4.m.26363,-0.0056342516809146,No,NA,NA,Q32KL8,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377392.4.4.m.65974,-0.00301359046594456,No,NA,NA,Q32KL8,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377398.1.1.m.44441,0.0201144355118553,No,NA,NA,Q9N285,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100377412.1.1.m.41404,-0.00300987477670788,No,NA,NA,Q80Y75,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC100377435.1.1.m.46017,0.0134622271549738,No,NA,NA,Q2KHM9,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_LOC100377460.1.1.m.38781,0.00176716943560573,No,NA,NA,Q3ZBD3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC100377487.1.1.m.27964,0.0191486238503096,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100377495.1.1.m.17707,0.0108228277303515,No,NA,NA,Q03164,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of megakaryocyte differentiation [GO:0045652]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377501.1.1.m.13155,-0.0195922950125124,No,NA,NA,Q7ZWS1,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_LOC100377541.2.4.m.15307,0.0188829186471217,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377560.1.1.m.66612,-0.0172155813936702,No,NA,NA,O75486,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377596.1.1.m.7350,-0.0140960554484351,No,NA,NA,Q571G4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC100377647.1.2.m.10110,-0.0127545866794782,No,NA,NA,Q5VZQ5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377677.1.2.m.23471,0.00748134547346692,No,NA,NA,P15848,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377677.2.2.m.27049,0.00894432405926611,No,NA,NA,P50430,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377682.1.1.m.31441,0.00870798614971219,No,NA,NA,Q8TDX5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; protein complex oligomerization [GO:0051259]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC100377736.1.1.m.251,-0.0106439139487573,No,NA,NA,P97478,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1;4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100377751.1.1.m.26359,-0.00507442512480039,No,NA,NA,Q8TBY9,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1005,0.0011705571441721,No,NA,NA,O75534,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; male gonad development [GO:0008584]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1006,-0.00369573290722285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377759.10.15.m.45798,1.03597853160651e-05,No,NA,NA,A6QPC8,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022],NA,NA,NA
CHOYP_LOC100377759.15.15.m.64824,0.0085887918779281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377771.1.1.m.7044,0.000975114170613987,No,NA,NA,Q4R7V3,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_LOC100377780.8.11.m.53259,-0.0188597284929015,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC100377783.1.1.m.14549,-0.00336576317703367,No,NA,NA,P56399,NA,NA,NA,cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377801.1.1.m.10929,-0.0143414062756168,No,NA,NA,Q1RML7,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC100377837.2.2.m.7996,-0.00052786065312676,No,NA,NA,Q6P5B0,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],NA,NA,NA
CHOYP_LOC100377856.1.2.m.13657,-0.00628086518646033,No,NA,NA,Q9Z221,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377856.2.2.m.43339,0.00300543884510664,No,NA,NA,Q9Z221,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377864.1.1.m.33298,-0.0204591451131952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377872.1.1.m.30372,-0.00365884545548233,No,NA,NA,Q16513,NA,NA,NA,apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100377901.1.1.m.7173,0.00299922655895894,No,NA,NA,Q62077,NA,NA,NA,cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100377934.1.1.m.48699,-0.0102592682112343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377974.1.1.m.6543,0.00816880194292682,No,NA,NA,Q96LI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377982.1.1.m.43510,-0.00931757880563546,No,NA,NA,Q9QXE5,NA,NA,NA,endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100378002.1.1.m.47564,0.00203771273546295,No,NA,NA,Q6DFB8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100378011.2.2.m.52041,-0.00847124010949605,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100378054.4.4.m.63855,0.000866643745708445,No,NA,NA,Q9VXX8,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100378071.1.1.m.40488,-0.00276562809971489,No,NA,NA,Q16960,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100378083.1.3.m.26711,-0.0206990856702799,No,NA,NA,Q9BYX4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378083.3.3.m.65631,0.00433222419851485,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22676,-0.00231681917142073,No,NA,NA,Q7LBC6,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22677,0.00872546232219717,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100378116.1.3.m.22707,0.00967890358649073,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378116.3.3.m.60538,0.00840556127393629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378195.1.1.m.46024,0.00138648300936769,No,NA,NA,Q1LV46,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100378204.1.1.m.40064,-0.0137408835746824,No,NA,NA,Q7ZUX6,NA,NA,NA,cofactor binding [GO:0048037]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612],NA,NA,NA
CHOYP_LOC100378209.1.2.m.7335,-0.00616174927976759,No,NA,NA,P25490,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100378221.1.1.m.29052,0.00178146055798915,No,NA,NA,Q8K4K5,NA,NA,NA,axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100378252.1.1.m.16877,-0.000566567962649581,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100378255.1.1.m.63185,-0.0109303473337546,No,NA,NA,Q8NHU2,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378269.1.2.m.12226,-0.0181678505971227,No,NA,NA,Q2NL11,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378295.1.4.m.3278,0.00365757008796258,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100378322.1.1.m.16268,0.000194386322231204,No,NA,NA,Q4V8C9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378331.1.1.m.47480,-0.00416290329423014,No,NA,NA,Q8TD57,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100378364.1.1.m.53053,-0.00282280044382661,No,NA,NA,Q0V8S0,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405],NA,NA,NA
CHOYP_LOC100378410.1.1.m.18106,-0.00245834124978407,No,NA,NA,Q8IZL8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378414.1.1.m.34038,-0.00605841121364067,No,NA,NA,B4PZ52,NA,NA,NA,mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_LOC100378430.1.1.m.63142,-0.00770408627403238,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100378510.1.1.m.9865,0.002499734410356,No,NA,NA,Q14318,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378526.1.1.m.16747,0.00241919636202606,No,NA,NA,Q5ZJU4,NA,NA,NA,cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC100378553.1.1.m.7444,-0.00141423687916684,No,NA,NA,Q8BMQ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586],NA,NA,NA
CHOYP_LOC100378570.1.1.m.25501,-0.00172338381545252,No,NA,NA,O15527,NA,NA,NA,mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7;8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair; DNA incision [GO:0033683]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100378584.1.3.m.38091,-0.00344400450543407,No,NA,NA,Q28I85,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378607.1.2.m.17330,0.000121623861197421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378615.1.2.m.25321,0.00750007575284049,No,NA,NA,Q9NRA2,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739],NA,NA,NA
CHOYP_LOC100378618.1.1.m.48704,0.00221667849249325,No,NA,NA,Q6ZU80,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; spindle pole [GO:0000922]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100378619.1.2.m.21468,-0.0186500204344822,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378619.2.2.m.36047,-0.00806147846920052,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378642.1.1.m.54868,0.0272846694153182,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378644.2.2.m.58497,0.000936325026419865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378652.1.1.m.5656,-0.000761907814009333,No,NA,NA,Q8BKE9,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5657,-0.000261244495168944,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5658,0.00239685380876253,No,NA,NA,O75096,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378653.1.3.m.42107,0.00685982405260229,No,NA,NA,P47967,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100378658.1.1.m.38454,0.00882836929936354,No,NA,NA,Q5EAD5,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342],NA,NA,NA
CHOYP_LOC100378676.3.8.m.43012,-0.00929036280692928,No,NA,NA,Q6ZRF8,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],NA,NA,NA
CHOYP_LOC100378691.2.2.m.40118,-0.00487960884788001,No,NA,NA,Q2KI56,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100378714.2.4.m.30802,-0.00083493662103571,No,NA,NA,Q8IT98,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100378719.1.1.m.7367,-0.00427227039650482,No,NA,NA,Q6UUV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378760.1.1.m.37015,-0.000917754978013034,No,NA,NA,P68037,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription; DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100378816.1.1.m.10997,-0.0225188548783965,No,NA,NA,Q4R642,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100378818.2.2.m.27217,0.0117234963415584,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_LOC100378821.1.1.m.8967,-0.00635706578930912,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100378839.1.1.m.21328,-0.00372319254093834,No,NA,NA,Q86UC2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378844.1.4.m.7322,-0.00201010316750412,No,NA,NA,B5X5D0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378848.1.1.m.29949,0.00486825502024584,No,NA,NA,Q96JC1,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport; endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100378849.1.1.m.21445,-0.0046887360987732,No,NA,NA,Q8BJM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378873.3.3.m.30410,-0.0207715121482813,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378881.1.1.m.29212,0.00130194667986055,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378892.1.1.m.41502,-0.000210632539907202,No,NA,NA,Q7ZYB4,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],NA,NA,NA
CHOYP_LOC100378901.1.2.m.29418,-0.00229832674390004,No,NA,NA,P31331,NA,NA,NA,extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC100378967.1.1.m.62298,0.00462885734299819,No,NA,NA,B0BM24,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378969.2.2.m.31240,-0.00548321187009662,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378993.1.1.m.13997,0.00011183664711468,No,NA,NA,Q13029,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100378999.1.1.m.36850,-0.013875773250079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100379008.4.4.m.54023,0.0102466546686519,No,NA,NA,Q12912,NA,NA,NA,azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_LOC100379027.1.1.m.27022,-0.00335555196298846,No,NA,NA,Q5RK00,NA,NA,NA,cell junction [GO:0030054]; mitochondrial large ribosomal subunit [GO:0005762]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC100379049.1.1.m.51860,-0.0132814246746534,No,NA,NA,A6N6J5,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; phosphatidylinositol binding [GO:0035091]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100402577.1.1.m.44548,0.0144425661954699,No,NA,NA,P0DMW7,NA,NA,NA,extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_LOC100459096.3.3.m.45135,0.00447492415784475,No,NA,NA,F1QYJ6,NA,NA,NA,sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466],NA,NA,NA
CHOYP_LOC100462678.2.2.m.28619,0.00988516075915124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100465916.1.1.m.44328,-0.0119481722454858,No,NA,NA,Q5R8X6,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100471656.2.2.m.34266,-0.00821853770318624,No,NA,NA,Q6P360,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100472408.1.1.m.17281,0.00862991845478945,No,NA,NA,Q562D6,NA,NA,NA,RNA binding [GO:0003723]; tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100476601.1.1.m.9343,-0.0090403541281123,No,NA,NA,A6H619,NA,NA,NA,metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100485159.1.1.m.30340,-0.00491080365735241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485247.1.1.m.37690,0.0188233929603224,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485356.1.1.m.21339,0.00657102780267514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485485.1.1.m.27961,-0.00594499176390281,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100485536.1.1.m.48204,0.0182434188535651,No,NA,NA,A7SCH8,NA,NA,NA,cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_LOC100485604.1.1.m.45268,-0.00869162327568569,No,NA,NA,O43903,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule binding [GO:0008017]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle arrest [GO:0007050]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100486001.1.1.m.6209,0,No,NA,NA,Q8IX29,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100486063.2.9.m.5918,-0.00249740943642775,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.5.9.m.39538,0.0025427650618794,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC100486063.6.9.m.44250,-0.0050156078777319,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.9.9.m.65186,0.00632431925727,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486357.1.1.m.51050,-0.00675646415891808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100486738.1.2.m.63464,0.00780933084581581,No,NA,NA,Q99KF0,NA,NA,NA,cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100487213.2.4.m.53374,0.00600907624254289,No,NA,NA,E7F568,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; heart jogging [GO:0003146]; heart looping [GO:0001947],NA,NA,NA
CHOYP_LOC100488715.1.1.m.61241,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100488894.1.5.m.4048,-0.0106235847979947,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100489126.1.1.m.18822,-5.58424857388573e-05,No,NA,NA,Q0V8M0,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447],NA,NA,NA
CHOYP_LOC100489926.1.3.m.3642,0.0082340965097134,No,NA,NA,Q14676,NA,NA,NA,chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573],NA,NA,NA
CHOYP_LOC100489929.1.1.m.51437,0.0129227524079593,No,NA,NA,O73746,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100490321.2.2.m.54266,0.00629816387716075,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100490454.1.1.m.64455,0.00484401457992511,No,NA,NA,Q9DBL7,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937],NA,NA,NA
CHOYP_LOC100491753.1.3.m.45589,0.00718626508928417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100491886.1.1.m.26703,-0.00348525129580999,No,NA,NA,P55113,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465],NA,NA,NA
CHOYP_LOC100492442.1.1.m.16466,-0.00240938410093153,No,NA,NA,Q08379,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],NA,NA,NA
CHOYP_LOC100492576.1.1.m.7775,0.000496803992822475,No,NA,NA,Q14697,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; glucan 1;3-alpha-glucosidase activity [GO:0033919]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],NA,NA,NA
CHOYP_LOC100492683.1.1.m.63753,-0.0048981381230358,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100493179.5.15.m.32003,-0.00729446037792977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493440.1.2.m.17291,0.000125614562872246,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493600.1.1.m.58682,-0.009953864631464,No,NA,NA,Q3U5Q7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100495846.1.1.m.11305,-0.00282027038106406,No,NA,NA,O88554,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100496973.2.8.m.19997,0.00205469723065066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100496973.4.8.m.55256,-0.00714960296763085,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100497129.3.8.m.32060,-0.0151208309998392,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.6.8.m.41866,-0.0173376673151375,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.7.8.m.41875,0.0115323502223532,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100498109.3.3.m.55841,-0.00702578993721335,No,NA,NA,Q96DM1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100502592.1.1.m.27996,-0.00940911293974616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100524481.1.1.m.14740,0.0258777003425825,No,NA,NA,Q99PL6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100533218.1.1.m.56993,0.00541784810083129,No,NA,NA,O55173,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13989,0.00514932765455894,No,NA,NA,Q9Z139,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13990,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533220.2.2.m.13991,0.0111513303303261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533225.1.2.m.36896,-0.00735355655074974,No,NA,NA,Q6QM28,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31982,0.0152413260108908,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31983,0,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533258.6.6.m.48142,0.00159267682148594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533258.6.6.m.48143,0.00153871891861389,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533261.1.1.m.36141,0.00119262449303043,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_LOC100533283.1.1.m.54357,-0.000825931959658054,No,NA,NA,Q5ZKI0,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683],NA,NA,NA
CHOYP_LOC100533284.1.2.m.25143,0.000127635069240122,No,NA,NA,F1M7Y5,NA,NA,NA,apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular protein localization [GO:0034613]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LOC100533289.6.6.m.59221,-0.0155468221389115,No,NA,NA,P24524,NA,NA,NA,cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100533290.1.1.m.9001,-0.00351819183982113,No,NA,NA,Q9R152,NA,NA,NA,nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_LOC100533291.4.7.m.29195,-0.0129746158034663,No,NA,NA,P18445,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100533294.1.3.m.35108,0.00145558763773968,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533294.2.3.m.36820,0.0172033449338632,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533315.1.3.m.40003,-0.017382035560741,No,NA,NA,Q38PU3,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100533316.2.2.m.47773,-0.00981699722809076,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100533319.1.2.m.46,0.0056656073209775,No,NA,NA,P17972,NA,NA,NA,axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431],NA,NA,NA
CHOYP_LOC100533325.1.1.m.55617,-0.0123417426339355,No,NA,NA,O75976,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100533330.1.2.m.2565,-0.0097152769283651,No,NA,NA,P25228,NA,NA,NA,cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533341.1.1.m.1846,-0.000947056906966011,No,NA,NA,O35344,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein C-terminus binding [GO:0008022]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100533349.3.5.m.52212,-0.00169252050243215,No,NA,NA,Q9VF87,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100533356.6.6.m.63561,-0.0162420411442727,No,NA,NA,O01393,NA,NA,NA,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220],NA,NA,NA
CHOYP_LOC100533357.1.2.m.56848,0.000811312424796943,No,NA,NA,P34121,NA,NA,NA,actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100533367.1.1.m.49626,-0.016314863300189,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533383.1.2.m.10358,0.00328208476692746,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100533384.3.5.m.37350,-0.007016073165299,No,NA,NA,Q28FX0,NA,NA,NA,RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59082,0.00173063689335742,No,NA,NA,Q28GD4,NA,NA,NA,cell cortex [GO:0005938]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59083,-0.0160340146850079,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100533387.1.1.m.56131,-0.00229394790064385,No,NA,NA,Q14974,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; protein import into nucleus; translocation [GO:0000060]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_LOC100533388.1.6.m.3716,0.0293334254122082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.2.6.m.5374,-0.0013539733587751,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.4.6.m.45039,0.0276554027357649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.6.6.m.45695,0.000435784943358739,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533400.1.4.m.12300,0.0078104925041197,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533400.3.4.m.28214,-0.00275849033232341,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533411.1.1.m.37112,0.0192152281325003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533437.1.2.m.4596,-0.00876158501793731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533444.1.1.m.33578,-0.00435695538389433,No,NA,NA,Q9XSC1,NA,NA,NA,extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510],NA,NA,NA
CHOYP_LOC100533447.1.3.m.37261,-0.00228106898656771,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44496,0.00182326137623519,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44497,0.019067599855276,No,NA,NA,O43639,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_LOC100533450.1.1.m.54334,0.00130335709116455,No,NA,NA,Q3L1C9,NA,NA,NA,neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100533455.1.9.m.3607,0.00308959340155887,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_LOC100533521.2.2.m.52097,0.00288945953749072,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC100533524.1.1.m.33932,-0.00308826781239649,No,NA,NA,E2RDZ6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566],NA,NA,NA
CHOYP_LOC100533528.2.2.m.26125,0.000397484019536032,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533537.1.1.m.36,-0.00233791645123696,No,NA,NA,Q921J2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100535066.1.2.m.15640,-0.00122156909525168,No,NA,NA,O54891,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100535716.2.3.m.39162,-0.00212106930998203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100536597.1.1.m.52329,-0.0113012404375185,No,NA,NA,Q14657,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100537361.1.1.m.55516,0.00727539728685349,No,NA,NA,P10076,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100538313.1.1.m.64152,0.00451810407138551,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100538996.1.1.m.14935,-0.00175939774747418,No,NA,NA,Q5R7P7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352],NA,NA,NA
CHOYP_LOC100539769.1.1.m.36990,0.00152514326555809,No,NA,NA,O60879,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_LOC100540539.1.1.m.14519,0.00237304459943497,No,NA,NA,Q15643,NA,NA,NA,cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi organization [GO:0007030]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_LOC100541322.1.1.m.43256,0.00366253031911521,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_LOC100543236.1.2.m.20322,-0.0108244846980906,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_LOC100543709.1.1.m.32086,0.0133966849028252,No,NA,NA,O08688,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100546924.1.2.m.34506,0.00223079677486551,No,NA,NA,Q8BP86,NA,NA,NA,snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796],NA,NA,NA
CHOYP_LOC100547490.1.1.m.5822,0.00334057039764211,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100548534.1.1.m.26484,-0.0142770741308747,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100548534.1.1.m.26485,-0.0139027814943061,No,NA,NA,Q01177,NA,NA,NA,extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF; modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707],NA,NA,NA
CHOYP_LOC100549486.1.1.m.54965,-0.00659301222147672,No,NA,NA,P70610,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100552087.1.1.m.26238,0.0030853383231576,No,NA,NA,Q15853,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100552337.1.1.m.19614,-0.00262484613252082,No,NA,NA,Q6ZQ58,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysome [GO:0005844]; TORC1 complex [GO:0031931]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100552374.1.1.m.21979,9.24894554963995e-05,No,NA,NA,Q3T0Y3,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100552730.1.1.m.18699,-0.00775118684463013,No,NA,NA,O35375,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_LOC100553519.1.1.m.20707,-0.0136758287714254,No,NA,NA,Q8VDM6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100553663.1.1.m.58460,0.0107093572427798,No,NA,NA,Q6P7A9,NA,NA,NA,lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; alpha-1;4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; glycogen catabolic process [GO:0005980],NA,NA,NA
CHOYP_LOC100553687.1.1.m.61663,-0.000838817599544821,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_LOC100553809.1.1.m.45965,0.000540002478888382,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100554313.1.1.m.20949,-0.0190315821600651,No,NA,NA,Q6P069,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; repressing transcription factor binding [GO:0070491]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077],NA,NA,NA
CHOYP_LOC100554450.1.1.m.66550,-0.0023118345512582,No,NA,NA,Q8R3Q6,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100554578.1.2.m.7421,0,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100554670.1.1.m.4865,0.00593192589387736,No,NA,NA,Q8IZD4,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_LOC100555223.1.1.m.47612,-0.00210292576300995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100555295.1.1.m.51356,-0.0226658448038275,No,NA,NA,Q9DBU0,NA,NA,NA,autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_LOC100555755.1.1.m.58711,-0.00866804657605006,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_LOC100555907.1.1.m.27452,-0.0180171025799797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100556034.2.2.m.15378,-0.0172515799062552,No,NA,NA,Q5TFE4,NA,NA,NA,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100556517.1.1.m.22221,0.000613695102036997,No,NA,NA,P79942,NA,NA,NA,metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100558815.1.1.m.30536,0.00415618392575218,No,NA,NA,P23193,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC100558843.1.1.m.14396,-0.0121005104027061,No,NA,NA,Q5VWZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LOC100559879.1.1.m.8598,-0.00306947793378108,No,NA,NA,Q9D8N6,NA,NA,NA,transcriptional repressor complex [GO:0017053],NA,NA,NA
CHOYP_LOC100559941.1.2.m.12240,-0.00132241168111171,No,NA,NA,Q3TLH4,NA,NA,NA,cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_LOC100560334.2.3.m.42997,0.0210123767881134,No,NA,NA,Q9DAG6,NA,NA,NA,acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm connecting piece [GO:0097224]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100560768.1.1.m.18804,-0.0172509072840365,No,NA,NA,Q6PBT7,NA,NA,NA,integral component of membrane [GO:0016021]; PAM complex; Tim23 associated import motor [GO:0001405]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100561086.1.1.m.13015,-0.0233170928575652,No,NA,NA,Q7Z9I4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095],NA,NA,NA
CHOYP_LOC100561262.1.1.m.16846,-0.00358402891352489,No,NA,NA,P47791,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100561810.1.1.m.8656,-0.0031942856825582,No,NA,NA,Q80UY1,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498],NA,NA,NA
CHOYP_LOC100561894.1.1.m.45814,-0.00400687371911133,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100562697.1.1.m.27375,0.00126744896236199,No,NA,NA,Q3SZ45,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100562954.1.1.m.27429,0.00380587150369519,No,NA,NA,O70309,NA,NA,NA,cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta5 complex [GO:0034684]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100563402.1.1.m.5257,0.0239328170793541,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100563554.1.1.m.49953,0.005274630792436,No,NA,NA,Q1LY46,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100563867.1.1.m.11836,0.000814343539940099,No,NA,NA,Q8BGB5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100563952.1.1.m.30232,0.00349365432789305,No,NA,NA,Q32PA9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100564140.2.2.m.10031,0.000284190132330147,No,NA,NA,Q92010,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC100564354.1.1.m.46361,-0.00248241277602411,No,NA,NA,Q9NQP4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100564832.1.1.m.43026,-0.00197464481597275,No,NA,NA,Q95JD5,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100565366.1.1.m.49990,-0.00330345565464196,No,NA,NA,Q5SFM8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833],NA,NA,NA
CHOYP_LOC100565534.2.3.m.29570,-0.0025126050930215,No,NA,NA,Q40302,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100566943.1.2.m.35349,-0.0211624699083574,No,NA,NA,P02693,NA,NA,NA,apical cortex [GO:0045179]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; long-chain fatty acid transport [GO:0015909],NA,NA,NA
CHOYP_LOC100566968.1.1.m.15268,-0.000658392216724315,No,NA,NA,Q8AXY6,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100567114.1.1.m.39091,0.0137766007300506,No,NA,NA,Q3T052,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100567407.1.1.m.8503,-0.00235229721482362,No,NA,NA,Q5RB75,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100567969.1.1.m.26460,-0.00669884972792626,No,NA,NA,P36876,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100568234.1.1.m.60837,-0.012075537210697,No,NA,NA,Q8R0F3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; protein homodimerization activity [GO:0042803]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],NA,NA,NA
CHOYP_LOC100571875.1.1.m.48861,-0.0034183437510552,No,NA,NA,Q16595,NA,NA,NA,cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281],NA,NA,NA
CHOYP_LOC100575377.1.10.m.10592,0.000181464518870571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100576447.2.2.m.55515,0,No,NA,NA,Q9CR48,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100577801.1.1.m.7007,0.00484493140443674,No,NA,NA,Q9VPQ6,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell fate determination [GO:0007393]; ectoderm development [GO:0007398]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of cell fate specification [GO:0009996]; negative regulation of crystal cell differentiation [GO:0042690]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pigment metabolic process [GO:0042440]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100617548.1.1.m.64248,0.011279065421986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100618341.1.1.m.42477,0.00339231047205295,No,NA,NA,O15394,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_LOC100619435.1.2.m.28884,0.00357222733032489,No,NA,NA,P97576,NA,NA,NA,mitochondrion [GO:0005739]; PAM complex; Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100631809.1.2.m.30895,0.0215856497148749,No,NA,NA,Q9QXT1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325],NA,NA,NA
CHOYP_LOC100632370.1.1.m.25156,-0.0144891867953779,No,NA,NA,Q9FKK7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732],NA,NA,NA
CHOYP_LOC100632618.1.3.m.23426,-0.00808053607039774,No,NA,NA,Q9FE17,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632618.2.3.m.30752,-0.00971294332916304,No,NA,NA,B8ARK7,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632738.1.1.m.4911,-0.0046725004609832,No,NA,NA,O14082,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100632832.1.1.m.45608,-0.00881722450059526,No,NA,NA,Q9ET47,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100633041.1.1.m.35428,-0.000704105608990649,No,NA,NA,Q13423,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100633059.1.1.m.20098,0.0116663989386626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633075.1.4.m.4467,0.0140480140644851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633077.1.4.m.4444,0.00151530290075422,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100633077.4.4.m.62658,-0.000374275011511639,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100634021.1.1.m.53536,0.00710299727201088,No,NA,NA,Q8IYJ1,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC100634556.1.1.m.45015,0.0154623043808817,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100634688.3.6.m.36725,0.00890612970839587,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634688.6.6.m.63689,0.00176586196625662,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634891.1.1.m.11488,-0.0161709725045233,No,NA,NA,F6PHZ6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100635245.3.4.m.44747,0.0228382365964155,No,NA,NA,Q54GB3,NA,NA,NA,integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100635352.1.1.m.9481,-0.00954817918594187,No,NA,NA,Q2KI83,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100635487.1.1.m.21915,-0.000770877923454683,No,NA,NA,Q0P4P2,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100635694.1.1.m.24761,-0.00190314112139347,No,NA,NA,P55008,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC100635715.2.9.m.8040,0.00240480730390332,No,NA,NA,O16277,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100636110.1.2.m.5041,0.00847932160437343,No,NA,NA,Q04336,NA,NA,NA,mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC100636340.1.4.m.5143,-0.00821556396846994,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.3.4.m.44279,-0.00843638341272257,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.4.4.m.50991,-5.06767385979804e-05,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636433.3.4.m.27077,0.00087903823570059,No,NA,NA,O42401,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100636493.1.1.m.65727,0.000575760008418184,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_LOC100636568.1.1.m.16013,0.00638176487187204,No,NA,NA,P10351,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100636813.1.1.m.19517,-0.00158925395336719,No,NA,NA,Q66J85,NA,NA,NA,DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100637812.1.1.m.1303,0.000171989000128988,No,NA,NA,Q8WWF8,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100637925.1.4.m.34491,0.00278606530432235,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_LOC100637925.3.4.m.48236,0.00770182891046807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638337.1.1.m.19693,0.023364201153942,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638372.1.1.m.60468,-0.00134149596203188,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100638431.10.10.m.59513,0,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.4.10.m.48496,0.00763945582522818,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.8.10.m.58430,-0.0238582179932393,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638860.2.2.m.44785,0.00390314472913975,No,NA,NA,O28987,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100638885.1.4.m.28187,-0.00721270441254165,No,NA,NA,Q95ND5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100639369.1.1.m.23669,0.018530022127508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639574.1.1.m.40201,-0.00840457826865338,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639626.1.1.m.61641,0.00108160401965256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639879.1.1.m.38832,-0.000790643473212393,No,NA,NA,Q8WZ64,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100640001.1.2.m.37241,0.0032537980014249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640001.2.2.m.62667,0.00193091618246617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640206.1.1.m.48266,-0.000201581873128544,No,NA,NA,O35075,NA,NA,NA,endosome [GO:0005768]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100640260.1.2.m.21931,-0.00680145461498068,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100640618.1.1.m.4378,0.0279525705181599,No,NA,NA,Q5U3U0,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100641267.1.2.m.49206,0.00310513011590443,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641267.2.2.m.57947,0.000721686641753423,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641892.1.1.m.56601,0.00492225452735109,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100641969.1.1.m.7196,-0.0101092322903138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100642024.1.2.m.38402,0.000734476161157959,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_LOC100642349.1.1.m.53035,-0.00449561511041555,No,NA,NA,Q6DKB0,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC100642494.1.1.m.58088,0.000515693623292664,No,NA,NA,Q3V384,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC100642680.1.1.m.6611,-0.00878337040580746,No,NA,NA,Q8TCA0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100642881.1.1.m.14183,-0.0197089160346482,No,NA,NA,Q8NCN5,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25639,-0.00949910544025396,No,NA,NA,Q9CPY6,NA,NA,NA,ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100642984.1.1.m.28915,0.023322031099181,No,NA,NA,Q9UM13,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100643070.1.1.m.40176,-0.00200312178157862,No,NA,NA,Q24498,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347],NA,NA,NA
CHOYP_LOC100644321.3.7.m.24037,0.00152225128722666,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644321.6.7.m.56495,-0.0022329725846769,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54959,-0.00529906521261134,No,NA,NA,Q9UBI9,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54960,0.0131847600909056,No,NA,NA,Q5PQP2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100645183.1.1.m.53488,0.00377830549452024,No,NA,NA,Q6NTN5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100645380.1.1.m.14246,0.0047021237691073,No,NA,NA,Q9DBG7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_LOC100645450.1.1.m.39898,-0.0213452675278457,No,NA,NA,O60502,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100645706.1.1.m.62733,-0.00953142253195587,No,NA,NA,A5D794,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100646524.1.1.m.44445,0.000443596248405137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100646535.1.1.m.61774,-0.00286198673489475,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC100646574.1.1.m.55144,0.00164768177464059,No,NA,NA,Q7SXN5,NA,NA,NA,cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821],NA,NA,NA
CHOYP_LOC100646810.1.1.m.25033,-0.00333014639645312,No,NA,NA,O95045,NA,NA,NA,cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine metabolic process [GO:0046108],NA,NA,NA
CHOYP_LOC100647135.1.2.m.21531,0.00330250360309843,No,NA,NA,C9D7C2,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100647521.2.2.m.59908,-0.00794544597749239,No,NA,NA,P50416,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_LOC100647948.1.1.m.9650,-0.000868100714312265,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100648051.2.2.m.61174,-0.00134378997773878,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC100648516.1.1.m.64902,0.00303801128196006,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100649130.1.1.m.58207,0.00117307714175912,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100649205.1.1.m.39938,0.0111903054696892,No,NA,NA,O43257,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063],NA,NA,NA
CHOYP_LOC100649375.1.1.m.21222,-0.000169734650712972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100650469.1.2.m.42139,-0.0106788276195835,No,NA,NA,Q9JM52,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative thymic T cell selection [GO:0045060]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100650552.1.1.m.44153,-0.00337847083490604,No,NA,NA,Q9VHN6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100650613.1.1.m.10270,0.000199789304834246,No,NA,NA,Q9UJX6,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100650648.1.2.m.24726,-0.00507650012659053,No,NA,NA,W0LYS5,NA,NA,NA,ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100650709.1.1.m.12958,-0.0198032527020678,No,NA,NA,Q9CQ90,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100651274.1.1.m.26220,-0.00216333375792042,No,NA,NA,O54941,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100651327.1.1.m.34619,-0.000537030654061573,No,NA,NA,F1RD40,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_LOC100651687.1.1.m.39884,-0.0044640980437595,No,NA,NA,Q76I76,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_LOC100653683.1.1.m.7478,-0.0166363703208517,No,NA,NA,Q9R0Z7,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100655005.1.1.m.51334,-0.00183732876076762,No,NA,NA,Q6P4S8,NA,NA,NA,integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474],NA,NA,NA
CHOYP_LOC100656236.1.1.m.27240,0.0072019476709593,No,NA,NA,Q8HY12,NA,NA,NA,integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100658481.1.1.m.8712,-0.00822316017588522,No,NA,NA,Q14978,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100659825.1.1.m.62706,0.0129300962109478,No,NA,NA,Q8K2L8,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234],NA,NA,NA
CHOYP_LOC100668913.1.1.m.6819,-0.0234924914408541,No,NA,NA,Q9WVF8,NA,NA,NA,mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567],NA,NA,NA
CHOYP_LOC100669963.1.1.m.57300,-0.00281498857800422,No,NA,NA,Q5RJR8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090],NA,NA,NA
CHOYP_LOC100670231.1.1.m.6369,-0.0111795573894557,No,NA,NA,Q8BHT6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100672555.1.1.m.15827,0.00336400565720038,No,NA,NA,B6D5P6,NA,NA,NA,axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100677972.1.1.m.12181,0,No,NA,NA,Q60738,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_LOC100678100.1.1.m.14602,-0.00410416321279351,No,NA,NA,B4U7S7,NA,NA,NA,cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100678410.1.1.m.16114,0.00515372667543608,No,NA,NA,Q3MII6,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096],NA,NA,NA
CHOYP_LOC100679233.1.1.m.21455,-0.00629683473732726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679608.1.3.m.1597,-0.0183143427999554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679620.1.1.m.66367,-0.00519894740626687,No,NA,NA,Q6DFN1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100680210.1.1.m.5750,-0.00105999750858428,No,NA,NA,Q02427,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100681683.1.1.m.60729,0.0139536001809288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100689951.1.1.m.56514,-0.00181601119739343,No,NA,NA,P11179,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100690782.1.1.m.26094,0.000814362079749685,No,NA,NA,A2VDC2,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_LOC100690874.1.2.m.62880,0.0199877010535421,No,NA,NA,O14832,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC100691034.1.2.m.10976,0.0232296078586866,No,NA,NA,Q9D0S9,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100691144.1.1.m.47006,0.000714204090316562,No,NA,NA,Q4QQW3,NA,NA,NA,mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539],NA,NA,NA
CHOYP_LOC100691455.1.1.m.3282,0.00327274716102294,No,NA,NA,Q505H4,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24964,0.0159893973001548,No,NA,NA,Q9Y305,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24965,0.00651476871478477,No,NA,NA,P62255,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100691601.2.2.m.40748,0.00733300376521856,No,NA,NA,P31597,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813],NA,NA,NA
CHOYP_LOC100691676.1.1.m.64226,-0.0039709737580622,No,NA,NA,Q9UKK9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_LOC100692139.1.1.m.27787,-0.00122077571283488,No,NA,NA,O57478,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783],NA,NA,NA
CHOYP_LOC100692402.2.2.m.49856,-0.00969072746970335,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55157,0.00116449836173295,No,NA,NA,P45954,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55158,-0.00541965618992433,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100692795.2.2.m.50682,0.0114399183697679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100692883.1.1.m.5437,0.00175822130814301,No,NA,NA,Q5IS41,NA,NA,NA,extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100692894.1.1.m.10137,-0.00715518609181336,No,NA,NA,Q8WWT9,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746],NA,NA,NA
CHOYP_LOC100693418.1.2.m.990,-0.0135540797253433,No,NA,NA,P56389,NA,NA,NA,cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC100693575.1.1.m.19082,-0.00555938554763785,No,NA,NA,Q8K4P0,NA,NA,NA,collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_LOC100693708.1.1.m.7688,0.000128216065258363,No,NA,NA,Q5RGU1,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100693867.1.1.m.27278,0.00404729761594233,No,NA,NA,Q03249,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_LOC100694272.1.1.m.19247,0.00188706062838909,No,NA,NA,P78318,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100694623.1.1.m.14876,0.00657346160875792,No,NA,NA,Q80Z30,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496],NA,NA,NA
CHOYP_LOC100694648.1.1.m.18881,-0.00964970092881865,No,NA,NA,Q8K268,NA,NA,NA,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607],NA,NA,NA
CHOYP_LOC100694901.3.3.m.66949,-0.00230068772016719,No,NA,NA,Q3SZE2,NA,NA,NA,cytosol [GO:0005829]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082],NA,NA,NA
CHOYP_LOC100695151.2.2.m.30573,0.00192088531535162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100695307.1.1.m.51209,-0.0178320520361453,No,NA,NA,A9JS71,NA,NA,NA,mitochondrion [GO:0005739]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100695438.1.1.m.8594,0.000213278948255433,No,NA,NA,Q9QYE0,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100696358.1.1.m.27370,-0.0171622313728177,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696668.1.1.m.31105,0.00221868792854828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696985.1.1.m.17599,0.0207909735840426,No,NA,NA,O43719,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; regulation of DNA-templated transcription; elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC100697247.1.2.m.37588,0.0284325314172195,No,NA,NA,Q60438,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697247.2.2.m.56896,0.00187942630714133,No,NA,NA,Q4V7M2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697720.1.2.m.5790,0.0167179977312365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697793.5.6.m.62286,-0.0101367447259908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697862.1.1.m.27738,-0.000871057666521913,No,NA,NA,O02467,NA,NA,NA,lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC100698013.1.1.m.5420,1.14313566072595e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100698240.2.4.m.14964,0.00727212564306305,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100698638.1.1.m.45171,0.000189665871849636,No,NA,NA,A2AJ88,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100699093.1.1.m.20134,0.0012865449113813,No,NA,NA,Q2KJC9,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100699161.1.1.m.35139,0.00743795466516483,No,NA,NA,Q5U247,NA,NA,NA,exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100699383.1.1.m.63490,0.0027679580664557,No,NA,NA,Q95VY2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100699837.1.1.m.54956,0.00870463312616707,No,NA,NA,Q5E9P6,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],NA,NA,NA
CHOYP_LOC100699850.1.3.m.3523,0.000383238327739859,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100700188.1.1.m.30931,-0.0102244139326779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100700230.1.1.m.57851,-0.000845754386967293,No,NA,NA,A4IGH4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC100700626.2.2.m.17262,0.000186796380223951,No,NA,NA,Q13395,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100700757.1.1.m.23394,-0.00839505043022521,No,NA,NA,Q8N0X4,NA,NA,NA,mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],NA,NA,NA
CHOYP_LOC100701105.1.1.m.56657,-0.00681597811251983,No,NA,NA,Q91XF0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_LOC100701406.1.1.m.23796,-0.00729426724773093,No,NA,NA,Q6UX04,NA,NA,NA,catalytic step 1 spliceosome [GO:0071012]; catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100701551.1.7.m.3948,0.00194808330535314,No,NA,NA,Q9CQR2,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000461],NA,NA,NA
CHOYP_LOC100701725.1.1.m.54512,0.00269957635986552,No,NA,NA,Q8HXM1,NA,NA,NA,cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100702367.1.1.m.62543,-0.0218172913373302,No,NA,NA,Q5U3V9,NA,NA,NA,ESCRT II complex [GO:0000814]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_LOC100703090.1.1.m.46433,0.0118581450769241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703202.1.1.m.10370,0.00138607357805466,No,NA,NA,Q503I8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],NA,NA,NA
CHOYP_LOC100703289.1.1.m.53585,0.00335989418206146,No,NA,NA,Q8CF97,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100703423.1.1.m.940,-0.00105545197773365,No,NA,NA,P40939,NA,NA,NA,mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_LOC100703423.1.1.m.941,-0.000976085828552261,No,NA,NA,O46629,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100703585.2.4.m.39510,0.00973439943661193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703956.1.1.m.31550,-0.00850318697785319,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100704039.1.1.m.21695,-0.011849298648758,No,NA,NA,E9PTA2,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100704264.1.1.m.49420,-0.0144890014753557,No,NA,NA,P52333,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; MAPK cascade [GO:0000165]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL biosynthetic process [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of JAK-STAT cascade [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100704562.1.1.m.25340,0.000644704287335812,No,NA,NA,Q8YWD8,NA,NA,NA,peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_LOC100704819.1.2.m.14210,0.0098557411055507,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100704819.2.2.m.49100,-0.00098050085808268,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100705265.3.3.m.40296,-0.0027862740992909,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LOC100705460.1.3.m.4908,0.0106325526783571,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC100705726.1.1.m.17900,-0.00491751985860174,No,NA,NA,Q8JZL3,NA,NA,NA,cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100706133.1.1.m.56708,0.00782009932203188,No,NA,NA,Q28EW0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100706374.1.1.m.51988,-0.0219046646896505,No,NA,NA,Q9UBS3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100706747.1.1.m.14818,0.00948147246521138,No,NA,NA,P23965,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100707249.1.1.m.15336,-0.0168362943939328,No,NA,NA,P50219,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520],NA,NA,NA
CHOYP_LOC100707367.1.1.m.16292,0.00016441142819423,No,NA,NA,Q9JLV6,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; double-stranded DNA binding [GO:0003690]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100707656.1.1.m.10569,0.00734722752701793,No,NA,NA,Q8VXZ0,NA,NA,NA,chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100707920.1.1.m.27511,-0.0138909176209159,No,NA,NA,Q8C4J7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_LOC100708024.1.2.m.7177,-0.00412224539456572,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100708054.1.1.m.57813,0.00308522030125107,No,NA,NA,P42566,NA,NA,NA,aggresome [GO:0016235]; AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; ciliary membrane [GO:0060170]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; epidermal growth factor receptor signaling pathway [GO:0007173]; Golgi to endosome transport [GO:0006895]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cell proliferation [GO:0042127]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_LOC100708199.3.6.m.23799,-0.0101148982210542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708199.6.6.m.57028,-0.00430514102230959,No,NA,NA,P10394,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_LOC100708329.1.1.m.3319,-0.0136403227606132,No,NA,NA,P47224,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100708602.1.1.m.65805,0,No,NA,NA,Q66IH2,NA,NA,NA,nucleus [GO:0005634]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100708650.1.3.m.10354,0.00890473638367595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708717.1.1.m.5825,0.00319224779157033,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100708991.1.5.m.740,-0.0222638726333912,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.2.5.m.29236,-0.00957903786912555,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100708991.3.5.m.40072,0.0164354831028026,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.5.5.m.59991,0.00818698745441332,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100709262.1.2.m.17960,-0.00738105379694315,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100709316.1.1.m.17221,0.000367728228605934,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100709493.2.2.m.59425,-0.0146677020262429,No,NA,NA,A6NHC0,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709538.1.2.m.4299,-0.00121967995331676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100709617.1.1.m.10644,0.000436113443351199,No,NA,NA,Q76IC5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709948.1.1.m.9245,-0.0111881187456489,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100710392.2.2.m.14004,0.000210904565299237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710565.1.1.m.5315,0.00383813364952198,No,NA,NA,O46640,NA,NA,NA,cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685],NA,NA,NA
CHOYP_LOC100710612.1.1.m.5449,0.00239851814243143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710670.1.2.m.7245,-0.00227018388516797,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710670.2.2.m.45011,0.00278301003276065,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710965.1.1.m.15140,-0.0169849932941077,No,NA,NA,Q99ND9,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825],NA,NA,NA
CHOYP_LOC100711334.1.1.m.16928,-0.00189061635315767,No,NA,NA,P17078,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100711559.1.1.m.10313,0.00533685456372218,No,NA,NA,Q6NW52,NA,NA,NA,mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_LOC100711617.1.1.m.9209,0.00531571725911112,No,NA,NA,Q9D7M8,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100713637.1.1.m.16691,-0.00612793327440179,No,NA,NA,Q5RL51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100714922.1.1.m.39817,0.00673289445391449,No,NA,NA,Q9WTN5,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100717261.1.1.m.51839,0.00260699003871682,No,NA,NA,Q8JG30,NA,NA,NA,cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100718468.1.1.m.11334,-0.0124895833360873,No,NA,NA,Q96ER3,NA,NA,NA,extracellular space [GO:0005615]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100720440.1.2.m.11473,0.000207947348950823,No,NA,NA,Q9Y4C0,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100721364.1.1.m.15879,-0.00729603504924788,No,NA,NA,Q8IYB9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100721584.1.1.m.52602,0.0210163031158077,No,NA,NA,Q2M385,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_LOC100723342.1.1.m.58414,-0.00487516734882551,No,NA,NA,Q9UHB7,NA,NA,NA,ELL-EAF complex [GO:0032783]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; spermatid development [GO:0007286]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100725472.1.2.m.5970,-0.006976579483471,No,NA,NA,Q95KI0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100726220.1.1.m.8701,-0.0103623541519545,No,NA,NA,Q6PEE2,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC100726448.1.1.m.26536,0.0160895598871791,No,NA,NA,Q711G3,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100727159.1.1.m.60272,-0.009360056970722,No,NA,NA,Q5SSZ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9365,0.00822490783941231,No,NA,NA,Q5U2Z0,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9366,0.00563859307981588,No,NA,NA,Q6AXS5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; mRNA 3'-UTR binding [GO:0003730]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100728625.2.2.m.51928,-0.00541363935729283,No,NA,NA,Q9S9V0,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to salicylic acid [GO:0009751],NA,NA,NA
CHOYP_LOC100729623.1.2.m.6310,-5.47071909680918e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100740578.1.1.m.65702,-0.00893863255407945,No,NA,NA,Q04870,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; transferase activity [GO:0016740]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100740873.1.1.m.46472,-0.0014957297043711,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_LOC100741247.2.2.m.27816,0.00160646828908858,No,NA,NA,Q9Z1G4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_LOC100741250.1.2.m.48951,0.00302968331371304,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100741406.1.1.m.29038,-4.37012378697591e-05,No,NA,NA,Q6PD03,NA,NA,NA,centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100742152.1.2.m.4504,-0.00152944716361202,No,NA,NA,Q5ZLR5,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_LOC100742289.1.1.m.25180,-0.0015157986928456,No,NA,NA,Q91447,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],NA,NA,NA
CHOYP_LOC100743250.1.1.m.12309,0.0079956039731679,No,NA,NA,Q14642,NA,NA,NA,membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100743251.1.1.m.16814,-0.00169658306437062,No,NA,NA,Q8BMF3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; pyruvate metabolic process [GO:0006090],NA,NA,NA
CHOYP_LOC100743492.1.1.m.58896,0.0102481986260335,No,NA,NA,P49963,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane; signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC100743548.1.2.m.18991,0.00648157412951158,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100743601.1.1.m.37797,0.00945858519082037,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100743901.1.1.m.4559,0.000449130377278238,No,NA,NA,Q6DC04,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; histone arginine methylation [GO:0034969]; histone H3-R17 methylation [GO:0034971]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100744089.1.1.m.58530,0.0221224232845996,No,NA,NA,Q7ZVK3,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],NA,NA,NA
CHOYP_LOC100744356.1.1.m.49326,0.00259296366673552,No,NA,NA,Q9P2K3,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212],NA,NA,NA
CHOYP_LOC100744369.1.1.m.56678,-0.00221624854441947,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100744506.1.1.m.44043,0.0106288993317905,No,NA,NA,O46037,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100745330.1.1.m.65802,0.012126012777884,No,NA,NA,O35598,NA,NA,NA,cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; amyloid-beta formation [GO:0034205]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100745429.1.1.m.27818,-0.00334262182710315,No,NA,NA,O95758,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100745778.1.1.m.27697,0.00070116068560099,No,NA,NA,Q7T3N8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100748006.1.2.m.19013,-0.00734617546240914,No,NA,NA,Q6P9H4,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765],NA,NA,NA
CHOYP_LOC100748395.4.7.m.40663,-0.00133923118343942,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748395.6.7.m.57994,0.011467320820883,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748436.1.1.m.33164,0.0134366466597897,No,NA,NA,P13216,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100748625.1.1.m.24479,0.0017780097996996,No,NA,NA,Q9JIH2,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100749296.1.1.m.45471,0.0128313238058527,No,NA,NA,A1A4S6,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100749463.1.1.m.6770,-0.00518537824939549,No,NA,NA,Q93009,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8950,0.00637307689911959,No,NA,NA,Q9CWL2,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription; DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8951,-0.0131393101745154,No,NA,NA,O35125,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC100749745.1.1.m.11523,0.00772042110335296,No,NA,NA,P48545,NA,NA,NA,external side of plasma membrane [GO:0009897]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100752270.1.1.m.23081,-0.0108485135469235,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100755189.1.1.m.33307,0.00253251906890386,No,NA,NA,Q9CQM5,NA,NA,NA,cytosol [GO:0005829]; peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100759507.1.1.m.30604,-0.00100883952408142,No,NA,NA,P17900,NA,NA,NA,apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC100769755.1.1.m.59793,0.0107277264152581,No,NA,NA,Q8IV20,NA,NA,NA,peroxisome [GO:0005777]; copper ion binding [GO:0005507],NA,NA,NA
CHOYP_LOC100770235.1.1.m.2514,0.00733111125392203,No,NA,NA,Q9R001,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; negative regulation of cold-induced thermogenesis [GO:0120163]; tooth eruption [GO:0044691],NA,NA,NA
CHOYP_LOC100770313.1.1.m.3513,-0.0163546478169542,No,NA,NA,O00748,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100808508.1.1.m.59055,-4.19272048301111e-05,No,NA,NA,Q93XW5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme regulator activity [GO:0030234]; glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028],NA,NA,NA
CHOYP_LOC100841619.1.1.m.40382,-0.0043491942566402,No,NA,NA,P10447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100862999.1.1.m.11759,0.00326156748389022,No,NA,NA,Q6PEC4,NA,NA,NA,Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100863242.1.1.m.9849,0.00116110713267105,No,NA,NA,Q767L0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100863386.1.1.m.37224,-0.00441475911846519,No,NA,NA,P98156,NA,NA,NA,apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; glycoprotein transporter activity [GO:0034437]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100863781.1.1.m.33751,-0.00398245729615551,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC100863920.1.1.m.40408,-0.0038231022206048,No,NA,NA,B0W6M9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100864134.1.1.m.41690,0.00632654416316567,No,NA,NA,Q2PFD7,NA,NA,NA,cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_LOC100864501.1.1.m.7850,-0.00873245185341203,No,NA,NA,M9PBE2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration; open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282],NA,NA,NA
CHOYP_LOC100864577.1.1.m.8977,0.000811720714766155,No,NA,NA,Q9Y4K4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100865129.1.1.m.45329,0.00523279485213322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100865286.1.1.m.17958,-0.0104637134835358,No,NA,NA,O02695,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100865976.1.1.m.15403,-0.000474804618109776,No,NA,NA,Q9W445,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_LOC100866180.1.1.m.49582,-0.0217250613678883,No,NA,NA,Q8IV50,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100867381.8.8.m.53059,0.00919193738825428,No,NA,NA,Q62417,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; SH3/SH2 adaptor activity [GO:0005070]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_LOC100867487.2.2.m.65146,0.000266510960463915,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC100867628.1.1.m.1331,-0.000952592225403204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100867962.1.1.m.19193,-0.0238863607463884,No,NA,NA,A2AV36,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription; DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100869625.1.1.m.52959,0.00227988614279945,No,NA,NA,Q8VEG6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_LOC100870649.1.2.m.13573,0.0200828037444737,No,NA,NA,Q9UKI8,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672],NA,NA,NA
CHOYP_LOC100872239.1.1.m.53052,0.000228921035578569,No,NA,NA,Q9H9H4,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC100872507.1.1.m.21152,0.0115365835884428,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_LOC100874620.1.1.m.23782,0.00317631678022717,No,NA,NA,Q01063,NA,NA,NA,apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100875369.1.1.m.31446,0.00767457469169284,No,NA,NA,P20936,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_LOC100875390.1.1.m.24780,-0.000527232946940205,No,NA,NA,Q641Z6,NA,NA,NA,ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_LOC100875404.1.1.m.8506,-0.0137308721882422,No,NA,NA,Q6AXY7,NA,NA,NA,precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100875479.1.2.m.42509,-0.00774309690465051,No,NA,NA,Q7PHR1,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100875585.1.1.m.8714,-0.00386291517990422,No,NA,NA,Q00174,NA,NA,NA,axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth; open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100875705.1.1.m.10980,-0.00964940375468673,No,NA,NA,Q9V9W8,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription; DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_LOC100875978.1.1.m.34640,-0.0126521641282194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100875987.1.2.m.7720,-0.00261161706497279,No,NA,NA,P42026,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100876012.1.1.m.8280,-0.0210697236271925,No,NA,NA,Q16831,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218],NA,NA,NA
CHOYP_LOC100876515.2.2.m.54514,0.00225234630363958,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876659.1.1.m.19405,7.73304839233479e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100876663.1.1.m.4368,0.00958013487728712,No,NA,NA,O01404,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620],NA,NA,NA
CHOYP_LOC100877311.1.1.m.25123,-0.00206472985148998,No,NA,NA,Q9NX05,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100877335.1.1.m.8851,0.000844158306498491,No,NA,NA,Q61329,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; response to transforming growth factor beta [GO:0071559],NA,NA,NA
CHOYP_LOC100877393.1.1.m.26310,0.00635520926930313,No,NA,NA,Q5F499,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053],NA,NA,NA
CHOYP_LOC100877438.2.2.m.37290,-0.0103850660529048,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_LOC100877549.1.1.m.8321,-0.00506453571373354,No,NA,NA,Q91WD2,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100877554.2.2.m.34916,-0.00504002284378971,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100877618.1.1.m.39871,0,No,NA,NA,Q86V88,NA,NA,NA,metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100877689.1.2.m.14376,0.00803919826060907,No,NA,NA,Q9ERG0,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],NA,NA,NA
CHOYP_LOC100877689.2.2.m.26187,0.000424029231676879,No,NA,NA,Q9BT23,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100877728.1.1.m.19879,0.00136127422275701,No,NA,NA,Q5ZLS7,NA,NA,NA,nuclear speck [GO:0016607]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100877749.1.1.m.65236,-0.00286373027120583,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100877947.1.1.m.51907,-0.00777401220663924,No,NA,NA,Q6PFX9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome; telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome; telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100877992.1.1.m.1507,-0.00186391422495687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100878123.1.1.m.55730,0.0164932708974483,No,NA,NA,A5PK45,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028],NA,NA,NA
CHOYP_LOC100878391.1.1.m.28644,0.000511340295710802,No,NA,NA,O35094,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; cardiac muscle cell differentiation [GO:0055007]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; response to 3;3';5-triiodo-L-thyronine [GO:1905242],NA,NA,NA
CHOYP_LOC100878601.1.1.m.15486,-0.0148702726650218,No,NA,NA,Q803E1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028],NA,NA,NA
CHOYP_LOC100879052.1.1.m.53743,0.00832641449904841,No,NA,NA,A1XBS5,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100879129.1.1.m.44467,0.00551154134065389,No,NA,NA,Q5DTY9,NA,NA,NA,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],NA,NA,NA
CHOYP_LOC100879250.1.1.m.24381,0.000407911630667905,No,NA,NA,Q589R5,NA,NA,NA,cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],NA,NA,NA
CHOYP_LOC100879339.1.1.m.20204,0.0001612294115344,No,NA,NA,Q8TBG4,NA,NA,NA,mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC100879389.2.2.m.63959,-0.00103462223482139,No,NA,NA,Q92804,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100879487.1.3.m.20887,0.013845003967381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879487.2.3.m.32793,0.0123557144663109,No,NA,NA,Q8K480,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; eye photoreceptor cell development [GO:0042462]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33048,-1.94270198952866e-05,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33049,0.0052518271073218,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100879690.1.1.m.18064,0.00526209992878607,No,NA,NA,Q6AWC2,NA,NA,NA,cytosol [GO:0005829]; kinase binding [GO:0019900]; protein-containing complex scaffold activity [GO:0032947]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100879804.1.1.m.59833,0.00325597101899337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879890.1.1.m.4963,0.00543425325110021,No,NA,NA,O00499,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cell proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle arrest [GO:0071156]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; T-tubule organization [GO:0033292]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100879964.1.1.m.1780,-0.00319051062516692,No,NA,NA,Q924I2,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to UV [GO:0009411]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100879981.1.1.m.57826,0.000521170791125669,No,NA,NA,O75808,NA,NA,NA,cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100880308.1.1.m.6158,-0.0154279154448473,No,NA,NA,Q5EA98,NA,NA,NA,microfibril [GO:0001527]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100880757.2.2.m.41249,-0.00114229857373532,No,NA,NA,Q4PIN7,NA,NA,NA,nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100880815.3.7.m.45911,-0.00578399894496534,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100880815.5.7.m.54594,0.00840784840609419,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100880948.1.1.m.25232,-0.00512034761764344,No,NA,NA,P52632,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100881280.1.1.m.39133,0.012518843415048,No,NA,NA,Q9EQW7,NA,NA,NA,centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cargo loading into vesicle [GO:0035459]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_LOC100881316.1.1.m.51540,0.000394112591478572,No,NA,NA,P47812,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100881430.1.1.m.4201,0.00124031912381052,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100881900.1.3.m.1852,-0.000745902952729018,No,NA,NA,P54357,NA,NA,NA,cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048],NA,NA,NA
CHOYP_LOC100882263.1.1.m.48839,-0.00250750483540204,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100882621.1.2.m.25860,0.00442743476413873,No,NA,NA,Q8IRG6,NA,NA,NA,cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100883123.1.1.m.704,-0.011645240490772,No,NA,NA,P62501,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100883412.1.1.m.25657,-0.00569372574865432,No,NA,NA,O15550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],NA,NA,NA
CHOYP_LOC100883571.1.1.m.42323,0.000735806535100773,No,NA,NA,Q9UPY6,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100883586.1.1.m.268,-0.0131454796451349,No,NA,NA,Q641Z2,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to plasma membrane [GO:1903078],NA,NA,NA
CHOYP_LOC100883864.1.1.m.41791,0.000706574144066921,No,NA,NA,Q9WUB3,NA,NA,NA,cytoplasm [GO:0005737]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; AMP binding [GO:0016208]; carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; cellular calcium ion homeostasis [GO:0006874]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; response to cAMP [GO:0051591]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC100888253.1.1.m.18761,-0.00637140737035161,No,NA,NA,A2RRH5,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100888299.1.3.m.3738,0.00462545092628544,No,NA,NA,Q6MHJ5,NA,NA,NA,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC100888300.1.2.m.10203,0.0171367290675865,No,NA,NA,Q92805,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,NA,NA
CHOYP_LOC100888608.1.3.m.5445,0.017249223779577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100888702.1.1.m.56287,0.00550118853057496,No,NA,NA,P35448,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC100888889.1.1.m.14397,-0.00677898930023746,No,NA,NA,Q5HY98,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100888910.1.1.m.64827,0.0228664200474902,No,NA,NA,Q7ZWI4,NA,NA,NA,cytoplasm [GO:0005737]; protein kinase A binding [GO:0051018]; regulation of canonical Wnt signaling pathway [GO:0060828],NA,NA,NA
CHOYP_LOC100888919.1.1.m.1193,-0.00374418079661604,No,NA,NA,P25455,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; regulation of neuromuscular synaptic transmission [GO:1900073],NA,NA,NA
CHOYP_LOC100888944.1.1.m.45112,-0.018642705765579,No,NA,NA,P53500,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100889245.1.2.m.999,0.00564010879992973,No,NA,NA,A2ALS5,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC100889318.1.1.m.61506,-0.00475774670883869,No,NA,NA,Q9VCX1,NA,NA,NA,apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification; ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_LOC100889336.1.1.m.18327,-0.0242220796012567,No,NA,NA,Q6ZV65,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100889562.1.1.m.27158,0.00752867907811633,No,NA,NA,A9VFD6,NA,NA,NA,ATP binding [GO:0005524]; S-methyl-5-thioribose kinase activity [GO:0046522]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_LOC100889564.1.1.m.17148,-0.00126451431655994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100889564.1.1.m.17149,-0.0211951737321195,No,NA,NA,Q6DF46,NA,NA,NA,cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100889738.1.1.m.41184,-0.00369814835224302,No,NA,NA,Q6NXI6,NA,NA,NA,RNA polymerase II; holoenzyme [GO:0016591],NA,NA,NA
CHOYP_LOC100889837.1.2.m.2516,0.000398265682444629,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889837.2.2.m.31074,0.0178204351647446,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889942.1.1.m.57041,0.00564035347026184,No,NA,NA,Q96PN7,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding; bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cholesterol catabolic process [GO:0006707]; homeostatic process [GO:0042592]; multicellular organism development [GO:0007275]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of hormone biosynthetic process [GO:0046885]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100890015.1.1.m.8302,0.000251737020310645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890106.1.1.m.40543,0.0195354500884099,No,NA,NA,Q2M2T5,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],NA,NA,NA
CHOYP_LOC100890342.1.1.m.10194,0.00862125680410747,No,NA,NA,O15259,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; ciliary basal body-plasma membrane docking [GO:0097711]; excretion [GO:0007588]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_LOC100890433.1.1.m.30609,0.0159332265514586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890512.1.1.m.36422,-0.00365841897954774,No,NA,NA,Q8IYX7,NA,NA,NA,axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100890512.1.1.m.36423,0.00184754791165281,No,NA,NA,Q29L80,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100890517.2.2.m.22207,-0.00881112327760568,No,NA,NA,Q08E31,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome; centromeric region [GO:0000780]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100890554.1.1.m.28894,-0.00977428677842716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890653.1.1.m.13755,-0.0233915210652653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890753.2.3.m.53551,-0.00559969510007675,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890762.1.1.m.31399,-0.00625563323880028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891184.1.1.m.18226,-0.00982153122582729,No,NA,NA,O95477,NA,NA,NA,endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_LOC100891282.1.1.m.41107,0.00102271194627311,No,NA,NA,O00115,NA,NA,NA,extracellular exosome [GO:0070062]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100891402.2.3.m.27268,0.0087553185008212,No,NA,NA,P60897,NA,NA,NA,proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_LOC100891466.2.10.m.9752,-0.00762804552541745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891502.1.1.m.14627,0.00214527875479611,No,NA,NA,Q3ZBD2,NA,NA,NA,cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100891594.2.2.m.54602,0.000525340146924832,No,NA,NA,Q1MTN8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100891656.1.1.m.62466,-0.00258351394193291,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100891888.1.1.m.20756,0.0019518694288983,No,NA,NA,P29218,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100892150.1.1.m.10319,-0.00404451107323026,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100892193.1.5.m.13369,0.00209025012979376,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892193.2.5.m.28130,-0.00155391087830024,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892461.2.2.m.55369,0.00437771348469735,No,NA,NA,Q6PK81,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100892516.1.1.m.38152,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892637.1.1.m.49164,0.00721930648817866,No,NA,NA,Q2NKS3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100892743.1.1.m.55850,0,No,NA,NA,O54926,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],NA,NA,NA
CHOYP_LOC100892914.1.1.m.53491,-0.0201309884185054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892925.1.2.m.44655,0.00463281007574717,No,NA,NA,Q5F359,NA,NA,NA,endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC100893261.2.3.m.49437,0.00814408056355553,No,NA,NA,D4AR77,NA,NA,NA,extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_LOC100893889.1.2.m.7738,-4.19303951043413e-05,No,NA,NA,Q8IXR9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100893889.2.2.m.64935,0.00298044747284589,No,NA,NA,P04113,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100893981.1.1.m.56774,0.004922507660381,No,NA,NA,B0JZV4,NA,NA,NA,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],NA,NA,NA
CHOYP_LOC100897892.1.1.m.1462,0.0143311843621803,No,NA,NA,P82147,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_LOC100898095.9.19.m.32685,-0.00776984864089696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100898860.1.1.m.7386,0.00820704343790977,No,NA,NA,O76387,NA,NA,NA,cytosol [GO:0005829]; aminoacyl-tRNA hydrolase activity [GO:0004045],NA,NA,NA
CHOYP_LOC100899149.1.2.m.6146,0,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100899149.2.2.m.29105,-0.0124219041473743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899229.1.1.m.12157,-0.0174052475026627,No,NA,NA,Q9VRJ2,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730],NA,NA,NA
CHOYP_LOC100899437.1.1.m.28953,0.000359638617697947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899732.1.1.m.26595,-0.0172954512263924,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899882.1.3.m.27725,-0.00861653268120065,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100900162.1.1.m.58237,-0.00377300720274453,No,NA,NA,Q8AV57,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_LOC100900174.1.1.m.14983,-0.0056104453613826,No,NA,NA,A8K0R7,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100900429.1.1.m.13158,-0.00169357204532447,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100900935.1.1.m.56691,-0.00513380608939293,No,NA,NA,Q6P5E8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],NA,NA,NA
CHOYP_LOC100900939.1.1.m.15284,-0.0115644825354705,No,NA,NA,P11031,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7834,-0.0221337623519526,No,NA,NA,Q9VA73,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7835,0.00983320556150635,No,NA,NA,O14929,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100902046.1.1.m.11187,-0.0108879130179626,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100902075.1.1.m.10103,-0.00692189251538095,No,NA,NA,Q96FN5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100902565.1.1.m.19044,0.00763580104704031,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC100902628.1.1.m.1200,0.00116322334751189,No,NA,NA,O45947,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100902807.1.4.m.12152,-0.0112140530397434,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902807.4.4.m.59166,-0.00424166183240795,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902912.1.1.m.9008,-0.0113411789105916,No,NA,NA,Q1HCL7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741],NA,NA,NA
CHOYP_LOC100903522.1.3.m.2296,0.00134751496270574,No,NA,NA,Q28DR4,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100903758.1.1.m.43697,0.00748250343126667,No,NA,NA,Q47944,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100903812.1.1.m.65786,0.00430384049471996,No,NA,NA,Q15149,NA,NA,NA,brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100903999.1.1.m.16840,-0.00914553865682445,No,NA,NA,Q923M0,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC100904232.1.1.m.38777,-0.000663238834635374,No,NA,NA,Q96L92,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100904451.3.11.m.13002,0.00992390413605631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100904558.2.2.m.26621,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905188.1.1.m.2446,0.00786204491090057,No,NA,NA,Q9WYP5,NA,NA,NA,inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC100905387.1.1.m.30579,-0.0226926085260571,No,NA,NA,Q5TM62,NA,NA,NA,cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100905544.1.3.m.6504,-0.00740494569211869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905729.1.3.m.13789,0.0160636082503008,No,NA,NA,Q8WPI2,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC100906408.1.1.m.3002,0.00867490547425646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907253.3.3.m.27327,-0.000881778570562239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907408.1.1.m.24444,0.0096401860546243,No,NA,NA,Q9Z2P6,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100907708.1.1.m.16095,0.00125876258198853,No,NA,NA,O13035,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100907797.3.4.m.54168,0.00426564449450455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907841.1.1.m.39986,0.00807026263840876,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100907845.2.3.m.23111,-0.0124770800301998,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100908241.1.1.m.52509,0.00254292347215967,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_LOC100908688.1.5.m.30293,2.69714177944232e-05,No,NA,NA,P35979,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100910862.2.2.m.45085,0.000416676725290403,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100914852.1.1.m.29079,-0.00549876490121667,No,NA,NA,Q9W735,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485],NA,NA,NA
CHOYP_LOC100918713.1.1.m.17833,0,No,NA,NA,Q4V348,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100922782.1.1.m.5582,0.00734716008286877,No,NA,NA,Q8BK48,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209],NA,NA,NA
CHOYP_LOC100927475.1.1.m.28390,-0.00672779226241178,No,NA,NA,Q8VCT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acyl-CoA metabolic process [GO:0006637]; acylglycerol catabolic process [GO:0046464]; cholesterol biosynthetic process [GO:0006695]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379],NA,NA,NA
CHOYP_LOC100929680.1.2.m.17333,0.0109421997148144,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929680.2.2.m.28318,-0.00635521290453812,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929997.1.1.m.23658,0.00950836456110615,No,NA,NA,Q9H2H8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100931580.2.2.m.44310,0.00414890008303065,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_LOC100932567.1.1.m.26590,-0.0125557608234266,No,NA,NA,Q5T5Y3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC100933241.16.45.m.30626,-0.0172471361251026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100933589.3.3.m.59374,-0.0119401738867033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100934353.1.1.m.11772,-0.0155229919609507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101020089.1.1.m.9396,-0.000132445097600693,No,NA,NA,P10077,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101033229.1.1.m.38291,-0.0113573365833142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101040300.1.2.m.6533,0.00222152659947617,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC101058182.1.1.m.57909,-0.00934798093894485,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101060411.1.1.m.54761,0.00766957001691695,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061101.1.1.m.50165,0.00860651365051016,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061332.1.1.m.25069,0.00902519062937199,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_LOC101061667.1.1.m.8351,0.0178566592112666,No,NA,NA,Q80V24,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101062323.1.1.m.15918,0.00144143341326438,No,NA,NA,P54106,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101062578.1.1.m.56255,-0.000387084030568222,No,NA,NA,Q9R0D8,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_LOC101063181.1.1.m.12864,-0.00123487104880164,No,NA,NA,Q9EP82,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC101063699.1.1.m.18944,-0.0213601130482179,No,NA,NA,Q9UUI3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_LOC101063890.1.1.m.7895,-0.0112710313311201,No,NA,NA,P50607,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; phagocytosis; recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC101064182.1.1.m.8320,0.00572813406858389,No,NA,NA,Q5E9S4,NA,NA,NA,mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],NA,NA,NA
CHOYP_LOC101064384.1.1.m.19175,-0.0100854862288223,No,NA,NA,Q8NFH5,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101064472.1.1.m.66819,0.00407702414853734,No,NA,NA,P13944,NA,NA,NA,collagen type XII trimer [GO:0005595]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101064693.1.2.m.30288,-0.0180237143512075,No,NA,NA,A8TX70,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC101064793.1.1.m.27191,-0.0018493266663447,No,NA,NA,Q99471,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription; DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription; DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC101065571.1.2.m.36430,-0.0120389749008803,No,NA,NA,P24540,NA,NA,NA,acylphosphatase activity [GO:0003998],NA,NA,NA
CHOYP_LOC101065647.2.2.m.10863,-0.00897969885520078,No,NA,NA,Q5SZD4,NA,NA,NA,mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],NA,NA,NA
CHOYP_LOC101065695.1.1.m.13611,0.00435171476632529,No,NA,NA,Q6NVR9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC101066074.1.1.m.19291,0.00688377675805958,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101066924.1.1.m.16031,-0.0238374146829729,No,NA,NA,A7YY46,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission; dopaminergic [GO:0032225],NA,NA,NA
CHOYP_LOC101067075.1.2.m.30552,0,No,NA,NA,Q6AX44,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC101067376.1.1.m.40668,0.00708360574087203,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC101067698.2.2.m.27457,-0.0178045938806298,No,NA,NA,Q5R1U3,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; hyperosmotic response [GO:0006972]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC101067777.1.1.m.52432,-0.00202334424901826,No,NA,NA,Q4QQV2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101067833.2.3.m.25528,6.35915157024199e-05,No,NA,NA,Q8TDB6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC101067857.1.1.m.36995,-0.00184566938593735,No,NA,NA,Q63413,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_LOC101067905.1.1.m.42386,-0.00667418956348435,No,NA,NA,P41214,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_LOC101068003.1.1.m.14900,-0.010968344080207,No,NA,NA,Q9NZJ6,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1;4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC101068028.1.1.m.48693,-0.000100271278628907,No,NA,NA,Q9DCS2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101068272.1.3.m.40396,0.0154339438965943,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101068378.2.3.m.20090,0.00317812351304526,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC101068378.3.3.m.29759,0.00472774526255051,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC101068677.1.1.m.30685,-0.0096372902509994,No,NA,NA,Q00536,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101069006.1.2.m.5484,0.0253043614505242,No,NA,NA,Q60648,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC101069440.1.3.m.4206,0.000896511161231372,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.2.3.m.16645,0.0108146230169658,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.3.3.m.28439,-0.00360979640165356,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069588.1.1.m.34189,0.00293078603433155,No,NA,NA,Q6B855,NA,NA,NA,metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC101069759.1.1.m.40708,0.000692124418491192,No,NA,NA,P28024,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC101070424.1.1.m.64148,-0.00045685116104263,No,NA,NA,P85834,NA,NA,NA,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC101070553.1.1.m.9549,0.00655744614110903,No,NA,NA,Q9JII1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4;5-bisphosphate phosphatase activity [GO:0106019]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],NA,NA,NA
CHOYP_LOC101070737.2.3.m.11531,-0.0033987882647478,No,NA,NA,Q9CQZ5,NA,NA,NA,mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101071050.1.1.m.38421,0.000302015698992635,No,NA,NA,Q9HCN4,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC101071230.1.1.m.22193,-6.11300779930673e-06,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101071441.1.1.m.64484,-0.00254581513789694,No,NA,NA,P60899,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC101071891.1.2.m.31440,-0.0124642784153653,No,NA,NA,Q68EV6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC101071902.1.1.m.49967,-0.00384376635488581,No,NA,NA,Q9CQE3,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC101072178.1.1.m.65566,-0.0109282610769954,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_LOC101072646.1.1.m.8800,-0.00233941972714244,No,NA,NA,Q9D3D9,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63778,-0.00324243359960796,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63779,9.40206876639742e-05,No,NA,NA,Q25381,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101073830.1.1.m.42117,-0.0038376922344235,No,NA,NA,Q9DB91,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC101075536.1.1.m.42991,-0.00463894829780895,No,NA,NA,Q9GLW9,NA,NA,NA,mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC101075808.1.1.m.17712,-0.00281882242438136,No,NA,NA,Q5RE33,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101076145.1.1.m.26253,0.00862051290310831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101076498.2.2.m.25096,-0.00829242977602282,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_LOC101076790.1.1.m.45316,-0.00933690374182035,No,NA,NA,Q6Q4G4,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241],NA,NA,NA
CHOYP_LOC101077059.1.1.m.57292,-0.00853186300624748,No,NA,NA,P54864,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_LOC101077542.1.1.m.58180,0.0103952461608438,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC101077597.2.3.m.25843,-0.0100981650978051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101077787.2.3.m.65668,-0.00800135516453631,No,NA,NA,O95149,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339]; import into nucleus [GO:0051170]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101078033.1.1.m.42470,0.00398830620981087,No,NA,NA,P49816,NA,NA,NA,caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC101078145.1.1.m.54616,0.00929296493753251,No,NA,NA,Q9DDT2,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC101078252.1.1.m.39219,-0.0163338631059497,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101078542.1.1.m.44610,0.00355724619941853,No,NA,NA,Q01518,NA,NA,NA,azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101078914.1.1.m.34199,0.000181395371694368,No,NA,NA,Q148G5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_LOC101079138.1.4.m.4320,0.0101537806987405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101079642.1.1.m.56374,-0.0177071939077758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101107626.1.1.m.1051,0.00530200422139968,No,NA,NA,Q5TYW1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription; DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC101154772.1.1.m.55397,-0.00956691740382673,No,NA,NA,P49442,NA,NA,NA,inositol-1;4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC101155522.1.1.m.45101,0.00113305177712937,No,NA,NA,Q9VU84,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_LOC101155562.1.1.m.51414,-0.0240523852057904,No,NA,NA,Q5TYQ8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_LOC101155629.1.1.m.30633,-0.0129961843300027,No,NA,NA,Q93425,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101156197.1.1.m.31571,0.00997000262130496,No,NA,NA,Q9EQ28,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair; DNA gap filling [GO:0006297],NA,NA,NA
CHOYP_LOC101156767.1.1.m.65605,0.00423652499633654,No,NA,NA,Q9QYP0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC101156833.1.1.m.38739,0.00490271012832701,No,NA,NA,O13008,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC101156914.1.1.m.30383,-0.00336675838249983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101156984.2.2.m.22956,0.00149861902438919,No,NA,NA,P54985,NA,NA,NA,cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC101157039.2.2.m.54697,0.0264090985156177,No,NA,NA,Q27546,NA,NA,NA,inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC101157079.2.2.m.7067,0.00524519379261099,No,NA,NA,Q9BZA8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101157371.3.3.m.51109,0.00549758031130655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157864.1.2.m.9913,0.00128574973159062,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157895.2.2.m.28009,0.00924830833868777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101158638.1.2.m.5931,-0.0227747426059819,No,NA,NA,Q2TAL6,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC101158638.2.2.m.27400,0.0100496823636591,No,NA,NA,B0UZC8,NA,NA,NA,cell junction [GO:0030054]; extracellular region [GO:0005576]; synapse [GO:0045202]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC101158923.1.2.m.27410,-0.00791425547057682,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC101159074.1.1.m.29872,0.0118614667535196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101159719.1.1.m.21443,-0.00733861088670769,No,NA,NA,A4IGL7,NA,NA,NA,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101160004.1.1.m.48946,-0.00677129695529415,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101160053.1.1.m.18848,0.00185239068401914,No,NA,NA,Q6AY09,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101160063.1.4.m.2465,0.000617880136298873,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101160163.2.2.m.44944,2.98500947090826e-05,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC101160363.1.1.m.194,-0.0154346492845909,No,NA,NA,Q9HAC7,NA,NA,NA,mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],NA,NA,NA
CHOYP_LOC101161108.1.1.m.52561,-0.00576456889778232,No,NA,NA,Q9NR21,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101161976.1.1.m.43986,-0.00031391488051098,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC101162499.1.1.m.47400,-0.00724191848516171,No,NA,NA,O95428,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC101162528.1.1.m.17841,0.00718143881892449,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC101163682.1.1.m.10220,-0.00334678515898313,No,NA,NA,Q6DRD9,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC101164168.1.1.m.24728,-0.0172304822563955,No,NA,NA,Q9UK41,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC101164444.1.1.m.42364,-0.00258005031822341,No,NA,NA,Q6P1J6,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_LOC101164482.1.1.m.44586,0.000131007155137465,No,NA,NA,Q5SRX1,NA,NA,NA,cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101165304.1.1.m.54576,-0.00356705751062916,No,NA,NA,Q9QY36,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion; centromeric [GO:2000719]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_LOC101165968.2.7.m.18121,0.00598647467145715,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.3.7.m.49147,0.023115831165323,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC101165968.5.7.m.54243,0.00227980281573244,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.6.7.m.55758,-0.00886683394601026,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101166328.1.1.m.14447,-0.0170226244025163,No,NA,NA,Q9NXZ2,NA,NA,NA,intracellular [GO:0005622]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101166335.1.1.m.5463,-0.000963532154489713,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC101167642.1.1.m.31028,-0.00230566241235708,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_LOC101167938.1.1.m.27316,0.00215199753322012,No,NA,NA,Q01538,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101168798.1.1.m.6128,-0.0144313774570829,No,NA,NA,Q9D0R4,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101168834.1.1.m.9567,-0.0236027923766783,No,NA,NA,Q96BK5,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome; telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_LOC101168891.1.1.m.30839,0.012179395986959,No,NA,NA,Q6DRG1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; lens development in camera-type eye [GO:0002088],NA,NA,NA
CHOYP_LOC101169402.1.1.m.7122,0.00810039093620472,No,NA,NA,Q9BWU0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729],NA,NA,NA
CHOYP_LOC101169524.1.1.m.4630,-0.0161193087575039,No,NA,NA,O00566,NA,NA,NA,chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101169658.1.3.m.18820,0.012140782170302,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169658.2.3.m.20752,0.0124642801405837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169976.1.1.m.55723,0.0010134254078864,No,NA,NA,Q91XU0,NA,NA,NA,nuclear chromosome; telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replisome [GO:0030894]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA recombination [GO:0006310]; DNA replication; Okazaki fragment processing [GO:0033567]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_LOC101170942.1.1.m.47597,-0.000489243586540614,No,NA,NA,P41105,NA,NA,NA,cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101171340.1.1.m.29474,-0.000198827549416911,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC101171379.1.1.m.27459,-0.0077628218277512,No,NA,NA,Q08BY0,NA,NA,NA,mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation; to symmetrical-dimethyl arginine [GO:0019918],NA,NA,NA
CHOYP_LOC101173065.1.1.m.11998,-0.0110782727666055,No,NA,NA,Q8IY37,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101173335.2.4.m.33982,0.00922900806362108,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101173404.1.1.m.27554,0.00330515524293381,No,NA,NA,Q9LZG0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101173869.1.1.m.32090,-0.00057223491877045,No,NA,NA,Q8C5L6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription; DNA-templated [GO:0045892]; neuromuscular junction development; skeletal muscle fiber [GO:0098529]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC101174856.1.1.m.47585,0.0104258580329614,No,NA,NA,Q9Y6R4,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC101175128.1.1.m.13811,0.0115506658963248,No,NA,NA,Q99LC9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix; translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC101175542.1.1.m.39653,0.00651949310884646,No,NA,NA,Q15542,NA,NA,NA,actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription; initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101175582.1.1.m.59321,0.000508839676285706,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_LOC101175670.1.1.m.37,0.0147571321742281,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC101234062.1.1.m.27366,-1.20021618558089e-05,No,NA,NA,Q2KIR8,NA,NA,NA,mitochondrion [GO:0005739]; coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC101236385.3.6.m.4348,-0.0135425353269847,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101238350.1.1.m.23002,-0.0100190557606364,No,NA,NA,B3EWY8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101242114.1.1.m.13149,0.00575707866033787,No,NA,NA,Q8N7A1,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC101242248.1.2.m.24785,-0.00346235049767156,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC101242430.1.2.m.23519,0.00810294936988295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101345275.1.1.m.1796,-0.00951709978452423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101384981.1.1.m.53468,0.00596475163994694,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101416772.1.1.m.30815,0.00237199046671048,No,NA,NA,Q9W6X3,NA,NA,NA,mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC101439509.1.1.m.65851,-0.00179990423637721,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_LOC373223.1.1.m.48226,0.00166905556673243,No,NA,NA,Q17R14,NA,NA,NA,apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC373229.2.3.m.43412,7.36593852935202e-05,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC373274.1.1.m.29721,0.0088592674025888,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC373275.4.7.m.47547,0.000961360660809284,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC373275.6.7.m.57854,0.00710865108945701,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC373275.7.7.m.63851,0.0124834266686186,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC408431.1.1.m.18046,-5.64562067464985e-05,No,NA,NA,Q9VY77,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LOC408643.1.1.m.50154,0.0126858430559822,No,NA,NA,Q4J781,NA,NA,NA,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC409619.1.4.m.13984,0.0013209308450554,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC410403.1.1.m.31535,-0.0104017743590038,No,NA,NA,Q5F3J5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],NA,NA,NA
CHOYP_LOC410511.1.2.m.10509,0.00581650879470266,No,NA,NA,Q2KHT3,NA,NA,NA,cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263],NA,NA,NA
CHOYP_LOC411194.1.1.m.8502,-0.0104439988246988,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC412116.1.1.m.42829,0.000237257078540024,No,NA,NA,Q8BHN5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC413005.1.1.m.63172,-0.00478860485558362,No,NA,NA,Q6AYR2,NA,NA,NA,cytoplasm [GO:0005737]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC420515.1.1.m.15613,-0.00645111641027898,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC494408.1.1.m.29208,-0.0228763660966522,No,NA,NA,Q9ET66,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC496139.1.1.m.39321,-0.0103382731380451,No,NA,NA,Q9D187,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC549476.1.1.m.42388,-0.00114048296938831,No,NA,NA,P62264,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC551931.1.1.m.9934,-0.00176972335617229,No,NA,NA,Q99447,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_LOC552012.1.1.m.65224,0,No,NA,NA,Q9NRF2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],NA,NA,NA
CHOYP_LOC552024.1.1.m.5290,0.00694603551660897,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC552081.1.1.m.51439,0.022730756599469,No,NA,NA,A4IG32,NA,NA,NA,integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],NA,NA,NA
CHOYP_LOC552559.1.2.m.39702,9.39764513521753e-06,No,NA,NA,Q9VU02,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC552662.1.1.m.15078,-0.000134558517969878,No,NA,NA,Q68ED3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050],NA,NA,NA
CHOYP_LOC557305.1.1.m.18011,0.00702303086221525,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC558150.4.4.m.53050,-0.00402942661939123,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_LOC558213.1.1.m.27293,-0.0116568125889265,No,NA,NA,Q4VGL6,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; cytoplasmic mRNA processing body assembly [GO:0033962]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470],NA,NA,NA
CHOYP_LOC559490.1.1.m.44696,0.0221054638349393,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_LOC562156.1.2.m.16403,0.00183043321004481,No,NA,NA,Q5G265,NA,NA,NA,axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC564392.1.1.m.29701,-0.0186267347410533,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_LOC565211.1.2.m.34982,-0.0107513390542328,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC565211.2.2.m.55017,0.00548234143664849,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC566621.1.1.m.45550,0.0144266218209951,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC566887.1.1.m.45765,0.000423927166325295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC567383.1.1.m.16245,0.0129684734820322,No,NA,NA,Q75NR7,NA,NA,NA,chromosome [GO:0005694]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_LOC567820.1.1.m.51203,-0.00832836171392937,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC569612.1.1.m.18528,0.0090467150687685,No,NA,NA,Q6P9H5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC571721.1.3.m.36443,0.00631487387304054,No,NA,NA,Q52M93,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC571721.2.3.m.53122,0.000820519969638815,No,NA,NA,A6NNF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC574569.1.1.m.61069,0.0084971485261882,No,NA,NA,O54922,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC574602.1.1.m.44079,0,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_LOC574740.1.1.m.29924,-0.00736279697200298,No,NA,NA,Q4V8G4,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC574855.4.9.m.22339,0.0172602148000426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.6.9.m.46549,0.0261682672531214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574928.1.2.m.48221,-0.00151178181470703,No,NA,NA,Q9D5V6,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203],NA,NA,NA
CHOYP_LOC574943.1.1.m.56446,-0.0238572748348931,No,NA,NA,P23800,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleosomal DNA binding [GO:0031492]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC575058.1.1.m.9531,-0.0124336657203239,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC575132.2.2.m.66125,-0.00269687150579794,No,NA,NA,Q9WVM7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex scaffold activity [GO:0032947]; apoptotic process [GO:0006915]; negative regulation of cell proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510],NA,NA,NA
CHOYP_LOC575161.4.5.m.42590,0.00614467457433954,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575161.5.5.m.55590,-0.00604085578923787,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575203.2.6.m.6856,-0.000185853162618993,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575203.6.6.m.30705,-0.00119493465215514,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575264.1.1.m.10111,-0.00201098341186255,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575405.1.1.m.18640,-7.60460892143422e-06,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_LOC575478.1.1.m.6923,-0.0137237302341707,No,NA,NA,Q86U38,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC575509.2.2.m.63548,-0.00362472599913496,No,NA,NA,Q7T0Y4,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC575600.1.1.m.27851,-0.000329551882317489,No,NA,NA,Q9Y5X2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC575625.1.2.m.50064,0.00640828366759351,No,NA,NA,O95405,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; serine-type peptidase activity [GO:0008236]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC575793.1.2.m.34690,-0.00626762005591957,No,NA,NA,Q3T042,NA,NA,NA,nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_LOC575793.1.2.m.34691,0.0133230599386214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575893.1.1.m.62614,0.000475401508320299,No,NA,NA,Q3T0Z7,NA,NA,NA,cytoplasm [GO:0005737]; 6;7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC575944.1.5.m.22547,0.00998413116600002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575944.3.5.m.24887,0.00563658555738945,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC576041.1.1.m.28220,-0.00508286915131832,No,NA,NA,Q92051,NA,NA,NA,carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539],NA,NA,NA
CHOYP_LOC576200.3.4.m.38681,0.00128215710622314,No,NA,NA,A6X942,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC576326.1.1.m.49857,0.0164803852858725,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC576341.1.2.m.9414,-0.00680873549929482,No,NA,NA,Q4AC94,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_LOC576511.1.1.m.53180,0.000613293983879309,No,NA,NA,Q5RG45,NA,NA,NA,centriole [GO:0005814]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457],NA,NA,NA
CHOYP_LOC576660.1.1.m.33760,-0.0216965238593326,No,NA,NA,A6QLU1,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]; multicellular organism growth [GO:0035264],NA,NA,NA
CHOYP_LOC576665.1.2.m.10867,-0.011436027769812,No,NA,NA,A6QQL5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC576665.1.2.m.10868,-0.00184871875378648,No,NA,NA,Q96L03,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516],NA,NA,NA
CHOYP_LOC576698.1.1.m.32335,-0.0161680795591284,No,NA,NA,Q3V096,NA,NA,NA,nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092],NA,NA,NA
CHOYP_LOC577063.1.1.m.30814,-0.0151457395066976,No,NA,NA,P05090,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC577184.1.1.m.62005,0.00552149595556511,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC577190.1.1.m.18117,-0.00460503860616506,No,NA,NA,C3XRY1,NA,NA,NA,nucleus [GO:0005634]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC577313.2.5.m.45484,-0.00371404760561219,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577338.1.1.m.9819,-0.00826876300883401,No,NA,NA,Q6GPB8,NA,NA,NA,nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC577351.1.1.m.17664,-0.0203170383489714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577371.1.2.m.46335,-0.0151672460975699,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577550.1.1.m.36506,-0.00315180435592196,No,NA,NA,Q28IH8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC577551.1.1.m.30278,0.0101358609774873,No,NA,NA,Q8BHL8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577573.1.1.m.13979,2.58017246415763e-05,No,NA,NA,Q9NVE5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577730.2.5.m.11065,0.0192621983528445,No,NA,NA,A7RT29,NA,NA,NA,lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC577805.1.4.m.9698,0.0032765125660972,No,NA,NA,Q39575,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577805.3.4.m.46026,0,No,NA,NA,Q96JB1,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577905.1.2.m.2598,0.00110995710731547,No,NA,NA,P40757,NA,NA,NA,mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256],NA,NA,NA
CHOYP_LOC577931.3.3.m.35020,4.62523210187592e-05,No,NA,NA,P07589,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; disordered domain specific binding [GO:0097718]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC578003.1.1.m.64329,-0.00479971642645331,No,NA,NA,Q5M7D6,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC578045.4.5.m.61073,0.0142361324506987,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578045.5.5.m.65293,-0.00876706725959683,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578169.1.1.m.63470,-0.00167149170077762,No,NA,NA,Q5T1B0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC578260.1.1.m.21677,0.020883234634446,No,NA,NA,Q5R2J2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC578280.1.1.m.42277,0.00632409502195499,No,NA,NA,O95490,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_LOC578284.1.1.m.30567,0.000272369604075504,No,NA,NA,Q5ZM33,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC578349.1.1.m.51923,0.0147076314316862,No,NA,NA,Q9BUH6,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC578371.1.1.m.56054,-0.01611616331692,No,NA,NA,Q9P2S6,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC578464.1.1.m.46553,0.00891383110952366,No,NA,NA,P49109,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_LOC578599.1.8.m.12749,0.00527756841226638,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578599.8.8.m.57682,0.000262514183801251,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578600.1.1.m.45849,0.00351633137504449,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC578627.1.1.m.61950,-0.000602896334401313,No,NA,NA,P51147,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; lipid droplet [GO:0005811]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC578656.8.15.m.42294,-0.0132869419632514,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578656.9.15.m.53454,-0.00501357618321737,No,NA,NA,Q9JI18,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC578672.1.2.m.29847,0.00363924679655815,No,NA,NA,Q9BUJ2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578672.2.2.m.44884,-0.00248825754191807,No,NA,NA,Q00839,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing; via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578680.1.1.m.49370,-0.00599292606794048,No,NA,NA,Q8CDU5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC578781.1.5.m.2353,0.0174052273879399,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578781.2.5.m.8827,0.0128500512079948,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578858.2.2.m.25157,0.00624271963342572,No,NA,NA,Q6SP97,NA,NA,NA,acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC578881.1.1.m.9743,0.000105539981116224,No,NA,NA,Q9HBU6,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC578897.1.1.m.11932,-0.0120533728872915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC578968.1.2.m.41294,-0.00525569034118865,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578968.2.2.m.54316,0.00863761253223851,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578979.1.1.m.10409,-0.00464355907911031,No,NA,NA,Q4R6I5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC579012.1.1.m.10830,-0.0166844780580411,No,NA,NA,Q8N865,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579123.1.1.m.65215,0.00984543103040689,No,NA,NA,Q9UNS1,NA,NA,NA,nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478],NA,NA,NA
CHOYP_LOC579332.1.1.m.41750,0.00113728177545022,No,NA,NA,Q92538,NA,NA,NA,cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC579381.1.1.m.10900,-0.00667536419355913,No,NA,NA,Q8BUG5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579644.1.1.m.16828,0.00620336343791701,No,NA,NA,Q9Z0R0,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome; centromeric region [GO:0071459]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC579656.3.5.m.41908,-0.020484528362315,No,NA,NA,Q9Y3Q0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC579681.1.1.m.25827,0.00236602707144073,No,NA,NA,Q6IP50,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579713.1.1.m.17440,-0.0128420010362151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC579737.1.1.m.14356,-0.00198551570838586,No,NA,NA,Q64350,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC579832.2.2.m.47454,0.00467646834191908,No,NA,NA,Q5SUV2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC579833.1.1.m.23271,-0.0158277990833928,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC579914.1.1.m.13347,-0.00991521234920129,No,NA,NA,Q07DZ5,NA,NA,NA,cell cortex [GO:0005938]; dendritic spine [GO:0043197],NA,NA,NA
CHOYP_LOC579934.1.1.m.59523,-0.00219661467528954,No,NA,NA,Q6NY77,NA,NA,NA,mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; glyoxylate catabolic process [GO:0009436],NA,NA,NA
CHOYP_LOC579946.11.24.m.42367,0.00452732681723157,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.17.24.m.53406,0.006686656404162,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.20.24.m.55163,0.0123911379250249,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_LOC579946.7.24.m.39737,0.00524812560182132,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC580197.1.1.m.4591,0.00248503001594718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC580207.1.1.m.49071,0.00627785819708979,No,NA,NA,Q3MHG0,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC580355.1.1.m.29389,-0.0205083529899611,No,NA,NA,P07314,NA,NA,NA,extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]; transferase activity; transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOC580466.1.2.m.18704,0.00919351674535929,No,NA,NA,Q640V9,NA,NA,NA,nucleus [GO:0005634]; endodeoxyribonuclease activity; producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC580666.1.2.m.21929,0.0115338235756333,No,NA,NA,B0C431,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC580669.1.1.m.7758,-0.0196009794392053,No,NA,NA,Q9Y7Y3,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC580670.1.6.m.4085,0.0060814556485675,No,NA,NA,A2AJX4,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858],NA,NA,NA
CHOYP_LOC580670.5.6.m.34028,0.00569116150042411,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580670.6.6.m.40875,-0.000238343905191387,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580675.1.1.m.44042,-0.00881364211246979,No,NA,NA,Q5ZQU0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC580687.1.1.m.1044,0.00405100805080783,No,NA,NA,P82094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription; DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC580832.1.1.m.66146,0.000613760889300695,No,NA,NA,Q92947,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568],NA,NA,NA
CHOYP_LOC580840.1.1.m.45392,-0.00394909444010377,No,NA,NA,Q32L77,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC581113.2.2.m.57598,-0.0059598777419165,No,NA,NA,Q8AV28,NA,NA,NA,apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC581128.1.1.m.46711,0.00672068170148726,No,NA,NA,P83436,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC581183.1.1.m.49767,-0.0154259567494861,No,NA,NA,Q7ZU45,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_LOC581387.1.1.m.56997,-0.00131052176878151,No,NA,NA,A8E5W8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC581447.1.1.m.65782,0.0225287919095163,No,NA,NA,P23913,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; DNA binding [GO:0003677]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC581452.2.4.m.25348,0.00680788873976695,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581452.3.4.m.41000,8.78282849383423e-05,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581491.1.2.m.56125,-0.0039935301221532,No,NA,NA,Q9Y283,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC581508.1.1.m.26966,8.79715781969445e-05,No,NA,NA,Q96FN9,NA,NA,NA,cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399],NA,NA,NA
CHOYP_LOC581594.2.3.m.34837,-0.00365043233742993,No,NA,NA,Q4FZG9,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC581711.1.1.m.14276,0.00743019819905241,No,NA,NA,Q9CY21,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476],NA,NA,NA
CHOYP_LOC581748.1.1.m.47690,2.06409474671732e-05,No,NA,NA,P53753,NA,NA,NA,cell septum [GO:0030428]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; glucan endo-1;3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1;3-beta-glucanase activity; C-3 substituted reducing group [GO:0052861]; glucan endo-1;4-beta-glucanase activity; C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920],NA,NA,NA
CHOYP_LOC581773.1.1.m.56865,0.00280626012246833,No,NA,NA,Q9WV48,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; intracellular [GO:0005622]; ionotropic glutamate receptor complex [GO:0008328]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; ankyrin repeat binding [GO:0071532]; GKAP/Homer scaffold activity [GO:0030160]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; adult behavior [GO:0030534]; associative learning [GO:0008306]; brain morphogenesis [GO:0048854]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC581886.1.3.m.23639,-0.00179099574875761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC581927.10.27.m.32671,-0.00829571436236934,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC581927.9.27.m.31886,0.000133900179284838,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC582121.1.1.m.30176,0.000953707552398129,No,NA,NA,P23034,NA,NA,NA,cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC582154.1.1.m.58922,0.00187954794103792,No,NA,NA,P46952,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3;4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC582174.2.16.m.16430,0.00351415077493072,No,NA,NA,O95613,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; calmodulin binding [GO:0005516]; protein-containing complex scaffold activity [GO:0032947]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582178.1.1.m.42729,-0.00198898837676093,No,NA,NA,Q91VD9,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_LOC582352.1.1.m.30199,-0.0160239995451162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC582570.1.1.m.65944,-0.00397088983141817,No,NA,NA,Q9P2F6,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582626.1.1.m.5567,-0.0115497260445368,No,NA,NA,Q9H9J2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC582726.1.1.m.29762,0.00150965107850262,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC582782.1.4.m.8110,0.0107800370882364,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582782.4.4.m.62807,0.0103276931947308,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582784.1.1.m.53921,-0.00363118934179782,No,NA,NA,Q9BY77,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405],NA,NA,NA
CHOYP_LOC582874.1.1.m.5135,0.000290373514724057,No,NA,NA,O55096,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC583072.4.25.m.20255,-0.00620669573977895,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC583138.1.1.m.8990,-0.00902481662711689,No,NA,NA,A9UMP7,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_LOC583253.1.1.m.11773,0.00559130736171506,No,NA,NA,A9ZSZ2,NA,NA,NA,cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC583472.1.1.m.25642,0.00259605881927169,No,NA,NA,P13010,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription; DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC583843.1.1.m.11191,0.0214205861650324,No,NA,NA,Q6DCY9,NA,NA,NA,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC583865.2.2.m.15485,0.0114733181874611,No,NA,NA,Q6NYV5,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding; bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC583890.1.1.m.14405,0.00507630833091722,No,NA,NA,P12426,NA,NA,NA,cytoplasm [GO:0005737]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_LOC583954.1.1.m.777,-0.0029739673293915,No,NA,NA,Q8AVG9,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC584001.1.1.m.46452,0.0097244474424223,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584015.1.1.m.10227,-0.0159645577442895,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC584052.1.1.m.6375,-4.36485540167219e-05,No,NA,NA,Q6DJN2,NA,NA,NA,cytoplasm [GO:0005737]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122],NA,NA,NA
CHOYP_LOC584058.1.1.m.59244,0,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_LOC584062.1.1.m.62279,-0.0159308220701476,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC584095.1.1.m.6815,-0.00419279850849748,No,NA,NA,Q9DE46,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; cell proliferation [GO:0008283]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication; synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272],NA,NA,NA
CHOYP_LOC584238.1.1.m.30307,-0.0159485615502323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584281.1.1.m.34958,0.00101097943208685,No,NA,NA,P51650,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_LOC584318.1.1.m.35309,-0.00587715487360912,No,NA,NA,Q6A098,NA,NA,NA,ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_LOC584333.1.1.m.42540,-0.00573656128215106,No,NA,NA,P14133,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC584368.1.2.m.10628,0.00125375770030432,No,NA,NA,P80513,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC584392.1.1.m.24512,-0.0135048073368495,No,NA,NA,Q32KI9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],NA,NA,NA
CHOYP_LOC584416.1.1.m.34286,0.00804815073450909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584481.10.10.m.66365,-0.00354555189690442,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.5.10.m.52126,-0.00670477095236129,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.8.10.m.61433,-0.00865688791995837,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584567.1.1.m.29825,-0.00757880110402277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584665.1.1.m.28760,0.0163694050234995,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC584905.1.1.m.51595,-0.0133779768495183,No,NA,NA,Q6P2D8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC585032.1.2.m.1235,0.00135216389521902,No,NA,NA,Q15276,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC585158.1.2.m.18137,-0.0230872016337256,No,NA,NA,O14095,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454]; negative regulation of signal transduction [GO:0009968]; protein folding [GO:0006457]; response to pheromone [GO:0019236],NA,NA,NA
CHOYP_LOC585322.1.2.m.8217,-0.00214293653025023,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC585438.1.1.m.44017,-0.0203974521693982,No,NA,NA,Q9NVX2,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_LOC585494.1.1.m.64158,-0.00552409320335201,No,NA,NA,Q99LG0,NA,NA,NA,nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC585591.1.1.m.62390,-0.0170904037827222,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585638.1.1.m.10100,0.000156895434404703,No,NA,NA,Q9NNW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC585734.1.1.m.36212,-0.00766351683665104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585839.1.1.m.51865,-0.00924543240794703,No,NA,NA,Q5XIJ8,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC585963.1.2.m.36775,-0.000237623360621098,No,NA,NA,Q27991,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration; cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC586005.1.1.m.63556,0.00365221578818998,No,NA,NA,Q8WVM8,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_LOC586039.1.1.m.27100,-0.00289439027319463,No,NA,NA,P81799,NA,NA,NA,ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_LOC586044.1.1.m.60359,0.00426564449450455,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC586471.1.1.m.8913,-0.00644745104819465,No,NA,NA,Q13569,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression; epigenetic [GO:0040029],NA,NA,NA
CHOYP_LOC586494.1.1.m.50214,-0.0108884360905347,No,NA,NA,Q96T60,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair; DNA damage removal [GO:0000718]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC586604.1.1.m.30509,0.0119420401976672,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586661.1.1.m.56660,-0.0192088571482344,No,NA,NA,Q9XGA0,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165],NA,NA,NA
CHOYP_LOC586678.1.1.m.35070,-0.00260766001597949,No,NA,NA,Q8CAQ8,NA,NA,NA,MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560],NA,NA,NA
CHOYP_LOC586835.1.1.m.9967,-0.00194819201887159,No,NA,NA,Q96MU7,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing; via spliceosome [GO:0048024],NA,NA,NA
CHOYP_LOC586835.1.1.m.9969,0.00035865792034541,No,NA,NA,Q28FE4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC586953.1.1.m.19600,-0.00796262326868749,No,NA,NA,Q28FY0,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; epithelial cilium movement [GO:0003351]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC587133.1.1.m.61281,0.00117269589224272,No,NA,NA,P72745,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587136.1.3.m.7607,0.00431185854692471,No,NA,NA,Q8BW94,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC587346.1.1.m.17791,0.00590479553980084,No,NA,NA,A1A5V9,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC587439.1.1.m.45707,-0.0065065346512363,No,NA,NA,Q5HYI8,NA,NA,NA,cell [GO:0005623]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_LOC587610.1.3.m.16984,0.0107083597220339,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587610.3.3.m.27175,0.00499732108260623,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587700.1.1.m.42534,-0.00203846497996539,No,NA,NA,Q9D6R2,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC587705.1.2.m.11702,-0.00171353167330986,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587705.2.2.m.11817,-0.00156878315877712,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587740.1.4.m.22830,-0.000827462367844857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC587752.1.1.m.66173,0.0239705755805827,No,NA,NA,P53369,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC587791.2.3.m.33887,0,No,NA,NA,Q86TZ1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587803.1.1.m.9452,-0.00352894632181409,No,NA,NA,Q8BYR1,NA,NA,NA,protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591],NA,NA,NA
CHOYP_LOC587840.1.1.m.10143,0.00122850200637941,No,NA,NA,Q90744,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC587946.1.1.m.5037,0.00712812586419893,No,NA,NA,P46012,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587966.1.1.m.10698,-0.00120256577385932,No,NA,NA,Q9JK84,NA,NA,NA,apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341],NA,NA,NA
CHOYP_LOC587972.1.2.m.3283,-0.000582229352712226,No,NA,NA,P09848,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245],NA,NA,NA
CHOYP_LOC588385.1.2.m.18390,0.00923339584940403,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC588440.1.1.m.4951,0.00345649537338079,No,NA,NA,Q6TUG0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604],NA,NA,NA
CHOYP_LOC588549.1.2.m.1855,-0.000887589928723246,No,NA,NA,O75376,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC588572.1.2.m.17892,-0.0137769658525426,No,NA,NA,Q52KI8,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC588827.1.1.m.11601,0.00211089487268074,No,NA,NA,Q8WV99,NA,NA,NA,anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC588883.2.3.m.14590,-0.00148645928983702,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588883.3.3.m.38321,-0.00169726591802297,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588932.3.3.m.35464,-0.00758132076502843,No,NA,NA,Q9UMZ2,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC589108.1.2.m.9688,-0.00348659181734125,No,NA,NA,Q4V7T8,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC589108.2.2.m.48073,0.00736068245970971,No,NA,NA,Q969T9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570],NA,NA,NA
CHOYP_LOC589177.1.1.m.52878,-0.00230199292815143,No,NA,NA,Q5U2V4,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC589201.1.1.m.59863,-0.00196667802854382,No,NA,NA,F1N9Y5,NA,NA,NA,cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of mast cell degranulation [GO:0043306]; protein phosphorylation [GO:0006468]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554],NA,NA,NA
CHOYP_LOC589390.1.1.m.11589,-0.00761477463807219,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC589479.2.2.m.57247,-0.00129517934164355,No,NA,NA,Q9JLI7,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC589644.2.3.m.21781,-0.000316343742727402,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC589720.1.1.m.63687,0.000233970759621788,No,NA,NA,Q9UHV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC589750.3.5.m.42967,0,No,NA,NA,Q5F478,NA,NA,NA,,NA,NA,NA
CHOYP_LOC589839.1.1.m.29309,-0.00474952236136304,No,NA,NA,Q5XX13,NA,NA,NA,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC589952.1.5.m.2235,-0.0232526186635854,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.2.5.m.21623,-0.00941288458290247,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.3.5.m.29284,-0.00587071242678621,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC589952.4.5.m.31147,-0.0223813359137248,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC590125.6.7.m.53735,-0.00967432196297213,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC590298.2.3.m.4191,0.0229871651204251,No,NA,NA,P80109,NA,NA,NA,cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_LOC590567.1.1.m.29483,0.00232457497096445,No,NA,NA,O02350,NA,NA,NA,extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC590568.2.4.m.38593,-0.0128894728975142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590633.1.1.m.32259,0.00729495600077733,No,NA,NA,Q3UMR0,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC590657.1.1.m.633,5.97414024765718e-05,No,NA,NA,Q8BZ25,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC590657.1.1.m.634,0.00698752166931496,No,NA,NA,Q6PIP5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC590729.1.1.m.35259,-0.00763136363348637,No,NA,NA,Q2T9T9,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC590756.2.6.m.28777,-0.000279659255262583,No,NA,NA,Q86XZ4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC590756.4.6.m.48555,-0.0168757018126632,No,NA,NA,A7MBP4,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC590931.1.1.m.7446,-0.00224123737192671,No,NA,NA,Q6PGZ3,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC590949.1.2.m.13540,-0.0100309976986097,No,NA,NA,P27987,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1;4;5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC590969.1.1.m.15822,-0.00547984595320339,No,NA,NA,Q9Z160,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC590971.1.1.m.30661,-0.00117970592783417,No,NA,NA,O43175,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_LOC590989.3.3.m.32047,0.0132414254418861,No,NA,NA,Q6J6I8,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC591073.1.1.m.50375,-0.0109195418668113,No,NA,NA,Q5XHC1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC591084.2.2.m.59355,-0.00497094784069083,No,NA,NA,Q8BRH4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC591177.1.1.m.1476,0.00905054320335431,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC591426.1.1.m.19353,0.0134345559620103,No,NA,NA,Q9UGU0,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC591426.1.1.m.19354,0.00679332722285348,No,NA,NA,Q9Y6D9,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],NA,NA,NA
CHOYP_LOC591441.1.1.m.19965,0.00167118130665951,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC591570.1.1.m.4767,-0.00140726986111873,No,NA,NA,Q2T9W3,NA,NA,NA,axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC591690.1.1.m.30550,-0.00125651395809688,No,NA,NA,Q4R4T9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC591797.1.3.m.11526,-0.0139800030599798,No,NA,NA,Q60596,NA,NA,NA,ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC591797.1.3.m.11527,-0.004176426423466,No,NA,NA,P22232,NA,NA,NA,nucleolus [GO:0005730]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC591898.1.2.m.28918,-0.000130925454299105,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591898.2.2.m.29158,-0.00151931676146822,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591926.1.1.m.27235,0.0239394594237473,No,NA,NA,Q9H0U6,NA,NA,NA,extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC591968.1.1.m.37093,0.00176832668141416,No,NA,NA,Q9DAZ9,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466],NA,NA,NA
CHOYP_LOC592001.1.1.m.43470,-0.00791560373115101,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC592006.1.1.m.18498,-0.0104970859440176,No,NA,NA,Q96AJ9,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC592013.1.1.m.20072,0.00733652656146571,No,NA,NA,Q9HAS0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_LOC592142.5.9.m.53066,0.0159104740548854,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.6.9.m.54976,-0.00278740546553381,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.7.9.m.55467,0.00128706449433632,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592215.1.1.m.34856,0.00433885996915058,No,NA,NA,Q8R2E9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417],NA,NA,NA
CHOYP_LOC592357.1.1.m.27228,0.00446860146772585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC592528.1.2.m.17290,0.001170582942964,No,NA,NA,O88545,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_LOC592585.1.1.m.51309,0.00241234606557158,No,NA,NA,P16444,NA,NA,NA,anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC592624.1.1.m.45639,-0.0110970932243439,No,NA,NA,Q32PH2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC592709.1.1.m.22553,0.0146304531450015,No,NA,NA,A6NCI4,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC592745.1.1.m.47718,-0.00267729176715573,No,NA,NA,Q10002,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_LOC592825.1.1.m.43751,-0.00588772312117907,No,NA,NA,Q5RBB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926],NA,NA,NA
CHOYP_LOC592888.1.1.m.63240,0.0051505188130312,No,NA,NA,Q6DFB7,NA,NA,NA,centriole [GO:0005814]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC592990.1.1.m.17663,-0.00513848216630637,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC593134.1.1.m.29711,-0.0238113619644212,No,NA,NA,O88630,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of vesicle targeting; to; from or within Golgi [GO:0048209]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC593247.1.1.m.56872,-0.005295209110954,No,NA,NA,Q9HU55,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_LOC593338.1.2.m.31413,-0.00686722404352477,No,NA,NA,Q18297,NA,NA,NA,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_LOC593467.2.4.m.66724,0.0045720932409393,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC593522.1.2.m.5381,-0.00314154475105394,No,NA,NA,P23246,NA,NA,NA,chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC593522.2.2.m.33858,0.000217625963375679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC593529.1.1.m.59343,-0.0247045738652665,No,NA,NA,Q4KM30,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC593558.3.4.m.36843,0.00760118991123425,No,NA,NA,B6RSP1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC593741.1.1.m.11514,-0.00597164690347593,No,NA,NA,Q567I9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC594038.1.1.m.8864,0.00112806767760872,No,NA,NA,B0WIW5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC594130.1.1.m.48747,0.00331595877601425,No,NA,NA,P32755,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_LOC594151.1.2.m.7270,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594176.1.1.m.9662,-0.0118259793654933,No,NA,NA,Q14186,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083],NA,NA,NA
CHOYP_LOC594315.1.1.m.28047,0.00044467011160288,No,NA,NA,Q78PY7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC594379.1.1.m.55370,-0.0111705737625003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594407.1.1.m.38463,0.00267791584444836,No,NA,NA,Q8BWQ6,NA,NA,NA,early endosome [GO:0005769]; integral component of membrane [GO:0016021]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC594533.1.1.m.58830,0.00647895480531936,No,NA,NA,Q8IYE1,NA,NA,NA,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_LOC594590.1.2.m.10772,-0.00740203301467428,No,NA,NA,B5XGE7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC594665.1.1.m.8448,0.00430873555863187,No,NA,NA,P16435,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC594665.1.1.m.8449,0.00138777666125272,No,NA,NA,O77622,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC594676.1.1.m.8936,-0.0221447721172857,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC654860.3.3.m.63750,0.00181750543020393,No,NA,NA,Q13492,NA,NA,NA,cell surface [GO:0009986]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; Rab GTPase binding [GO:0017137]; tau protein binding [GO:0048156]; amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; membrane organization [GO:0061024]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription; DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC654949.1.1.m.9313,-0.00150155602558964,No,NA,NA,O74503,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_LOC654994.1.1.m.39461,-0.00150961313846874,No,NA,NA,Q9VLN1,NA,NA,NA,histone methyltransferase complex [GO:0035097]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182],NA,NA,NA
CHOYP_LOC655520.2.2.m.14178,-0.00297199712077259,No,NA,NA,Q9NQC3,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_LOC655529.1.3.m.1225,-0.00421816871779939,No,NA,NA,Q8NI08,NA,NA,NA,intracellular [GO:0005622]; nucleus [GO:0005634]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC655570.1.2.m.9210,-0.00737006826491353,No,NA,NA,Q49GP5,NA,NA,NA,endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC656201.1.1.m.8657,3.76608359222336e-05,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC656402.1.1.m.62053,0.00289722643858873,No,NA,NA,Q9R062,NA,NA,NA,glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978],NA,NA,NA
CHOYP_LOC656459.1.1.m.34956,-0.00745264297602608,No,NA,NA,B7ZMP1,NA,NA,NA,mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC656615.1.1.m.66274,-0.00313568700541056,No,NA,NA,Q6GPD0,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC656702.1.1.m.14425,0.00256790514743064,No,NA,NA,Q13045,NA,NA,NA,brush border [GO:0005903]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC656741.1.1.m.19820,0.0140398242109751,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC656867.1.1.m.28658,-0.00105689303643742,No,NA,NA,Q6P799,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_LOC656899.1.1.m.15417,-0.00131049784858051,No,NA,NA,Q6NSR8,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_LOC657235.1.1.m.1711,0.0122743387924888,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC657327.1.1.m.54811,-0.00158552376646662,No,NA,NA,M9NDE3,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance; open tracheal system [GO:0035002]; regulation of tube length; open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274],NA,NA,NA
CHOYP_LOC657378.1.1.m.14648,0.00317587871578503,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC657466.1.1.m.38710,0.00232024225130574,No,NA,NA,Q95KE5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC657473.1.1.m.55374,-0.000585966179847825,No,NA,NA,O55203,NA,NA,NA,cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_LOC657674.1.1.m.21821,-0.00287043543804301,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_LOC657694.1.1.m.34526,0.0133866568685459,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC657811.1.1.m.29214,-0.00943191066231134,No,NA,NA,Q08D57,NA,NA,NA,chromosome [GO:0005694]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_LOC658003.1.1.m.29101,-0.00848215864089559,No,NA,NA,Q7ZWP1,NA,NA,NA,cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC658092.1.2.m.22901,-0.000265627082407705,No,NA,NA,Q58DA0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC658092.2.2.m.60940,-0.00434857675465807,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC658201.1.1.m.42880,0.00176069757590471,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC658242.1.1.m.41709,0.00217816316374528,No,NA,NA,Q9UQ03,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036],NA,NA,NA
CHOYP_LOC658248.1.1.m.11054,-0.0173099297528909,No,NA,NA,Q5FWY5,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; transcription coregulator activity [GO:0003712]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC658280.1.1.m.18469,0.00118878204458716,No,NA,NA,Q6TH22,NA,NA,NA,cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC658414.1.3.m.6219,0.00416678935099258,No,NA,NA,Q9HCD6,NA,NA,NA,glutamatergic synapse [GO:0098978]; postsynaptic density; intracellular component [GO:0099092]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC658593.1.1.m.25202,0.0016698726665918,No,NA,NA,P56380,NA,NA,NA,mitochondrion [GO:0005739]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC658611.1.1.m.11239,-0.000658303708897597,No,NA,NA,Q96PE2,NA,NA,NA,cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC658640.1.2.m.36016,0.0223661284565329,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658640.2.2.m.56941,-0.0140863365174574,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658895.1.1.m.20262,0.00161859553021095,No,NA,NA,Q8BFR5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC659024.1.2.m.31136,-0.000105276585286938,No,NA,NA,P70318,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell proliferation [GO:0008284]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC659206.1.6.m.3536,0.00165660940927455,No,NA,NA,P62890,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; positive regulation of selenocysteine incorporation [GO:1904571]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC659206.6.6.m.43541,0.0142439591955582,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_LOC659226.1.3.m.16864,-0.00142959078701653,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC659306.1.1.m.11580,0.00704422283938599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC659398.1.1.m.9611,-0.0052473671959863,No,NA,NA,Q7ZVR8,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC659409.1.1.m.24437,-0.0240223312083155,No,NA,NA,Q96PX1,NA,NA,NA,cell body [GO:0044297]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC659512.1.4.m.6122,0.00273056016833094,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.3.4.m.26463,0.00503346985280167,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.4.4.m.31246,-0.00392653013090639,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659617.1.1.m.23473,-0.00632658736468353,No,NA,NA,Q6PB03,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC659702.1.1.m.7231,0.013305636224962,No,NA,NA,P56377,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC659901.1.1.m.348,0.000136884526146829,No,NA,NA,Q5C9Z4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_LOC659964.1.1.m.25995,0,No,NA,NA,Q9V439,NA,NA,NA,chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064],NA,NA,NA
CHOYP_LOC660067.1.1.m.20126,-0.00423936249830343,No,NA,NA,Q9DBE9,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; rRNA methylation [GO:0031167],NA,NA,NA
CHOYP_LOC660183.1.1.m.8143,-0.00052680458757087,No,NA,NA,Q62902,NA,NA,NA,COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC660225.1.1.m.35196,0.00763686063251218,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC660225.1.1.m.35197,-0.0103527276320632,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660338.1.1.m.33595,-0.00236727730218025,No,NA,NA,Q91W90,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC660381.1.1.m.6379,0.00399424771781713,No,NA,NA,Q9VRP9,NA,NA,NA,nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513],NA,NA,NA
CHOYP_LOC660501.1.2.m.5218,-0.0200932153952454,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660501.2.2.m.19155,-0.00187669205245022,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660560.1.4.m.31035,0.00833302993523952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660560.1.4.m.31036,-0.000415185156365822,No,NA,NA,P39872,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC660560.4.4.m.54542,0,No,NA,NA,Q5T0B9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC660590.1.1.m.26950,-0.0111096762731692,No,NA,NA,Q2T9U5,NA,NA,NA,nucleolus [GO:0005730]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC660684.1.1.m.28592,-0.00911169260585733,No,NA,NA,Q949P2,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC660898.1.1.m.38632,-0.00292343468748334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC661043.1.1.m.11553,-0.00321221976463037,No,NA,NA,P14543,NA,NA,NA,basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_LOC661226.1.1.m.62936,0.00290074187470398,No,NA,NA,Q16658,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; protein binding; bridging [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cell-cell junction assembly [GO:0007043]; cytokine-mediated signaling pathway [GO:0019221]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],NA,NA,NA
CHOYP_LOC661306.1.3.m.11419,-0.00359037507983152,No,NA,NA,Q9VX32,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC661626.1.1.m.53878,-0.00882443385894831,No,NA,NA,Q8BH75,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_LOC661769.1.1.m.10866,-0.0186768059239498,No,NA,NA,Q3SYS1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC661829.1.1.m.64858,-0.000890030368414748,No,NA,NA,C0H906,NA,NA,NA,cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC661955.1.1.m.37858,-0.00537757050635796,No,NA,NA,Q5R4R9,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC662072.1.1.m.51458,0.0130240183902247,No,NA,NA,Q10131,NA,NA,NA,endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; calcium ion regulated exocytosis [GO:0017156],NA,NA,NA
CHOYP_LOC662115.2.2.m.15477,0.000693065938394001,No,NA,NA,O60841,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC662190.1.3.m.1532,-0.00154418465953014,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662190.3.3.m.62554,-0.00421498370146568,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662211.1.1.m.23378,0.00735148152386524,No,NA,NA,Q13905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC662241.1.1.m.66905,0.0221796284354128,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC662320.1.2.m.18374,-0.0155637531002296,No,NA,NA,Q66II8,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; hematopoietic stem cell differentiation [GO:0060218]; mRNA splicing; via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_LOC662357.1.1.m.64851,-0.0107514827304139,No,NA,NA,Q961D9,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC662408.1.1.m.44393,-0.00598798786507908,No,NA,NA,Q9GKY8,NA,NA,NA,integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],NA,NA,NA
CHOYP_LOC662543.1.1.m.39811,-0.00216924351662914,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC662585.2.2.m.7262,-0.00920326471107921,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC663138.1.1.m.7661,-0.0135494810966912,No,NA,NA,Q9Y2H2,NA,NA,NA,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],NA,NA,NA
CHOYP_LOC663155.1.1.m.62768,-0.00961043220139788,No,NA,NA,Q2L969,NA,NA,NA,mitochondrial sorting and assembly machinery complex [GO:0001401]; nucleolus [GO:0005730]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC663249.1.1.m.25441,-0.0178092468338912,No,NA,NA,P06280,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC663261.1.1.m.21784,-0.00615945934120312,No,NA,NA,Q922K7,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; blastocyst formation [GO:0001825]; positive regulation of cell proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_LOC663375.1.1.m.11969,-0.000123722850915183,No,NA,NA,Q76IQ7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698],NA,NA,NA
CHOYP_LOC663422.1.1.m.57246,-0.00502490214107899,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_LOC663424.1.2.m.49957,-0.00406535585461616,No,NA,NA,D3ZSI8,NA,NA,NA,cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC663518.1.1.m.11968,0.00185721041939237,No,NA,NA,Q7KMJ6,NA,NA,NA,nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC663776.1.1.m.66113,0.00438403757327242,No,NA,NA,Q29RP8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC663838.2.2.m.43318,-0.0020886076936331,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC663855.2.5.m.747,0.00494811255822139,No,NA,NA,Q9DC07,NA,NA,NA,Z disc [GO:0030018]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; cardiac muscle thin filament assembly [GO:0071691]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC663855.5.5.m.51311,-0.000364344022194036,No,NA,NA,P34416,NA,NA,NA,cell junction [GO:0030054]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC664087.1.1.m.19351,-0.00690651215537378,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_LOC664138.1.1.m.26660,-0.0140768089570977,No,NA,NA,Q9VRN5,NA,NA,NA,cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription; DNA-templated [GO:0006355]; symmetric stem cell division [GO:0098724],NA,NA,NA
CHOYP_LOC664527.1.1.m.16232,0.0042362767770615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC684934.1.1.m.1807,-0.0158854925156351,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC689840.1.1.m.6512,-0.00764479676909046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC720058.1.1.m.11127,-0.000844611693990106,No,NA,NA,A0JNB1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC724172.1.1.m.24081,0.0158411728754579,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC724467.1.1.m.38548,0.00788403164382888,No,NA,NA,Q5R788,NA,NA,NA,mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC725565.1.1.m.19064,0.00302675937286262,No,NA,NA,Q6P829,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC725703.1.1.m.31182,-0.0231603282973927,No,NA,NA,P04570,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC726145.1.1.m.27163,-0.000638068200413373,No,NA,NA,P52486,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC732900.1.1.m.62814,-0.002626833679783,No,NA,NA,Q641Y2,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC732961.1.1.m.29082,0.000797986791555685,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC751836.2.6.m.25437,0.0015115548081318,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC751836.5.6.m.43257,-0.0190690643206771,No,NA,NA,Q6AYR9,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC752244.2.2.m.45622,0.00854897458395048,No,NA,NA,Q9UDY4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC752782.1.1.m.53938,0.00138245933267907,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752884.1.1.m.4412,3.03303234395916e-05,No,NA,NA,Q8NE09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968],NA,NA,NA
CHOYP_LOC753176.3.3.m.54259,0.0075228828556594,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC753178.2.2.m.60569,-0.0116464114622071,No,NA,NA,Q4R744,NA,NA,NA,,NA,NA,NA
CHOYP_LOC753709.10.44.m.22246,0.00654187445992104,No,NA,NA,Q8IWZ3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC753939.1.1.m.44379,-0.00239524875527233,No,NA,NA,Q9H845,NA,NA,NA,dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC754102.1.1.m.57575,-0.00296930180158532,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754102.1.1.m.57578,0.0116327750610023,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC754150.1.1.m.29730,0,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC754355.1.1.m.66745,-0.00397102259700269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754396.1.1.m.39126,-0.00158860240483592,No,NA,NA,Q6INX4,NA,NA,NA,mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular carbohydrate catabolic process [GO:0044275],NA,NA,NA
CHOYP_LOC754557.1.2.m.5492,0.00194701605281272,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754557.2.2.m.22904,-0.00515665704524388,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754728.5.6.m.42237,-0.00360296073572203,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC754820.1.1.m.57329,2.68237978306154e-06,No,NA,NA,Q6NV18,NA,NA,NA,DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; DNA end binding [GO:0045027]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC755229.1.1.m.5006,-0.017986483690838,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_LOC755290.2.4.m.31794,-0.0150057857264442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC755521.5.28.m.32618,0.00212215291915441,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC755594.2.6.m.51265,0.000299355023766792,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.4.6.m.53187,-0.000116424647077937,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.5.6.m.54446,-0.00653731029888863,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC756222.1.2.m.62,0.00663896459890872,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_LOC756760.1.1.m.1259,-0.000464035990951024,No,NA,NA,Q9BW91,NA,NA,NA,extracellular exosome [GO:0070062]; intracellular [GO:0005622]; mitochondrial matrix [GO:0005759]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656],NA,NA,NA
CHOYP_LOC756946.1.1.m.49284,0.00743123568920718,No,NA,NA,Q9C0I9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC756958.1.2.m.17672,-0.00363706985226706,No,NA,NA,Q7Z591,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC757096.1.1.m.9762,-0.00635242784462318,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC762368.1.1.m.8991,0.0103367956051023,No,NA,NA,Q08DU8,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; transport vesicle [GO:0030133]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; endosome to melanosome transport [GO:0035646]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; neuron projection development [GO:0031175]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_LOC762575.1.1.m.54012,-0.0137877574328599,No,NA,NA,Q9D2U5,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; polysome [GO:0005844]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_LOC762871.1.1.m.37896,0.00305185881693698,No,NA,NA,Q5R8Z8,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC762961.3.5.m.46330,0.00793770558155805,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC763087.1.1.m.9110,-0.0148746117841923,No,NA,NA,Q5EAN7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription; DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833],NA,NA,NA
CHOYP_LOC763287.1.1.m.43472,0.0118719887262472,No,NA,NA,P86880,NA,NA,NA,cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC763308.3.3.m.63145,0.000853419827783758,No,NA,NA,O35186,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC763340.1.1.m.60271,-0.00944846107258149,No,NA,NA,Q8VCM3,NA,NA,NA,endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763378.1.1.m.7889,0.00476432005147241,No,NA,NA,Q9C0D2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_LOC763463.1.1.m.1366,-0.00161757067306885,No,NA,NA,Q6GLT8,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763793.3.7.m.24306,0.00836194838848466,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC763845.1.1.m.35345,-0.00351487993829047,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC763960.1.2.m.17062,0.00363203753664381,No,NA,NA,Q5JR59,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_LOC764565.1.1.m.3966,0.00230543121245006,No,NA,NA,Q9GKX2,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090],NA,NA,NA
CHOYP_LOC764722.1.3.m.16471,0.00861854520495889,No,NA,NA,Q7YT83,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC764722.3.3.m.43616,0.0197563101222719,No,NA,NA,A1BQQ5,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC764806.1.2.m.17636,0.000747296802773756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764850.1.8.m.5396,0.00277670846513966,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764949.1.1.m.44351,-0.000356787015249407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC769726.1.1.m.26365,-0.00696770818141674,No,NA,NA,G4V4G1,NA,NA,NA,extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LOC778718.1.1.m.29230,-0.00287732749704795,No,NA,NA,O54879,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC794295.1.1.m.42748,0.0102393783405747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC797197.1.1.m.49426,-0.00346253264302479,No,NA,NA,Q8IYF3,NA,NA,NA,central element [GO:0000801]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_LONM.1.1.m.7031,-0.000852986691915994,No,NA,NA,Q8CGK3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LR16A.1.3.m.9037,0.0234335452410432,No,NA,NA,Q6EDY6,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59538,0.00368510808655869,No,NA,NA,Q5VZK9,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59539,-0.00869127788399488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRC40.1.2.m.20043,0.000361507543120773,No,NA,NA,Q7SXW3,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LRCH2.2.2.m.56149,-0.00503742280245055,No,NA,NA,Q96II8,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576],NA,NA,NA
CHOYP_LRIG1.1.3.m.954,0.00119973787957722,No,NA,NA,F7D3V9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263],NA,NA,NA
CHOYP_LRP1.5.5.m.54869,-0.000178127954254532,No,NA,NA,Q91ZX7,NA,NA,NA,basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; transcytosis [GO:0045056],NA,NA,NA
CHOYP_LRP12.1.2.m.30870,0.0122786004451007,No,NA,NA,Q5R662,NA,NA,NA,clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_LRP1B.1.2.m.7346,-0.0101513453224707,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRP2.6.7.m.41365,0.00504619129502471,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LRP4.5.5.m.48010,0.0060635421743199,No,NA,NA,Q9QYP1,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP5.1.3.m.18025,0.00563217389131516,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP6.1.6.m.878,-0.00645197166974058,No,NA,NA,O88572,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell proliferation [GO:0042127]; regulation of transcription; DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRRF2.2.2.m.40846,0.0123228343968215,No,NA,NA,Q2T9W6,NA,NA,NA,regulation of transcription; DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRRX1.6.11.m.41895,0.0136294894907614,No,NA,NA,Q7Z5L3,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LS14A.2.3.m.10984,0.0023232442000096,No,NA,NA,Q8ND56,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytoplasmic mRNA processing body assembly [GO:0033962]; multicellular organism development [GO:0007275]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of translation [GO:0006417]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LSAMP.1.1.m.36104,1.92655346573226e-05,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LSDA.1.1.m.28040,-0.0163203897315503,No,NA,NA,Q5NAI7,NA,NA,NA,cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; thermospermine oxidase activity [GO:1990534]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_LSG1.1.1.m.14762,0.000349321490836019,No,NA,NA,Q6NY89,NA,NA,NA,Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nuclear export [GO:0051168]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LSM12.1.1.m.24998,-0.00137662690165207,No,NA,NA,Q5RAT5,NA,NA,NA,,NA,NA,NA
CHOYP_LSM2.1.2.m.54283,8.84008853718255e-05,No,NA,NA,O35900,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein kinase binding [GO:0019901]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LSM3.1.1.m.9505,-0.0150136234392421,No,NA,NA,P62311,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LSM4.1.3.m.2601,0.00245882557537061,No,NA,NA,Q9QXA5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LSM7.1.1.m.3617,0.00265473384585836,No,NA,NA,Q9CQQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LTN1.1.2.m.7693,0.0024445172810515,No,NA,NA,Q6A009,NA,NA,NA,cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_LTOR2.2.2.m.61709,0.00107871019432268,No,NA,NA,B5X7X4,NA,NA,NA,late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LTV1.1.1.m.19482,0.000335693412128947,No,NA,NA,Q4V838,NA,NA,NA,,NA,NA,NA
CHOYP_LYAM3.2.4.m.3333,-0.0134653079671922,No,NA,NA,P98109,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; leukocyte tethering or rolling [GO:0050901],NA,NA,NA
CHOYP_LYPA2.1.1.m.45740,-0.000869522361170934,No,NA,NA,Q9QYL8,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LYRM4.2.3.m.7011,0.0258162970039737,No,NA,NA,Q6DCS1,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LYS3.1.1.m.31221,0.00426322657437637,No,NA,NA,B3A003,NA,NA,NA,extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_M1I1L.1.1.m.4329,-0.0120972185110707,No,NA,NA,Q9CQ20,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890],NA,NA,NA
CHOYP_M2OM.1.1.m.11786,0.00913608982935484,No,NA,NA,P22292,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367],NA,NA,NA
CHOYP_M3K1.1.1.m.7202,-0.00904033368843102,No,NA,NA,Q62925,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_M3K7.1.4.m.7880,-0.0104224949453565,No,NA,NA,P0C8E4,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; activation of MAPKK activity [GO:0000186]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_M3K7.2.4.m.17369,-0.00140968059558476,No,NA,NA,Q3U3C9,NA,NA,NA,,NA,NA,NA
CHOYP_M6PR.1.1.m.51635,0.0111096637855694,No,NA,NA,Q6AY20,NA,NA,NA,integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; mannose binding [GO:0005537]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_MA1B1.1.1.m.22675,-0.0105173792555468,No,NA,NA,B2GUY0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_MA2A1.1.1.m.19620,-0.00788577944286595,No,NA,NA,P28494,NA,NA,NA,cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_MA2A2.1.1.m.8261,0.00480386051222661,No,NA,NA,Q8BRK9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MA2C1.1.1.m.46709,0.0109251936319962,No,NA,NA,Q91W89,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MABP1.1.2.m.21698,0.000637365942912503,No,NA,NA,Q6DFF9,NA,NA,NA,,NA,NA,NA
CHOYP_MABP1.1.2.m.21699,0.00142730912340616,No,NA,NA,Q7L2H7,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_MAD1.1.1.m.48542,-0.00733397582678552,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MAD2L1.1.1.m.10353,-0.00316499011558826,No,NA,NA,Q13257,NA,NA,NA,chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_MAGI1.1.1.m.66921,0.00527543857760466,No,NA,NA,O88382,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_MALT1.1.1.m.53909,0.0096619155220732,No,NA,NA,Q9UDY8,NA,NA,NA,CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_MAN2B1.1.1.m.38450,0.00151625404621986,No,NA,NA,Q29451,NA,NA,NA,lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_MANBA.2.2.m.47433,0.00564529967232964,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MANL.2.9.m.16934,0.00769638334924085,No,NA,NA,P86856,NA,NA,NA,extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_MANL.5.9.m.42622,0.000951632611686526,No,NA,NA,Q90YP3,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_MARE3.1.1.m.30069,0.00209686839757357,No,NA,NA,Q9UPY8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription; DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MARH5.1.1.m.45222,0.00960179942681283,No,NA,NA,Q5ZJ41,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; GTPase binding [GO:0051020]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_MASP2.1.1.m.3029,0.000227097442103976,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_MAST4.1.1.m.25573,-0.00369246525820674,No,NA,NA,Q811L6,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105],NA,NA,NA
CHOYP_MATN1.2.5.m.45361,0.00125518313819789,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_MATN1.3.5.m.46206,0.00283152465607867,No,NA,NA,P21941,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500],NA,NA,NA
CHOYP_MB21L.1.1.m.35723,-0.0086552280520086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MBCDH18.1.1.m.34344,-0.0069650058642084,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_MBLK1.1.1.m.51933,-0.00211050257616773,No,NA,NA,Q5BJS9,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_MCA3.1.1.m.5766,0.000372661108570374,No,NA,NA,O43324,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of cell proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_MCA3A.1.2.m.24375,0.0065582599100172,No,NA,NA,G3MWR8,NA,NA,NA,cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MCCA.1.1.m.18170,-0.000588297749087639,No,NA,NA,Q96RQ3,NA,NA,NA,3-methylcrotonyl-CoA carboxylase complex; mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_MCEE.1.1.m.62224,0.00386539843397862,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_MCES.1.2.m.15348,-0.0159276125770891,No,NA,NA,Q5U2U7,NA,NA,NA,fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_MCM2.1.1.m.14569,-0.00582819112024649,No,NA,NA,P55861,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM3.1.1.m.14853,-0.00551158388331871,No,NA,NA,Q28BS0,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270],NA,NA,NA
CHOYP_MCM4.1.1.m.61253,-0.00256024237186611,No,NA,NA,Q6GL41,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM4.1.1.m.61254,0.000968450800113505,No,NA,NA,Q9XUY5,NA,NA,NA,sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376],NA,NA,NA
CHOYP_MCM5.1.1.m.48534,-0.0102257923245204,No,NA,NA,P55862,NA,NA,NA,chromatin [GO:0000785]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM7.1.1.m.50070,-0.00383410786660149,No,NA,NA,Q6NX31,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCMBP.1.2.m.3994,-0.0147284569632879,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MCMBP.2.2.m.18631,0.00352273523880834,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MDHC.1.1.m.57053,0.00170439465111956,No,NA,NA,Q5ZME2,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDHM.1.1.m.43603,0.000238299146328958,No,NA,NA,Q5NVR2,NA,NA,NA,mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDM1.1.2.m.7535,-0.0100699690112735,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_MDN1.2.8.m.1779,0.000169679231302997,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.3.8.m.3846,-0.00856411921017524,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.4.8.m.6155,-0.00505590234279945,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.6.8.m.52635,-0.0101080696026652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.7.8.m.63476,-0.0234235347790143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDR1A.1.1.m.47026,0.00629892414148351,No,NA,NA,P06795,NA,NA,NA,apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843],NA,NA,NA
CHOYP_MDR1B.1.2.m.12480,0.00538790861251581,No,NA,NA,P21440,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],NA,NA,NA
CHOYP_MDR3.3.3.m.66641,-0.00875834907925825,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ME3.1.1.m.58433,-0.00171859527999304,No,NA,NA,P40927,NA,NA,NA,cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_MEC2.3.4.m.30735,0.0118072496679488,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_MECR.1.1.m.6989,-0.00424967410603776,No,NA,NA,Q6GQN8,NA,NA,NA,mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MED17.1.1.m.1678,-0.00666241139640154,No,NA,NA,Q0VFR9,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED18.1.1.m.28719,0.0101734098681148,No,NA,NA,Q9BUE0,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_MED21.1.1.m.6955,-0.00689018170938905,No,NA,NA,Q16RX1,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MED24.4.10.m.16708,0.00265528590564131,No,NA,NA,Q2PW47,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538],NA,NA,NA
CHOYP_MED25.2.2.m.42845,0,No,NA,NA,A4IHD9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_MED4.1.1.m.12006,0.0165507782503231,No,NA,NA,Q7QH62,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED7.1.1.m.48813,-0.00974068481616854,No,NA,NA,Q7PR68,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED8B.1.1.m.7004,-0.0189254508459333,No,NA,NA,Q5HZZ6,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MEF2A.1.1.m.21731,-0.00227627067138637,No,NA,NA,A2VDZ3,NA,NA,NA,cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription; DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005],NA,NA,NA
CHOYP_MEG10.11.91.m.21604,0.00762178595312944,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.19.91.m.24289,0.000432007826278199,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEG10.22.91.m.28727,-0.0153621125616489,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.47.91.m.45614,-0.00981449859531608,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.50.91.m.46730,-0.00779316070366299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.56.91.m.47515,-0.00989527988210206,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.58.91.m.48257,0.00744458302339606,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.61.91.m.50119,0.00137127350669192,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.67.91.m.52967,0,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG10.70.91.m.54892,0.0181417390397103,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEG10.78.91.m.58715,-0.00364123845882962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.79.91.m.59237,0.000135345040887477,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEG10.80.91.m.60740,0.0104722446761978,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.83.91.m.61586,0.00340738369918726,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_MEG10.9.91.m.20215,0.00687557851342733,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG11.15.25.m.46952,0.0158762908955113,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_MEG11.8.25.m.39826,0.00867473948129229,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF10.8.12.m.38635,-0.00807826029935274,No,NA,NA,Q06805,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.1.59.m.1169,0,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.11.59.m.24279,0.0127364844109764,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.13.59.m.24300,6.17449988499831e-05,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.15.59.m.24311,-0.00503786714949156,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.3.59.m.2378,0.00196758639173773,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.32.59.m.41698,-0.000118384780266827,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.35.59.m.42904,-0.00631125180052769,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEGF6.36.59.m.43203,0.0143569145154819,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.44.59.m.47511,-0.00700161741778808,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.48.59.m.51016,-0.0057618478050238,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.52.59.m.54262,-0.0118866708431078,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.55.59.m.59497,-0.0106836642436423,No,NA,NA,Q5ND28,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976],NA,NA,NA
CHOYP_MEGF6.8.59.m.7292,-0.000418142734098273,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEGF6A.1.2.m.17795,-0.00830706931659096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEP50.1.1.m.12931,-0.00381701699376053,No,NA,NA,Q5RBZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327],NA,NA,NA
CHOYP_MERL.1.1.m.1067,0.00661324944131367,No,NA,NA,P35240,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010],NA,NA,NA
CHOYP_MESD.1.1.m.52095,0.012460848007084,No,NA,NA,A1L243,NA,NA,NA,endoplasmic reticulum [GO:0005783]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_MESH1.1.3.m.13824,-0.0227416924013889,No,NA,NA,Q9D114,NA,NA,NA,guanosine-3';5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_MEST.2.2.m.55065,-0.00554344711709052,No,NA,NA,Q6GQN0,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; tubulin-glutamic acid ligase activity [GO:0070740]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MET14.1.1.m.5074,0.0249548847134157,No,NA,NA,Q9Y6G5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MET23.1.1.m.14359,-0.00967391128572579,No,NA,NA,Q6DJF8,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_METEV_0975.1.1.m.28991,0.00145521471797658,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_METH.1.1.m.18095,-0.00821113194588653,No,NA,NA,Q4JIJ3,NA,NA,NA,cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558],NA,NA,NA
CHOYP_METK.1.2.m.3732,-0.00150860621838281,No,NA,NA,Q2KJC6,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_METTL15.1.1.m.14094,0.00760045574316802,No,NA,NA,A6NJ78,NA,NA,NA,rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_MF.CPA.1.1.m.3630,0.00359504443642949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MFAP4.3.3.m.62664,0.0179461094561453,No,NA,NA,D8VNS8,NA,NA,NA,extracellular region [GO:0005576]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_MGA.2.2.m.66484,-0.00301179932098758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MGC154513.1.1.m.20908,-0.0143192712776715,No,NA,NA,Q9H9L4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_MGC78792.1.1.m.45233,-0.0037987768562004,No,NA,NA,Q08288,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MGC81574.1.1.m.8983,0.0183895076041029,No,NA,NA,Q91XN4,NA,NA,NA,integral component of membrane [GO:0016021]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_MGC82409.1.1.m.44657,-0.00136317856666697,No,NA,NA,P05689,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_MGC89016.1.2.m.76,0.000978836947424657,No,NA,NA,Q03168,NA,NA,NA,lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190],NA,NA,NA
CHOYP_MGN2.1.1.m.9330,0.00048878696534068,No,NA,NA,Q96A72,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_MIB.2.3.m.30418,-0.0131218455919388,No,NA,NA,Q8R412,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; aging [GO:0007568]; response to virus [GO:0009615],NA,NA,NA
CHOYP_MIB1.2.4.m.35815,0.00156928364171523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MIB1.3.4.m.57545,0.00567669892704245,No,NA,NA,Q86YT6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_MIB1.4.4.m.64019,0.00860296072136668,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.2.6.m.23029,0.00691357182041815,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.4.6.m.43287,-0.00749311143412758,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.5.6.m.43978,0.0140718696073474,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MICPUCDRAFT_54866.2.4.m.37897,0.0183611589552027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUCDRAFT_54866.4.4.m.57185,-0.0187376765482934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MIF.2.2.m.30795,0.0266343358750006,No,NA,NA,P80928,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207],NA,NA,NA
CHOYP_MINP1.1.1.m.13284,0.000524012870868144,No,NA,NA,Q9Z2L6,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1;3;4;5;6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1;4;5;6-tetrakisphosphate 6-phosphatase activity [GO:0030352],NA,NA,NA
CHOYP_MINT.1.1.m.54605,-0.010235652503727,No,NA,NA,Q8SX83,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_MK01.1.1.m.48878,0.00215319151770387,No,NA,NA,P26696,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849],NA,NA,NA
CHOYP_ML12B.1.1.m.27220,0.00136792041412798,No,NA,NA,Q09510,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; embryonic body morphogenesis [GO:0010172]; establishment of cell polarity [GO:0030010]; meiosis I cytokinesis [GO:0007110]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; protein localization [GO:0008104],NA,NA,NA
CHOYP_MLE.1.9.m.15462,0.00162179466556607,No,NA,NA,P07291,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLE.4.9.m.38686,0.0230464856585851,No,NA,NA,P05945,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLL.1.1.m.33426,-0.00434856527724019,No,NA,NA,O08550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_MLL3.2.3.m.25295,-0.00705898726093649,No,NA,NA,Q8NEZ4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_MLP2.4.4.m.62619,0.00159219254174179,No,NA,NA,Q24400,NA,NA,NA,nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_MLRA.3.3.m.62296,-0.0198199790131367,No,NA,NA,P04113,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MMAC.1.1.m.8063,-0.00623909347017249,No,NA,NA,Q5ZL21,NA,NA,NA,cytoplasm [GO:0005737]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MMS19.1.1.m.18650,0.00409560775715274,No,NA,NA,Q0V9L1,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_MNB.1.1.m.14023,-0.00849793259208723,No,NA,NA,Q63470,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_MO25.1.1.m.62210,-0.00045292355918733,No,NA,NA,P91891,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014],NA,NA,NA
CHOYP_MO4L1.1.1.m.8106,-0.000609870783521798,No,NA,NA,Q9Y0I1,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme regulator activity [GO:0030234]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; chromosome separation [GO:0051304]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K36 methylation [GO:0000416],NA,NA,NA
CHOYP_MON2.1.1.m.65761,-0.0202067145608728,No,NA,NA,Q7Z3U7,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MONBRDRAFT_34536.1.1.m.30219,-0.00505046502988339,No,NA,NA,A0KDV2,NA,NA,NA,L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063],NA,NA,NA
CHOYP_MONBRDRAFT_34989.1.1.m.34385,0.015263693825285,No,NA,NA,O18823,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],NA,NA,NA
CHOYP_MORC2.1.1.m.6240,0.00404385555388598,No,NA,NA,Q9Y6X9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MORC3.1.2.m.38178,-0.0159799713728259,No,NA,NA,Q14149,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; viral process [GO:0016032],NA,NA,NA
CHOYP_MP2K4.1.1.m.10635,-0.000339263616836692,No,NA,NA,P47809,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45311,0.0116635084170855,No,NA,NA,Q13163,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45312,0.00112983800214446,No,NA,NA,P26446,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_MP2K6.1.1.m.38188,0.00356954978850951,No,NA,NA,P52564,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cell cycle arrest [GO:0007050]; cellular response to sorbitol [GO:0072709]; DNA damage induced protein phosphorylation [GO:0006975]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MPDZ.3.3.m.51236,0.00763912640046261,No,NA,NA,O75970,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032],NA,NA,NA
CHOYP_MPEG1.4.5.m.49975,-0.0070870773680316,No,NA,NA,Q2KJC3,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_MPET_1013.1.2.m.36696,-0.00218994667872856,No,NA,NA,Q5I0S8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_MPHOSPH9.1.1.m.9795,0.00415719621025766,No,NA,NA,A6H5Y1,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],NA,NA,NA
CHOYP_MPI.1.1.m.35645,0.00381470131887149,No,NA,NA,Q3SZI0,NA,NA,NA,cytoplasm [GO:0005737]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MPP2.1.1.m.62101,0.000662384805430426,No,NA,NA,D3ZAA9,NA,NA,NA,anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; ion channel binding [GO:0044325]; PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_MPPA.2.2.m.18272,-0.00332653729506175,No,NA,NA,Q9DC61,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_MPPA.2.2.m.18273,-0.0101618932098257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MPST.1.1.m.11853,0.0185761375841334,No,NA,NA,P97532,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_MROH1.1.1.m.24366,-0.000120614598022709,No,NA,NA,Q8NDA8,NA,NA,NA,,NA,NA,NA
CHOYP_MRP1.10.10.m.64931,0.000164964056842992,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRP1.4.10.m.27993,0.00514146235376679,No,NA,NA,Q5F364,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_MRP1.5.10.m.34368,-0.00856446004984487,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRPL42.1.1.m.61762,0.0204427690146435,No,NA,NA,Q9CPV3,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_MRPL45.1.1.m.11763,0.00891768501574023,No,NA,NA,Q3T142,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_MRPL55.1.1.m.1120,0.0122955499649992,No,NA,NA,P0C2B8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_MRPS28.1.1.m.29259,-0.0221484374093671,No,NA,NA,P82928,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],NA,NA,NA
CHOYP_MRPS35.1.1.m.20118,-0.0163320980879886,No,NA,NA,Q2YDF6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_MRRF.1.1.m.16730,0.00811381319943687,No,NA,NA,Q0VCQ4,NA,NA,NA,mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation [GO:0006412],NA,NA,NA
CHOYP_MRT4.1.1.m.1698,-0.00910810503054459,No,NA,NA,Q9UKD2,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MSH2.1.1.m.18340,-6.92195902093614e-05,No,NA,NA,Q5XXB5,NA,NA,NA,chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298],NA,NA,NA
CHOYP_MSI2H.3.3.m.35858,-0.0167692115795311,No,NA,NA,Q9VVE5,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_MSRB3.1.4.m.4844,-0.0115579538984454,No,NA,NA,Q5R930,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_MSRB3.2.4.m.17278,0,No,NA,NA,Q8BU85,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_MT.10.18.m.44063,0.00402465501499227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTA1.1.1.m.12640,-0.00102180304727597,No,NA,NA,Q13330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression; epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MTAP.1.1.m.15433,0.0062228646997062,No,NA,NA,Q7ZV22,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_MTBP.1.1.m.17026,0.00618980049843895,No,NA,NA,Q6NRW0,NA,NA,NA,cell cycle arrest [GO:0007050]; regulation of protein ubiquitination [GO:0031396],NA,NA,NA
CHOYP_MTHR.1.1.m.54596,-0.00850577776384862,No,NA,NA,Q5I598,NA,NA,NA,cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_MTIF2.1.1.m.17935,-0.0124251220929418,No,NA,NA,P46198,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_MTMR9.1.1.m.26430,-0.0223853730880039,No,NA,NA,Q9Z2D0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],NA,NA,NA
CHOYP_MTNA.1.1.m.1717,0.00254511436476951,No,NA,NA,Q16I17,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_MTNB.1.1.m.16051,0.0216085013004338,No,NA,NA,Q96GX9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372],NA,NA,NA
CHOYP_MTND.2.3.m.41824,0.000417215228409342,No,NA,NA,C3ZAH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],NA,NA,NA
CHOYP_MTOR.2.2.m.51573,-0.014984634092623,No,NA,NA,P42345,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing; spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse; modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060],NA,NA,NA
CHOYP_MTPN.2.2.m.58730,0.000650564935548124,No,NA,NA,Q55FM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; negative regulation of barbed-end actin filament capping [GO:2000813],NA,NA,NA
CHOYP_MTR_027S0011.1.1.m.29241,0.00374385506634012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTR_7G016900.1.1.m.39323,0.0103757245368028,No,NA,NA,Q9FMB4,NA,NA,NA,HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MTR1.1.1.m.59840,0.00244432515634548,No,NA,NA,Q803R5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009],NA,NA,NA
CHOYP_MTSS1.1.1.1.m.41595,0.010006089030686,No,NA,NA,O43312,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MTX1.1.1.m.43691,-0.00609990115920586,No,NA,NA,Q27HK4,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial sorting and assembly machinery complex [GO:0001401]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MUC1.1.5.m.5910,-0.00620220921735952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC21.1.1.m.41811,-0.0165606007334562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC4.1.1.m.41314,0.0170944275865498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5A.1.2.m.43407,-0.00482715714626068,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5AC.1.2.m.17430,0.0107497198630817,No,NA,NA,O35276,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_MUC5B.1.1.m.15734,0,No,NA,NA,Q685J3,NA,NA,NA,apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent; lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_MUG2.1.1.m.55656,-0.00880011170916152,No,NA,NA,Q6IE52,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_MUTA.1.1.m.31799,-0.00169698981552802,No,NA,NA,P22033,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_MVD1.1.1.m.28700,0.00211856888409334,No,NA,NA,Q99JF5,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process; mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_MVP.1.1.m.56230,-0.00105182810409823,No,NA,NA,Q5EAJ7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MYBA.1.1.m.48052,-4.19175627334263e-05,No,NA,NA,P10242,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription; DNA-templated [GO:0006355]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_MYBPP.1.1.m.45264,0.00643493905616314,No,NA,NA,Q8TBZ2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_MYBV.1.1.m.62683,-0.00451834012889584,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_MYBX.3.4.m.53061,0.0045714498402719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYCB2.1.2.m.13017,0.00147875457459592,No,NA,NA,O75592,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_MYCBP2.1.1.m.27070,-0.00057423120290434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYD88.2.7.m.21423,-0.00999182061010532,No,NA,NA,A8QMS7,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_MYD88.4.7.m.31202,0.0118478952805135,No,NA,NA,Q5XJ85,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237],NA,NA,NA
CHOYP_MYD88.5.7.m.41603,-0.00771399196694934,No,NA,NA,Q99836,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_MYEF2.1.1.m.18999,-0.000123986771120582,No,NA,NA,Q8C854,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815],NA,NA,NA
CHOYP_MYG1.1.1.m.4971,-0.00387991026967347,No,NA,NA,Q9JK81,NA,NA,NA,mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641],NA,NA,NA
CHOYP_MYO15.1.1.m.66281,-0.00333585950106947,No,NA,NA,Q9UKN7,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO16.4.4.m.65831,0.00899140685887368,No,NA,NA,Q9Y6X6,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134],NA,NA,NA
CHOYP_MYO18.1.1.m.3952,-0.00102981844262536,No,NA,NA,Q92614,NA,NA,NA,actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030],NA,NA,NA
CHOYP_MYO1B.1.1.m.53598,0.00190876674030046,No,NA,NA,P46735,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_MYO1E.1.1.m.49109,0.00407215527269013,No,NA,NA,Q12965,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_MYO22.2.2.m.24750,-0.000233131696725319,No,NA,NA,Q9U1M8,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847],NA,NA,NA
CHOYP_MYO3.2.2.m.59993,0.00500633104576479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYO3AL.1.1.m.8123,-0.00644171609557954,No,NA,NA,Q1EG27,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine/threonine kinase activity [GO:0004674]; auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO5A.2.4.m.11575,0.00240880932906087,No,NA,NA,Q9Y4I1,NA,NA,NA,actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; smooth endoplasmic reticulum [GO:0005790]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO6.1.1.m.4131,0.000758715691648746,No,NA,NA,Q9UM54,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II; holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.1.3.m.59205,0.000361574570348281,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.2.3.m.63360,-0.000889095629297447,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYOF.3.3.m.53228,0.00185293187998502,No,NA,NA,Q9ESD7,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_MYPH.1.2.m.36560,-0.000543431334097587,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_MYS.1.7.m.433,0.00320658604974669,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.1.7.m.435,0.00111617775770808,No,NA,NA,Q32LJ4,NA,NA,NA,calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_MYS.2.7.m.2064,0.0122847052141346,No,NA,NA,Q2VJ60,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_MYS.2.7.m.2069,-0.0134923186683885,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2070,-0.000241504945621971,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2075,0.00242010105662175,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.4.7.m.18188,0.00236264152016169,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44341,-1.62021258696094e-05,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44342,0.00211411934426374,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS3.1.2.m.31829,0.000144621544199998,No,NA,NA,Q91ZR3,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to virus [GO:0009615]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_MYSP.1.9.m.1097,0.010519404762862,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.1.9.m.1100,-4.78122511847377e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYSP.4.9.m.2302,-0.00251293034755128,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.5.9.m.28124,0.0197645979444639,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.8.9.m.44813,-0.0244375544845496,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSTI_04398.1.1.m.27734,-0.0148039264265916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_N2F1A.1.1.m.63063,0.0206661548180427,No,NA,NA,Q06725,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; endothelial cell proliferation [GO:0001935]; vasculature development [GO:0001944],NA,NA,NA
CHOYP_NAA15.1.1.m.34959,-0.000158705759239463,No,NA,NA,Q9BXJ9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription; DNA-templated [GO:0045893]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NAA25.1.1.m.11255,-0.00431395279125468,No,NA,NA,Q14CX7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_NAA35.1.1.m.60092,-0.00708280252275508,No,NA,NA,Q5ZHV2,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],NA,NA,NA
CHOYP_NACA.2.9.m.11875,-0.00172659491103031,No,NA,NA,Q8AWF2,NA,NA,NA,nascent polypeptide-associated complex [GO:0005854]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NAEGRDRAFT_49892.1.1.m.10608,0.00791748923923717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAEGRDRAFT_71860.1.1.m.2556,-0.00569417484596143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAF1.1.1.m.13716,-0.00695268661111674,No,NA,NA,Q52KK4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NAGLU.2.2.m.60267,-0.0026735624074921,No,NA,NA,P54802,NA,NA,NA,extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548],NA,NA,NA
CHOYP_NAGT1.1.1.m.8857,1.88747892783654e-05,No,NA,NA,Q8VCV9,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_NAS13.1.1.m.30415,-0.0189773306564875,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NASP.2.4.m.13404,-0.0037810053487811,No,NA,NA,Q02508,NA,NA,NA,nucleus [GO:0005634]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NASP.4.4.m.56613,0.0163686891159757,No,NA,NA,P49321,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_NAV2.1.3.m.9737,-0.00308142859776172,No,NA,NA,Q8IVL1,NA,NA,NA,interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564],NA,NA,NA
CHOYP_NBEL1.1.1.m.33217,-0.0086252569119702,No,NA,NA,Q6ZS30,NA,NA,NA,,NA,NA,NA
CHOYP_NC2A.1.1.m.22786,0,No,NA,NA,Q14919,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NCAH.1.5.m.8672,0.00420757659114199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCAH.3.5.m.51972,-0.0181386622667785,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NCBP2.1.1.m.60410,0.0235796840619841,No,NA,NA,B4KCD5,NA,NA,NA,nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_NCDN.1.1.m.58381,-0.0107028309300727,No,NA,NA,Q640K1,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_NCER_101848.1.1.m.63547,0.000352319447127129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCKP1.1.4.m.24694,-0.00260275560117432,No,NA,NA,P28660,NA,NA,NA,filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis; embryo [GO:0007354],NA,NA,NA
CHOYP_NCLIV_053520.1.1.m.8896,0.00718315647010947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCOA4.1.1.m.5549,-0.0124397733966391,No,NA,NA,Q13772,NA,NA,NA,autolysosome [GO:0044754]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; cellular iron ion homeostasis [GO:0006879]; male gonad development [GO:0008584]; positive regulation of transcription; DNA-templated [GO:0045893]; protein targeting to lysosome [GO:0006622],NA,NA,NA
CHOYP_NCU02236.1.1.m.28628,-0.0155786990736095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ND1.2.5.m.36938,0.000597593795445592,No,NA,NA,Q61425,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_ND1.4.5.m.42588,-0.00797188708378534,No,NA,NA,Q9ER88,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; apoptotic mitochondrial changes [GO:0008637],NA,NA,NA
CHOYP_ND4.3.5.m.19536,-0.000555105284245449,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_NDK7.1.1.m.64883,-0.000320182234644271,No,NA,NA,Q9Y5B8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_NDL1A.1.1.m.10230,-0.00557069011214511,No,NA,NA,Q9CZA6,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_NDUA5.1.2.m.2750,0.0135927907319338,No,NA,NA,Q18359,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_NDUFA7.2.2.m.57153,-0.00132201892680901,No,NA,NA,Q9Z1P6,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_NDUFB7.1.1.m.27222,-0.0224078190997773,No,NA,NA,P90789,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_NDUFB9.1.2.m.37494,-0.007513730322199,No,NA,NA,Q02369,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_NDUFS4.1.1.m.66417,-0.00318648391492099,No,NA,NA,P0CB96,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591],NA,NA,NA
CHOYP_NEC1.1.1.m.63094,0.00290264116400756,No,NA,NA,P28840,NA,NA,NA,axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NECA3.1.1.m.106,-0.00467752156356944,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_NECX.1.1.m.56979,-0.00237627332553594,No,NA,NA,Q16982,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NED4L.1.1.m.7792,0.00145919449013886,No,NA,NA,Q62940,NA,NA,NA,cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEDD1.1.1.m.10741,-0.00652550466641692,No,NA,NA,P33215,NA,NA,NA,apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex; centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201],NA,NA,NA
CHOYP_NEFH.1.2.m.59956,-0.000270329477099701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEK1.1.5.m.9137,-0.00226755274015067,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK1.4.5.m.32116,0.00459238515837683,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK9.1.1.m.19497,0.0174195391038683,No,NA,NA,Q8TD19,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear envelope disassembly [GO:0007077],NA,NA,NA
CHOYP_NELFB.1.2.m.9922,-0.014418442213873,No,NA,NA,Q9Y113,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NEMF.1.1.m.57807,0.0217612973339157,No,NA,NA,Q8CCP0,NA,NA,NA,nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.1.2.m.26774,0.00287275040318527,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.2.2.m.65547,0.00159787721177297,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G106520.1.1.m.14881,-0.0049678464733997,No,NA,NA,P50532,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G114289.1.1.m.17188,-0.0102046866659526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120119.1.2.m.6082,0.00103055791549914,No,NA,NA,P28825,NA,NA,NA,membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120526.4.5.m.36926,-0.0117393645202025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122785.1.1.m.57840,-0.0233819044763236,No,NA,NA,P33450,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length; open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122840.1.2.m.28819,0.000134428955582863,No,NA,NA,Q4R7T5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G135670.1.1.m.18689,-0.00294297034437588,No,NA,NA,Q52I78,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G140878.1.1.m.18069,0.000830081615813112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G141380.2.4.m.8974,0.00677720434372302,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154303.1.1.m.3521,-0.00123926560817442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157638.1.1.m.31214,-0.00044042104266399,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157950.1.1.m.4584,-0.00776228385518146,No,NA,NA,A2VD82,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G159364.1.1.m.22912,-0.0189555521440698,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G160170.1.1.m.66042,-0.0114135561608248,No,NA,NA,P0DJG4,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G162365.1.1.m.8038,0.00030433124485974,No,NA,NA,Q7JZB4,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G163820.1.1.m.6391,0.00770872928610346,No,NA,NA,Q5R5L3,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.1.3.m.46942,0.00126564210774663,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.3.3.m.59979,-0.0103005917283176,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165338.1.1.m.60296,0.00238922622372166,No,NA,NA,P60517,NA,NA,NA,actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165649.1.1.m.2893,0.0124282383718808,No,NA,NA,Q6DF67,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G166546.1.1.m.10454,-0.0116154910001768,No,NA,NA,O35130,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167304.1.1.m.10864,-0.00242793121433784,No,NA,NA,P49596,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167758.1.1.m.66572,0.000552632094605982,No,NA,NA,Q5PQQ6,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167835.1.1.m.6190,0.00182625425450771,No,NA,NA,Q567Y6,NA,NA,NA,cell [GO:0005623]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167853.1.2.m.20047,-0.0140825618881748,No,NA,NA,A4FU69,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168076.2.2.m.56942,-0.00396349997875085,No,NA,NA,Q54271,NA,NA,NA,phosphonopyruvate decarboxylase activity [GO:0033980]; thiamine pyrophosphate binding [GO:0030976]; antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168163.1.1.m.63148,0.000346974210068475,No,NA,NA,Q9Z2U1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168923.1.1.m.29344,0.0189315303439835,No,NA,NA,O95825,NA,NA,NA,cytosol [GO:0005829]; NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960]; quinone metabolic process [GO:1901661],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169195.1.1.m.2476,-0.00242726063064983,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.1.2.m.18155,0.00904602376053308,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.2.2.m.29703,-0.00467211472194968,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G171044.1.1.m.44527,0.0203362869674518,No,NA,NA,Q62356,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173323.2.2.m.55211,-0.000315928447676367,No,NA,NA,P28075,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173435.1.1.m.37344,0.00224816405174572,No,NA,NA,Q711T7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13511,-0.0117901359208746,No,NA,NA,O62742,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13512,-0.00170670029993354,No,NA,NA,Q6PAY8,NA,NA,NA,peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179696.1.1.m.40556,-0.0226214678787003,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179716.1.1.m.55972,-0.000911049373993128,No,NA,NA,P15651,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G180651.1.2.m.2808,-0.00607634918083908,No,NA,NA,P06797,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G181421.1.1.m.3106,0.00153084771860761,No,NA,NA,P30837,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G182319.1.1.m.5048,-0.000852557276046471,No,NA,NA,Q5ZIE6,NA,NA,NA,cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G183894.1.1.m.55454,0.00394005359546991,No,NA,NA,A5A6H9,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G185623.1.1.m.62696,-0.00131277392351028,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188927.1.1.m.17076,-0.011322325172851,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188942.1.1.m.6629,-0.00122604752381766,No,NA,NA,Q9WUA2,NA,NA,NA,phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G191841.1.1.m.1745,-0.00435106957208392,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G192713.1.1.m.16224,0.0021586378851275,No,NA,NA,O88696,NA,NA,NA,endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G193373.1.2.m.19292,-0.00680242060429779,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.1.2.m.11442,0.0013090498349219,No,NA,NA,Q8WPW2,NA,NA,NA,pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.2.2.m.40726,-0.0186326235895604,No,NA,NA,P23606,NA,NA,NA,intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197278.1.1.m.45568,0.00148213811542029,No,NA,NA,A6X391,NA,NA,NA,carboxylic ester hydrolase activity [GO:0052689]; deacetylase activity [GO:0019213]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197314.1.2.m.61420,0.000483287514995104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.1.15.m.3453,0.00312866831110993,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.12.15.m.51327,-0.00933390105854631,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.14.15.m.61843,0.0103852771854286,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198846.1.1.m.25649,3.31604707101552e-05,No,NA,NA,Q8R2L5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.2.6.m.4748,0.000517637575232383,No,NA,NA,Q56R14,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.4.6.m.52548,-0.000775404022755656,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G199721.1.1.m.64387,-0.00403289882447495,No,NA,NA,Q9UGM1,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201445.4.5.m.54666,-0.00975281844316611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.1.6.m.2876,0.00503152401023287,No,NA,NA,Q04786,NA,NA,NA,beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.4.6.m.22239,-0.00755068101615945,No,NA,NA,P13670,NA,NA,NA,cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60812,0.00148792121408868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60815,-0.0180120681811244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.1.2.m.15590,-0.02060095256548,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.2.2.m.27972,0.00168094176547927,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206150.1.1.m.39762,0.0184542261490537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206950.1.1.m.37574,-0.00623511747602667,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G208725.1.1.m.36498,-0.013580916201324,No,NA,NA,Q2KIR0,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212280.3.3.m.30224,0.0072822618902411,No,NA,NA,E7FAM5,NA,NA,NA,P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212312.2.5.m.45586,-0.0024335640528632,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.22.34.m.54623,0,No,NA,NA,Q9D9R9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.25.34.m.55918,-0.00083126713223945,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.29.34.m.57719,-0.0105298646549945,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.9.34.m.28637,0.0067132309102682,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214960.1.1.m.2485,0.0290405396146971,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G215851.2.2.m.18129,-0.00529101227712728,No,NA,NA,Q49A92,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218264.11.14.m.51529,-0.00754728310797569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218914.4.4.m.62116,-0.000135952949595236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221088.1.1.m.66380,-0.011325793501777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221688.1.1.m.52819,-0.000161492991650358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.4.5.m.31140,0.011904806321275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.5.5.m.50649,-0.00997950820729752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224392.2.3.m.36325,0.000261014068550036,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G226328.1.1.m.11691,-0.00295189144663101,No,NA,NA,Q8IVN8,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix structural constituent [GO:0005201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G229510.4.4.m.47762,0.000273890225667908,No,NA,NA,Q03650,NA,NA,NA,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G230495.1.1.m.61211,0.000860478320959387,No,NA,NA,P52209,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G232294.1.1.m.22465,0.000169752622617279,No,NA,NA,P16230,NA,NA,NA,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233184.1.1.m.18285,-0.00770762740214869,No,NA,NA,Q5RC69,NA,NA,NA,dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.6.13.m.49823,-0.0141852326566256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.8.13.m.55781,-0.0114668703626708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G234225.1.1.m.49490,0.00211335838729872,No,NA,NA,O77834,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19147,-0.00128525944790844,No,NA,NA,Q9CQ62,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235970.1.1.m.34141,-0.0026776035813429,No,NA,NA,Q6DGA6,NA,NA,NA,allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.2.2.m.47233,0.00393218751924828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236653.1.1.m.59422,0.00787280463718093,No,NA,NA,Q8VBT9,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.3.6.m.24704,0.000736720555396395,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.4.6.m.30181,0.00282749164221102,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237029.1.1.m.64370,0.0231342276107441,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237545.1.1.m.34853,0.000170335667008324,No,NA,NA,Q4KM33,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; actin cytoskeleton reorganization [GO:0031532]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237598.1.1.m.11619,0.00261980562691108,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237629.1.1.m.24486,0.00779023803080123,No,NA,NA,Q96PM5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237797.1.1.m.40688,-0.00845857540427826,No,NA,NA,Q9BW85,NA,NA,NA,U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA processing [GO:0006397]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237881.1.1.m.10098,-0.00974539833269327,No,NA,NA,Q5C9L6,NA,NA,NA,cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238062.3.6.m.5146,0.00127586939956686,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238590.1.1.m.49168,-5.56919936564455e-05,No,NA,NA,Q9QUM7,NA,NA,NA,mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synapsis [GO:0007129],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238593.1.1.m.8407,0.00880475471522707,No,NA,NA,Q6UPR8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238894.7.11.m.61041,0.0158686305803403,No,NA,NA,Q6PDJ1,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G239043.2.6.m.4886,0.00605810850021279,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240471.1.1.m.10922,-0.001771763748622,No,NA,NA,Q8K4F6,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.1.3.m.5221,0.0122071700687906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.3.3.m.30812,-0.0010073462019386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240887.2.2.m.37649,-0.0129059425443222,No,NA,NA,Q9CPU4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241267.1.1.m.7467,-0.00553584763492572,No,NA,NA,Q6PDZ2,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription by RNA polymerase I [GO:0006360],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.1.2.m.22601,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.2.2.m.47394,0.00987962166864564,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242065.1.1.m.21817,0.00191370622900748,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.2.4.m.15572,-0.0037608871584853,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.4.4.m.60071,0.00300840844718784,No,NA,NA,Q2FXL6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244077.1.1.m.14957,-0.0100742322676182,No,NA,NA,Q17Q97,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244113.1.1.m.22167,-0.0134650713438878,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244537.2.3.m.10401,0.000577619222834595,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244727.1.1.m.35118,0.000731269902832175,No,NA,NA,Q9SKC3,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244806.2.2.m.52012,-0.00348766545065207,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245101.1.1.m.56451,0.0023553423819484,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.11.11.m.63026,0.00649369011004686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.2.11.m.22482,-0.00429962310650848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.5.11.m.34248,-0.010283052061815,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245744.1.1.m.36806,0.00609129166470124,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245969.1.2.m.347,-0.014584339129367,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246111.1.2.m.45249,-0.00677785354037208,No,NA,NA,A7SLZ2,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246422.1.1.m.1312,0.0121900546387489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246686.1.1.m.53126,-0.0108941529134033,No,NA,NA,B3EWY7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247177.1.1.m.63233,0.000146853317221847,No,NA,NA,Q18786,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247395.1.8.m.5020,-0.0119659466133326,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G248362.1.1.m.62940,-0.00128279257109226,No,NA,NA,Q03958,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G52068.2.3.m.36345,0.00647725196569697,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G61368.1.1.m.42775,-0.0057207357064151,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G69851.3.4.m.5191,0.00825596734823028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.1.2.m.17299,0.0171607405049776,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.2.2.m.38500,0.00165429093826229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G79897.1.1.m.52661,0.00296267958086466,No,NA,NA,Q9Z1J2,NA,NA,NA,ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription; DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80221.1.1.m.12716,-0.0072701947479514,No,NA,NA,Q8BFR4,NA,NA,NA,lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; keratan sulfate catabolic process [GO:0042340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80846.1.1.m.24713,-0.00300698369492918,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G83869.3.3.m.30283,-0.00817341485171376,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G86312.1.1.m.10844,-0.016611109134263,No,NA,NA,Q9Y6J8,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G92762.1.1.m.1253,-0.00917933074806526,No,NA,NA,Q6ZHE5,NA,NA,NA,mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G957.1.1.m.27284,3.40186925433026e-05,No,NA,NA,O11780,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.1.2.m.34546,0.00808396634027682,No,NA,NA,Q9GLK0,NA,NA,NA,membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63646,-0.0036086361883097,No,NA,NA,Q9JLF6,NA,NA,NA,cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein metabolic process [GO:0019538],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63648,0.000390648735143583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEO1.3.3.m.61836,0.000939866968068294,No,NA,NA,P97798,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_NEUL4.2.2.m.54340,-0.00397059138438022,No,NA,NA,A1L0Y2,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_NF70.4.4.m.63507,-0.00181416872870209,No,NA,NA,Q01241,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NFH.1.1.m.53607,0.00103145271979842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NFIL3.1.1.m.26076,-0.00701650406156991,No,NA,NA,Q16649,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_NFKB.1.1.m.51558,0.00557532452346796,No,NA,NA,Q04861,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; NF-kappaB binding [GO:0051059]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NFRKB.1.1.m.18027,0,No,NA,NA,Q6PIJ4,NA,NA,NA,Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_NFRKB.1.1.m.18028,-0.00223640097711534,No,NA,NA,Q9DCH4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_NFS1.1.1.m.1622,-0.00308772313071907,No,NA,NA,Q9Z1J3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],NA,NA,NA
CHOYP_NFX1.1.2.m.13487,0.000409682596407827,No,NA,NA,Q12986,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032],NA,NA,NA
CHOYP_NGAP.2.2.m.63455,0.0149699751358404,No,NA,NA,Q3UHC7,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein complex assembly [GO:0043254]; regulation of protein heterodimerization activity [GO:0043497]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_NHP2.1.1.m.57624,-0.00262988081144467,No,NA,NA,Q6P8C4,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]; translation [GO:0006412],NA,NA,NA
CHOYP_NID2.1.2.m.5776,-0.00381437657071675,No,NA,NA,P81439,NA,NA,NA,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_NIF3L.1.2.m.28817,0.00814181244711441,No,NA,NA,Q9GZT8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NIPA.1.1.m.13987,0.0144934430271897,No,NA,NA,Q80YV2,NA,NA,NA,nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NIPLB.1.1.m.11155,0.00497033391156282,No,NA,NA,Q6KCD5,NA,NA,NA,chromatin [GO:0000785]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038],NA,NA,NA
CHOYP_NIPSNAP3A.B.1.1.m.62397,0.00627208539113281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NISCH.1.2.m.17955,-0.00295086635978405,No,NA,NA,Q9Y2I1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_NIT2B.1.1.m.18389,0.00122285873481129,No,NA,NA,Q6INI7,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; nitrogen compound metabolic process [GO:0006807],NA,NA,NA
CHOYP_NKRF.1.1.m.61828,-0.00724624595314066,No,NA,NA,O15226,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NKX23.1.1.m.25439,5.67923396409482e-05,No,NA,NA,A6NCS4,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_NLRC3.1.1.m.57383,0.00545172533757385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NMT2.1.2.m.10421,-0.0052564879235546,No,NA,NA,O60551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400],NA,NA,NA
CHOYP_NNRE.2.2.m.27199,0,No,NA,NA,B7QDG3,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_NOC41.1.1.m.53790,0.00381896310890087,No,NA,NA,Q6NU91,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOG2.1.1.m.41399,-0.0179935490962225,No,NA,NA,Q99LH1,NA,NA,NA,nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL11.1.1.m.6423,-0.0200305484633845,No,NA,NA,Q6INI5,NA,NA,NA,nucleolus [GO:0005730]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],NA,NA,NA
CHOYP_NOL5.1.1.m.49429,-0.0015965339558658,No,NA,NA,Q4R779,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL9.1.2.m.16473,-0.010473523124607,No,NA,NA,Q3TZX8,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460],NA,NA,NA
CHOYP_NOLC1.3.3.m.66629,-0.00972317083914756,No,NA,NA,P41777,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970],NA,NA,NA
CHOYP_NOMO1.2.2.m.46404,-0.00246619469971432,No,NA,NA,Q15155,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NOP56.1.1.m.55664,-0.00183191789265016,No,NA,NA,O00567,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NOSC.1.1.m.6346,-0.00626214836016296,No,NA,NA,Q9Z0J4,NA,NA,NA,azurophil granule [GO:0042582]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density; intracellular component [GO:0099092]; postsynaptic specialization; intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; exogenous drug catabolic process [GO:0042738]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_NOTC3.1.1.m.20877,-0.00546274704663816,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_NOV.1.2.m.27550,0.0205519913374039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NPC2.2.7.m.29742,-0.00110303606328742,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.4.7.m.30775,0.00121320776038203,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPC2.5.7.m.30911,0.00281120742330914,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.6.7.m.31030,0.00070700687830379,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPL.1.3.m.4064,-0.00400482306051136,No,NA,NA,Q66H59,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL.3.3.m.29352,-0.000251547109424449,No,NA,NA,Q9DCJ9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL4.1.1.m.62114,0.00293759641469515,No,NA,NA,P60670,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport; ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NPTN.1.1.m.50315,0.00348734785394159,No,NA,NA,P35613,NA,NA,NA,acrosomal membrane [GO:0002080]; axon [GO:0030424]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NR1AA.1.1.m.39226,0.00303813567782423,No,NA,NA,Q9ULB1,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle cycle [GO:0098693]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by endocannabinoid [GO:0099542]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_NRG.1.1.m.10622,-0.00757062439082686,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_NRP.1.4.m.29956,-0.0127141864883905,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NRP.2.4.m.39720,0.00710189304080436,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NRP.4.4.m.44647,0.00431223361645443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX3A.1.1.m.1705,0.00209748260055279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX4.1.1.m.8135,0.00630398642600289,No,NA,NA,Q94887,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_NSF1C.1.1.m.62502,-0.000863582980814078,No,NA,NA,Q9CZ44,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; VCP-NSFL1C complex [GO:1990730]; ATPase binding [GO:0051117]; phospholipid binding [GO:0005543]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NSUN2.1.1.m.14138,-0.010830954301862,No,NA,NA,Q08J23,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_NT5M.1.1.m.6188,3.96660559821708e-05,No,NA,NA,Q9NPB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_NTF.2.1.1.m.38498,0.00198271569888352,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NTM1A.1.1.m.614,-0.00125226867809168,No,NA,NA,Q6NWX7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_NU107.1.2.m.46092,-0.00263091240275342,No,NA,NA,Q8BH74,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NU160.1.1.m.46155,-0.00224026370191264,No,NA,NA,Q9Z0W3,NA,NA,NA,kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406],NA,NA,NA
CHOYP_NU188.2.2.m.51343,0.00628230875680428,No,NA,NA,Q5SRE5,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUBP1.1.1.m.65721,0.00523671771129419,No,NA,NA,Q6P298,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_NUBPL.1.1.m.15123,0.00537368071186929,No,NA,NA,Q9CWD8,NA,NA,NA,mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584],NA,NA,NA
CHOYP_NUCB2.2.2.m.55289,0.000734944319234723,No,NA,NA,Q9JI85,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]; insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NUCL.1.2.m.19135,-0.00419760454458187,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUCL.2.2.m.21719,-0.000255832867766259,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUD16.1.2.m.10250,-0.002205817088207,No,NA,NA,P0DKY8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_NUD17.1.1.m.13156,-0.0210951265807899,No,NA,NA,Q4V8V2,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_NUDT14.1.1.m.64313,-0.0224084581758481,No,NA,NA,Q05B60,NA,NA,NA,cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_NUFIP1.1.1.m.8979,-0.00663718870306532,No,NA,NA,Q641W3,NA,NA,NA,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_NUMB.1.1.m.19732,-0.000731756852526488,No,NA,NA,P16554,NA,NA,NA,basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; Notch signaling pathway [GO:0007219]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_NUP153.1.1.m.34857,0.00403604788836373,No,NA,NA,Q640Z6,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NUP205.1.1.m.54932,-0.00414775852837861,No,NA,NA,Q92621,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.2.3.m.20892,0.00516429329605935,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.3.3.m.52826,-0.00647867480719819,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP50.1.1.m.17104,-0.00507505749468175,No,NA,NA,Q9UKX7,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP54.1.1.m.24886,0.00492644224780121,No,NA,NA,Q8BTS4,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_NUP62L.1.1.m.15606,0.00307384052864265,No,NA,NA,P17955,NA,NA,NA,annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription; DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; spermatogenesis [GO:0007283]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_NUP85.1.1.m.16167,0.00185745683920602,No,NA,NA,Q6DBY0,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NUP98.1.1.m.8689,-0.00214598348832253,No,NA,NA,P49793,NA,NA,NA,kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; DNA replication [GO:0006260]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398],NA,NA,NA
CHOYP_NUPL2.1.2.m.4693,0.0165425713317721,No,NA,NA,Q8CIC2,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_NXF1.1.2.m.28017,0.0101866254463982,No,NA,NA,Q9UBU9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032],NA,NA,NA
CHOYP_OAT.1.1.m.3069,-0.000515322317164522,No,NA,NA,Q9VW26,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591],NA,NA,NA
CHOYP_OCDH.1.1.m.1284,-0.000898393795277454,No,NA,NA,Q9BHM6,NA,NA,NA,coenzyme binding [GO:0050662]; D-octopine dehydrogenase activity [GO:0047830]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OCTC.1.1.m.31819,0.00720109241162528,No,NA,NA,Q9UKG9,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; signaling receptor binding [GO:0005102]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ODC1.1.1.m.12032,-0.000515226992748975,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ODH.1.2.m.1327,-0.000395892271508988,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODH.2.2.m.16624,-0.00222169328865102,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODO1.2.2.m.23540,-0.000428308139306686,No,NA,NA,Q60HE2,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ODPX.1.1.m.29097,0.00512308674989018,No,NA,NA,Q8BKZ9,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity; transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732],NA,NA,NA
CHOYP_ODPX.1.1.m.29098,-0.0174597555749495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OFD1.1.1.m.29513,0.00369346093979377,No,NA,NA,O75665,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_OFUT1.1.1.m.41737,0.00681848606404738,No,NA,NA,Q9V6X7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; cell-cell adhesion [GO:0098609]; endocytosis [GO:0006897]; fucose metabolic process [GO:0006004]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of Notch signaling pathway [GO:0045747]; protein catabolic process [GO:0030163]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_OGFD1.1.1.m.10563,0.000173658200491337,No,NA,NA,Q5R4R3,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_OGFRL1.1.1.m.44422,0.00169617130239055,No,NA,NA,Q5TC84,NA,NA,NA,membrane [GO:0016020]; opioid receptor activity [GO:0004985],NA,NA,NA
CHOYP_OGT1.3.3.m.54325,0.00709593257780596,No,NA,NA,P56558,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],NA,NA,NA
CHOYP_OLA1.2.2.m.28588,0.00129023468363913,No,NA,NA,Q9NTK5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_ONEC2.1.3.m.22857,0.00068011690200807,No,NA,NA,O95948,NA,NA,NA,actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_ORC1.1.2.m.17178,-0.00288044933500831,No,NA,NA,Q5RDD2,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_OS11G0657400.1.2.m.24816,0.00283768779718567,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OSA.1.2.m.6579,-0.00166567898664711,No,NA,NA,Q8IN94,NA,NA,NA,brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_OSBL6.1.1.m.24967,0.0056516959014005,No,NA,NA,Q9BZF3,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699],NA,NA,NA
CHOYP_OSBL8.1.2.m.7583,0.0106461253911972,No,NA,NA,B9EJ86,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204],NA,NA,NA
CHOYP_OSBL9.1.2.m.17667,-0.00068019535156996,No,NA,NA,Q0IJ05,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248],NA,NA,NA
CHOYP_OSBP1.1.1.m.12788,0.00274855884886743,No,NA,NA,P22059,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; positive regulation of growth of symbiont in host [GO:0044128]; sterol transport [GO:0015918],NA,NA,NA
CHOYP_OSGEP.1.1.m.29582,0.00986849695025379,No,NA,NA,A7SXZ6,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_OSGI2.1.1.m.11055,-0.00739109344232685,No,NA,NA,Q9Y236,NA,NA,NA,growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28852,0.00012306982880338,No,NA,NA,Q6R7L4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28853,0,No,NA,NA,Q6R7L3,NA,NA,NA,,NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28854,-0.00902961663493265,No,NA,NA,Q6R7L5,NA,NA,NA,,NA,NA,NA
CHOYP_OST48.1.1.m.43513,0.000525261928950978,No,NA,NA,Q5R501,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_OSTA.1.1.m.11011,0.00882399170972068,No,NA,NA,Q8R000,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702],NA,NA,NA
CHOYP_OTER_1386.1.1.m.15303,0.0212266250629065,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_OTU5B.1.1.m.6212,0.0116702271408574,No,NA,NA,Q6DHK1,NA,NA,NA,extracellular region [GO:0005576]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OTU6B.1.2.m.31547,0.00731804395092489,No,NA,NA,Q7ZV00,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_OTUB1.1.1.m.29705,0.000106833856137333,No,NA,NA,B2RYG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_OTX5B.1.1.m.10054,-0.00856817822234038,No,NA,NA,Q9PT61,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_OX2R.3.3.m.44161,-0.000779584226210198,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_OXDD.1.4.m.2688,-0.00689806086827977,No,NA,NA,P31228,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; signaling receptor binding [GO:0005102]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; D-amino acid metabolic process [GO:0046416],NA,NA,NA
CHOYP_OXSM.1.1.m.30217,-0.00995062455457862,No,NA,NA,Q9NWU1,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],NA,NA,NA
CHOYP_P121C.1.1.m.57092,-0.0116588516840785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_P20D2.1.2.m.9005,-0.00239273732272675,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.1.2.m.9006,-0.0122994787579723,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.2.2.m.47191,0.00832845904186396,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P4HA1.4.5.m.59821,-0.00302451831737566,No,NA,NA,Q10576,NA,NA,NA,cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018],NA,NA,NA
CHOYP_P4R3A.1.1.m.1043,-0.00342346521424582,No,NA,NA,Q5SP90,NA,NA,NA,,NA,NA,NA
CHOYP_P66A.1.1.m.22279,-0.00113321282107217,No,NA,NA,Q86YP4,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein binding; bridging [GO:0030674]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_PA1B2.1.2.m.10637,0.000336246192215198,No,NA,NA,O35264,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PABP2.1.1.m.12768,-0.0030803468350425,No,NA,NA,Q7KNF2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; positive regulation of protein glycosylation [GO:0060050],NA,NA,NA
CHOYP_PABP4.4.6.m.38167,-0.000327037231500926,No,NA,NA,Q13310,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],NA,NA,NA
CHOYP_PABP4.5.6.m.38922,-0.00999454407851291,No,NA,NA,Q9EPH8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PACN2.2.2.m.25018,0.00430176876308535,No,NA,NA,Q9WVE8,NA,NA,NA,caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PAGR1.1.1.m.18447,-0.0160488916948582,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAK1.1.1.m.50796,-0.000710175971462971,No,NA,NA,Q08E52,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_PAK7.1.1.m.35662,-9.43465380180461e-05,No,NA,NA,Q5R8Z4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613],NA,NA,NA
CHOYP_PAN2.1.1.m.44690,-0.00551614064691949,No,NA,NA,A1Z7K9,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_PAN2.1.1.m.44691,0.00164767513872984,No,NA,NA,Q25381,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PANG1.1.2.m.10756,0.00817217399802731,No,NA,NA,P91943,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis; open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PAPOG.1.2.m.33182,0.012944908919646,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_PAPSS.1.1.m.53055,0.00279596219144145,No,NA,NA,Q27128,NA,NA,NA,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103],NA,NA,NA
CHOYP_PAR14.15.17.m.60687,-1.50956194706827e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAR15.2.6.m.21081,0.0124146411523468,No,NA,NA,O43734,NA,NA,NA,signaling receptor binding [GO:0005102]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; immunoglobulin secretion [GO:0048305]; intracellular signal transduction [GO:0035556]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_PAR15.5.6.m.60634,0.00705006803678547,No,NA,NA,Q8BZH4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_PARG.1.1.m.24813,-0.00227523154417522,No,NA,NA,O02776,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282],NA,NA,NA
CHOYP_PARN.1.1.m.19023,-0.0101303967241793,No,NA,NA,Q90ZA1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402],NA,NA,NA
CHOYP_PARP12.1.2.m.42887,-0.00433827207269042,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PARP14.14.22.m.52621,-0.00492552814157407,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_PARP16.1.1.m.1294,-0.0212774184450934,No,NA,NA,Q5U2Q4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PARP8.1.1.m.55346,0.00645413917702145,No,NA,NA,Q8N3A8,NA,NA,NA,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PAT3.1.4.m.21678,-0.0060169641326888,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAT3.4.4.m.54228,-0.00666123112169391,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAX2A.1.2.m.10577,0.00267482009818344,No,NA,NA,Q02962,NA,NA,NA,centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; aging [GO:0007568]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription; DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription; DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PAXB1.1.2.m.42816,-0.0121599097993547,No,NA,NA,Q9Z1W9,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PB1.2.6.m.11467,-0.000119412132490397,No,NA,NA,Q90941,NA,NA,NA,RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PC11X.1.2.m.24796,0.0180034893906351,No,NA,NA,Q8IW45,NA,NA,NA,mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356],NA,NA,NA
CHOYP_PC2.1.2.m.34944,-0.0108284067699078,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_PC2.1.2.m.34945,-0.0119257985452121,No,NA,NA,Q03333,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],NA,NA,NA
CHOYP_PCCA.2.2.m.45684,0.000786544247762593,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_PCCB.1.2.m.3057,0.000629723622405465,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_PCCB.1.2.m.3058,-0.00022746829820867,No,NA,NA,P05166,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768],NA,NA,NA
CHOYP_PCDH1.2.3.m.8055,0.00566971878551733,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH1.3.3.m.63887,0.0113717411830028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCDH7.1.3.m.6236,-0.00729109325912445,No,NA,NA,Q6KEQ9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.2.5.m.34196,0.00553535212431134,No,NA,NA,Q6WYY1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.4.5.m.58558,0.0105444129254044,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCF11.1.1.m.49191,0.00774425036364133,No,NA,NA,O94913,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_PCH2.1.1.m.7113,0.00029618125852775,No,NA,NA,Q6P4W8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_PCID2.1.1.m.28679,0.00121411229640499,No,NA,NA,Q5JVF3,NA,NA,NA,transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription; DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PCKG.1.2.m.43784,0.0014589366350574,No,NA,NA,P05153,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; DBD domain binding [GO:0050692]; epinephrine binding [GO:0051379]; GTP binding [GO:0005525]; inosine kinase activity [GO:0008906]; malate oxidase activity [GO:0019157]; manganese ion binding [GO:0030145]; mRNA binding [GO:0003729]; nucleoside diphosphate kinase activity [GO:0004550]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein-disulfide reductase activity [GO:0047134]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; aging [GO:0007568]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; kidney interstitial fibroblast differentiation [GO:0072071]; lactate metabolic process [GO:0006089]; lipid catabolic process [GO:0016042]; malate transport [GO:0015743]; NADH regeneration [GO:0006735]; negative regulation of carbohydrate metabolic process [GO:0045912]; oviposition [GO:0018991]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_PCKG.1.2.m.43785,0.0025666302083456,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCKG.2.2.m.50139,-0.00874752556544335,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCP.1.1.m.59309,0.000154180105325302,No,NA,NA,Q2TA14,NA,NA,NA,lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535],NA,NA,NA
CHOYP_PCS.1.1.1.m.8305,-0.00825257631000189,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCX1.1.1.m.55309,0.00338507727036247,No,NA,NA,Q96RV3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PCYB_062570.1.1.m.58917,-0.00738193204646185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDCD2L.1.1.m.43699,0.000232108864050086,No,NA,NA,Q5ZID2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_PDCL3.1.1.m.7323,0.00140106306710359,No,NA,NA,Q5RB77,NA,NA,NA,cytoplasm [GO:0005737]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; viral process [GO:0016032],NA,NA,NA
CHOYP_PDDC1.1.1.m.16484,-0.00671005093667874,No,NA,NA,Q8BFQ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_PDE11.1.3.m.8788,-0.00651650926627998,No,NA,NA,Q9VJ79,NA,NA,NA,cytosol [GO:0005829]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE2A.3.3.m.60225,0.0156681535701775,No,NA,NA,P14099,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of protein import into nucleus; translocation [GO:0033159]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE3A.1.3.m.22256,0.0109616006965564,No,NA,NA,Q14432,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493],NA,NA,NA
CHOYP_PDE6D.1.2.m.6439,-0.0018816944337554,No,NA,NA,O55057,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PDHA.1.1.1.m.67024,0.000777625356482985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDHA1.1.1.m.42807,-0.00162542183743331,No,NA,NA,P52899,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_PDIA1.1.1.m.5297,-0.000321501675610802,No,NA,NA,P04785,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA3.1.1.m.60223,-0.00195712140636305,No,NA,NA,Q8JG64,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; myelin sheath [GO:0043209]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA4.1.1.m.54958,0.00472588328729122,No,NA,NA,P13667,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA6.1.2.m.9012,0.00206935917120544,No,NA,NA,Q922R8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_PDIA6.2.2.m.58490,-0.00753576955357633,No,NA,NA,P38661,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_PDLI1.2.2.m.2094,0.00326473196253114,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PDS5B.1.1.m.16690,-0.000628729034616606,No,NA,NA,Q4VA53,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; DNA repair [GO:0006281]; enteric nervous system development [GO:0048484]; lens development in camera-type eye [GO:0002088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell proliferation [GO:0008285]; neuroblast migration [GO:0097402]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_PDXDC1.1.1.m.11298,-0.000700965767500177,No,NA,NA,Q99K01,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_PDXK.1.1.m.14904,0.00600587983699424,No,NA,NA,P82197,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443],NA,NA,NA
CHOYP_PDZRN3.1.1.m.18229,0.00795019001501085,No,NA,NA,Q69ZS0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PE2R3.2.2.m.61863,0.00780000367417856,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PEAR1.10.16.m.42850,-0.00873984893164038,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_PEAR1.6.16.m.37314,0.00881455429558112,No,NA,NA,P59222,NA,NA,NA,integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],NA,NA,NA
CHOYP_PEAR1.8.16.m.41400,-0.0130535622299681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PECR.1.1.m.58859,-0.00900223912191642,No,NA,NA,Q9WVK3,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306],NA,NA,NA
CHOYP_PELO.1.1.m.14458,0.00222467056598068,No,NA,NA,P48612,NA,NA,NA,cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process; non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137],NA,NA,NA
CHOYP_PEO1.1.1.m.14775,0.0095555913755729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PEPM.1.1.m.14235,-0.00258826882017911,No,NA,NA,P56839,NA,NA,NA,metal ion binding [GO:0046872]; phosphoenolpyruvate mutase activity [GO:0050188]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_PERMA_0370.1.1.m.41998,-0.000618797560502622,No,NA,NA,Q9VFD5,NA,NA,NA,ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_PERQ2.2.2.m.40796,-0.0042261592646128,No,NA,NA,O75420,NA,NA,NA,protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009],NA,NA,NA
CHOYP_PESC.1.1.m.16875,-0.00138944384598156,No,NA,NA,Q7ZY69,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; cell proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_PEX2.2.2.m.26981,-0.0179268508075034,No,NA,NA,P40855,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_PF10_0308.1.1.m.43529,0.00099221661236822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFB0115W.2.2.m.65461,-7.11436276517416e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFD3.1.1.m.56418,-0.000752977564677702,No,NA,NA,Q5RCG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding [GO:0006457],NA,NA,NA
CHOYP_PGBM.2.3.m.44777,0.011070586967929,No,NA,NA,Q810U3,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; septate junction [GO:0005918]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_PGDH.3.5.m.36973,0.000574475444377256,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGDH.5.5.m.66725,-0.0104332965625373,No,NA,NA,P15428,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGK1.1.1.m.27254,0.000279603014645516,No,NA,NA,Q3T0P6,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]; response to hypoxia [GO:0001666]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_PGM1.1.1.m.38482,0.000770723420592321,No,NA,NA,P36871,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_PGM2.1.1.m.65095,0.000663738481756392,No,NA,NA,Q96G03,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_PGPS1.1.1.m.10148,-0.00716619995075347,No,NA,NA,Q5ZHN9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049],NA,NA,NA
CHOYP_PGRMC1.1.1.m.38547,0.0125925125369837,No,NA,NA,Q5XIU9,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; steroid binding [GO:0005496],NA,NA,NA
CHOYP_PGTA.1.1.m.43418,0.0123161950345667,No,NA,NA,Q5EA80,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344],NA,NA,NA
CHOYP_PGTG_12376.1.2.m.43330,0.0237150673200424,No,NA,NA,P37167,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042],NA,NA,NA
CHOYP_PHATRDRAFT_43152.1.1.m.15003,-0.00108921265844638,No,NA,NA,P25007,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PHC2.1.1.m.48379,0.00627789938586338,No,NA,NA,Q8QHL5,NA,NA,NA,PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHF10.1.1.m.6981,0.0135017159528839,No,NA,NA,Q8WUB8,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_PHF14.1.1.m.27257,-0.0164524209903219,No,NA,NA,O94880,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHF5A.1.1.m.32389,-0.00475201639003198,No,NA,NA,P83871,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PHLP.1.1.m.25742,-0.00170730457756807,No,NA,NA,Q13371,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex binding [GO:0044877]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; negative regulation of protein refolding [GO:0061084]; positive regulation of smoothened signaling pathway [GO:0045880]; protein folding [GO:0006457]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PHOCN.1.1.m.40660,0.00155575855278495,No,NA,NA,Q9QYW3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; vesicle budding from membrane [GO:0006900],NA,NA,NA
CHOYP_PHR.1.1.m.7664,-0.0136545516696669,No,NA,NA,Q28811,NA,NA,NA,deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298],NA,NA,NA
CHOYP_PHT4.1.1.m.18841,-0.00962012104501611,No,NA,NA,O34371,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM009400.1.1.m.35298,-0.00264004448488795,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PHUM_PHUM035190.1.1.m.16675,0.00651032228501798,No,NA,NA,Q9ERH3,NA,NA,NA,synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_PHUM_PHUM049590.1.4.m.14204,0.0127975022347416,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM060390.1.1.m.12993,-0.00711262401585472,No,NA,NA,Q642H7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_PHUM_PHUM066670.2.3.m.42178,-0.0101928510085715,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM068980.4.5.m.56739,0.0110669967294843,No,NA,NA,Q8NFZ8,NA,NA,NA,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM071280.1.1.m.25507,-0.000311048616593337,No,NA,NA,Q9Y6E0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PHUM_PHUM075600.1.1.m.35072,0.00062090373116213,No,NA,NA,Q9U6M0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341],NA,NA,NA
CHOYP_PHUM_PHUM076810.1.1.m.24070,0.00528975428158802,No,NA,NA,O75369,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_PHUM_PHUM092120.1.1.m.33493,-0.00749774523367839,No,NA,NA,Q5JWR5,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PHUM_PHUM122670.1.1.m.38346,0.00665380171618164,No,NA,NA,Q9BKZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PHUM_PHUM125580.1.1.m.47466,0.00311663469117105,No,NA,NA,P04069,NA,NA,NA,extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PHUM_PHUM128460.1.7.m.3477,0.00824616306079179,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.3.7.m.27983,-0.0155538547790503,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.4.7.m.38295,0.0219217975982027,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.6.7.m.60989,0.0148691385813679,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM135440.1.1.m.40573,-0.00598673835139897,No,NA,NA,Q8IS64,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; peptide hormone processing [GO:0016486],NA,NA,NA
CHOYP_PHUM_PHUM137710.1.1.m.19548,6.08625727650706e-05,No,NA,NA,Q5ZJP5,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017],NA,NA,NA
CHOYP_PHUM_PHUM169900.2.2.m.61606,-0.00416785584460985,No,NA,NA,Q8C033,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_PHUM_PHUM174810.1.1.m.31029,-0.00715107226197228,No,NA,NA,Q8N5N7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_PHUM_PHUM174820.1.1.m.57391,0.00558024808002375,No,NA,NA,Q5SWW4,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; signaling receptor activity [GO:0038023]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cholesterol homeostasis [GO:0042632]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328],NA,NA,NA
CHOYP_PHUM_PHUM176650.1.1.m.13332,-0.00837906258352552,No,NA,NA,Q6P9N1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_PHUM_PHUM184790.1.1.m.41715,-0.0142737464865314,No,NA,NA,Q92626,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PHUM_PHUM215460.1.1.m.33815,0.00433632523359637,No,NA,NA,Q8JZP9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; cell cycle arrest [GO:0007050]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_PHUM_PHUM226120.1.7.m.673,0.00698605134247579,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_PHUM_PHUM226120.2.7.m.2274,-0.000863736762053405,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.3.7.m.20773,-0.011683476500332,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.5.7.m.43551,-0.00733543515932846,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.6.7.m.48915,7.21235952134821e-05,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.7.7.m.54053,0.00693365312620218,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM228480.1.1.m.498,0.00672860908853248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM229210.1.1.m.50089,-0.00927366141070363,No,NA,NA,Q3T0L3,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_PHUM_PHUM233260.1.1.m.6315,0.00111728148010828,No,NA,NA,O08715,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_PHUM_PHUM234540.1.1.m.9211,-0.0184968923448933,No,NA,NA,Q5ZHY5,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],NA,NA,NA
CHOYP_PHUM_PHUM241330.1.3.m.29132,-0.00365953202660852,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PHUM_PHUM244880.1.2.m.691,0.00011946737226904,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM244880.2.2.m.41653,0.000600496003701757,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM268120.1.1.m.23332,0.022761444717015,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM278110.1.1.m.17560,0.0160251028710539,No,NA,NA,Q6GLE1,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44778,-0.0028208566087216,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44779,0.00329402402917763,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_PHUM_PHUM305910.1.2.m.58404,0.00129730369199833,No,NA,NA,O35867,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM310360.1.1.m.21767,0.010132130259364,No,NA,NA,Q5R7A4,NA,NA,NA,cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport; endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_PHUM_PHUM317840.1.2.m.29476,-0.0200649503048653,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM317840.2.2.m.36471,0.0122478714045934,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM319040.1.1.m.54919,0.000542304350395711,No,NA,NA,Q5ZJ39,NA,NA,NA,mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_PHUM_PHUM328150.1.1.m.8592,0.00979631159663371,No,NA,NA,O76463,NA,NA,NA,bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139],NA,NA,NA
CHOYP_PHUM_PHUM332570.1.1.m.56283,-0.000469374534531022,No,NA,NA,Q9XYM0,NA,NA,NA,receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion; thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis; engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_PHUM_PHUM349810.1.2.m.7707,0.0086933999232444,No,NA,NA,A7SMW7,NA,NA,NA,mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545],NA,NA,NA
CHOYP_PHUM_PHUM350510.1.1.m.44180,-0.00737908902477612,No,NA,NA,Q9UI36,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription; DNA-templated [GO:0006355]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967],NA,NA,NA
CHOYP_PHUM_PHUM353470.1.1.m.63458,0.00498360004348486,No,NA,NA,A2TLM1,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_PHUM_PHUM361660.1.1.m.63423,-0.00248405920642045,No,NA,NA,Q7Z3K6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHUM_PHUM370970.1.2.m.40102,0.012673308928879,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_PHUM_PHUM375280.1.2.m.23797,-0.000473414773005007,No,NA,NA,Q9W6Z2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription; initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM377430.1.2.m.29459,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM378040.1.1.m.15341,-0.00585148081854579,No,NA,NA,Q9Y5B0,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHUM_PHUM411900.1.1.m.50272,0.000322317873163481,No,NA,NA,Q9WYG0,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM423190.1.1.m.18351,-0.0172721648551934,No,NA,NA,Q8C3P7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of cap-independent translational initiation [GO:1903679]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_PHUM_PHUM427190.1.1.m.57126,0.00563940026484097,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_PHUM_PHUM445570.1.1.m.18708,0.00970007919254054,No,NA,NA,O15460,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_PHUM_PHUM450820.1.1.m.40803,0.000159301127566304,No,NA,NA,Q5R416,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density; intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; modification of postsynaptic actin cytoskeleton [GO:0098885]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM454570.1.1.m.28665,0.00318757391837224,No,NA,NA,Q3UHU5,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule motor activity [GO:2000576]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_PHUM_PHUM465390.1.1.m.21142,0.00731633617259843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM470230.1.1.m.29432,-0.0138657760459117,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_PHUM_PHUM477110.1.1.m.53813,-0.000990621950067809,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_PHUM_PHUM477570.1.1.m.2101,0.00099772780087255,No,NA,NA,P11240,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_PHUM_PHUM477850.1.1.m.19067,-0.00279770090466332,No,NA,NA,H2QII6,NA,NA,NA,annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_PHUM_PHUM479110.1.1.m.54103,0,No,NA,NA,O95822,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_PHUM_PHUM494500.1.1.m.9430,0.00824046122209246,No,NA,NA,Q09024,NA,NA,NA,axon [GO:0030424]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; insulin binding [GO:0043559]; insulin-like growth factor binding [GO:0005520]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; determination of adult lifespan [GO:0008340]; entry into reproductive diapause [GO:0055116]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid storage [GO:0010888]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of insulin receptor signaling pathway [GO:0046628]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_PHUM_PHUM498110.1.1.m.60692,0.000859803700386492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM498130.1.1.m.12138,-0.000303017389083847,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM500930.1.1.m.21562,-0.00330161693862021,No,NA,NA,P15215,NA,NA,NA,basement membrane [GO:0005604]; basement membrane assembly [GO:0070831]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_PHUM_PHUM516040.1.1.m.55603,0.00586479641837947,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PHUM_PHUM519460.1.1.m.3701,-0.00164883932626108,No,NA,NA,Q9JHE7,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM536560.1.2.m.12360,-0.0135151087131665,No,NA,NA,P82808,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM536560.2.2.m.59367,0.00178143901583238,No,NA,NA,P47856,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM537100.1.1.m.62217,-0.0149457889161364,No,NA,NA,Q80XC3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport; plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_PHUM_PHUM538050.1.1.m.56205,0.00247262027840098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM538580.1.1.m.43268,-0.000481504373774883,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PHUM_PHUM544530.1.1.m.38469,5.5922612538639e-05,No,NA,NA,Q15428,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_PHUM_PHUM547410.1.1.m.10964,-0.0125610960761624,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHUM_PHUM549040.1.1.m.10284,0.000206826588709297,No,NA,NA,O46036,NA,NA,NA,ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_PHUM_PHUM559420.1.1.m.8620,0.0173114340922629,No,NA,NA,D2GXS7,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_PHUM_PHUM562900.1.1.m.43674,0.00482738510706067,No,NA,NA,Q8QFV0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PHUM_PHUM563970.1.1.m.13515,-0.00327393495114277,No,NA,NA,O15381,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_PHUM_PHUM574190.1.1.m.24768,0.0100969989945324,No,NA,NA,Q05209,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_PHUM_PHUM574550.1.1.m.59401,-0.00259510466180065,No,NA,NA,Q5XJK1,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635],NA,NA,NA
CHOYP_PHUM_PHUM579670.1.1.m.63016,-0.000711544459884271,No,NA,NA,Q8R500,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron death [GO:1901215]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PHUM_PHUM596890.1.1.m.10989,-0.00190213779037031,No,NA,NA,Q9VGG5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PHUM_PHUM596940.1.1.m.2151,0.00107133704501529,No,NA,NA,Q91YE8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; autophagosome assembly [GO:0000045]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298],NA,NA,NA
CHOYP_PHUM_PHUM600390.1.1.m.6641,-0.00563647419567607,No,NA,NA,Q6DID3,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM602670.1.1.m.52487,0.00221344634193083,No,NA,NA,Q9NZ56,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_PHUM_PHUM616130.1.1.m.47653,0.0243071017504036,No,NA,NA,P92204,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHYD1.1.2.m.17822,-0.00186555909902301,No,NA,NA,Q0IIB1,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PI3R4.1.1.m.14910,-0.00154511642097885,No,NA,NA,Q99570,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex; class III [GO:0035032]; phosphatidylinositol 3-kinase complex; class III; type I [GO:0034271]; phosphatidylinositol 3-kinase complex; class III; type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_PI4KB.1.1.m.8669,0.00946821395773794,No,NA,NA,B1MTG7,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_PIDD.1.1.m.54294,-0.0135153691064989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PIF.3.6.m.18904,0.0124697556231426,No,NA,NA,C7G0B5,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030],NA,NA,NA
CHOYP_PIF.6.6.m.44699,0.00886737467255078,No,NA,NA,Q99715,NA,NA,NA,collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PIGS.1.1.m.18959,0.00153232191256904,No,NA,NA,Q2HJ98,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_PININ.1.1.m.56667,-0.00472013713430553,No,NA,NA,Q9H307,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; exon-exon junction complex [GO:0035145]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PIPNA.1.1.m.37750,0.00134293056575797,No,NA,NA,P53810,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_PIR.1.1.m.48663,0.00789554566315268,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PISD.2.2.m.30086,0.00803649256758719,No,NA,NA,P27465,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540],NA,NA,NA
CHOYP_PITG_07096.1.1.m.4922,0.0240547335108537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PK1IP.1.1.m.49466,0.00369323305590657,No,NA,NA,Q80VC6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_PK3C3.1.1.m.13959,0.00060654854331514,No,NA,NA,Q6AZN6,NA,NA,NA,midbody [GO:0030496]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_PK3CD.1.1.m.53039,0.025167048280223,No,NA,NA,O00329,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mast cell granule [GO:0042629]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_PKH_082300.1.1.m.29388,-0.00948582906766734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKH_143120.1.1.m.6777,0.0024342788683785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKHL1.3.3.m.42452,-0.00555896451578892,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PLB1.1.1.m.16558,0.00853372565326856,No,NA,NA,Q06HQ7,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_PLC.2.5.m.5277,0.000309617312797453,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLC.3.5.m.7658,0.0240001986254328,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLCB4.1.2.m.1637,-0.00482613236727146,No,NA,NA,Q15147,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PLCD1.1.1.m.63908,0.00676354788149183,No,NA,NA,P10688,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of norepinephrine secretion [GO:0010701]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of phospholipase C activity [GO:1900274]; response to aluminum ion [GO:0010044]; response to calcium ion [GO:0051592]; response to hyperoxia [GO:0055093]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to prostaglandin F [GO:0034696],NA,NA,NA
CHOYP_PLCL2.1.1.m.62311,0.0152396263050903,No,NA,NA,Q9UPR0,NA,NA,NA,cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_PLEKHA1.2.2.m.21816,0.00605768899254649,No,NA,NA,Q9HB19,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of cell-matrix adhesion [GO:0001954],NA,NA,NA
CHOYP_PLIN2.1.1.m.23758,-0.000440124534994704,No,NA,NA,Q4PLW0,NA,NA,NA,intracellular [GO:0005622]; lipid droplet [GO:0005811]; membrane [GO:0016020],NA,NA,NA
CHOYP_PLK1.1.2.m.26371,0.0234028791049182,No,NA,NA,P62205,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_PLMN.1.11.m.5524,-0.000922484464723185,No,NA,NA,P00765,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_PLMN.4.11.m.29150,0,No,NA,NA,P06867,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance involved in symbiotic interaction [GO:0052213]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_PLOD3.1.1.m.41788,0.0211869490037891,No,NA,NA,Q5U367,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_PLRG1.1.1.m.65600,-0.00218841148218863,No,NA,NA,Q922V4,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504],NA,NA,NA
CHOYP_PLSP.4.5.m.44386,0.00849941764889138,No,NA,NA,H2A0M7,NA,NA,NA,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PLXA3.1.1.m.51322,0.0118191701052829,No,NA,NA,O15031,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_PLXB2.2.2.m.47843,-0.00656271550267582,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PM20D2.1.1.m.27186,0.0152022554100485,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_PMAA_001770.1.1.m.11519,0.0222608802187203,No,NA,NA,Q54RA4,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PMAR_PMAR003946.2.2.m.31102,-0.00106327331441019,No,NA,NA,P55142,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_PMAR_PMAR009545.1.1.m.28734,0.0106732000615687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PMAR_PMAR019172.1.1.m.2563,0.0173999718048371,No,NA,NA,B8DKP2,NA,NA,NA,magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_PMS2.1.1.m.16450,0.00236845214893821,No,NA,NA,P54278,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_PMTR.1.1.m.46450,0.00735843775378406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PNCB.1.1.m.57201,-0.00196694967619125,No,NA,NA,Q9VQX4,NA,NA,NA,cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PNO1.1.3.m.2044,-0.0156037823785035,No,NA,NA,Q6VEU3,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PNO1.2.3.m.47801,0.00781629494576008,No,NA,NA,Q8VCX6,NA,NA,NA,KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],NA,NA,NA
CHOYP_PNP5B.1.1.m.21997,-0.00515072440876766,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_PO2F1.1.1.m.11428,-0.00717519458086916,No,NA,NA,Q9UKI9,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_POGLUT1.1.1.m.45796,0.00838473163863906,No,NA,NA,G3V9D0,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470],NA,NA,NA
CHOYP_POLD1.1.1.m.61169,-0.00974065955023693,No,NA,NA,P28340,NA,NA,NA,aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair; gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_POMGNT1.1.1.m.33377,0.00712798127933328,No,NA,NA,Q5XIN7,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_POPTRDRAFT_1091519.1.1.m.56854,-0.00728533305362097,No,NA,NA,Q8BWF0,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_POPTRDRAFT_655879.1.1.m.46190,-0.00189376823099282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PP1A.1.1.m.25950,0.0112314940055689,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PP1B.2.3.m.22075,0.000878700025801915,No,NA,NA,Q5I085,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],NA,NA,NA
CHOYP_PP1RA.1.1.m.9915,0.00847815486000211,No,NA,NA,Q6GLQ4,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864],NA,NA,NA
CHOYP_PP4C.1.1.m.10112,-0.00593397196275733,No,NA,NA,Q5R6K8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569],NA,NA,NA
CHOYP_PP4R1.1.1.m.11682,-0.00347463019873773,No,NA,NA,Q8VI02,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PP6R3.1.1.m.43072,-0.00338491323248831,No,NA,NA,Q5F471,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666],NA,NA,NA
CHOYP_PPA5.1.1.m.36087,0.00590921148244045,No,NA,NA,P09889,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; ossification [GO:0001503]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_PPAC1.1.1.m.51347,0.00100946036145974,No,NA,NA,P82890,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPAL.2.2.m.32405,0.00100305937008341,No,NA,NA,Q0P5F0,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PPAN.B.1.1.m.2112,0.000916383334857418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPBT.1.4.m.5115,-0.00448283046314825,No,NA,NA,Q29486,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PPIB.2.4.m.40019,-0.0135620330116173,No,NA,NA,O94273,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPID.1.1.m.55261,0.00053406088443326,No,NA,NA,Q9CR16,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIE.1.1.m.18580,-0.00343800288766067,No,NA,NA,Q5R723,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_PPIG.1.1.m.63308,-0.00555404698095573,No,NA,NA,P30414,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPIH.1.1.m.18923,5.67515028504558e-06,No,NA,NA,O43447,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIL2.1.1.m.55184,-0.00719179166448063,No,NA,NA,Q9D787,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_PPM1H.1.1.m.24782,-0.0213413185028416,No,NA,NA,Q5M821,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722],NA,NA,NA
CHOYP_PPME1.1.1.m.56260,0.00332116282087236,No,NA,NA,Q8BVQ5,NA,NA,NA,protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482],NA,NA,NA
CHOYP_PPN.2.4.m.44929,-0.0124633876634569,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPN.3.4.m.50209,0.0248177398522287,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPOX.1.1.m.45234,-0.014858179041636,No,NA,NA,P56602,NA,NA,NA,intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_PPP1CC.1.1.m.13937,-0.00215155380935081,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PPP1R7.1.1.m.37778,0.000802868239882285,No,NA,NA,Q5HZV9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_PPP6.1.1.m.16278,0.0010056467600313,No,NA,NA,Q64620,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPR27.1.1.m.10278,0.00224732358887669,No,NA,NA,Q86WC6,NA,NA,NA,phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPR37.1.1.m.27483,0.00589308777475828,No,NA,NA,Q1L994,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPT2A.1.2.m.30339,-0.00753274842971311,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_PPUTW619_2764.1.1.m.44946,0.00936209797210872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPWD1.1.1.m.48713,0.0021932084372603,No,NA,NA,Q29RZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRB2.2.2.m.41331,-0.00128669646750282,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_PRCC.2.2.m.58572,-0.00623682677183938,No,NA,NA,Q92733,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRG4.1.2.m.7441,-0.00527037421783588,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRIM.1.1.m.30784,0.00504965317084297,No,NA,NA,Q6R7L6,NA,NA,NA,DNA primase activity [GO:0003896],NA,NA,NA
CHOYP_PRKAB1B.1.3.m.19788,0.0158163951143451,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB1B.2.3.m.31228,0.00291202652015986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB2.1.1.m.12513,-0.00404855412567633,No,NA,NA,O43741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PRKCSH.1.1.m.28109,0.00489244017569976,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_PRKDC.1.1.m.47256,-0.00720192763220903,No,NA,NA,Q8QGX4,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_PRKN2.1.1.m.54903,-0.0080721808658996,No,NA,NA,Q9JK66,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to L-glutamine [GO:1904845]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to curcumin [GO:1904643]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle activity [GO:0014850]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_PROF.2.2.m.41295,-0.0168776684707194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PROM1.3.3.m.58805,-0.000992679699897723,No,NA,NA,O77302,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_PRP16.1.1.m.19094,0.0100119103119319,No,NA,NA,Q17R09,NA,NA,NA,spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRP18.1.1.m.2214,0.00565966503458448,No,NA,NA,Q2HJ41,NA,NA,NA,nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048],NA,NA,NA
CHOYP_PRP31.3.6.m.8812,-0.00284586831454251,No,NA,NA,Q7SXM7,NA,NA,NA,Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing; via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP4B.1.1.m.28423,-0.00515179141493285,No,NA,NA,Q08DZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRP6.1.2.m.28600,-0.00426221113629597,No,NA,NA,A1A5S1,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP8.1.1.m.51584,-0.00550906426984023,No,NA,NA,Q99PV0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF3.1.1.m.736,-0.00867780040779922,No,NA,NA,Q5ZJ85,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF4.1.1.m.62194,-0.00707205943110623,No,NA,NA,O43172,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_PRPS1.1.1.m.10083,-0.0023578449185499,No,NA,NA,P60892,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_PRRC1.1.1.m.6820,0.00521774504528037,No,NA,NA,A6H8J1,NA,NA,NA,Golgi apparatus [GO:0005794],NA,NA,NA
CHOYP_PRRT1.2.5.m.28553,0.0100533072179922,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_PRS4.1.1.m.45626,-0.00292261270098062,No,NA,NA,P48601,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PRS6B.1.1.m.66735,-0.00380246586285601,No,NA,NA,Q4R7L3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRS7.1.1.m.31825,-0.00175789413473655,No,NA,NA,Q4R4R0,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_PRS8.1.1.m.40757,5.32444380154027e-05,No,NA,NA,P54814,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRTG.2.3.m.27411,0.00499230700880633,No,NA,NA,Q2EY13,NA,NA,NA,integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PRUN2.1.1.m.38759,-0.00976086790924172,No,NA,NA,Q5BJR4,NA,NA,NA,cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798],NA,NA,NA
CHOYP_PSA.1.1.m.27259,0.000881937424908504,No,NA,NA,Q11011,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSA1.1.1.m.44276,0.000289610276543495,No,NA,NA,P25786,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSA2.1.1.m.57091,-0.00096983637236308,No,NA,NA,P25787,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; response to virus [GO:0009615],NA,NA,NA
CHOYP_PSA4.1.1.m.19303,-0.00198654464165885,No,NA,NA,P25789,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; viral process [GO:0016032],NA,NA,NA
CHOYP_PSA6.1.1.m.30357,-0.00221422978176834,No,NA,NA,P60901,NA,NA,NA,cytoplasm [GO:0005737]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_PSB1.2.2.m.63827,-0.000334258539558246,No,NA,NA,Q2TBX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSD7.1.1.m.19729,1.76230909812683e-05,No,NA,NA,P26270,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSDE.1.1.m.38562,0.000969738734775462,No,NA,NA,Q9V3H2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSIP1.1.1.m.61157,-0.00250392164046494,No,NA,NA,Q9Y3E1,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; cell proliferation [GO:0008283]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_PSMB2.1.1.m.62965,0.000416361394585609,No,NA,NA,P40307,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_PSMC6.1.1.m.13888,-0.000422389354114714,No,NA,NA,P62334,NA,NA,NA,cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_PSMD1.1.1.m.21682,-0.00138591141491289,No,NA,NA,Q99460,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD1.1.1.m.21683,-0.0082204045838192,No,NA,NA,Q99805,NA,NA,NA,endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_PSMD2.1.3.m.13362,0.00116982728839185,No,NA,NA,P56701,NA,NA,NA,nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD2.3.3.m.59657,-0.00801903432966193,No,NA,NA,Q5VUA4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PSMD2.3.3.m.59658,-0.00444564788714222,No,NA,NA,Q13200,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD6.1.1.m.60839,-0.00234681473550306,No,NA,NA,Q15008,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSMD9.1.1.m.5055,0.00163842268153029,No,NA,NA,Q3SZ19,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome regulatory particle assembly [GO:0070682],NA,NA,NA
CHOYP_PSME4.1.1.m.18992,-0.0161380166081913,No,NA,NA,Q6NRP2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_PSMG2.1.1.m.66279,0.000736269788970458,No,NA,NA,Q1LXS2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_PSTA_4372.1.1.m.39115,-0.0208607080700134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.1.2.m.4739,0.0039069312912936,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.2.2.m.9655,0.000899259223132582,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTPIP1.1.1.m.39114,0.0212536739069114,No,NA,NA,O43586,NA,NA,NA,actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTCD3.1.1.m.24655,-0.0170658595455522,No,NA,NA,Q5R8W8,NA,NA,NA,mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_PTEN.1.1.m.5408,0.0118565910484331,No,NA,NA,P60484,NA,NA,NA,apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein deubiquitination [GO:0016579]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission; GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_PTER.1.2.m.28985,0.00214883355172481,No,NA,NA,Q7SZS2,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_PTGR1.1.1.m.29812,-0.002106139229654,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_PTH1R.4.4.m.65130,0.00210773153267178,No,NA,NA,P25107,NA,NA,NA,integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_PTHB1.1.1.m.35678,-0.00064094277405572,No,NA,NA,Q6AX60,NA,NA,NA,BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_PTN11.4.4.m.62827,0.00532131036235166,No,NA,NA,Q90687,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of multicellular organism growth [GO:0040014]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_PTN11.4.4.m.62828,-0.0131286458000457,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PTP10.3.3.m.46720,0.00499493731105772,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPA.1.1.m.18579,-0.00116854352768363,No,NA,NA,Q2KJ44,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516],NA,NA,NA
CHOYP_PTPN23.1.1.m.16408,-0.011032239319978,No,NA,NA,Q6PB44,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PTPRA.19.22.m.59233,-0.00547462004969608,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRA.2.22.m.3118,0.00721688842937615,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46545,-0.00536931419897454,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46547,0.0117156527808257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PTPRB.1.4.m.21615,0.00343758777454577,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.3.4.m.52977,-0.0153336706257014,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.4.4.m.66782,0.00419991784624804,No,NA,NA,P35992,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRC.5.14.m.34957,-0.0103815870605564,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRE.7.19.m.34309,0.00549599248010093,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPREA.1.2.m.4823,0.00382650222402544,No,NA,NA,B9EKR1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRF.2.6.m.17540,0,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRF.3.6.m.28841,0.0144583865003639,No,NA,NA,P16621,NA,NA,NA,axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124],NA,NA,NA
CHOYP_PTPRG.1.3.m.56419,-0.00176688808104468,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.2.3.m.61939,0.00547111504287026,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.3.3.m.65311,0.00557108163635804,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.10.20.m.31769,0.00538219708485473,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.13.20.m.40023,-0.00555656138640169,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRK.17.20.m.60780,0.0113770106629846,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRK.18.20.m.62712,-0.00607464978833438,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRK.4.20.m.2624,0.00712733157381067,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.6.20.m.6291,0.00969601504890539,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.8.20.m.8333,-0.000257419623894189,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRM.11.15.m.52054,0.0105357335179699,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRM.14.15.m.57240,0.00621725647777853,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRQ.6.8.m.45809,0.0167030807400792,No,NA,NA,P0C5E4,NA,NA,NA,integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; protein tyrosine phosphatase activity [GO:0004725]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],NA,NA,NA
CHOYP_PTPRT.11.45.m.39468,0.00280417745604999,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.12.45.m.39573,0.000414841918764843,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.17.45.m.42361,-0.0047492259605844,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.22.45.m.47112,-0.00388586423413132,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.26.45.m.52045,0.00039835971729028,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.30.45.m.53464,0.0010892349448279,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.38.45.m.60044,-0.0114806862703495,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.40.45.m.61584,0.00627545839867512,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.6.45.m.24275,-0.0053803967718033,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRU.2.2.m.58388,0.000413847818577654,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRZ.1.9.m.12735,0.00995296313062363,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRZ.4.9.m.21524,5.33742606469513e-05,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PUA1A.1.1.m.6287,-0.00350283100817428,No,NA,NA,Q561L1,NA,NA,NA,cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208],NA,NA,NA
CHOYP_PUM1.1.1.m.8674,-0.00186392007194804,No,NA,NA,Q80U58,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_PUR2.1.1.m.17810,0.00565413029703637,No,NA,NA,Q64737,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654],NA,NA,NA
CHOYP_PUR8.1.1.m.2748,-0.00236644205373687,No,NA,NA,P21265,NA,NA,NA,cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1;2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_PUS3.1.1.m.9880,-0.00335635123643984,No,NA,NA,Q9BZE2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PUS7.1.1.m.53798,-0.00915621083579922,No,NA,NA,Q96PZ0,NA,NA,NA,nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PVX_111155.1.1.m.25208,-0.0166648822368103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWAP.1.1.m.44818,0.000186804384597673,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWP2.1.1.m.7530,-0.0167414862545113,No,NA,NA,Q5RFQ3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_PXK.1.1.m.27815,0.0157219567109554,No,NA,NA,Q8BX57,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PY03350.1.1.m.8097,0.00863481229630387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY03697.1.1.m.58980,-0.0229040201952664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY04960.1.1.m.26352,-0.00545133723674115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PYR1.1.1.m.61565,-0.000201449226837064,No,NA,NA,Q91437,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541],NA,NA,NA
CHOYP_PYRG1.1.1.m.13552,-0.0158037302352504,No,NA,NA,Q6PEI7,NA,NA,NA,cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856],NA,NA,NA
CHOYP_QARS.2.2.m.18038,-0.000704970252339863,No,NA,NA,P47897,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription; DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_QCR2.1.1.m.35612,-0.00518065901204862,No,NA,NA,P22695,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_QCR2.1.1.m.35613,-0.00294487976095939,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_QTRTD1.1.1.m.19041,0.0167609665589091,No,NA,NA,Q28DX0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_R3HDM1.1.1.m.36018,-0.00648979881093898,No,NA,NA,Q15032,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_RAB1A.1.3.m.10036,0.00193803677414611,No,NA,NA,Q05974,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_RAB21.1.1.m.56542,-0.000603072107174646,No,NA,NA,P35282,NA,NA,NA,axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157],NA,NA,NA
CHOYP_RAB35.1.1.m.8277,-0.000555342275372908,No,NA,NA,Q5U316,NA,NA,NA,anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_RAB35.1.1.m.8278,0.00127879366453307,No,NA,NA,P62282,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412],NA,NA,NA
CHOYP_RAB4B.1.1.m.55402,-0.0177986846002678,No,NA,NA,Q68EK7,NA,NA,NA,endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_RAB7A.1.2.m.23789,8.22079535854288e-05,No,NA,NA,Q5D013,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022],NA,NA,NA
CHOYP_RAB7A.1.2.m.23790,-0.00197608462453792,No,NA,NA,H9BW96,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAB8A.2.3.m.33866,0.00211957391947931,No,NA,NA,Q4R5P1,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_RABGAP1.1.1.m.50532,0.00684789120968831,No,NA,NA,A2AWA9,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RABP2.1.1.m.29597,0.00557730023358267,No,NA,NA,P22935,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573],NA,NA,NA
CHOYP_RABX5.1.2.m.26033,0.0146204145335756,No,NA,NA,O18973,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAC1.1.3.m.20870,0.0149342368403549,No,NA,NA,Q9QX22,NA,NA,NA,cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144],NA,NA,NA
CHOYP_RAC1.1.3.m.20871,-0.0119973335267157,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RAC1.2.3.m.23406,-0.00996478670511339,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RADI.1.2.m.2373,0.000535146719475465,No,NA,NA,P26043,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium [GO:0032420]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_RADI.2.2.m.22446,-0.00728753674581632,No,NA,NA,E1BBQ2,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_RAEL1.1.1.m.40419,-0.00233856803154192,No,NA,NA,A5GFN6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],NA,NA,NA
CHOYP_RAGP1.1.1.m.64037,0.000115626372367011,No,NA,NA,P46060,NA,NA,NA,aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RALA.1.4.m.8443,0.00367844464067633,No,NA,NA,P48555,NA,NA,NA,cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; dorsal closure [GO:0007391]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_RALA.4.4.m.26414,-0.020056718088874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RAN.1.3.m.3468,0.00204319444773329,No,NA,NA,H9D1R1,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAN.3.3.m.59027,-0.0101668219433593,No,NA,NA,A0MZ67,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_RANB9.1.2.m.40766,0.000981070166042536,No,NA,NA,A1L252,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RANGRF.1.2.m.18930,-0.00979699994491888,No,NA,NA,A3KPP3,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; heart contraction [GO:0060047]; heart looping [GO:0001947]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAS.1.1.m.57089,0.00362788839053409,No,NA,NA,P23175,NA,NA,NA,host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RAS3.1.1.m.15706,-0.000629259378952979,No,NA,NA,Q640R7,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486],NA,NA,NA
CHOYP_RAVR1.1.1.m.62572,-0.015394613967479,No,NA,NA,Q9HCJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RB3GP.1.2.m.53902,0.00496651459129605,No,NA,NA,Q642R9,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096],NA,NA,NA
CHOYP_RB6I2.2.2.m.65652,0.00494153926157992,No,NA,NA,Q99MI1,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; I-kappaB phosphorylation [GO:0007252]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_RBBP4.1.1.m.62913,0.00110895071697224,No,NA,NA,Q60972,NA,NA,NA,CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336],NA,NA,NA
CHOYP_RBCC1.1.2.m.7288,-0.00962717176840404,No,NA,NA,Q9ESK9,NA,NA,NA,Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709],NA,NA,NA
CHOYP_RBEL1.1.1.m.174,-0.00406023278454347,No,NA,NA,Q3YEC7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_RBM10.2.2.m.59955,0.00440052858032937,No,NA,NA,A4IGK4,NA,NA,NA,nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RBM19.1.2.m.28228,0.0114963772118123,No,NA,NA,Q9Y4C8,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RBM20.1.2.m.2222,-0.00338302607812523,No,NA,NA,Q8K310,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_RBM22.1.1.m.43645,0.000898230393070102,No,NA,NA,Q5ZM16,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; cellular response to drug [GO:0035690]; mRNA cis splicing; via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RBM25.1.2.m.41094,-0.00606438626851792,No,NA,NA,B2RY56,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBM39.1.1.m.19427,-0.000710007291874305,No,NA,NA,Q5RC80,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBMX.1.1.m.26723,-0.00503818987838793,No,NA,NA,Q7ZWA3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RBP6.1.2.m.6061,-0.00191374889053386,No,NA,NA,Q9VVE5,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_RBSK.1.1.m.17187,0.00524604908793784,No,NA,NA,Q9H477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_RBX1A.1.1.m.63168,-0.00494414594658928,No,NA,NA,P62878,NA,NA,NA,anaphase-promoting complex [GO:0005680]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; eukaryotic initiation factor 4E binding [GO:0008190]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RCC1.1.1.m.15249,-0.000784761395540858,No,NA,NA,P18754,NA,NA,NA,chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],NA,NA,NA
CHOYP_RCL1.1.1.m.7474,-0.00843733591022054,No,NA,NA,Q9JJT0,NA,NA,NA,nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RCOM_1886900.1.1.m.11248,-0.0159064584637555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RD23B.1.1.m.38952,-0.00239904262542593,No,NA,NA,P54727,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RDH13.1.3.m.10433,0.00914504449955644,No,NA,NA,Q8NBN7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],NA,NA,NA
CHOYP_RED.1.2.m.8931,-0.00274570023050959,No,NA,NA,Q9Z1M8,NA,NA,NA,cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing; via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501],NA,NA,NA
CHOYP_RED1.1.2.m.60684,0.00955008724433723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RED1.2.2.m.61084,0.00842779269242998,No,NA,NA,Q91ZS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],NA,NA,NA
CHOYP_RELN.3.4.m.48195,0.00898461184186959,No,NA,NA,P58751,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511],NA,NA,NA
CHOYP_RENT1.1.1.m.44133,-0.00226189505569653,No,NA,NA,Q9EPU0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_RENT2.1.1.m.50589,0.0213474952775001,No,NA,NA,Q9HAU5,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_REPS1.1.2.m.35334,0.0082345089942275,No,NA,NA,O54916,NA,NA,NA,clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_RER1.1.1.m.49089,-0.0160577533417748,No,NA,NA,A5PJ65,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RFA1.1.1.m.16020,-0.00158207995316537,No,NA,NA,P27694,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFA2.1.1.m.6290,-0.00211591173376166,No,NA,NA,Q62193,NA,NA,NA,chromatin [GO:0000785]; chromosome; telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heteroduplex formation [GO:0030491]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; mitotic recombination [GO:0006312]; nucleotide-excision repair [GO:0006289]; positive regulation of helicase activity [GO:0051096]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_RFC1.1.3.m.8918,-8.05171906430024e-05,No,NA,NA,P35251,NA,NA,NA,cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA damage response; detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; positive regulation of transcription; DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFC2.1.2.m.12862,-0.0113122497463559,No,NA,NA,Q6DGR4,NA,NA,NA,,NA,NA,NA
CHOYP_RFC2.1.2.m.12863,-0.00867087361894424,No,NA,NA,Q641W4,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_RFC3.1.1.m.48357,0.00685652233201766,No,NA,NA,Q8R323,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683],NA,NA,NA
CHOYP_RFIP4.1.2.m.976,0.00707489262838509,No,NA,NA,Q3LGD4,NA,NA,NA,cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_RFOX2.1.2.m.24118,-0.01407162532574,No,NA,NA,O43251,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of cell proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RFX3.1.1.m.55790,-0.00370007206143792,No,NA,NA,Q0V9K5,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_RGD1309762.1.1.m.47917,0.00963971258465977,No,NA,NA,Q9Y4D8,NA,NA,NA,integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RGD1310712.1.1.m.16487,-0.0120603643102382,No,NA,NA,Q7ZUV7,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_RGD1561408.1.2.m.4308,0.000540994910434387,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_RGN.1.1.m.30406,-0.00214274662196904,No,NA,NA,Q6DF62,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_RGPA1.1.1.m.50924,0.000179336043448728,No,NA,NA,Q2PPJ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_RHDF1.2.3.m.45435,0.00586707860706565,No,NA,NA,Q6PIX5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHDF1.3.3.m.54744,0.00729084406436938,No,NA,NA,Q6PJF5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHG07.1.1.m.14019,0.000460877797081535,No,NA,NA,Q923Q2,NA,NA,NA,lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHG17.1.2.m.32099,0.00217597604552227,No,NA,NA,Q9CYH6,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_RHG18.1.1.m.24618,0.00407914815820221,No,NA,NA,Q8K0Q5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHG44.1.1.m.982,-0.000567038284869779,No,NA,NA,Q68EM7,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHO.1.1.m.2313,-0.00948445170976551,No,NA,NA,P01122,NA,NA,NA,plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHO1.3.3.m.44337,0.00367014716768125,No,NA,NA,Q5ZIN1,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_RHO1.3.3.m.44338,0.0060155132483051,No,NA,NA,P48148,NA,NA,NA,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation; open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis; open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060],NA,NA,NA
CHOYP_RHOM172_0471.1.1.m.60636,0.0165964783678777,No,NA,NA,Q96C23,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RIF1.1.1.m.13682,-0.00356704980420206,No,NA,NA,E1C2U2,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at telomere [GO:0006348]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247],NA,NA,NA
CHOYP_RIMB2.3.5.m.17363,-0.00401822042321553,No,NA,NA,O15034,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274],NA,NA,NA
CHOYP_RINT1.1.1.m.9402,0.00259818608488724,No,NA,NA,Q6NUQ1,NA,NA,NA,cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RIOK3.1.1.m.54195,0.00513275880279335,No,NA,NA,Q9DBU3,NA,NA,NA,cytosol [GO:0005829]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],NA,NA,NA
CHOYP_RIPL1.1.1.m.59984,0.00557195062616363,No,NA,NA,D3ZUQ0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214],NA,NA,NA
CHOYP_RIR1.2.2.m.30556,0.00380088225691255,No,NA,NA,P07742,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RIR2.1.1.m.19831,0.000722902933818807,No,NA,NA,P07201,NA,NA,NA,metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_RL10.1.3.m.11695,0.000953674417869267,No,NA,NA,O61231,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_RL10A.1.2.m.7633,-0.00269233241654168,No,NA,NA,Q9N4I4,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412],NA,NA,NA
CHOYP_RL11.2.7.m.12991,-0.00256776227978832,No,NA,NA,P62914,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; peroxisome proliferator activated receptor binding [GO:0042975]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL14.2.9.m.10151,0.0016779938510243,No,NA,NA,O46160,NA,NA,NA,ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL17.2.7.m.34420,-0.00674413159990279,No,NA,NA,Q8TBZ5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791],NA,NA,NA
CHOYP_RL17.7.7.m.57535,-0.00139552900360917,No,NA,NA,Q09JW2,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL18A.1.8.m.12900,-0.00363140510051906,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL18A.6.8.m.61646,0.0064551658150677,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL21.1.4.m.19435,0.00156138076875994,No,NA,NA,P49666,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL22.4.4.m.37418,0.0015162029276437,No,NA,NA,P67985,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; presynapse [GO:0098793]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse; modulating synaptic transmission [GO:0099577]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23.1.11.m.2901,0.000112816411078714,No,NA,NA,P48159,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL23.4.11.m.13922,0.00365344641901539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL23A.3.6.m.31005,0.00295897292269861,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23A.6.6.m.63333,-0.0191152149663717,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL24.6.9.m.43123,0.00451424007861945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL24.6.9.m.43124,0.0162320415244563,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_RL39.1.2.m.5372,0.00333932381248061,No,NA,NA,Q9D1L0,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037],NA,NA,NA
CHOYP_RL39.2.2.m.64898,-0.00711435943328166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4480,-0.00782783965517342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4481,-0.00180882133743398,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL4.6.6.m.66341,0.00110748660372624,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL40.1.7.m.3623,-0.00240663545047857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL44.1.2.m.28788,-0.020964099704239,No,NA,NA,P90702,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL7A.2.6.m.5689,-0.00653942245497926,No,NA,NA,Q9ESD1,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_RL8.10.10.m.65636,-0.0186718706232183,No,NA,NA,Q6PBF0,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL8.3.10.m.22753,-0.00118603815825997,No,NA,NA,Q90YV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412],NA,NA,NA
CHOYP_RL9.4.6.m.43062,-0.00225642635790719,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL9.5.6.m.63453,-0.00128450277549404,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RLA0.3.7.m.42195,-0.00235121157427141,No,NA,NA,O75689,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1;3;4;5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RLA0.3.7.m.42196,0.000457996587654484,No,NA,NA,Q9DG68,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_RLA0.5.7.m.56220,-0.0133319402062041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RLA1.3.12.m.12071,0.000354604613982455,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.5.12.m.15482,-0.000364311395175973,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.8.12.m.25631,2.30156590572424e-05,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLP24.2.2.m.51354,-0.0161069871417554,No,NA,NA,Q7ZTZ2,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM10.1.2.m.26850,-0.00798570308539671,No,NA,NA,Q29NV5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],NA,NA,NA
CHOYP_RM11.1.1.m.9390,-0.00195122528259788,No,NA,NA,Q9VFJ2,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM22.1.1.m.63127,0.000427833474223868,No,NA,NA,Q0VFH6,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; ribosome assembly [GO:0042255]; translation [GO:0006412],NA,NA,NA
CHOYP_RM23.1.1.m.173,-0.0103564078591585,No,NA,NA,Q5TUE9,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RM37.1.1.m.14517,-0.0174476232285794,No,NA,NA,Q6AXT0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM49.1.1.m.1644,0.0160467663995119,No,NA,NA,Q9CQ40,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM51.1.1.m.12099,-0.0114887664606718,No,NA,NA,Q22438,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RMI1.1.1.m.17246,-0.00831978460148144,No,NA,NA,Q9H9A7,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RecQ helicase-Topo III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749],NA,NA,NA
CHOYP_RN19A.1.1.m.35894,-0.0229565023018649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RN213.11.13.m.59720,-0.0124870839860196,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.12.13.m.60577,-0.000842902033252869,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.4.13.m.27716,-0.0136405264812002,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.6.13.m.42268,0.00363837640118255,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45975,-0.00203321598215352,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45976,-0.00544025911425638,No,NA,NA,E9Q555,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.8.13.m.52889,0.0050295029533695,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN45S.2.5.m.14111,0.0235252813909189,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_RN45S.4.5.m.43162,-0.00087604776136075,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RNF17.1.1.m.17312,0.000164812036352799,No,NA,NA,Q99MV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_RNF213.1.4.m.3458,0,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RNP1B.1.1.m.59888,-0.0168825049721983,No,NA,NA,Q3KPW1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RNZ1.1.1.m.29553,-0.00294308593270059,No,NA,NA,Q9H777,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RO60.1.6.m.24126,0.00851115816275647,No,NA,NA,O08848,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_ROA3.2.2.m.11068,0.0150585271555185,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_ROAA.3.6.m.39522,0.00010077444504736,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_ROCK2.1.1.m.26830,0.00232537769656182,No,NA,NA,Q28021,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_RORA.1.2.m.59037,0.0153187865731859,No,NA,NA,P28699,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_RPA1.1.2.m.3320,0.00955196661304249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPA1.2.2.m.6583,-0.0104952999723622,No,NA,NA,O35134,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303],NA,NA,NA
CHOYP_RPA12.1.1.m.48818,-0.00678279367257919,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_RPAB1.1.1.m.11586,-0.0116326891641782,No,NA,NA,B0BNE2,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAB3.2.4.m.30639,0.000129420250949348,No,NA,NA,Q923G2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAC1.1.1.m.36389,-0.0115033984338034,No,NA,NA,P52432,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPB1.1.1.m.36612,0.00131873042337913,No,NA,NA,P04052,NA,NA,NA,nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPB2.1.1.m.38872,0.0044641948193874,No,NA,NA,P30876,NA,NA,NA,membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_RPB3.1.1.m.45705,-0.0130100132754921,No,NA,NA,P97760,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPC1.1.1.m.16568,0.00103337076577151,No,NA,NA,Q15637,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RPF2.2.2.m.27891,-0.0196589344860063,No,NA,NA,Q9JJ80,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_RPGRB.1.1.m.59104,-0.000799448177602671,No,NA,NA,Q9N1T2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_RPL36.1.1.m.57199,-0.00013212101221908,No,NA,NA,P15771,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RPOC1.1.1.m.34397,-0.00241957311107714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPS27L.1.1.m.21535,-0.0034548257061838,No,NA,NA,O01369,NA,NA,NA,mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_RPZ3.1.1.m.26308,-0.00181054242579731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RRAGA.1.1.m.41224,0.00231776128464576,No,NA,NA,Q63486,NA,NA,NA,cytoplasm [GO:0005737]; EGO complex [GO:0034448]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200],NA,NA,NA
CHOYP_RREB1.1.1.m.11945,0.00171987452092652,No,NA,NA,O57415,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_RRP1B.1.1.m.21811,-0.015440702228356,No,NA,NA,Q14684,NA,NA,NA,cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RRP5.1.1.m.7375,-0.000164955836591028,No,NA,NA,Q14690,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RS14.3.6.m.23056,0.00137610095702386,No,NA,NA,Q920P5,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_RS15A.5.11.m.18785,0.00241775349926703,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS15A.6.11.m.23616,0.0189587062511829,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS16.1.5.m.29365,-0.00180217854921601,No,NA,NA,Q98TR7,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS17.10.11.m.58728,-0.0146602200967006,No,NA,NA,Q94519,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; lipid A biosynthetic process [GO:0009245]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_RS19.3.12.m.15295,0.000923935987981,No,NA,NA,Q8ITC3,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.2.10.m.5562,-0.00178882645833048,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.7.10.m.39920,-0.00931272827031661,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS21.1.4.m.13400,0.000334157841682148,No,NA,NA,O14463,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation; phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379],NA,NA,NA
CHOYP_RS23.1.9.m.12948,-0.00274705326250126,No,NA,NA,Q86FP7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS23.4.9.m.24810,-0.00597793171459594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS26.14.15.m.57342,0.00862827717497788,No,NA,NA,P27085,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS27L.1.4.m.9354,0.00154050268641044,No,NA,NA,Q3T0B7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RS27L.3.4.m.33064,-0.00769234251164386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS3.2.7.m.23037,-0.000271239202408258,No,NA,NA,P62909,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; kinase binding [GO:0019900]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]; regulation of apoptotic process [GO:0042981]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3.4.7.m.42801,0.0169735701606442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS32.1.1.m.57158,-0.01409613775352,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_RS3A.14.15.m.57763,-0.0163963403424924,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.2.15.m.2682,-0.0166077737871018,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.4.15.m.15366,0.00883636478674473,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RS3A.4.15.m.15367,-0.0122592888836631,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.8.15.m.27207,-0.0198044994361524,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.10.11.m.60432,0.00946266784802279,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS4.11.11.m.63584,-0.000131095890274669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.3.11.m.15465,-0.0036139414082889,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS5.1.2.m.146,0.0010629324132545,No,NA,NA,P46782,NA,NA,NA,cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RS6.10.12.m.44863,0.000137317533912965,No,NA,NA,Q9BMX5,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.5.12.m.23146,0,No,NA,NA,O01727,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.8.12.m.36342,-0.00143091101212104,No,NA,NA,O61462,NA,NA,NA,ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS7.5.9.m.38700,-0.0101769568850592,No,NA,NA,Q969G6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],NA,NA,NA
CHOYP_RS7.6.9.m.44704,0.000697334547497231,No,NA,NA,P02362,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS8.12.14.m.59492,0.000148649438343565,No,NA,NA,Q6ZQ03,NA,NA,NA,nuclear speck [GO:0016607],NA,NA,NA
CHOYP_RS9.11.13.m.49921,0.00023912786321033,No,NA,NA,B4PEU8,NA,NA,NA,nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.8.13.m.41198,-0.00200001766750728,No,NA,NA,P29314,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.9.13.m.44486,0.0185943341811347,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_RSMB.1.2.m.12400,-0.00292696798061019,No,NA,NA,Q9N1Q0,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RSPH4A.1.1.m.15217,-0.000167295152413768,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_RSRC2.1.1.m.14844,0.000771527405171361,No,NA,NA,Q7ZYR8,NA,NA,NA,,NA,NA,NA
CHOYP_RSSA.1.10.m.2054,0.00182451819306526,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RSU1.1.1.m.44138,0.000756106022642136,No,NA,NA,Q15404,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RT10.2.4.m.12766,-0.00784698186515631,No,NA,NA,Q9VFB2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RT16.1.1.m.16545,-0.013224887162904,No,NA,NA,P82915,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RTCB.1.2.m.27510,0.00186587385818428,No,NA,NA,Q6NZS4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA exon ligation utilizing 2';3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_RTEL1.1.1.m.16665,-0.00140053079384021,No,NA,NA,Q5RJZ1,NA,NA,NA,chromosome; telomeric region [GO:0000781]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657],NA,NA,NA
CHOYP_RTF1.1.1.m.10685,0.00108274371336953,No,NA,NA,A2AQ19,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_RTTN.1.3.m.9025,-0.0109418459713592,No,NA,NA,Q86VV8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_RTTN.1.3.m.9026,-0.00294751395689641,No,NA,NA,Q5I0P2,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; enzyme binding [GO:0019899]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_RU1C.1.2.m.50387,0.00273625761459791,No,NA,NA,C3Z1P5,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RU2A.1.1.m.20848,-0.00650387297600564,No,NA,NA,P57784,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing; via spliceosome [GO:0000398]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RUNX1.1.1.m.49526,-0.0145076280483111,No,NA,NA,Q01196,NA,NA,NA,core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive; alpha-beta T cell differentiation [GO:0043371]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive; alpha-beta T cell differentiation [GO:0043378]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111],NA,NA,NA
CHOYP_RUVB1.1.1.m.25669,-0.00053052490916042,No,NA,NA,Q9DE26,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RUVB2.1.1.m.19005,0.000443140608702535,No,NA,NA,Q9DE27,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RXR.1.2.m.45987,0.00171881949863579,No,NA,NA,Q5I7G2,NA,NA,NA,cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_S12A2.1.2.m.32137,-0.00377380946288561,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S12A2.2.2.m.39394,0.00403979325051721,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S26A5.2.2.m.9883,0.012594920999619,No,NA,NA,P58743,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_S28A3.2.3.m.7477,0.00752300978911134,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_S30BP.1.1.m.62845,-0.00529708898422812,No,NA,NA,Q9UHR5,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_S4A10.3.4.m.28397,0.0158126076501007,No,NA,NA,Q8JZR6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_S4A8.1.1.m.28334,0.00517553805176805,No,NA,NA,Q80ZA5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_SAC1.1.1.m.40164,0.0160551221537833,No,NA,NA,Q6GM29,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_SACS.11.17.m.53250,0.00203583310878999,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.12.17.m.53659,0.000478682211947447,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.14.17.m.61817,-0.00570947117814961,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.4.17.m.32398,-0.00225165411050717,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.6.17.m.35149,0.0116266275910614,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.9.17.m.52781,0.00220722732352185,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SAE1.1.1.m.46861,-0.00207447465085679,No,NA,NA,Q8JGT5,NA,NA,NA,SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAE2.1.1.m.59765,-0.000831910928022144,No,NA,NA,Q28GH3,NA,NA,NA,cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAFB2.2.3.m.30765,-0.000801912618812057,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAFB2.3.3.m.33384,-0.0108051976685586,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAHH3.2.2.m.51221,0.00779814647818911,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_SAHHA.1.1.m.62610,-0.000146913164214609,No,NA,NA,P51893,NA,NA,NA,adenosylhomocysteinase activity [GO:0004013]; NAD binding [GO:0051287]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510],NA,NA,NA
CHOYP_SALIVA_1456.1.1.m.19330,-0.00983212938674479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SAM9L.1.2.m.51914,-0.00674850123868209,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_SAMD15.1.1.m.27733,-0.00913827794356803,No,NA,NA,Q95JY5,NA,NA,NA,,NA,NA,NA
CHOYP_SAMH1.10.12.m.55275,0.0103997565005076,No,NA,NA,Q9Y3Z3,NA,NA,NA,intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_SAMH1.12.12.m.66249,-0.000233304406771604,No,NA,NA,Q6INN8,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_SAP.1.2.m.13958,0.000108839056368899,No,NA,NA,Q12959,NA,NA,NA,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],NA,NA,NA
CHOYP_SARM1.1.1.m.377,0.00703023723267918,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SARNP.1.1.m.46095,-0.00164054469495972,No,NA,NA,Q9D1J3,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_SART1.1.1.m.14398,-0.00423245336769912,No,NA,NA,O43290,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_SASB.2.3.m.37538,0.00720704367645397,No,NA,NA,Q8N0W4,NA,NA,NA,asymmetric; glutamatergic; excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric; GABA-ergic; inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_SASB.3.3.m.51787,-0.00479933672248631,No,NA,NA,P23953,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity; acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_SBDS.1.1.m.27786,0.00987292636163065,No,NA,NA,P70122,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SBNO1.1.1.m.7257,-0.00549961634315955,No,NA,NA,A3KN83,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_SBP1.1.2.m.2083,-0.00130185158279535,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SBP1.2.2.m.49372,-0.00268674555677551,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SC22B.1.1.m.62900,-0.00151826049824394,No,NA,NA,Q6P7L4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_SC24B.1.2.m.95,-4.52841541093896e-05,No,NA,NA,O95487,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24B.2.2.m.54667,0.00694176469683333,No,NA,NA,O95487,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24C.1.1.m.9387,0.00104068691828848,No,NA,NA,P53992,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8240,0.00201003707752915,No,NA,NA,Q5F3X8,NA,NA,NA,COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8241,0.00257601134391569,No,NA,NA,O57521,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; regulation of cellular protein localization [GO:1903827]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_SC5A9.3.5.m.27017,-0.00702159983617966,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_SC6A5.3.7.m.20491,0.00155761199404764,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.5.7.m.49357,-0.00869024147285586,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.7.7.m.62985,0.00711740792333643,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SC6A6.2.2.m.37040,0.000784328745606695,No,NA,NA,P31646,NA,NA,NA,integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836],NA,NA,NA
CHOYP_SC6A9.4.6.m.26535,0.0264898732729591,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SC6A9.6.6.m.57818,-0.00681591224823921,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SCAM1.1.1.m.5509,-0.0150294245229459,No,NA,NA,Q8K021,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SCAPER.1.1.m.34551,-0.0147665800106041,No,NA,NA,Q9BY12,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_SCE4070.1.1.m.29642,0.00858748408397045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SCMH1.1.1.m.1166,-0.0139636985637095,No,NA,NA,Q96GD3,NA,NA,NA,chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SCN1.1.2.m.28878,0.0188264374783212,No,NA,NA,P15390,NA,NA,NA,axon [GO:0030424]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_SCOT1.1.1.m.59655,-0.000691370149332974,No,NA,NA,B2GV06,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_SCP.3.12.m.27952,-0.00291532000829202,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.6.12.m.50694,-0.0102742157703917,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.8.12.m.57173,0.001232550189331,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.9.12.m.62606,0.000807729395665357,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCPDL.1.1.m.55687,-0.00129657969555218,No,NA,NA,Q8NBX0,NA,NA,NA,extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_SDA1.1.1.m.12704,-0.0230323201657669,No,NA,NA,Q9NVU7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_SDHC.1.1.m.31276,-0.0102011676613981,No,NA,NA,P70097,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SDR16C5.1.1.m.7423,-0.0141857701036859,No,NA,NA,Q8N3Y7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; retinol dehydrogenase activity [GO:0004745]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_SEC13.1.1.m.20714,0.00164198421958501,No,NA,NA,Q5XFW8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SEC23B.1.1.m.12147,-0.00264113651648175,No,NA,NA,Q7SZE5,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; cargo loading into COPII-coated vesicle [GO:0090110]; cartilage development [GO:0051216]; embryonic neurocranium morphogenesis [GO:0048702]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; pectoral fin morphogenesis [GO:0035138]; regulation of cell shape [GO:0008360]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_SEC23IP.1.1.m.41425,0.00335750270651378,No,NA,NA,Q6NZC7,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; single fertilization [GO:0007338]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_SEH1.1.1.m.55025,-0.002517025111118,No,NA,NA,Q6TGU2,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SELD.1.2.m.8600,-0.000818824392560154,No,NA,NA,P62716,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of microtubule binding [GO:1904528]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_SELJ.1.1.m.21559,0.00626733589586762,No,NA,NA,P40821,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_SEM1A.1.2.m.57703,0.0114809160064848,No,NA,NA,Q26473,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEM2A.1.1.m.43497,0.0065449424804538,No,NA,NA,Q9XZC8,NA,NA,NA,extracellular region [GO:0005576]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEP11.1.2.m.19430,-0.00067612125525823,No,NA,NA,P54359,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_SEPT2.1.1.m.40428,0.00109286182961824,No,NA,NA,Q63ZQ1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_SEPT5.1.2.m.11458,0.00291126360259546,No,NA,NA,Q99719,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle targeting [GO:0016080],NA,NA,NA
CHOYP_SEPT7.1.1.m.59134,0.00184266633321083,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SERB.1.1.m.7242,-0.00093427236185838,No,NA,NA,Q2KHU0,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563],NA,NA,NA
CHOYP_SETD2.1.1.m.25547,-0.00289994826165122,No,NA,NA,Q9BYW2,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription; DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SETD3.1.1.m.42582,-0.00358520181624493,No,NA,NA,B1MTJ4,NA,NA,NA,nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; transcription coactivator activity [GO:0003713]; histone H3-K36 methylation [GO:0010452]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_SETD6.1.1.m.14704,0.00412889235981953,No,NA,NA,Q9CWY3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_SF3A1.1.3.m.41531,-0.00597739663866354,No,NA,NA,Q15459,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3A3.1.1.m.50392,0.00275683982315233,No,NA,NA,Q9D554,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B1.1.3.m.24001,-0.00420891129798898,No,NA,NA,O57683,NA,NA,NA,spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SF3B3.1.1.m.45473,-0.00353371465240056,No,NA,NA,Q15393,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_SF3B4.1.1.m.14985,0.00241448312198184,No,NA,NA,O14102,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B5.1.1.m.12205,-0.00916535987877565,No,NA,NA,Q9VHI4,NA,NA,NA,precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SGPL1.1.1.m.42223,-0.00835454403016832,No,NA,NA,Q8CHN6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_SGPP1.1.1.m.5606,-0.0189346485315328,No,NA,NA,Q99P55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_SH3KBP1.1.1.m.30545,-0.0111027950829433,No,NA,NA,Q96B97,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SH3L1.2.5.m.9176,-0.018033386358226,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_SHD.1.1.m.20907,0.0146371224990575,No,NA,NA,Q8CG80,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHEP.1.1.m.27990,-0.000133445662021672,No,NA,NA,Q5RBD3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_SHLB1.2.2.m.54016,0.000704901671825599,No,NA,NA,Q5ZIR1,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHMT2.1.1.m.10572,-0.0010434772273244,No,NA,NA,P34897,NA,NA,NA,BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_SHROOM3.1.1.m.15543,0.00159359472089471,No,NA,NA,Q27IV2,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SI_CH211.197G15.10.6.7.m.50389,-0.000605328401429461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.197G15.7.3.3.m.61063,0.0133818176990929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.250G4.3.1.2.m.7118,0.00217323434009303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.21N12.1.1.1.m.65205,-0.00215151813196318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.5N18.1.1.2.m.5489,-0.0236961565454685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEYP.75B4.10.2.2.m.54469,1.07844340391648e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI1L1.1.2.m.7671,0.00327853792576721,No,NA,NA,Q80TE4,NA,NA,NA,GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_SIK3.1.1.m.8214,0.00703327189052295,No,NA,NA,Q6P4S6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_SIP.1.1.m.5724,0.00204289663273284,No,NA,NA,Q3T168,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507],NA,NA,NA
CHOYP_SIP.1.1.m.5725,-0.00941821422760394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SIRT1.1.1.m.9844,0.0062976723447747,No,NA,NA,Q923E4,NA,NA,NA,axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; establishment of chromatin silencing [GO:0006343]; fatty acid homeostasis [GO:0055089]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; maintenance of chromatin silencing [GO:0006344]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell proliferation [GO:0042127]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; rRNA processing [GO:0006364]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_SIX1.1.2.m.49270,0.00824928137835781,No,NA,NA,Q27350,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; eye-antennal disc morphogenesis [GO:0007455]; glial cell migration [GO:0008347]; negative regulation of transcription; DNA-templated [GO:0045892]; optic lobe placode formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SK2L2.1.1.m.35679,0.00202720143295483,No,NA,NA,P42285,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing; via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SKAP2.1.1.m.63022,0.0259602425552314,No,NA,NA,Q6PG29,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; B cell activation [GO:0042113],NA,NA,NA
CHOYP_SKIV2L.3.4.m.25390,-0.0209702126762087,No,NA,NA,Q15477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SLAI2.1.2.m.8777,-0.00205266989005483,No,NA,NA,Q3MHV6,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116],NA,NA,NA
CHOYP_SLC31.5.5.m.57886,0.00437510778982795,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC34A2.1.2.m.9501,-0.00203972098215495,No,NA,NA,Q9DBP0,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341],NA,NA,NA
CHOYP_SLC3A1.1.1.m.14892,-0.0214912319094356,No,NA,NA,Q64319,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC40A1.1.1.m.55100,0.000206039092303942,No,NA,NA,Q9JHI9,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron channel activity [GO:0097689]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345],NA,NA,NA
CHOYP_SLC6A14.1.1.m.43828,-0.00105942120040159,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SLK.1.1.m.59382,-0.00385700993703092,No,NA,NA,Q7SY52,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_SLMAP.2.8.m.897,0.00486833974984141,No,NA,NA,Q14BN4,NA,NA,NA,integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150],NA,NA,NA
CHOYP_SLX4.1.1.m.278,0.00480756226241723,No,NA,NA,Q8IY92,NA,NA,NA,cell junction [GO:0030054]; chromosome; telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; endodeoxyribonuclease activity [GO:0004520]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_SMAD1.2.2.m.60397,-0.00408483005362105,No,NA,NA,Q5R6H7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast fate commitment [GO:0002051]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD3.1.1.m.51679,-0.0158998304016135,No,NA,NA,P84025,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD4.3.4.m.13408,0.00211652376885842,No,NA,NA,Q1HE26,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_SMARCA5.1.1.m.31708,-0.00199598321623602,No,NA,NA,O60264,NA,NA,NA,chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; chromatin silencing at rDNA [GO:0000183]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMC.3.5.m.51502,-0.00769018105453824,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMC2.1.4.m.17836,-0.0120087401411097,No,NA,NA,P50533,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261],NA,NA,NA
CHOYP_SMC2.1.4.m.17837,0.0066837455741036,No,NA,NA,Q6Q0C0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_SMC3.1.1.m.65133,0.00353267809282546,No,NA,NA,O93309,NA,NA,NA,chromatin [GO:0000785]; chromosome; centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_SMCA4.1.1.m.54020,-0.00206560562569736,No,NA,NA,A7Z019,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_SMG1.1.1.m.46694,0.00354363790055461,No,NA,NA,Q8BKX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204],NA,NA,NA
CHOYP_SMG5.1.1.m.21320,0.00946138237343132,No,NA,NA,Q6ZPY2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG7.1.1.m.21983,-0.00929348723653587,No,NA,NA,Q5RJH6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG9.1.1.m.2906,-0.00779304458794737,No,NA,NA,B5X165,NA,NA,NA,nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_SMHD1.1.1.m.47344,0.000532389611058717,No,NA,NA,Q6P5D8,NA,NA,NA,Barr body [GO:0001740]; nuclear chromosome; telomeric region [GO:0000784]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; heterochromatin organization involved in chromatin silencing [GO:0070868]; inactivation of X chromosome by DNA methylation [GO:0060821]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],NA,NA,NA
CHOYP_SMOX.1.2.m.3830,-0.00376013671990094,No,NA,NA,Q99K82,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],NA,NA,NA
CHOYP_SMP_005500.1.1.m.34627,-0.00670160428538578,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_SMP_006860.2.1.4.m.8660,0.00355003379915573,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_006860.2.2.4.m.24582,-0.00825524976584943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_006860.2.3.4.m.63036,0.000100069479592276,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_012720.2.2.m.34968,-0.00139404597124308,No,NA,NA,Q9WUM3,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_039300.1.1.m.1202,0.00214035825569728,No,NA,NA,F7H9X2,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_SMP_043120.1.1.m.12494,-0.00426700804248448,No,NA,NA,Q49YE0,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_SMP_045300.1.1.m.927,0.00121480129396512,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_048560.1.2.m.58825,0.0145815956895946,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_SMP_051990.1.7.m.327,-0.00123431353689205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.2.7.m.611,-0.00389647539552367,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.4.7.m.9424,0.00126573108419096,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.5.7.m.43424,0.00167477830316209,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.7.7.m.57569,0.00370860339929455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_076400.2.2.m.49169,0.0122196726422949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_078690.3.5.m.2272,0.00135538941409355,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_078690.4.5.m.41580,-0.0182448572865643,No,NA,NA,P37801,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_078690.5.5.m.64878,0.000742167426057244,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_082940.1.1.m.3343,-0.00120377258920121,No,NA,NA,Q9N2W7,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_SMP_087250.2.2.m.25167,0.0014300881262287,No,NA,NA,P97314,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_SMP_089460.1.1.1.m.34779,0.00097046471645443,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_SMP_102490.1.2.m.22219,0.0020968856949957,No,NA,NA,P0C2C1,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_SMP_105540.1.1.m.40275,0.0108660325661167,No,NA,NA,Q8JZW5,NA,NA,NA,cell junction [GO:0030054]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211],NA,NA,NA
CHOYP_SMP_137640.1.2.m.40559,-0.0106436963498337,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_SMP_140370.1.1.m.35365,-0.00323785483324873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_143090.1.1.m.6805,-0.00531631394742624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_147320.1.1.m.27463,0.00928012047871946,No,NA,NA,Q96M20,NA,NA,NA,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148530.1.1.m.18051,0.00315146272896475,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_149390.1.1.m.8819,-0.011377041950889,No,NA,NA,Q8C419,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SMP_149990.1.1.1.m.44960,0.000266932568339511,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_158990.1.1.m.28205,0.000465650826563633,No,NA,NA,P36609,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SMP_159010.1.1.1.m.56000,0.00415452259972105,No,NA,NA,P26818,NA,NA,NA,ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SMP_159780.1.2.m.41665,0.00876644775466298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_171550.1.1.m.44645,0.0091016798894899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_173720.2.3.m.52988,0.00456227898742518,No,NA,NA,Q8CIR4,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_SMP_176410.1.1.m.18565,-0.000866145940981527,No,NA,NA,Q9UJT9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SMP_194720.1.1.m.53496,0.00184299801778663,No,NA,NA,O02485,NA,NA,NA,,NA,NA,NA
CHOYP_SMRC2.2.2.m.49912,0.00131070595981415,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMRD1.1.2.m.1725,0.00987257341877274,No,NA,NA,Q61466,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_SMU1.1.1.m.58635,-0.00122047597324675,No,NA,NA,Q6NRT3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SMYD5.1.1.m.27234,-0.0110250519802509,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_SNF1A.1.1.m.52779,0.000541614688183824,No,NA,NA,P54646,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_SNUT2.1.1.m.19264,-0.00247101996629685,No,NA,NA,Q3TIX9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SNW1.2.2.m.19563,-0.00142526477093244,No,NA,NA,Q5R7R9,NA,NA,NA,nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_SNX2.1.1.m.25425,0.000543333122403473,No,NA,NA,O60749,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_SODM.1.2.m.45531,-0.000886961116006959,No,NA,NA,P41976,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; age-dependent response to reactive oxygen species [GO:0001315]; aging [GO:0007568]; regulation of transcription by RNA polymerase II [GO:0006357]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_SON.1.3.m.26634,0.00202128112084931,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_04G037735.1.1.m.52863,-0.0132067569782118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_06G032450.1.1.m.16356,0.0167457874265469,No,NA,NA,Q7XR46,NA,NA,NA,peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_SORL.1.3.m.4531,0.00868149608369047,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_SORL.3.3.m.58779,-0.00578178234696726,No,NA,NA,O88307,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],NA,NA,NA
CHOYP_SOS1.1.1.m.52801,0.00487163863137021,No,NA,NA,Q07890,NA,NA,NA,cytosol [GO:0005829]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_SOSB1.1.2.m.1668,0.012673200782725,No,NA,NA,Q3SWT1,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_SOX2.1.2.m.31411,-0.0144796997532264,No,NA,NA,P48430,NA,NA,NA,cell [GO:0005623]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; endodermal cell fate specification [GO:0001714]; eye development [GO:0001654]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of transcription; DNA-templated [GO:0006355]; response to growth factor [GO:0070848]; response to wounding [GO:0009611]; sensory organ precursor cell fate determination [GO:0016360]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_SP3.1.1.m.9839,0.0109114095270158,No,NA,NA,Q02446,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SPAG16.1.1.m.51927,-0.00494904689151253,No,NA,NA,Q8N0X2,NA,NA,NA,axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_SPAG7.1.1.m.66661,-0.00914524846748074,No,NA,NA,Q7SYJ9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_SPAT6.1.1.m.11699,-0.00627290889642428,No,NA,NA,Q3U6K5,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPB3.1.1.m.31072,-0.00685652891521858,No,NA,NA,Q5BIR5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_SPCA.1.1.m.6746,0.00570413354534845,No,NA,NA,P98194,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-transporting ATPase activity [GO:0005388]; manganese ion binding [GO:0030145]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_SPCS.1.1.m.65784,-0.00496896673147997,No,NA,NA,Q803A7,NA,NA,NA,cytoplasm [GO:0005737]; transferase activity; transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412],NA,NA,NA
CHOYP_SPF45.1.1.m.22111,-0.0214254650857267,No,NA,NA,Q96I25,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing; via spliceosome [GO:0000380]; DNA repair [GO:0006281]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SPH127.1.1.m.56840,0.00278383388893098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.16.37.m.16200,0.00275241921660957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.25.37.m.28547,0.00301750179035152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.29.37.m.30551,0.00182073433210194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.30.37.m.30616,-0.011679411628975,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.8.37.m.4837,0.00140696122677329,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPR.2.3.m.21888,0.00992053072476254,No,NA,NA,Q8SWR3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity; post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042],NA,NA,NA
CHOYP_SPT20.1.1.m.35908,0.00969361774568956,No,NA,NA,Q8TB22,NA,NA,NA,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPT4H.1.1.m.40744,-0.00423155560432357,No,NA,NA,Q6DGQ0,NA,NA,NA,DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription; elongation [GO:0032786],NA,NA,NA
CHOYP_SPT5H.1.1.m.60053,-0.00105225913665706,No,NA,NA,O00267,NA,NA,NA,DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SPT6H.1.1.m.55595,-0.00264702194374245,No,NA,NA,Q7KZ85,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032],NA,NA,NA
CHOYP_SPTCA.1.2.m.1905,0.0234179365080171,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SPTCA.2.2.m.25615,0.000196413029752914,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SQPA.2.2.m.61080,0.0129310623497406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SR140.1.2.m.11983,0.0140473832609597,No,NA,NA,Q6NV83,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_SRA1.1.1.m.56432,-0.00964157511382502,No,NA,NA,Q80VJ2,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SRAP.10.18.m.43353,0.000892946788525067,No,NA,NA,Q9Y4F5,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874],NA,NA,NA
CHOYP_SRAP.14.18.m.50950,0.000114043155548047,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_SRAP.16.18.m.58654,-0.000384635520338724,No,NA,NA,Q8K561,NA,NA,NA,anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_SRC.1.2.m.2503,0.00135470546151803,No,NA,NA,Q9W596,NA,NA,NA,axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582],NA,NA,NA
CHOYP_SRC1.1.1.m.63625,0.00965511662662272,No,NA,NA,P09324,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRC2.1.1.m.6537,-0.00279668586303506,No,NA,NA,Q9V9J3,NA,NA,NA,adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRCR12.1.1.m.53668,9.35566736289917e-05,No,NA,NA,Q9NR16,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044],NA,NA,NA
CHOYP_SREC2.7.9.m.44662,0.00976266035073014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SRFB1.1.2.m.18320,0.00755005206104766,No,NA,NA,Q5XGC9,NA,NA,NA,90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_SRP54.1.2.m.21986,-0.00148392828717046,No,NA,NA,P14576,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP68.1.1.m.61852,-0.000145669578853973,No,NA,NA,Q9UHB9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP72.1.1.m.60789,-0.000430977842328865,No,NA,NA,O76094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_SRPK2.1.1.m.5002,0.00255072002586768,No,NA,NA,O70551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SRPX2.1.1.m.37317,-0.000165047211769855,No,NA,NA,Q8TER0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_SRSF4.6.6.m.44673,0.01557983570993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SSPO.1.14.m.962,-0.0007234433103865,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSPO.11.14.m.53093,0.0104939594821287,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_SSPO.12.14.m.53188,-0.00420444089220275,No,NA,NA,Q9Y493,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609],NA,NA,NA
CHOYP_SSPO.2.14.m.3787,0.00225974015098689,No,NA,NA,Q28178,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_SSPO.6.14.m.26542,-0.00610643777022364,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSRB.1.2.m.5816,-0.00182980060889058,No,NA,NA,Q5E9E4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_SSRP1.1.1.m.19377,-0.00967970310539199,No,NA,NA,Q04678,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_SSSCA1.1.2.m.25666,-0.00255894162350173,No,NA,NA,O60232,NA,NA,NA,identical protein binding [GO:0042802]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_ST1C1.1.1.m.45503,0.0110693544254484,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST1C4.2.3.m.14628,-0.00209178411450819,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST5.1.1.m.54184,0.00566831532208013,No,NA,NA,P78524,NA,NA,NA,Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_STAB2.1.1.m.64132,-0.0024445472392781,No,NA,NA,Q8R4U0,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_STAR5.2.2.m.39352,0.00343290009592524,No,NA,NA,A1A4M6,NA,NA,NA,bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; cholesterol import [GO:0070508],NA,NA,NA
CHOYP_STAT1.1.2.m.1003,-0.000583250553824805,No,NA,NA,P42232,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_STERM_3136.1.1.m.53971,0.000182658121333569,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_STIM1.1.1.m.13316,0.0129647384714714,No,NA,NA,P84903,NA,NA,NA,endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; myotube differentiation [GO:0014902]; positive regulation of adenylate cyclase activity [GO:0045762]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],NA,NA,NA
CHOYP_STING.3.3.m.61083,0.0157083974434852,No,NA,NA,Q86WV6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; neutrophil degranulation [GO:0043312]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus; translocation [GO:0033160]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; regulation of type I interferon production [GO:0032479]; viral process [GO:0016032],NA,NA,NA
CHOYP_STIP1.1.2.m.12856,0.00706892742636992,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STIP1.2.2.m.54723,-0.00733211246153374,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STK17A.1.1.m.24446,0.00599814791481468,No,NA,NA,Q9UEE5,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_STK31.1.1.m.16297,-0.0130947455158891,No,NA,NA,Q9BXU1,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nuclease activity [GO:0004518]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_STK33.1.1.m.8044,0.0106774954530674,No,NA,NA,Q924X7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint [GO:0044773]; protein autophosphorylation [GO:0046777]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_STRN.MLCK.2.3.m.9348,-0.00521437263010682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_STRN3.3.5.m.25133,-0.00249490723122622,No,NA,NA,A5D7H2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_STRUM.1.1.m.42335,-0.00786568294398461,No,NA,NA,Q5R5P0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; WASH complex [GO:0071203]; protein transport [GO:0015031],NA,NA,NA
CHOYP_STT3A.1.1.m.40532,0.000516822713418805,No,NA,NA,Q2KJI2,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_STX.1.1.m.30392,-0.00912503289287491,No,NA,NA,Q16932,NA,NA,NA,cell [GO:0005623]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_STX12.1.1.m.34092,-0.00902149583635571,No,NA,NA,Q86Y82,NA,NA,NA,early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_STXB1.1.1.m.56878,0.0019217548416753,No,NA,NA,P61765,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission; GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion; neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_STXB5.1.2.m.50466,-0.00378503012932923,No,NA,NA,Q5T5C0,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504],NA,NA,NA
CHOYP_SUCB1.1.1.m.41299,0.000655680789962876,No,NA,NA,Q9Z2I9,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUCB2.1.1.m.7164,-0.000446470672167976,No,NA,NA,P53590,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUDX.1.1.m.4577,-0.00277770074589229,No,NA,NA,Q8BZZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lung development [GO:0030324]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SUIS.2.2.m.16063,0.00756786383272645,No,NA,NA,O43451,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1;4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1;4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983],NA,NA,NA
CHOYP_SUOX.1.1.m.32255,-0.00317229549801212,No,NA,NA,Q9VWP4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790],NA,NA,NA
CHOYP_SUV3.1.1.m.14574,-0.0136429437832241,No,NA,NA,Q9VN03,NA,NA,NA,mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SVEP1.2.8.m.26503,0.00758786387660432,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_SVIL.1.1.m.1136,-0.0247782878368473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SYAC.2.2.m.18500,-0.00157033989494704,No,NA,NA,Q8BGQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_SYB.1.3.m.25801,-0.0238591021957383,No,NA,NA,P35589,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_SYCC.1.1.m.11415,-0.000825488156442444,No,NA,NA,Q9ER72,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423],NA,NA,NA
CHOYP_SYCP2.1.2.m.47476,0.00998114454417906,No,NA,NA,Q9CUU3,NA,NA,NA,lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_SYFA.1.1.m.53256,0.00116726859426559,No,NA,NA,Q1JPX3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_SYFA.1.1.m.53257,-0.023091921135412,No,NA,NA,Q08BI9,NA,NA,NA,calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],NA,NA,NA
CHOYP_SYHC.1.1.m.65924,-0.00136427991369561,No,NA,NA,Q61035,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_SYMC.1.1.m.18367,-0.00210416934402457,No,NA,NA,P56192,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_SYMPK.1.1.m.1791,-0.00609503400416971,No,NA,NA,Q92797,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_SYNE1.1.1.m.51183,-0.00124049964321385,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SYNJ1.1.1.m.42275,0.00136595819891394,No,NA,NA,Q8CHC4,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_SYPL1.1.1.m.49654,-0.00467793808099217,No,NA,NA,Q16563,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_SYRC.1.2.m.36309,-0.000409445345390808,No,NA,NA,P37880,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420],NA,NA,NA
CHOYP_SYTC.1.1.m.35709,0.000763223731668749,No,NA,NA,Q9D0R2,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435],NA,NA,NA
CHOYP_SYWC.3.5.m.26200,0.000536605899127093,No,NA,NA,P23381,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.4.5.m.36166,0.00447010793237135,No,NA,NA,P17248,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.5.5.m.54889,0.0278524736355598,No,NA,NA,Q9NQC3,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_SYYC.1.2.m.23460,0.00381780164429852,No,NA,NA,Q6TGS6,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_SYYC.2.2.m.58390,0.0174749120862565,No,NA,NA,Q6TGS6,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_T23O.5.6.m.52216,0.0172740599685356,No,NA,NA,Q5U4U6,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_T24B8.5.1.2.m.5660,-0.00185918143432957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T24B8.5.2.2.m.46909,0.0195096632003945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T3HPD.1.2.m.24627,0.00944382105272877,No,NA,NA,Q66II5,NA,NA,NA,hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346],NA,NA,NA
CHOYP_TAB3.1.1.m.25766,-0.00615633369678191,No,NA,NA,Q99K90,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860],NA,NA,NA
CHOYP_TACC1.2.2.m.53512,0.00412924627753623,No,NA,NA,Q6Y685,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],NA,NA,NA
CHOYP_TACC3.3.3.m.16099,0.0104731521530966,No,NA,NA,Q9PTG8,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_TAD2A.1.1.m.27478,-0.0108376194421897,No,NA,NA,Q5M823,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TAF1.1.1.m.31656,0.0187932923921374,No,NA,NA,P21675,NA,NA,NA,MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA-templated transcription; initiation [GO:0006352]; midbrain development [GO:0030901]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; regulation of transcription; DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_TAF13.1.3.m.20331,0.00955088036938227,No,NA,NA,Q5R9W6,NA,NA,NA,nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_TAF9.1.1.m.10395,0.0054996578040789,No,NA,NA,A5PJA1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_TAGL3.1.1.m.31031,0.003950151340966,No,NA,NA,P37805,NA,NA,NA,actin filament binding [GO:0051015],NA,NA,NA
CHOYP_TALDO.2.2.m.43331,-0.00156281930157036,No,NA,NA,P37837,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999],NA,NA,NA
CHOYP_TBA.3.6.m.29936,-0.0179095502140451,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.3.6.m.29937,0.000146682183123143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA1.2.9.m.9962,0.00550464650987223,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_TBA1.7.9.m.44107,0.0222553222096411,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_TBA2.1.1.m.955,0.00201254753903363,No,NA,NA,P68370,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_TBA3.1.1.m.5111,-0.0079313198026963,No,NA,NA,Q68FR8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB.2.7.m.37919,0.00409766791825557,No,NA,NA,P02554,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_TBB.5.7.m.60062,-0.000180490448028435,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_TBB2.1.2.m.45096,-0.00105654160343846,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53000,0.00784016881873936,No,NA,NA,P41387,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB2.2.2.m.53001,-0.0107541408824869,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53003,0.0108414043021417,No,NA,NA,P41386,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4.1.1.m.40048,-0.0131771731672043,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.1.7.m.12262,0.000623488047909014,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.3.7.m.22777,-0.00691941542739544,No,NA,NA,P43006,NA,NA,NA,axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_TBB4B.7.7.m.63980,-0.00316231871208191,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBC13.1.1.m.24396,-0.0243537044294708,No,NA,NA,Q9NVG8,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBC15.1.1.m.4226,-0.00897756088660324,No,NA,NA,Q9CXF4,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_TBC1D22A.1.1.m.24510,0.00637555564386477,No,NA,NA,Q9NU19,NA,NA,NA,cell [GO:0005623]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBCA.1.1.m.12075,0.000146080286163527,No,NA,NA,O75347,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD.1.2.m.35202,-0.000636190046562091,No,NA,NA,Q9BTW9,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD1.1.1.m.14806,-0.00956580784559587,No,NA,NA,O60343,NA,NA,NA,cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_TBCE.1.1.m.14005,-0.000400451240879329,No,NA,NA,Q5U508,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023],NA,NA,NA
CHOYP_TBCEL.2.2.m.26805,-0.00740655785085475,No,NA,NA,Q5QJ74,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_TBL2.1.1.m.29917,0.00914265203254715,No,NA,NA,Q9Y4P3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968],NA,NA,NA
CHOYP_TBRG4.1.1.m.48213,0.00570067996010068,No,NA,NA,Q6PA48,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; cellular respiration [GO:0045333]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_TC1DB.1.1.m.22354,-0.0123132635490312,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_TCF25.1.1.m.28509,-0.00666981976710238,No,NA,NA,Q8R3L2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_TCFAP2B.2.2.m.11727,-0.00943942542232585,No,NA,NA,P34056,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; roof of mouth development [GO:0060021]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559],NA,NA,NA
CHOYP_TCPB.1.1.m.6398,-0.00191923928289875,No,NA,NA,Q3ZBH0,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_TCPD.1.1.m.13556,-0.00222962067076797,No,NA,NA,Q2T9X2,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPG.1.1.m.30926,-0.0245582325920743,No,NA,NA,P48605,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; unfolded protein binding [GO:0051082]; lumen formation; open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_TCPH.1.1.m.7312,-0.00238088307538036,No,NA,NA,Q5ZJK8,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPQ.1.1.m.57792,-0.00135450134501695,No,NA,NA,Q6EE31,NA,NA,NA,cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCRG1.1.1.m.1150,-0.00284140662601343,No,NA,NA,Q8CGF7,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_TDRD1.1.1.m.34821,0.00486725573650571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TDRD3.1.2.m.3301,-0.0126535961826325,No,NA,NA,Q5ZMS6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_TDRD3.2.2.m.8522,0.011153593405088,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEFF2.1.1.m.26857,0.0012734253409709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEKT3.1.1.m.37281,-0.00496909568008078,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60031,-0.0248306260385111,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60033,-0.00521046251025952,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEMPT.1.3.m.4934,0.00982469494911668,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEMPT.2.3.m.39578,0.0200263321491586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEMPT.3.3.m.40304,-0.0121055149504096,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEN2.1.2.m.44821,-0.00468512450781257,No,NA,NA,O61307,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_TENA.5.5.m.43448,0.0144247146039468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TENS3.2.4.m.45659,0.0138327274779378,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.3.4.m.52970,0.00164219032713566,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.4.4.m.60095,-0.00483560178793128,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENX.1.2.m.12929,-0.0118893790054013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TERA.1.1.m.29200,-0.000358041752090033,No,NA,NA,P23787,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_TEX10.2.3.m.28279,0.00770073356519034,No,NA,NA,Q803M3,NA,NA,NA,MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344],NA,NA,NA
CHOYP_TF2AA.1.1.m.50726,-0.0191265315153331,No,NA,NA,P52655,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_TFCP2.1.2.m.11029,-0.00136269261573935,No,NA,NA,Q12800,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TFG.1.1.m.8487,0.00272553105002635,No,NA,NA,Q92734,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_TFP11.1.1.m.65838,-0.00682183600888111,No,NA,NA,Q66J74,NA,NA,NA,spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_TGM1.1.2.m.5148,-0.00018877828876578,No,NA,NA,P52183,NA,NA,NA,plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_TGME49_066610.1.1.m.2678,0.0177519283652739,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_THERJR_2510.1.1.m.38407,0.0232561701507935,No,NA,NA,Q4R4Z9,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_THIKA.1.1.m.13333,-0.00632083080057791,No,NA,NA,P21775,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_THNS1.1.1.m.28661,0.000517686527859301,No,NA,NA,Q5R5P3,NA,NA,NA,,NA,NA,NA
CHOYP_THNS2.1.1.m.27131,0.00844379483213417,No,NA,NA,Q5RFE6,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_THOC1.1.1.m.62740,-0.00986390492412159,No,NA,NA,Q8R3N6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription; elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_THOC2.1.2.m.9631,-0.00450469334728523,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC2.2.2.m.19049,0.00325686769827285,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC5.1.1.m.12880,-0.0104267572968359,No,NA,NA,Q5ZJK1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC7.1.1.m.6771,-0.0039504478197342,No,NA,NA,Q6DGZ3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOP1.1.1.m.18269,-0.000558788510871573,No,NA,NA,Q8C1A5,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_THSD4.1.2.m.36522,0.0184702111761327,No,NA,NA,Q6ZMP0,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THSD4.2.2.m.57001,0.00217153616284992,No,NA,NA,Q3UTY6,NA,NA,NA,extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THTR.1.1.m.25923,0.00309516255438527,No,NA,NA,P25324,NA,NA,NA,mitochondrial matrix [GO:0005759]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029],NA,NA,NA
CHOYP_THTR.1.1.m.25924,-0.00938236914440712,No,NA,NA,Q95KV7,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein import into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593],NA,NA,NA
CHOYP_THUM1.1.1.m.47876,0,No,NA,NA,Q24K03,NA,NA,NA,RNA binding [GO:0003723]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_THUM3.1.1.m.17928,-0.000622457515573721,No,NA,NA,Q9BV44,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TIAP2.12.13.m.62840,0.0063074640088106,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_TIF1A.3.8.m.12841,0.0104600899731266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.4.8.m.23900,-0.00114435477456993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.5.8.m.32570,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIM8A.1.1.m.4787,0.00571133182743554,No,NA,NA,Q90YI5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321],NA,NA,NA
CHOYP_TIMP2B.1.1.m.29629,-0.00285685623447304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.4.9.m.28669,-0.0202403730697505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.5.9.m.39776,0.00344256262883708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.1.19.m.2116,0.00359657557293822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.19.19.m.66288,-0.00722807575581828,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.4.19.m.19569,0.000174237911852339,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_TITIN.6.19.m.31591,0.0282261746307939,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.8.19.m.35861,-0.00511348641682522,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TLE4.1.1.m.19069,0.00119586397914794,No,NA,NA,Q62441,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_TLN1.4.4.m.33719,0.00160472555021153,No,NA,NA,Q9Y490,NA,NA,NA,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],NA,NA,NA
CHOYP_TLN2.1.2.m.5591,-0.0114713427276482,No,NA,NA,Q9Y4G6,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_TLR1.1.3.m.1564,0.00710745089657649,No,NA,NA,Q9Y2C9,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_TM9S4.1.1.m.23520,-0.00434284363870325,No,NA,NA,Q8BH24,NA,NA,NA,early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],NA,NA,NA
CHOYP_TMC3.1.1.m.4078,0.00648302189274788,No,NA,NA,Q7TQ69,NA,NA,NA,integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381],NA,NA,NA
CHOYP_TMCO4.1.1.m.378,-0.0031880948312194,No,NA,NA,Q91WU4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMED7.1.3.m.6189,-0.00549921802855101,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMED7.2.3.m.28259,0.0157693558178077,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMEDA.1.2.m.42794,0.00303180716929999,No,NA,NA,Q9D1D4,NA,NA,NA,cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; protein complex oligomerization [GO:0051259]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; response to alkaloid [GO:0043279]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting; to; from or within Golgi [GO:0048199],NA,NA,NA
CHOYP_TMEDA.1.2.m.42795,0.000159352060957617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEM16.2.2.m.41752,-8.69987388429319e-05,No,NA,NA,A2AHL1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048],NA,NA,NA
CHOYP_TMEM2.1.4.m.6314,-0.00918307742709366,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.2.4.m.8174,-0.0234831010926972,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.3.4.m.10491,-0.0137140925850038,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.4.4.m.28440,-0.0062319282785135,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMM98.1.1.m.51750,-0.00977736358688822,No,NA,NA,Q6INX1,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMO_0856.1.3.m.5045,0.00854737032048781,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_TNNC.1.1.m.66691,0.00219983616697237,No,NA,NA,Q9BLG0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNC2.1.1.m.32533,0.0107098389029754,No,NA,NA,P02595,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNI.3.3.m.56962,0.00346092662121496,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_TNPO1.1.1.m.8874,-0.00134978579809191,No,NA,NA,Q92973,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus; translocation [GO:0000060]; regulation of mRNA stability [GO:0043488]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_TNPO3.1.1.m.11099,-0.000825784296386201,No,NA,NA,Q9Y5L0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; signaling receptor activity [GO:0038023]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_TNRC6A.1.2.m.16253,0.00454572780416563,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TNRC6A.2.2.m.59802,-0.0102893214832729,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TOL2_C08810.1.1.m.6377,-0.0126882603019497,No,NA,NA,C5BMZ8,NA,NA,NA,carboxyl-O-methyltransferase activity [GO:0010340]; malonyl-CoA methyltransferase activity [GO:0102130]; methyl indole-3-acetate esterase activity [GO:0080030]; biotin biosynthetic process [GO:0009102],NA,NA,NA
CHOYP_TOLIP.1.1.m.57590,0.00208446688614302,No,NA,NA,Q9H0E2,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1; type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TOLL.1.1.1.m.37581,-0.00582668279415575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TOM20.1.1.m.11207,-0.00161257543654583,No,NA,NA,Q6DFM9,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031],NA,NA,NA
CHOYP_TOMM70A.1.1.m.42370,0.000448316245451368,No,NA,NA,O94826,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_TONSL.1.1.m.18360,-0.0200936494873485,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TOP1.5.5.m.61515,0.00315621687632708,No,NA,NA,P11387,NA,NA,NA,DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032],NA,NA,NA
CHOYP_TOP2B.1.1.m.6674,-0.00457118130894894,No,NA,NA,Q64511,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; ribonucleoprotein complex binding [GO:0043021]; axonogenesis [GO:0007409]; cell aging [GO:0007569]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819],NA,NA,NA
CHOYP_TOP3B.1.1.m.1654,-0.0169826810370708,No,NA,NA,O95985,NA,NA,NA,condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265],NA,NA,NA
CHOYP_TPC2.1.2.m.19378,-0.0144099513946657,No,NA,NA,A0JMD4,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_TPM.15.19.m.50851,-0.0222990315567505,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.18.19.m.66023,-0.012900092314843,No,NA,NA,Q9GZ71,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.19.19.m.66623,0.0120053913892519,No,NA,NA,P43689,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.6.19.m.12415,0.00153798716065833,No,NA,NA,O02389,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.7.19.m.15554,-0.0218867466399911,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_TPM2.8.8.m.50799,0.0194653528733237,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPP2.1.1.m.24017,-0.00181589380913756,No,NA,NA,P29144,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_TPPC3.1.1.m.58563,0.00352347769521213,No,NA,NA,Q5ZI57,NA,NA,NA,cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_TPPC8.1.1.m.6302,0.00155091395962275,No,NA,NA,Q9Y2L5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_TPR.1.2.m.29645,0.00859770548424287,No,NA,NA,Q5EE04,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TPR.2.2.m.46877,-0.00118764999583673,No,NA,NA,F1MA98,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TR12A.1.2.m.32633,0.00886185859359345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRA2A.1.1.m.21305,-0.0168841466713369,No,NA,NA,P62997,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_TRAP1.1.1.m.60651,0.0015140514976485,No,NA,NA,Q5XHZ0,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386],NA,NA,NA
CHOYP_TRD7B.1.1.m.56981,-0.00928578095955957,No,NA,NA,Q5M7P8,NA,NA,NA,cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_TRI10.1.1.m.35702,0.00932326782466614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI45.13.23.m.35793,0.00608048649917141,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRI45.18.23.m.48495,0.00954055305543174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI46.2.3.m.61659,-0.0174414949880318,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_TRI56.4.4.m.61739,-0.00212582979333966,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIADDRAFT_19804.1.1.m.8993,0.0181570413416522,No,NA,NA,A6H603,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_TRIADDRAFT_21078.2.2.m.64279,-0.00631616886809316,No,NA,NA,Q89YT0,NA,NA,NA,deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_TRIADDRAFT_21752.1.1.m.62548,-0.0116380741950799,No,NA,NA,P91119,NA,NA,NA,3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3';5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],NA,NA,NA
CHOYP_TRIADDRAFT_23075.1.1.m.48886,-0.0129440512204892,No,NA,NA,Q9Z223,NA,NA,NA,cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_TRIADDRAFT_25769.1.1.m.25945,0.0160293122832055,No,NA,NA,Q5ZKX1,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_TRIADDRAFT_26208.1.1.m.10460,0.000884975620008698,No,NA,NA,P31029,NA,NA,NA,mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; signaling receptor binding [GO:0005102]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724],NA,NA,NA
CHOYP_TRIADDRAFT_26518.1.1.m.16475,-0.0162855976691932,No,NA,NA,P83088,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_TRIADDRAFT_26633.4.6.m.50465,0.0152104007058199,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_TRIADDRAFT_29967.1.1.m.56654,-0.00382093120875835,No,NA,NA,Q55G11,NA,NA,NA,extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],NA,NA,NA
CHOYP_TRIADDRAFT_29994.1.1.m.48948,-0.0231473574521151,No,NA,NA,P16273,NA,NA,NA,defense response [GO:0006952]; response to biotic stimulus [GO:0009607],NA,NA,NA
CHOYP_TRIADDRAFT_32712.2.4.m.28430,-0.0132100485881311,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.3.4.m.44104,0.0143453852264946,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.4.4.m.44519,0.0180164591352362,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_38448.1.1.m.27929,0.00343366025711582,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_50333.1.1.m.59774,-0.00410079088743276,No,NA,NA,Q8BHW2,NA,NA,NA,basal plasma membrane [GO:0009925],NA,NA,NA
CHOYP_TRIADDRAFT_51343.2.2.m.65118,0.00219010028384322,No,NA,NA,Q75JP5,NA,NA,NA,,NA,NA,NA
CHOYP_TRIADDRAFT_52608.1.2.m.25467,0.00528064067961683,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_TRIADDRAFT_53531.1.2.m.12127,-0.0105452678780197,No,NA,NA,P86734,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_TRIADDRAFT_53596.1.1.m.47642,-6.31677347278104e-05,No,NA,NA,Q9NTG1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982],NA,NA,NA
CHOYP_TRIADDRAFT_53677.1.1.m.35290,0.00598501079615141,No,NA,NA,Q8WWZ7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_TRIADDRAFT_55241.1.1.m.41679,0.00278929821404306,No,NA,NA,Q9TU34,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1;4;5 trisphosphate binding [GO:0070679]; inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209],NA,NA,NA
CHOYP_TRIADDRAFT_55525.1.1.m.53631,-0.00188266261786697,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_TRIADDRAFT_55768.1.2.m.4473,0.00910702627727873,No,NA,NA,Q8IZJ3,NA,NA,NA,extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654],NA,NA,NA
CHOYP_TRIADDRAFT_55768.2.2.m.14361,0.00201231525100503,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_TRIADDRAFT_57018.1.2.m.10706,-0.00698905146747467,No,NA,NA,Q05927,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166],NA,NA,NA
CHOYP_TRIADDRAFT_57086.1.1.m.25271,0.000272038532372471,No,NA,NA,Q6C0Y0,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_TRIADDRAFT_57945.3.3.m.55640,0.000201920839321389,No,NA,NA,Q55E58,NA,NA,NA,actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_TRIADDRAFT_60787.1.1.m.6621,-0.00649003809213708,No,NA,NA,Q32N22,NA,NA,NA,RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I preinitiation complex assembly [GO:0001188],NA,NA,NA
CHOYP_TRIADDRAFT_61434.1.1.m.8434,-0.00668740949013351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.1.2.m.5483,-0.00925423015594993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.2.2.m.56798,0.0222401339534804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_63204.1.2.m.30701,0.000721152496989065,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63204.2.2.m.38038,0.00286185712898149,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63666.3.3.m.57696,0.00184818643891985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64314.1.2.m.9124,-0.00572185385120186,No,NA,NA,Q93T20,NA,NA,NA,NAD(P)H dehydrogenase (quinone) activity [GO:0003955],NA,NA,NA
CHOYP_TRIADDRAFT_64314.2.2.m.54695,-0.000561826011100664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64367.1.1.m.42126,0,No,NA,NA,Q1JPJ2,NA,NA,NA,cytosol [GO:0005829]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815],NA,NA,NA
CHOYP_TRIB2.1.1.m.226,-0.014501911218686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.16.59.m.31979,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.42.59.m.43682,-0.0216148588020085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM33.1.1.m.36639,0.0132098003481055,No,NA,NA,Q9UPN9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],NA,NA,NA
CHOYP_TRIM5.1.2.m.60878,-0.0103424621594578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM56.2.2.m.59948,-0.014004720270039,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIO.1.1.m.49282,-0.00303123615888415,No,NA,NA,Q0KL02,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_TRIPC.1.1.m.6424,-0.00283178822219214,No,NA,NA,G5E870,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TRM13.1.1.m.16853,0.00755545681726559,No,NA,NA,Q8BYH3,NA,NA,NA,metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRM5.1.1.m.24347,-0.00750480415257818,No,NA,NA,Q3MHN8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939],NA,NA,NA
CHOYP_TRMT2A.1.1.m.17768,-0.00406882882623493,No,NA,NA,Q8IZ69,NA,NA,NA,RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_TRMT6.1.1.m.8062,0.00272037731504576,No,NA,NA,Q8CE96,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRNT1.1.1.m.1512,0.00770659351998152,No,NA,NA,Q8K1J6,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_TRPM3.1.7.m.9000,-0.000140107520516294,No,NA,NA,A8DYE2,NA,NA,NA,cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3;5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_TRPM3.3.7.m.16169,-0.00916686444761406,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRPM3.7.7.m.59826,0.0103312809305788,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRRAP.1.2.m.339,0.00820921797551132,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_TRXR2.1.1.m.10443,-0.0094342230116673,No,NA,NA,Q9JLT4,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],NA,NA,NA
CHOYP_TS101.4.4.m.57290,0.0144377922775284,No,NA,NA,Q61187,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; regulation of viral budding via host ESCRT complex [GO:1903772]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755],NA,NA,NA
CHOYP_TSC1.1.1.m.5136,-0.00743553044996161,No,NA,NA,Q9Z136,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chaperone complex [GO:0101031]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein heterooligomerization [GO:0051291]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of focal adhesion assembly [GO:0051893]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_TSIB_0893.1.1.m.10314,-0.0132800079037583,No,NA,NA,P0AGF9,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689],NA,NA,NA
CHOYP_TSN3.1.1.m.57074,0.00972531103928839,No,NA,NA,Q6NWG0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473],NA,NA,NA
CHOYP_TSP_00320.1.1.m.7280,-0.000318545521831134,No,NA,NA,Q2HJC9,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_TSP_03740.1.1.m.61194,0.00572329788323047,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_TSP_06726.1.1.m.7470,0.00772097560976512,No,NA,NA,Q3ZBG5,NA,NA,NA,axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_TSP_07884.1.1.m.41175,0.00732190222065828,No,NA,NA,Q96KE9,NA,NA,NA,cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_TSP_09282.1.1.m.18814,0.0234093813751344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10783.1.2.m.5651,0.00991455215671196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10831.1.1.m.47028,-0.0110319394380405,No,NA,NA,Q18206,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle; collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_TSP1.1.1.m.43967,0.0116834344258701,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_TSPAN18A.2.2.m.50689,-0.0122078269176227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSSC1.1.1.m.66470,0.0084463659790315,No,NA,NA,Q6DUZ9,NA,NA,NA,,NA,NA,NA
CHOYP_TT30A.1.1.m.28332,0.00137697327652323,No,NA,NA,Q6INU8,NA,NA,NA,axonemal microtubule [GO:0005879]; cilium [GO:0005929]; transporter activity [GO:0005215]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095],NA,NA,NA
CHOYP_TT39C.1.1.m.6317,-0.00785454000273625,No,NA,NA,Q8N584,NA,NA,NA,,NA,NA,NA
CHOYP_TTC1.1.2.m.53162,0.00061188473917722,No,NA,NA,Q3ZBR5,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_TTC12.1.1.m.14571,0.000277205277990714,No,NA,NA,Q9H892,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_TTC14.1.1.m.54084,0.00504493253132374,No,NA,NA,Q9CSP9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_TTC28.1.1.m.51607,0.00162842388545581,No,NA,NA,Q96AY4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_TTC38.1.1.m.27111,0.000955631199860681,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_TTC4.1.1.m.16365,-0.00137361114677898,No,NA,NA,O95801,NA,NA,NA,,NA,NA,NA
CHOYP_TTC8.1.1.m.35457,0.0172687548009568,No,NA,NA,Q8TAM2,NA,NA,NA,BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; sensory processing [GO:0050893],NA,NA,NA
CHOYP_TTHERM_00599920.1.1.m.38926,-0.0100621671815409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TTL11.1.1.m.51011,-0.00624929941592211,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_TTL12.1.1.m.6226,-0.00170348653574143,No,NA,NA,Q3UDE2,NA,NA,NA,ATP binding [GO:0005524]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_TTN.2.9.m.17508,0.00671869661288122,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TUT4.2.2.m.35505,-0.00596305829942268,No,NA,NA,Q5TAX3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition; RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_TVAG_008910.1.4.m.27225,0.00975907964891074,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_008910.2.4.m.37672,0.00698104720712835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_012450.7.8.m.63509,-0.00537189515771566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_020440.14.21.m.33137,0.00564199741799258,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_TVAG_087170.4.8.m.31291,-0.00055773215123076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087170.6.8.m.41156,0.00447523676371746,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.3.4.m.52917,-0.0145703638045333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.4.4.m.60594,3.89595390183811e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_098350.1.1.m.14015,-0.00304593071723157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_106580.1.1.m.44429,0.00820868697963966,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_TVAG_110290.2.8.m.6221,-0.00279758391121236,No,NA,NA,Q14980,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_TVAG_117920.1.1.m.65694,-0.00422326459340867,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_TVAG_127540.1.10.m.21803,0.00790430956308041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_166520.1.2.m.37665,0.000994258266268882,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_168130.1.2.m.10205,-0.00843865014764581,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_TVAG_193760.1.4.m.10065,0.000871550289791976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_199400.1.1.m.52426,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_216960.2.4.m.29368,0.00724180019959444,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_268110.1.13.m.574,-0.0115345005273639,No,NA,NA,Q96SN8,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664],NA,NA,NA
CHOYP_TVAG_268110.13.13.m.65590,0.0123961081991779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_283050.1.1.m.65542,0.000278462742943847,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_TVAG_286470.1.2.m.41541,-0.0196229715290681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_313830.1.4.m.32667,-0.00426787291814166,No,NA,NA,Q9VCA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_TVAG_355490.1.22.m.8202,-0.00420940321667531,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.12.22.m.45126,0.00800168037777229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.15.22.m.47579,-0.0118868728993255,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.16.22.m.50235,-0.00249964535049067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.19.22.m.56184,-0.00806629158337518,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.2.22.m.9582,0.00477636645688513,No,NA,NA,P49454,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription; DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TVAG_355490.3.22.m.9919,0.00562590655232593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.4.22.m.10865,-0.00285744553929527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.5.22.m.11608,0.00958643442667199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.6.22.m.13410,-0.00594968611763455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.1.3.m.7885,-0.00379991854447362,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.2.3.m.26257,-0.000333585386092577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.2.4.m.6401,-0.00567772186031848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.4.4.m.62673,0.0114453770581365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_410100.4.6.m.41037,-0.0236804108916419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_417100.1.2.m.19129,0.00852357336288009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_480920.2.3.m.38258,0.0160816504169544,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TWF1.1.1.m.62154,-8.35385884595088e-05,No,NA,NA,Q91YR1,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989],NA,NA,NA
CHOYP_TXND3.1.4.m.3505,-0.0217324915815713,No,NA,NA,Q95YJ5,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.4.4.m.64014,0.0186733338718623,No,NA,NA,P90666,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXNDC9.1.1.m.22863,-0.00457280606676132,No,NA,NA,O18883,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_TYRO.1.1.m.38876,0.00977775479722407,No,NA,NA,P86952,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.2.6.m.42960,-0.0238617478968634,No,NA,NA,H2A0L1,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.5.6.m.44175,-0.00656006272692715,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.6.6.m.44318,0.00869331226101686,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_U2AF2.1.1.m.30416,-0.00294901579327545,No,NA,NA,Q24562,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U520.1.1.m.7087,-0.00231639040770093,No,NA,NA,O75643,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388],NA,NA,NA
CHOYP_U5S1.1.1.m.49230,-0.00412291328051331,No,NA,NA,Q15029,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to cocaine [GO:0042220]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U728.1.1.m.63184,-0.00186889516841574,No,NA,NA,B6LS00,NA,NA,NA,,NA,NA,NA
CHOYP_UAFA.3.8.m.34702,0.0200642939420445,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UAFA.6.8.m.45002,-0.024481442789156,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UB2D2.1.1.m.56387,0.013499907814752,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UB2G2.1.1.m.7534,-0.00910044221540307,No,NA,NA,Q5RF84,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UB2R2.1.1.m.18979,-0.00367011135614541,No,NA,NA,Q8CFI2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cellular response to interferon-beta [GO:0035458]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA1.2.2.m.30036,-0.000627056698305158,No,NA,NA,Q5U300,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBA3.1.1.m.59856,-0.0074715899896606,No,NA,NA,Q8C878,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription; DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_UBA5.1.2.m.8624,-0.00245702210766928,No,NA,NA,A7MAZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_UBA6.3.4.m.53927,-0.00636746978079873,No,NA,NA,Q8C7R4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA6.4.4.m.63770,0.00801147642491026,No,NA,NA,A0AVT1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC12.1.1.m.51806,0.00103577207716516,No,NA,NA,Q6P8D9,NA,NA,NA,ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_UBC2.1.3.m.24138,-0.00174947805788125,No,NA,NA,P35129,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC9B.1.1.m.10688,0.00197872384784777,No,NA,NA,Q9DDJ0,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_UBCD1.1.2.m.50237,-0.00263778549125794,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBCD2.1.1.m.54558,-0.0123884773324559,No,NA,NA,P52485,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_UBCP1.1.1.m.7721,-0.0129549686382998,No,NA,NA,Q641F1,NA,NA,NA,nucleus [GO:0005634]; phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_UBD2A.1.1.m.63050,0.0109327085430856,No,NA,NA,Q6IP57,NA,NA,NA,,NA,NA,NA
CHOYP_UBE2A.1.1.m.48761,0.00347098828369606,No,NA,NA,Q9Z255,NA,NA,NA,chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411],NA,NA,NA
CHOYP_UBE2H.1.1.m.49863,0.0108428611258718,No,NA,NA,P62257,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2N.1.1.m.62056,-0.00123574865623342,No,NA,NA,Q5R7J6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; UBC13-MMS2 complex [GO:0031372]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; histone ubiquitination [GO:0016574]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone modification [GO:0031058]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; regulation of histone ubiquitination [GO:0033182]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2Z.1.1.m.61760,-0.00841915992712433,No,NA,NA,Q66KB0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE4A.2.2.m.59113,-0.00465909106718899,No,NA,NA,A5PKG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBE4B.1.1.m.11223,-0.00231780383451886,No,NA,NA,Q9ES00,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_UBL4A.2.2.m.18059,-0.00902536004392976,No,NA,NA,A4QND0,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; nucleus [GO:0005634]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],NA,NA,NA
CHOYP_UBL5.3.5.m.41673,0.0214069094698634,No,NA,NA,Q791B0,NA,NA,NA,cytoplasm [GO:0005737]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_UBP10.1.1.m.10603,-0.00209773960312856,No,NA,NA,Q6DIJ4,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP15.4.4.m.56615,0.00492789347020683,No,NA,NA,Q9R085,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP19.1.1.m.55642,-0.0100479004248268,No,NA,NA,O94966,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBP20.2.2.m.51412,-0.0149102206541839,No,NA,NA,Q9Y2K6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP24.1.1.m.54945,0.0127947061608691,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP25.1.1.m.61531,0.00263546593573535,No,NA,NA,P57080,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP32.1.1.m.56373,0.00883464856437745,No,NA,NA,Q8NFA0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP34.1.1.m.55124,-0.0138882281023738,No,NA,NA,Q70CQ2,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_UBP47.1.2.m.66121,-0.010116932876354,No,NA,NA,Q8BY87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP47.2.2.m.66754,-0.00212367829618806,No,NA,NA,A4II09,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_UBP48.1.1.m.25564,-0.00180988261579507,No,NA,NA,Q86UV5,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBQL4.1.1.m.37426,-0.00235318872131911,No,NA,NA,Q8R317,NA,NA,NA,aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBQL4.1.1.m.37429,-0.00838376002030998,No,NA,NA,Q6DEB4,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_UBR2.2.2.m.54412,-0.00411770356522206,No,NA,NA,Q6WKZ8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR3.1.1.m.43346,-0.000544962273130632,No,NA,NA,Q5U430,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR4.1.1.m.34997,0.00125317763194369,No,NA,NA,Q5T4S7,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_UBR5.1.1.m.44200,-0.00822639045906579,No,NA,NA,Q80TP3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus; translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_UBS3B.1.1.m.43636,0.00937015696029563,No,NA,NA,Q8TF42,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],NA,NA,NA
CHOYP_UBXN4.1.1.m.22642,0.00286908286069103,No,NA,NA,Q5R4I3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBXN7.1.1.m.64349,0.0102063185070338,No,NA,NA,Q5REY7,NA,NA,NA,nuclear body [GO:0016604]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_UCHL.1.1.m.29303,-0.000250964099404992,No,NA,NA,O01391,NA,NA,NA,cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCHL5.2.2.m.46419,-0.00250712535051552,No,NA,NA,Q9WUP7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCK2.1.1.m.6328,0.00188222136624489,No,NA,NA,B1H116,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CMP salvage [GO:0006238]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206],NA,NA,NA
CHOYP_UFC1.1.2.m.6917,0.000336546517217242,No,NA,NA,A7SM54,NA,NA,NA,UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592],NA,NA,NA
CHOYP_UFD1L.1.1.m.43606,-0.00553401625987923,No,NA,NA,Q92890,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport; ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UFL1.1.1.m.20000,0.00147073853947959,No,NA,NA,Q4R367,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; UFM1 transferase activity [GO:0071568]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UFSP2.1.1.m.36906,-0.00301274332260559,No,NA,NA,Q9NUQ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UGGG1.1.1.m.59266,-0.00114828660136456,No,NA,NA,Q9JLA3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; ER-associated misfolded protein catabolic process [GO:0071712]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_UGPA.1.1.m.49579,0.00272369697067012,No,NA,NA,Q07130,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_UHRF1.1.1.m.10935,-0.00297509600685656,No,NA,NA,B6CHA3,NA,NA,NA,euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UN45B.1.1.m.19072,0.00428105753145461,No,NA,NA,D7REX8,NA,NA,NA,cytosol [GO:0005829]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_UNC.89.1.2.m.1625,9.48426034053808e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC22.2.2.m.50516,0.000593419444249404,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_UNC89.1.19.m.7848,0.000554504388900083,No,NA,NA,A8T6P4,NA,NA,NA,cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_UNC89.15.19.m.55545,0.0044450361604188,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC89.16.19.m.57422,0.00446375001639855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_URIC.1.2.m.35940,0.012093546754296,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_URIC.2.2.m.54754,-0.00108609624442703,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_USH1C.1.1.m.30582,0.0195049907808495,No,NA,NA,Q9Y6N9,NA,NA,NA,apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_USO1.1.11.m.6354,0.00289672173111163,No,NA,NA,Q9Z1Z0,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_USO1.11.11.m.64787,0.00555873559974471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USO1.2.11.m.12785,0.00911150276930814,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USP2.1.1.m.44411,0.0138885089980039,No,NA,NA,H2A0M5,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_USP36.1.2.m.17402,-0.00523171428405066,No,NA,NA,B1AQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UT14A.1.1.m.44047,0.00644361136967763,No,NA,NA,Q3T0Q8,NA,NA,NA,nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UTP20.2.4.m.1508,0.00410426452918523,No,NA,NA,O75691,NA,NA,NA,90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome; small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; negative regulation of cell proliferation [GO:0008285]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UUR10_0415.1.1.m.64919,0.0149855849422723,No,NA,NA,B8I6E7,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_VA0D1.1.2.m.31117,-0.00194408970655859,No,NA,NA,Q9W4P5,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of Notch signaling pathway [GO:0008593]; terminal branching; open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_VAC14.1.1.m.31290,0.0129642820903009,No,NA,NA,Q66L58,NA,NA,NA,endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661],NA,NA,NA
CHOYP_VASP.1.1.m.15245,0.00589472545546129,No,NA,NA,Q2TA49,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_VATA.1.1.m.44460,-0.00110525290698816,No,NA,NA,P38606,NA,NA,NA,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_VATB.1.2.m.33785,0.00142049076630123,No,NA,NA,P31401,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034],NA,NA,NA
CHOYP_VATB.2.2.m.62084,-0.00829818171224937,No,NA,NA,Q8IYT3,NA,NA,NA,,NA,NA,NA
CHOYP_VATC1.1.1.m.38693,-0.0013127772315698,No,NA,NA,Q5XH14,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_VATD.2.2.m.64245,0.00966899459486296,No,NA,NA,Q5RCS8,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cilium assembly [GO:0060271]; ion transport [GO:0006811]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_VATE.1.1.m.21420,0.000130141481095212,No,NA,NA,P54611,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; liquid clearance; open tracheal system [GO:0035002]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_VATG.1.2.m.4407,-0.00206754505155146,No,NA,NA,Q25532,NA,NA,NA,apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_VAV2.1.3.m.40262,0.0157931216816368,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VAV2.3.3.m.62875,-0.00739328621207277,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VDE.1.1.m.30310,0.0162256035953756,No,NA,NA,Q40251,NA,NA,NA,chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422],NA,NA,NA
CHOYP_VIGLN.1.2.m.34766,-0.000630516445502309,No,NA,NA,Q00341,NA,NA,NA,cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_VIGLN.2.2.m.61191,-0.0101440898384274,No,NA,NA,Q61733,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_VIP2.1.1.m.54883,0,No,NA,NA,Q9VR59,NA,NA,NA,cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1;3;4;5;6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],NA,NA,NA
CHOYP_VIR.1.1.m.51105,-0.00221100638214366,No,NA,NA,A2AIV2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_VMA5A.1.1.m.24860,0.00615791575580032,No,NA,NA,O00534,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_VMP1.1.1.m.34831,0.00857195292638401,No,NA,NA,Q6INE8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],NA,NA,NA
CHOYP_VOLCADRAFT_121426.1.1.m.43175,0.00250990431360517,No,NA,NA,Q9Y6K8,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],NA,NA,NA
CHOYP_VOLCADRAFT_93060.1.2.m.3949,-0.00180784742431467,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VOLCADRAFT_93060.2.2.m.26741,-0.00544649549173845,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VP13D.2.3.m.58593,-0.00654835779277936,No,NA,NA,Q96GQ7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_VP33.1.2.m.1058,0.0038740274778994,No,NA,NA,Q16943,NA,NA,NA,cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202],NA,NA,NA
CHOYP_VP33A.1.1.m.58311,0.00290642870157762,No,NA,NA,Q63615,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein-containing complex binding [GO:0044877]; protein transport [GO:0015031]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPP1.2.2.m.13421,0.0143058155280267,No,NA,NA,Q8C2P3,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_VPRBP.1.1.m.15849,-0.0136809110887311,No,NA,NA,Q9Y4B6,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032],NA,NA,NA
CHOYP_VPS11.3.3.m.17579,-0.00826299812721025,No,NA,NA,Q9H270,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding; bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS18.1.1.m.38708,-0.00707138068050129,No,NA,NA,P59015,NA,NA,NA,endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS25.1.1.m.66093,-0.00469971110262297,No,NA,NA,Q6NWF4,NA,NA,NA,ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS35.1.1.m.55447,-8.19061803073156e-05,No,NA,NA,Q2HJG5,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer; cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_VPS36.1.1.m.27030,-0.018037036888544,No,NA,NA,A5PK00,NA,NA,NA,endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS45.1.1.m.8023,0.00345231907040087,No,NA,NA,P97390,NA,NA,NA,endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS4B.2.2.m.30053,0.00458272973306647,No,NA,NA,Q0VD48,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_VPS51.1.1.m.43266,-0.0121486750189058,No,NA,NA,Q155U0,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; regulation of phospholipase activity [GO:0010517]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS53.1.1.m.51625,0.00700889452525945,No,NA,NA,Q5ZLD7,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS8.1.1.m.51272,-0.00612511670278748,No,NA,NA,Q0P5W1,NA,NA,NA,CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_VRK1.1.1.m.10917,0.0212340381068663,No,NA,NA,Q32PI1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_VRP.2.4.m.18914,-0.00088187954537572,No,NA,NA,H2A0K6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_VTA1.1.1.m.36056,-0.000637846122129694,No,NA,NA,Q32L63,NA,NA,NA,endosome membrane [GO:0010008]; protein transport [GO:0015031],NA,NA,NA
CHOYP_VWA8.2.3.m.28001,-0.00329765115233037,No,NA,NA,B0R0T1,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_VWCE.1.3.m.5007,0.00470396551685552,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_VWDE.5.13.m.28163,-0.00489421016451958,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_VWDE.8.13.m.38775,-0.0028576617953572,No,NA,NA,O46581,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129],NA,NA,NA
CHOYP_WASP.1.1.m.35786,-0.00719078280297957,No,NA,NA,P42768,NA,NA,NA,actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of actin nucleation [GO:0051127]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WBP11.1.1.m.12849,0.000149965070323998,No,NA,NA,Q923D5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699]; mRNA cis splicing; via spliceosome [GO:0045292]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDHD1.1.1.m.23505,0.0110570595599135,No,NA,NA,O13046,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_WDR1.1.1.m.29076,-0.000969695229609492,No,NA,NA,Q9VU68,NA,NA,NA,actomyosin; actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_WDR11.2.2.m.58625,0.00582607615639076,No,NA,NA,Q9BZH6,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_WDR12.1.1.m.13380,-0.00806431816670057,No,NA,NA,B7PY76,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_WDR17.1.1.m.17546,0.0106175812120711,No,NA,NA,Q8IZU2,NA,NA,NA,,NA,NA,NA
CHOYP_WDR26.1.1.m.43030,0.0020715653259918,No,NA,NA,Q28D01,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_WDR31.2.2.m.65613,0.00833662345816558,No,NA,NA,Q9JHB4,NA,NA,NA,,NA,NA,NA
CHOYP_WDR37.1.1.m.57561,-0.00140521844838669,No,NA,NA,Q9Y2I8,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_WDR5.2.3.m.6293,0.00943334254851551,No,NA,NA,Q5M786,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_WDR52.1.1.m.21751,-0.00461845415685071,No,NA,NA,Q96MT7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_WDR59.4.5.m.55404,0.00504900715298552,No,NA,NA,Q5ZLG9,NA,NA,NA,GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008],NA,NA,NA
CHOYP_WDR61.1.2.m.7565,-0.00437776541572503,No,NA,NA,Q6P5M2,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_WDR63.1.1.m.21743,-0.00905524971405186,No,NA,NA,Q8IWG1,NA,NA,NA,dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_WDR70.1.1.m.7199,0.0112498223546664,No,NA,NA,Q0VA16,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173],NA,NA,NA
CHOYP_WDR74.1.1.m.19017,-0.0241989345030888,No,NA,NA,Q6RFH5,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR75.1.1.m.9234,-0.00801076493941775,No,NA,NA,Q6DFC6,NA,NA,NA,nucleolus [GO:0005730]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR89.1.1.m.30861,0.00404982386031559,No,NA,NA,Q5RBZ3,NA,NA,NA,,NA,NA,NA
CHOYP_WDR92.1.1.m.12560,0.00214146732933728,No,NA,NA,Q29RZ9,NA,NA,NA,ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_WFIKKN1.1.1.m.28942,0.000160098400999256,No,NA,NA,P84875,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_WHITE.1.1.m.38819,-0.00985806897638902,No,NA,NA,P10090,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; 3';5'-cyclic GMP transmembrane-transporting ATPase activity [GO:1905948]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; eye pigment precursor transporter activity [GO:0005395]; guanine-transporting ATPase activity [GO:0008558]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_WHSC1.1.1.m.15308,0.00473374851379167,No,NA,NA,O88491,NA,NA,NA,chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; gastrulation with mouth forming second [GO:0001702]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_WIBG.1.1.m.11521,0.0127790411969426,No,NA,NA,Q640E9,NA,NA,NA,cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_WIPI2.1.2.m.9192,0.0027627715179327,No,NA,NA,Q5ZHN3,NA,NA,NA,autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_WIPI3.1.1.m.13956,-0.00148530297153485,No,NA,NA,Q5ZL16,NA,NA,NA,cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_WKK_06610.2.2.m.50131,0.00686187676634133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_WN10A.1.1.m.28564,0.00840343908580527,No,NA,NA,Q98SN7,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WNK2.1.2.m.38552,-0.0107902455629222,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WNT7B.1.2.m.36042,0.01563703156823,No,NA,NA,Q3L254,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WRI_006090.1.1.m.34650,0,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_XCASPASE.7.1.4.m.26576,-0.000122561894848414,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XDH.1.3.m.46824,-0.0110361848161928,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.2.3.m.53113,-0.00264283579260986,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.3.3.m.55146,0.00385768038161318,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XFIN.1.4.m.606,0.0035305439822356,No,NA,NA,Q99KE8,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_XIAP.1.7.m.6021,-0.024190899235646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XPF.1.1.m.14801,0.0145767794928583,No,NA,NA,Q6GQN4,NA,NA,NA,nucleolus [GO:0005730]; apoptotic process [GO:0006915]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_XPO1.1.1.m.31560,-0.00210595014299514,No,NA,NA,Q80U96,NA,NA,NA,annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_XPO2.1.1.m.50289,0.00105184797218854,No,NA,NA,Q8AY73,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_XPO5.1.1.m.14207,-0.000614734058825115,No,NA,NA,Q9HAV4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825],NA,NA,NA
CHOYP_XPO6.1.1.m.15288,-0.0104223691296928,No,NA,NA,Q96QU8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPO7.1.1.m.50167,-0.00800064648352795,No,NA,NA,Q5ZLT0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPP1.1.2.m.16748,-0.00131552775452614,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XPP1.2.2.m.38696,-0.0124107850249558,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_Y003.1.1.m.31014,0.0132100047852785,No,NA,NA,Q6R7B4,NA,NA,NA,,NA,NA,NA
CHOYP_Y022.1.1.m.30669,-0.00022964224942376,No,NA,NA,Q6R7K1,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0417.2.2.m.29395,-0.00451921158749395,No,NA,NA,F1LNI5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_Y045.1.1.m.43767,0.00834273943050009,No,NA,NA,Q502K3,NA,NA,NA,,NA,NA,NA
CHOYP_Y054.1.1.m.9666,0.0116708204225961,No,NA,NA,Q6R7G0,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y061.1.1.m.29896,0.0148049849740979,No,NA,NA,Q6R7G4,NA,NA,NA,,NA,NA,NA
CHOYP_Y071.1.1.m.29248,0.0105579189052898,No,NA,NA,Q6R7F6,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y077.1.1.m.27629,0.00535040636510124,No,NA,NA,Q6R7F2,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0777.3.3.m.60141,-0.0069982997761257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_Y1004.1.1.m.18927,0.00283475057366884,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_Y118.1.1.m.30002,-0.0107241179540217,No,NA,NA,Q6R796,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_Y7557.3.3.m.42713,0.00640328276438778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YAHB.1.1.m.25422,0.00531723795701073,No,NA,NA,P42297,NA,NA,NA,,NA,NA,NA
CHOYP_YAP.1.2.m.23386,0.00312043460867409,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YAP.2.2.m.62060,-0.00405685749062,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YBOXH.2.4.m.3352,-0.00441721887098036,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_YDJC.1.1.m.4244,-0.000818233476243086,No,NA,NA,A2BIR6,NA,NA,NA,hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_YETS2.1.1.m.302,0.00509546296796169,No,NA,NA,Q9ULM3,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_YG31B.1.3.m.6174,-0.00914477163525767,No,NA,NA,Q7LHG5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_YG31B.2.3.m.9011,0.000140952410460383,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL086.1.1.m.33481,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL58.1.1.m.35411,-0.0090826753779833,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_YL8A.1.1.m.29604,-0.00108634008168348,No,NA,NA,Q9UTA8,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular detoxification [GO:1990748],NA,NA,NA
CHOYP_YLPM1.1.2.m.17086,0.00148368756276282,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_YMS5.1.1.m.5494,-0.0112560524231937,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_YNY5.2.4.m.50761,-0.00275772595274612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YQK4.2.2.m.31850,0.000894587921046551,No,NA,NA,Q09288,NA,NA,NA,defense response to Gram-negative bacterium [GO:0050829]; regulation of antimicrobial humoral response [GO:0002759]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_YS11.1.1.m.30657,0.0109584925715637,No,NA,NA,Q9W0Y2,NA,NA,NA,gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity; transferring acyl groups [GO:0016746]; cellular modified amino acid catabolic process [GO:0042219],NA,NA,NA
CHOYP_YTDC1.1.2.m.56405,-0.00374792371812323,No,NA,NA,Q9H2Y7,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286],NA,NA,NA
CHOYP_ZADH2.1.3.m.13137,0.00254517937893068,No,NA,NA,Q8BGC4,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599],NA,NA,NA
CHOYP_ZBTB5.4.4.m.42642,-0.00494071842406719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZC11A.1.1.m.60722,-0.000132168553826283,No,NA,NA,Q6NZF1,NA,NA,NA,cell [GO:0005623]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973],NA,NA,NA
CHOYP_ZC3H18.1.1.m.8085,0.0059151611784087,No,NA,NA,Q86VM9,NA,NA,NA,nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3H4.1.1.m.57516,0,No,NA,NA,P61129,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_ZC3HA.1.1.m.27569,0,No,NA,NA,Q8R205,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ZC3HDC1L.1.1.m.44413,-0.0203617940268557,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3HF.1.1.m.39867,-0.000672203507760172,No,NA,NA,Q8WU90,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ZCCHC8.1.1.m.18098,-0.0172090055059851,No,NA,NA,Q5F3D1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ZDHHC17.1.1.m.29726,0,No,NA,NA,Q8IUH5,NA,NA,NA,aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],NA,NA,NA
CHOYP_ZEB2.1.1.m.29733,-0.00629169392422749,No,NA,NA,Q9UDV7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.3.10.m.29555,0.00716748467813498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.5.10.m.34434,0.0023530014049789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_U1LIKE_.10.1.1.m.18971,-0.0116555762442925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZFP37.1.4.m.10878,-0.00691163986186489,No,NA,NA,Q6GQR8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFP37.3.4.m.48467,0.0095907775415772,No,NA,NA,A2T812,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFR.1.1.m.57469,-0.00456067830619773,No,NA,NA,Q96KR1,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ZFY27.1.1.m.31417,0.00873517137525841,No,NA,NA,Q6P7B7,NA,NA,NA,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ZGC_113208.1.1.m.15618,0.0176832262336325,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZGC_113625.1.2.m.2855,-0.00934483346273956,No,NA,NA,Q8NHV1,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039],NA,NA,NA
CHOYP_ZGC_136858.1.1.m.51274,-0.0012234893098698,No,NA,NA,Q9USY1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]; pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213],NA,NA,NA
CHOYP_ZGC_171566.1.1.m.22181,-0.0195051112540142,No,NA,NA,Q9Z0L8,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],NA,NA,NA
CHOYP_ZGC_73273.1.1.m.18633,-0.0002064696654626,No,NA,NA,Q9QY93,NA,NA,NA,cytosol [GO:0005829]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_ZGC_92203.1.1.m.55468,-2.4104177582069e-05,No,NA,NA,Q9HCU5,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_ZIP.1.1.m.15785,0.0200899860101372,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ZMY11.1.1.m.3621,0.00243527632491463,No,NA,NA,Q8R5C8,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243],NA,NA,NA
CHOYP_ZN207.1.1.m.6909,-0.00512093541471106,No,NA,NA,Q7ZXV8,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; nucleic acid binding [GO:0003676]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],NA,NA,NA
CHOYP_ZN330.1.2.m.7843,-0.00016256372869874,No,NA,NA,Q9VAU9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_ZN521.2.3.m.13584,9.97704362748229e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZN568.1.1.m.61611,0.00686960145473113,No,NA,NA,P08043,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZN609.1.1.m.44387,0.00492041261011408,No,NA,NA,O15014,NA,NA,NA,integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ZN622.1.1.m.2103,-0.00149162064686836,No,NA,NA,Q91VY9,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_ZN706.1.2.m.11926,0.00457088860128186,No,NA,NA,Q5ZMM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_ZN729.1.1.m.13702,0.00812471626496484,No,NA,NA,P52740,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF184.1.1.m.59420,-0.00377485899811373,No,NA,NA,Q76KX8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF259.1.1.m.10424,0.00211193254631094,No,NA,NA,Q62384,NA,NA,NA,axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; SMN complex [GO:0032797]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834],NA,NA,NA
CHOYP_ZNF382.1.1.m.21527,-0.0162540248347067,No,NA,NA,Q5T5D7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF43.1.1.m.6773,0.00860802404282441,No,NA,NA,A8MTY0,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF510.1.1.m.10853,0.00521817459891338,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZNF624.1.1.m.45743,0.00152509372323288,No,NA,NA,Q6ZNA1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF85.1.1.m.65738,-0.010746439693937,No,NA,NA,Q8BIQ3,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZNRD1.1.2.m.7107,-0.0232740468035075,No,NA,NA,Q6MFY5,NA,NA,NA,RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363],NA,NA,NA
CHOYP_ZW10.1.1.m.35287,0.000200803914590181,No,NA,NA,O54692,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096],NA,NA,NA
CHOYP_ZYRO0F11880G.1.1.m.7082,-0.00522001274384922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
